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Abstract 
 
Patients who develop kidney failure require renal replacement therapy (RRT) in order to 
survive. Renal transplantation is the best treatment but is often not forthcoming. Many 
patients therefore require haemodialysis treatment, for which a means of vascular access 
(VA) is necessary. There are substantial morbidity, mortality and cost benefits from using 
arteriovenous fistulae (AVF) rather than central venous catheters (CVC) for this purpose.  
Despite audit standards recommending that most patients should dialyse using AVF there has 
been longstanding, marked variation between centres in Scotland and further afield as to the 
proportions of patients who dialyse using each VA modality. Many studies have documented 
this variation and its clinical consequences, but little progress has been achieved over more 
than a decade of registry-documented practice. The present study aims to understand this 
variation using systems approaches to delineate the structure of VA clinical pathways in 
Scotland and the manner in which they function; to quantify the clinical workload associated 
with VA services; to illuminate gaps between ‘work-as-imagined’ and ‘work-as-done’ from 
the perspectives of those working in the services; and to present the findings in a manner that 
facilitates quality improvement activities.  
The study characterises VA as a complex socio-technical system, with reference to the patient 
safety, quality improvement and systems theory literatures. A novel approach to investigating 
complex clinical systems was developed, in keeping with the principles of Safety II and 
healthcare resilience engineering. A mixed-methods approach was used to investigate every 
Scottish VA service, including detailed semi-structured interviews, a clinical activity census, 
and linkage with pre-existing registry data.  
An in-depth, thematic analysis of audio-transcripts was considered in light of clinical activity 
and registry data. The results were distilled into four major themes: VA creation, VA 
maintenance, service performance, and development needs. A substantial associated clinical 
workload was quantified for the first time, despite a shortage of clinical resources dedicated 
to the service. VA creation procedures were proportional to the size of the local RRT cohort, 
but maintenance activities did not reflect the local cohort size and varied widely between 
centres. Recommendations for practice were disseminated using a novel ‘scorecard’ tool, 
designed with the principles of resilience engineering in mind. Centres were encouraged to 
report their concordance with recommendations; the resulting data suggested a statistical 
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relationship between published incident and prevalent AVF use, and the degree to which the 
recommendations were implemented by each centre. 
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Chapter 1: Introduction 
 
Patients with end-stage renal failure (ESRF) are reliant upon renal replacement therapy 
(RRT) for survival. While renal transplantation remains the gold standard of care1, for many 
patients this is not immediately forthcoming or a realistic possibility2. For this cohort 
alternative means of RRT, namely haemodialysis or peritoneal dialysis, are required to 
sustain life. 
A means of Vascular Access (VA) is required to provide haemodialysis treatment, with the 
main options in modern times comprising an arteriovenous fistula (AVF), an arteriovenous 
graft (AVG), or a central venous catheter (CVC)3,4. CVCs may be non-tunnelled (NTCVC) or 
tunnelled (TCVC) with the former typically providing temporary VA on an emergency basis, 
while the latter can provide longer-term bloodstream access5. Each VA modality has its 
relative advantages and disadvantages. There is a clear survival benefit for patients who 
dialyse with an AVF or AVG in comparison with those who dialyse using a TCVC6,7. Despite 
this, widespread variation has been described over many years in relation to the provision of 
VA in renal units across Scotland8, the United Kingdom9, Europe10 and further afield11,12. 
While audit standards in the United Kingdom recommend that 60% of incident patients, and 
80% of prevalent patients, should dialyse using an AVF or AVG3, most centres regularly fall 
short of this target and instead provide haemodialysis to a high proportion of their patients 
using TCVC8,9.  
This thesis seeks to explore this variation in detail by taking a systems approach to how VA 
care is delivered in Scotland, with the aim of delineating the structure, function and workload 
of VA care. The findings from this work will inform the development of recommendations 
for practice, which will be presented in a format that prompts and facilitates quality 
improvement (QI) in this area. In this introductory chapter, the context for the study will be 
delineated. There are two distinct parts to the introduction: the first, chapter 1A describes the 
clinical condition of ESRF. The various options for treatment are discussed, along with the 
variable timings in which they may become available or become necessary. The relative 
merits of RRT and VA modalities are explored with reference to the available literature 
concerning their longevity, clinical efficacy and associated complications. It will become 
apparent to the reader that many aspects of treating renal failure have significant associated 
uncertainty which vary depending upon the individual patient. These include the timing of 
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ESRF, the merits of active versus conservative treatment, the likelihood of receiving a renal 
transplant, and the burdens associated with haemodialysis or peritoneal treatment. 
The second part of this introduction, chapter 1B, frames this clinical problem and its 
associated challenges, in the context of the sociotechnical systems literature. In this section 
the sociotechnical systems literature, as it relates to healthcare, is described and reviewed. 
The reader is introduced to ‘systems thinking’, the differentiation between complicated and 
complex systems, and emerging work concerned with ‘resilience engineering’ in healthcare. 
Published works relevant to patient safety and healthcare quality improvement, along with 
models of investigating and modifying complex systems are also discussed. 
Together, these introductory sections set the scene for an exploration of VA care across 
Scotland. This thesis will describe VA care through the lens of systems theory, making use of 
the concepts introduced in chapter 1B. This approach is used for the first time to illuminate 
and understand the configuration and workings of VA services, and enables the design and 
implementation of strategies to improve patient care. 
Chapter 2 is concerned with methodology, both theoretical and practical. The reader is 
introduced to a novel approach to exploring complex clinical systems. The rationale for 
developing a new approach and its underpinning literature base are described here. The 
chapter emphasises the simplicity of this approach and its ability to inexpensively capture the 
relevant detail in a manner that facilitates the design and implementation of improvements to 
the system and its function. The chapter then describes the use of this model in the current 
study, to explore and broaden understanding of VA services across Scotland. A detailed 
description is provided as to the conduct of the study. Chapter 2 concludes by considering 
how one may assess the quality of qualitative research and goes on to describe a sub-study to 
quality assure the current work. The results and analysis provide assurance to the reader as to 
the validity of the following results chapters.  
Chapters 3 – 10 describe the study results. In chapter 3 the reader gains an understanding of 
the clinical pathways used to create VA, while chapter 4 concerns the influence of clinicians' 
opinions about the various VA modalities on VA creation practice. Chapter 5 considers the 
clinical pathways used to maintain VA and chapter 6 discusses variations in surveillance 
practice between centres. Chapter 7 contextualises the preceding chapters by demonstrating 
the volume of clinical work associated with the provision of VA services. This data sets the 
scene for chapters 8 and 9, which respectively consider the reported influences on VA 
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services' operational performance and their development needs. Chapter 10 considers the 
recommendations for practice arising from the study, alongside the VA ‘scorecards’, a novel 
tool developed during the study to present the findings to the clinical community. 
Chapter 11 discusses the findings from this work and likely implications for further study. It 
also relates the work to the sociotechnical systems literature described in the introduction. 
Chapter 12 draws conclusions on the study and considers the capacity to use this model to 
investigate other complex areas of clinical practice, and suggested further work.  
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Chapter 1A: Renal failure and renal replacement therapy 
 
The major roles of the kidneys are to excrete waste products and to manage fluid balance, 
with additional important functions including the activation of vitamin D, the stimulation of 
haematopoiesis and blood pressure modulation. A wide range of medical problems can result 
in renal failure13, and once ESRF is present the patient requires treatment with renal 
replacement therapy if they are to survive for the long term.  
The four main treatment options consist of renal transplantation, dialysis treatment in the 
form of haemodialysis or peritoneal dialysis, or conservative management. While 
transplantation and dialysis therapies address the primary functions of the kidneys in terms of 
waste product excretion and fluid balance, conservative management has a less invasive 
approach and seeks to provide high quality palliative care14. 
ESRF can arise over a variable time course, with variable disease trajectory15,16 and symptom 
burden17 as renal excretory failure progresses. Some patients first present to a renal physician 
many years before their kidneys fail, while others present late in the course of their illness, in 
some cases at the point of ESRF18,19. All therapeutic choices are intended, ultimately, to 
optimise the patient’s longevity and quality of life without causing undue suffering14. In most 
cases several treatment options are feasible for a particular patient but for medical, technical 
and logistical reasons some are more easily achieved than others. It is therefore common for 
patients to commence one form of RRT13, with a longer term plan to transfer to a preferred 
form when possible. 
Each treatment option brings with it a degree of complexity in terms of the demands it places 
upon the patient, the prerequisite procedures needed to facilitate treatment, and the resulting 
morbidity and mortality burden borne by the patient – which in turn may influence the 
potential viability or success of the preferred, alternative form of RRT. These are discussed 
below. 
 
Renal transplantation 
 
Renal transplantation is widely regarded as the gold standard RRT modality1. It conveys 
substantial benefit to patients in the form of increased life expectancy, improved quality of 
life and the ability to resume normal social and occupational function1,13. No other form of 
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RRT can provide equivalent morbidity or mortality benefit to transplantation1,20. Its utility is 
constrained by organ availability21 and the need for patients to be technically and medically 
suitable to receive the transplant and survive the perioperative period1.  
Patients may receive renal transplants from living or cadaveric donors. Specific legislation 
governs the use of organs donated by living donors in the United Kingdom: The Human 
Tissue (Scotland) Act 200622 and The Human Tissue Act 200423 (England, Wales, Northern 
Ireland). Live donors are mostly genetic or social relatives of the patient with kidney failure, 
and a small number are donated altruistically by members of the public21. Living donor 
transplantation is usually directed towards a specific patient, whereas cadaveric organs are 
made available on a national basis and allocated to patients on a transplant waiting list that is 
coordinated centrally using a published algorithm24. 
Kidney transplantation can fail due to technical problems arising during the surgical 
operation, but these are uncommon and transplant failure is more commonly caused by 
immune-mediated rejection25. The risk of rejection is minimised in two ways: matching the 
donor and recipient blood group and human leucocyte antigen (HLA) types as closely as 
possible; and using immunosuppressant medications to reduce the immune response to the 
implanted organ. These measures have proven highly successful in extending the longevity of 
transplanted organs25 but they also serve to limit the available pool of organs for individual 
patients, since only donors with the appropriate blood group and HLA type can ordinarily be 
matched. Techniques exist to limit this problem, including the paired pool matching scheme 
and blood group incompatible transplantation26, but these bring social and medical 
complications that many patients find unattractive. Even those receiving “perfectly” matched 
organs require immunosuppressive therapy, usually for the duration of the transplanted 
kidney’s lifespan. These drugs are recognised to cause various adverse effects including life-
threatening infections, malignancy, and sometimes reduced function of the transplanted 
organ13. 
Potential transplant recipients must undergo a series of assessments before being able to 
receive an organ. The perioperative morbidity burden around kidney transplantation is such 
that patients’ personal mortality risk becomes substantially higher in the first three months 
following transplantation than it would have been with alternative RRT1; only thereafter do 
the significant morbidity and mortality advantages emerge. Patients must therefore be able to 
withstand this perioperative risk if the procedure is to be beneficial.  
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Considerable time delays are common in transplant pathways. Potential living donors require 
extensive assessment before donation can proceed26, in a process that may take over a year to 
conclude. The waiting time to receive a cadaveric kidney in the United Kingdom can exceed 
thirty months, or significantly longer for those with unusual HLA types21. 
It is clear that kidney transplantation is commonly not available in the short or medium term, 
and for others it is unfeasible. In this context, most patients will require at least a short period 
of dialysis treatment: as a bridge to transplantation, or for the longer term. 
 
Haemodialysis 
 
Haemodialysis is the most common form of RRT in the non-transplanted ESRF population in 
Scotland8. This technique involves the passage of blood through an extra-corporeal circuit 
that includes an artificial dialyser. Waste products are removed using the processes of 
convection and diffusion, while excess fluid is removed by the process of ultrafiltration. 
Haemodialysis can be delivered in patients’ homes (‘home haemodialysis’) or in hospital 
(‘outpatient haemodialysis’) in a renal dialysis unit (RDU); the latter is substantially more 
common8,27. While the required duration of haemodialysis treatment can be calculated for 
individual patients, for practical purposes most patients’ haemodialysis prescription is for 
four hours of haemodialysis treatment, three times per week27. Patients treated with home 
haemodialysis often dialyse more frequently28; this conveys survival advantage29. 
VA is required for haemodialysis, and each means of VA for haemodialysis has an associated 
package of risks; these are discussed in the following sections. 
 
Central venous catheters 
 
NTCVC are typically utilised in the setting of emergent haemodialysis, whereas TCVC are 
preferred in the context of elective or semi-elective haemodialysis3,5. While NTCVC are 
typically inserted in a ward-based setting by middle grade nephrologists or equivalents30, 
TCVC are more commonly inserted by interventional radiologists under radiological 
screening, although practice varies considerably across the United Kingdom and 
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elsewhere30,31. Either form of CVC insertion can typically be achieved within 30 minutes, 
requires minimal preparation, and the CVC is available for use immediately after insertion32.  
Connection of a CVC to a haemodialysis machine requires minimal training. No needles, 
injections or other direct physical patient contact is required; similarly, when the 
haemodialysis treatment finishes patients can be ‘disconnected’ with minimal effort. Despite 
the relative logistical ease of CVC insertion and subsequent use, they come with a 
significantly increased burden of morbidity and mortality33,34 in comparison with other VA 
modalities, including particular problems with bloodstream infection and central venous 
stenosis35.  
Bloodstream infection is strongly associated with CVCs, particularly infections caused by 
Methicillin Sensitive Staphylococcus aureus (MSSA) or Methicillin Resistant Staphylococcus 
aureus (MRSA)34,36. These are often collectively termed Staphylococcus aureus bacteraemia 
(SAB) episodes. These infections are most prevalent in the three months following CVC 
insertion but can arise at any time a CVC is in-situ35. Significant efforts to reduce CVC-
associated infections have been reported37. MSSA and MRSA infections cause significant 
complications for patients, and financial costs for providers38. Patients typically develop a 
systemic inflammatory response requiring antibiotic treatment and, frequently, 
hospitalisation36,38. Metastatic infection deposits can cause endocarditis, discitis, or prosthetic 
device infection including orthopaedic implants or cardiac pacemakers38. The CVC usually 
requires removal (and replacement) to successfully treat the infection32; the associated 
mortality can be up to 28%38. All-cause hospitalisation approximately doubles for a given 
patient in the six months following an infective episode, in comparison with the prior six 
months38.  
The financial cost to provider organisations of CVC-associated SAB episodes can be over 
£8500 per patient38. SAB prevalence has reduced in recent years, in part because of 
government initiatives39. Various successful strategies have been reported including the use 
of citrate line locks; chlorhexidine impregnated dressings or adjuncts, and regular inspection 
and replacement of CVC dressings32,40 (although some doubt remains as to the efficacy of 
frequent dressing changes41). It remains difficult to entirely eradicate CVC-associated 
infections; registry data suggest an incidence of approximately 0.5 bacteraemia episodes per 
1000 haemodialysis-exposed days13. 
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While infective episodes are often acute, dramatic events with a clear temporal association 
with an in-situ CVC, central venous stenosis presents with a more indolent course. It is seen 
to develop in approximately 1 in 5 patients42, and reflects overall CVC use throughout a 
haemodialysis ‘career’ rather than arising from one particular CVC episode43,44. As a late 
complication, central venous stenosis within a patient cohort may reflect historical CVC use 
rather than current practice. It has also been reported in patients with no prior documented 
central venous catheter use44. As with infective episodes, central stenosis carries a high 
morbidity and mortality burden for patients, and substantial financial cost for provider 
organisations42. Subsequent CVC placement becomes increasingly difficult45 and AVF or 
AVG become less likely to function because of limited blood flow42. This can potentially 
render VA impossible to achieve; if alternative RRT (peritoneal dialysis or transplantation) is 
unavailable death will likely result within two weeks46. Established central venous stenosis 
requires periodic angioplasty procedures, usually performed by an interventional radiologist. 
This can cost up to £23,000 per patient per annum (personal communication). 
Notwithstanding these major complications, CVC may also fail for various practical 
reasons32. They may be inadvertently placed in inappropriate vessels; their position may 
migrate after insertion; or intra-luminal thrombus may form, limiting blood flow and 
effectively preventing CVC utilisation45. While these are anecdotally noted as ‘common’ 
complications of CVC use it is unusual for their occurrence to be formally, systematically 
recorded or otherwise measured47. 
Given the significant morbidity and mortality risks associated with TCVC use for 
haemodialysis, some authors consider their use to be ethically and potentially legally 
unacceptable for most patients48. 
 
Ateriovenous fistulae 
 
AVF are created by a surgical procedure and require up to 6 weeks maturation before they 
can support haemodialysis32. The procedure requires an artery and vein of sufficient calibre, 
along with patent proximal vessels and adequate cardiac function to supply blood to the 
resulting AVF and prevent its collapse49. AVF creation can be technically challenging in the 
setting of vascular disease (including central venous stenosis), repeated venepuncture, or with 
previous failed AVF or AVG more proximally in the same limb; various other factors have 
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also been reported50,51. Unintended complications of AVF creation include the development 
of distal limb ischaemia or neuropathy, high output cardiac failure, or aneurysmal AVF 
transformation52. 
The success of AVF creation surgery can be expressed according to ‘primary patency’ (the 
proportion of AVF that successfully mature) and ‘secondary patency’ (the longevity of 
matured AVF beyond the initial maturation period), although the definitions used in the 
literature vary considerably. Reports in the literature suggest primary patency sits between 
56-84% dependent upon the AVF’s anatomical location32,53, but in NHS practice neither 
primary nor secondary patency data is routinely reported by centres performing AVF creation 
surgery. 
AVF cannulation for haemodialysis requires a degree of technical skill and experience and is 
usually performed by a nurse whose primary role is the delivery of haemodialysis treatment54. 
The main approaches to cannulation are ‘rope ladder’ and ‘buttonhole’; these involve using 
needles to access the bloodstream3,55. ‘Rope ladder’ involves AVF cannulation at different 
locations for each haemodialysis session, using a sharp needle3. Moderate technical skill is 
required, the major consideration being to avoid cannulating the same area used in the 
preceding session. ‘Buttonhole’ cannulation prolongs AVF longevity by generating a tract 
from the skin to bloodstream using sharp needles inserted at the same place, using the same 
angle, over several haemodialysis sessions3; the tract can subsequently be cannulated with 
blunt needles by removing the superficial scab. Tract creation requires dexterity and technical 
skill; secondary patency is improved although the bloodstream infection risk slightly 
increases compared with rope ladder, but remains substantially below the equivalent risk for 
CVCs32,34. The third AVF cannulation strategy, known as ‘area puncture’, is associated with 
higher rates of access failure than rope ladder and buttonhole, and may also carry a higher 
risk of infection3,56. 
AVF failure is often mediated by the development of a proximal stenosis that ultimately 
results in AVF thrombosis or collapse. Early signs of stenosis include difficulty with 
cannulating, reduced haemodialysis blood flow and reduced haemodialysis efficiency 
(measured using urea reduction ratios)51. Suspected stenosis can be confirmed on a 
fistulogram imaging study and corrected with a fistuloplasty procedure. The optimal timing 
of this procedure is controversial57. 
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Arteriovenous grafts 
 
AVG represent an alternative approach when patients’ poor vasculature renders AVF creation 
impossible32. These prosthetic devices connect an artery and vein using a loop of prosthetic 
material that can be repeatedly cannulated for haemodialysis. The morbidity and mortality 
profile is similar to AVF, but AVG tend to require more intensive maintenance activity58. 
Significant technical expertise is needed for AVG insertion, which limits their availability. 
Several AVG products are licensed in the United Kingdom, including 'early cannulation' 
AVG (ecAVG) that can be utilised for haemodialysis immediately following insertion32,59, 
avoiding the need for a period of maturation before use. 
The logistical challenges of AVG insertion, maintenance and use are balanced by 
substantially improved morbidity and mortality compared to CVC34,60. The economic 
advantages of AVF or AVG are considerable. One study explored the financial cost of 
inserting and maintaining AVF, AVG and CVC in a large haemodialysis cohort61: the 
equivalent costs per patient with CVC were significantly more than the equivalent AVG or 
AVF costs, accounting for consumables, drugs, notional hospital admission charges and 
associated factors. Another study compared CVC versus ecAVG for emergency incident 
haemodialysis access, finding that ecAVG reduced SAB episodes and mortality while 
remaining cost neutral, in comparison with CVC60. 
 
Peritoneal dialysis 
 
Peritoneal dialysis (PD) presents a further, alternative, means of RRT. It is widely used but 
tends to be relatively underutilised in comparison with haemodialysis within any given 
centre8,9. 
The basic premise of PD is to utilise the peritoneum as a dialysis membrane, using dialysate 
fluid that is infused into the abdominal cavity. This requires that a ‘Tenckhoff’ catheter is 
surgically inserted into the lower abdomen, to facilitate the passage of dialysate fluid into the 
abdominal cavity. This fluid is left in-situ for a pre-determined number of hours, during 
which time the peritoneum acts as a dialysis membrane. The fluid is exchanged for fresh 
fluid, and the process repeats. Once inserted, the Tenckhoff catheter can remain in-situ for 
several years.  
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PD is a home therapy. Most patients are trained, over a period of days to weeks, to perform 
PD manually, or using a semi-automated PD machine installed in their home62. Alternatively 
a process of ‘assisted PD’ can be provided, whereby a trained member of staff attends 
patients’ home to conduct PD63. Typically, PD is performed every night using an automated 
machine while the patient sleeps; the patient may retain relatively normal occupational and 
social function despite their RRT treatment. Where assisted PD is provided, the treatment 
usually occurs during daytime hours for practical reasons.  
PD is a viable option for the majority of patients, however several practical issues require 
consideration. They require adequate housing, in terms of storage space and accessibility for 
consumables to be delivered; this is a key limiting factor in providing PD (and home 
haemodialysis)64. The patient also requires adequate cognition, visual acuity and manual 
dexterity, and should not have had significant previous abdominal surgery or illness65. 
PD confers equal survival benefit compared with outpatient haemodialysis66, but a slight 
survival disadvantage compared with home haemodialysis (albeit only when PD commences 
after at least six months haemodialysis)28. In other groups PD may confer a survival 
advantage, including those for whom haemodialysis would practically require TCVC use7. 
Avoiding bloodstream access avoids risks associated with haemodialysis such as VA-
associated bacteraemia or central venous stenosis, but PD carries its own risks of potentially 
life-threatening PD-associated peritonitis and encapsulating peritoneal sclerosis67.  
Some renal units offer acute PD, but across the UK it is mostly considered a chronic 
therapy68. Patients referred to nephrology late in the course of their renal disease, or who 
commence RRT using PD, are much more likely to choose haemodialysis for ongoing RRT69. 
While PD does not require VA, a Tenckhoff catheter needs to be inserted to facilitate 
treatment; when treatment commences soon after insertion the technique may fail due to 
leaks around the surgical wound70. Despite this a broadening body of literature supports acute 
PD71,72 and a forthcoming randomised study will explore its merits73. 
 
Conservative care 
 
Conservative management aims to address the symptomatology that develops in the latter 
stages of renal failure but without providing RRT14,74. This includes anaemia management, 
optimisation of mineral bone disease and fluid balance, and minimising harm associated with 
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reduced renal excretory function. It is designed to consider the wishes of patients and their 
relatives in the terminal phases of their illness75. 
Conservative management has traditionally been used to palliate symptoms rather than 
prolong life expectancy. It is recognised however that for some patients, including the elderly 
and those with significant comorbidity, active RRT may not ultimately bring significantly 
improved survival or quality of life76. Indeed, some patients in this cohort may gain survival 
benefit with conservative approaches to ESRF76,77. 
 
Complexity in renal replacement therapy 
 
RRT options are complex, have substantial morbidity and mortality burdens, and require 
planning before initiation. Options vary in their attractiveness and practicality between 
patients, and several options may require exploration in parallel for pragmatic reasons (table 
1). 
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Modality Potential challenges Potential benefits 
AVF Requires technically adequate artery 
and vein, surgical procedure 
(although not always with general 
anaesthetic), may then fail to mature 
sufficiently for use; 
Needs 6 weeks maturation after 
surgery before first use;  
Requires technical skill to cannulate; 
Periodic maintenance procedures 
may be required to detect or repair 
evolving AVF stenosis; 
Potential risks of bleeding, rupture,  
‘steal syndrome’ or ‘high-output 
cardiac failure’; 
Requires needle insertion for each 
haemodialysis session 
Better quality haemodialysis compared 
to other modalities; 
Lowest infection risk; 
Lowest mortality risk; 
No associated risk of central venous 
stenosis; 
Lowest overall financial cost of VA 
modalities. 
AVG High initial financial cost; 
Technically difficult procedure to 
insert into patients’ arm or leg, 
usually requiring general anaesthetic 
Requirement for more frequent 
maintenance procedures than AVF; 
Higher infection risk than AVF; 
Cannulation requires technical skill;  
Requires needle insertion for each 
haemodialysis sessin 
Potential to use them where patients’ 
artery or vein inadequate for AVF 
creation; 
Many are usable within hours of 
surgical insertion; 
Otherwise similar benefit profile to 
AVF. 
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CVC Higher financial cost than AVF; 
High associated mortality risk (vs 
other VA modalities); 
High associated infection and central 
venous stenosis risk; 
Requires patent vessels for insertion 
– this becomes increasingly difficult 
as central venous stenosis becomes 
apparent 
Does not require needles to be used for 
haemodialysis; 
Quick insertion with minimal advance 
planning; 
Can be used immediately after insertion 
for haemodialysis 
PD Requires adequate housing and 
easily accessed storage space at 
home for consumables; 
Patients requires adequate cognition, 
visual acuity and manual dexterity; 
Unable to use if previous abdominal 
surgery or illness; 
Requires insertion of Tenckhoff 
catheter, and brief delay before first 
use to deliver PD treatment; 
Risks of Tenckhoff exit-site 
infection, PD-peritonitis or 
encapsulating peritoneal sclerosis. 
Home therapy allowing patients to 
avoid unnecessary hospitalisation and 
to continue working / other social 
functions; 
Equivalent survival benefit to hospital 
haemodialysis; 
Avoids risks of central venous stenosis 
and bacteraemia. 
Table 1 Challenges and benefits of each Vascular Access modality 
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While the gold standard RRT is transplantation1, an organ must be available and the patient 
must be fit enough to undergo the operation. The pre-transplant assessment process for live 
donors may take longer than a year, and waiting times for cadaveric organs can exceed three 
years21,26. It is thus challenging to achieve the ‘ideal’ solution: a pre-emptive transplant just at 
the point where RRT first becomes necessary, avoiding the need for haemodialysis or 
peritoneal dialysis. 
While a patient awaits transplantation, or where transplantation is impossible, that alternative 
RRT must be delivered in a way that minimises morbidity. Factors associated with morbidity 
and mortality in PD and haemodialysis have been described8. Many such factors are not 
practically modifiable, but some can potentially be influenced, for example those associated 
with PD peritonitis78. The major modifiable risk factor in haemodialysis is the means of VA 
used to deliver treatment, with a clear hierarchy of risk across the available VA 
modalities33,34.  
As described above, many patients who requiring urgent initiation of RRT receive 
haemodialysis, although acute PD is increasingly an option. PD catheter insertion can be 
arranged at relatively short notice but still requires a degree of logistical coordination, along 
with patient education and consideration of the practicalities involved in using PD, and 
usually a period of postoperative recovery before beginning treatment. AVF or AVG require 
more detailed advanced planning, including consideration of the surgical approach most 
likely to succeed, patient education and their decision to proceed with AVF creation, 
scheduling of surgery, then a six -week period of maturation before the AVF can be used.  
In contrast, for patients who require RRT before a Tenckhoff catheter is in-situ for PD or an 
AVF has matured for haemodialysis, the default is usually to insert a CVC for 
haemodialysis32. TCVC are preferred from the perspective of reducing the associated 
infection risk, but in many centres only NTCVC are available out-of-hours or at short notice 
in normal working hours. Many patients therefore have an NTCVC inserted first, that is later 
replaced with a TCVC. 
 
Timing the initiation of renal replacement therapy 
 
A key challenge in RRT planning is determining the time at which ESRF will develop and 
RRT will become necessary. Formal assessment of renal excretory function requires the use 
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of specialist substances such as inulin, or radio-isotope imaging techniques that enable 
measurement of glomerular filtration rate79. Such measurements are impractical to regularly 
conduct, but the estimated glomerular filtration rate (eGFR) forms a useful surrogate 
measure79,80. This is derived from mathematical equations accounting for patients’ serum 
creatinine and other variables including gender, age and weight. eGFR enables patients’ 
kidney failure to be visualised on a spectrum ranging from ‘normal’ to ‘end-stage’, and the 
assessment of disease trajectory. Five stages of chronic kidney disease (CKD) are described, 
with stage 5 CKD, also called ESRF, representing eGFR <= 15ml/min81. 
Clinicians disagree about when RRT should be initiated based upon eGFR. This creates 
difficulties estimating the remaining time before RRT will be required. Symptomatology, 
fluid balance and biochemical markers all contribute to the final decision. One study 
evaluated the utility of protocol-driven haemodialysis initiation that compared ‘early’ (eGFR 
10-14ml/min) or ‘late’ (eGFR 5-7ml/min) strategies82. There was no survival benefit to 
earlier RRT initiation and no significant difference in adverse events between the groups, but 
most of those in the ‘late start’ required to start RRT earlier than protocolised because of 
intolerable symptoms. Other studies confirm this finding, although it is noted that the typical 
eGFR at RRT has risen in recent years, meaning RRT tends to be initiated earlier83. Patients’ 
symptom burden can become highly significant as CKD progresses, particularly in the later 
stages17,74. The relatively rapid appearance of symptoms may preclude the use of RRT 
modalities that require significant planning time in advance of commencing treatment, for 
example to create AVF for haemodialysis. The progression of symptoms and development of 
morbidity despite RRT is a recognised phenomenon and may be grounds for considering 
adopting a more conservative treatment strategy84,85. 
Further difficulty exists in the absence of a validated tool to predicting the timing of ESRF 
for a given patient. It is possible to consider the various clinical, physiological and other risk 
factors which have been described as contributory to the risk of developing ESRF. However, 
patients with advanced renal failure often have other serious comorbidities, which themselves 
are subject to flares and decompensation. The trajectory of declining renal function has been 
shown to be widely heterogeneous15,17,74 and for many patients a seemingly trivial 
intercurrent illness can be sufficient to prompt the initiation of RRT. 
 
Chapter 1: Introduction 
33 
 
Guidelines for Vascular Access care 
 
A number of professional groups have issued guidelines about aspects of VA practice.  
The Renal Association recommends that 60% of incident patients, and 80% of prevalent 
patients, should receive haemodialysis via AVF3. It suggests that AVF are preferable to 
AVG, which are preferable to TCVC, and that NTCVC should only be used when absolutely 
unavoidable. The guideline makes further recommendations as to the most appropriate 
location for AVF creation (distally, on the non-dominant upper limb); about vein preservation 
to facilitate AVF creation; preferred needling technique for AVF and AVG; and the need to 
perform regular VA surveillance and maintenance procedures.  
NICE mandates that NHS providers should specifically measure the proportions of incident 
and prevalent patients receiving haemodialysis with each VA modality, rates of VA 
associated-SAB and other infections, VA rupture, and VA interventions86. It also states that 
VA should be “monitored and maintained” but does not specify how this should be achieved. 
This ‘quality standard’ is based upon the Renal Association guidelines3.  
The European Dialysis and Transplant Association (EDTA) guidelines similarly recommend 
using AVF first, then AVG, before TCVC87. They also recommend implementing vein 
preservation strategies to facilitate AVF creation. They provide additional detail in relation to 
the manner in which VA surveillance should be performed (including regular physical 
examination and access blood flow measurement), along with the investigation and 
management of VA thrombosis, stenosis, infection, and VA-associated ischaemia.  
The National Kidney Foundation in the United States have produced a highly detailed 
guideline document that broadly agrees with the above recommendations88. The most recent 
guidelines, issued by the European Society of Vascular Surgeons, similarly agree with the 
earlier guidance89. They make detailed technical recommendations about the choice of AVF 
site, and several additional recommendations including the need for ‘early referral’ for AVF 
creation (specified as between 3-6 months prior to haemodialysis initiation); the potential 
benefits of Vascular Access Nurse (VAN) roles; and a need for educational programmes to 
provide exposure to at least 25 AVF creation operations for trainee vascular surgeons.  
The guidelines make clear what VA should be offered to patients, and the preferred 
approaches to creating, maintaining and using it. They acknowledge the lack of high-quality 
Chapter 1: Introduction 
34 
 
clinical evidence for many recommendations and, with the exception of the most recent 
guidelines, ignore how services might be configured in order to meet with these standards. 
 
Reality in Scotland and beyond: variation in Vascular Access practice 
 
Despite the uncertainty and complexity of planning for the initiation of RRT, there is broad 
agreement among experts that most patients should be evaluated for transplantation if this is 
deemed feasible90, and that where haemodialysis is contemplated the patient should ideally 
commence treatment, and be maintained on treatment, using an AVF for VA3. 
Renal registries around the world measure concordance with these guidelines and typically 
demonstrate wide variation in practice between centres8,12,68,91. In Scotland a substantial inter-
centre variation has existed for many years in the proportions of patients who commence and 
are maintained on haemodialysis using an AVF8 (figures 1 and 2). 
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Figure 1 Percentage arteriovenous fistula access for incident haemodialysis, by unit 
This data has been reproduced from the Scottish Renal Registry Report 201513.  Each bar 
represents the percentage of patients who commenced haemodialysis in the unit during the 
years 2012-2015 and who used an AVF for their first haemodialysis session. The data 
demonstrates substantial variation between units in respect of the proportion of patients 
using AVF for their first haemodialysis session each year. The Scottish average remained 
constant at 42-44% during this period. (Grampian = NHS Grampian, A&A = NHS Ayrshire 
& Arran, D&G = NHS Dumfries & Galloway, GGC = NHS Greater Glasgow & Clyde, Lan 
= NHS Lanarkshire, Tay = NHS Tayside, High = NHS Highland, Loth = NHS Lothian & 
Borders, Fife = NHS Fife.) 
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Figure 2 Percentage arteriovenous fistula access for prevalent haemodialysis, by unit 
This data has been reproduced from the Scottish Renal Registry Report 201513.  Each bar 
represents the percentage of patients whose haemodialysis was delivered using an AVF 
during each year (as measured on the annual census date). The data demonstrates 
substantial variation between units in respect of the proportion of patients using AVF for 
haemodialysis treatment each year. The Scottish average increased slightly from 72-77% 
during this period. (Grampian = NHS Grampian, A&A = NHS Ayrshire & Arran, D&G = 
NHS Dumfries & Galloway, GGC = NHS Greater Glasgow & Clyde, Lan = NHS 
Lanarkshire, Tay = NHS Tayside, High = NHS Highland, Loth = NHS Lothian & Borders, 
Fife = NHS Fife.) 
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The Scottish Renal Registry has measured concordance with these audit standards since 
2007, and has demonstrated persisting variation between centres in the proportions of patients 
who commence haemodialysis with an AVF, and who are maintained on haemodialysis 
treatment with an AVF8,13,92. In some parts of the country it is apparent that most patients 
have an AVF at the initiation of haemodialysis, while almost all prevalent patients dialyse 
using an AVF8. Elsewhere the opposite is true: in some centres less than one in five patients 
commence haemodialysis with an AVF, and less than half are maintained on haemodialysis 
with an AVF.  
It is recognised however that performance in respect of these standards should be considered 
in the context of variation between centres in the utilisation of different RRT strategies, 
including conservative care. The ‘take-on’ rate for RRT – meaning the number of patients 
who are offered active RRT rather than conservative management of ESRF - and the 
utilisation of renal transplantation, are also seen to vary by centre8,9,21. It has been suggested 
that pre-transplant counselling may vary between transplanting and non-transplanting renal 
units8. These findings are relevant when considering variation in AVF use for incident and 
prevalent haemodialysis patients because centres who are more likely to offer RRT rather 
than conservative care to frailer patients, or those who refer for  transplantation less 
frequently, could potentially have larger pools of patients for whom haemodialysis with a 
TCVC is the only realistic RRT option. The literature also suggests differences in patterns of 
referral for AVF creation according to patients’ gender, race and other factors93,94. Similarly, 
it is appreciated that later referral to a nephrologist reduces the likelihood of commencing 
haemodialysis with an AVF69. 
A similar pattern of inter-centre variation is seen in the broader UK renal registry68. Some 
centres in England report using PD in a much greater proportion of patients than is seen in 
Scotland; two units have almost 40% of patients commencing dialysis with PD rather than 
HD68, while much lower rates are more typical in Scotland8.  
Variation is also seen across Australia and New Zealand91. Incident AVF access ranges from 
8-64% in Australia and 17-45% in New Zealand, while prevalent AVF access ranges from 
69-100% in Australia and 71-93% in New Zealand.  While this still represents significant 
variation between centres, there is perhaps less variation overall than is seen with the 
equivalent measures in the Scottish haemodialysis cohort. Variation in AVF use is seen 
worldwide, with some studies attributing this to clinical, technical and geographical 
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factors95,96. “Geographical” factors related to undefined differences between centres rather 
than differences caused by physical geography. 
Interestingly, UK registry data suggests that timeliness of vascular surgeon review is the most 
significant predictor of commencing haemodialysis with an AVF; those seen by surgeons 
before commencing haemodialysis were seven times more likely to have a functioning AVF 
in place for their first haemodialysis treatment68. 
Concerns have been raised about the hidden pitfalls of strategies aimed at maximising AVF 
usage. In a hypothetical situation where every patient commences haemodialysis with an 
AVF, it would logically follow that some patients might have AVF fashioned but ultimately 
die without requiring its use, by dying from non-renal causes or opting for conservative 
ESRF management. Opinion also varies as to whether AVF genuinely represent ‘optimal’ 
VA for every patient97,98; for patients who opt for haemodialysis but who have a very limited 
life expectancy due to comorbid illness, some clinicians believe the overall burden of 
hospitalisation, procedures and associated morbidity does not justify the benefits of AVF 
over CVC use. Others argue that the substantial, adverse, difference in morbidity and 
mortality profiles between AVF and CVC justifies the use of AVF in every case99. 
It can be appreciated that VA for haemodialysis treatment is an extremely complex problem. 
While in one sense there is an aspiration to provide AVF for most patients, this is extremely 
difficult to achieve in practice. For many patients the reality of RRT is a lengthy wait for 
transplantation, during which time haemodialysis treatment is provided with suboptimal VA. 
Despite significant evidence favouring AVF use, it seems extremely difficult to provide this 
for most patients who require haemodialysis8,9,11,12. The complexity of the subject area, the 
failure to significantly improve AVF use over a long period of time, and patients’ interest in 
the subject100, demands the use of alternative approaches. 
This study frames these longstanding problems in the context of the sociotechnical systems 
literature. The literature provides ample descriptions of the complexities associated with 
providing RRT and widespread variation in practice between centres; the reasons 
underpinning this variation have been the subject of the discussion text in many of the studies 
cited earlier, but few studies have been specifically designed to explore this in detail. 
The following chapter 1B introduces concepts relevant to complexity in healthcare. The 
literature pertaining to sociotechnical systems theory is reviewed: this is a well-developed 
area of social science whose application remains unusual in healthcare settings. The reader is 
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invited to consider how challenges providing VA care could be seen through a systems theory 
lens. Existing approaches to approaching variation and complexity in healthcare are 
considered, setting the scene for chapter 2 which describes the development and use of an 
investigative model which is then used to explore the structure and function of VA services 
across Scotland. The results of the study, and the subsequent recommendations for practice, 
are described in the chapters that follow.  
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Chapter 1B: Healthcare and complexity 
 
Healthcare represents an extremely complex and high risk industry101. It has become 
enormously sophisticated, with the ability to identify, manage and cure many illnesses 
hitherto regarded as deadly or life limiting. With advances in technology and public 
expectations the processes involved in care delivery have increased in complexity, been 
subjected to greater scrutiny, and carry significant potential to cause physical harm to patients 
and financial harm to providers102. From a policy perspective it has become increasingly 
unacceptable for healthcare to be associated with harm, and clear mandates exist from 
government for healthcare providers to improve the safety and quality of delivered care103.  
The following sections discuss the ‘patient safety’ and ‘quality improvement’ literatures, and 
how variation in healthcare has been approached in other areas of practice. The chapter then 
discusses systems theory, the concept of complex sociotechnical systems, and provides 
context as to how this literature might be used to characterise and explore VA care. 
 
Patient safety and quality improvement 
 
'Patient safety' (PS) and 'quality improvement' (QI) movements have become prominent in 
western healthcare. They have complementary and overlapping, but not identical, aims: PS 
aims to eradicate avoidable harm, while QI seeks to improve the quality of care provided.  
The definition of 'safety' is complex. It is not simply the absence of harm, and it is neither 
static nor linear104–106. It encompasses a status relating to inadvertent, preventable or 
avoidable harm that arises within a constantly shifting context. In a healthcare setting it may 
be influenced by patients' physiology and pathology, staff skill mix, resource availability, 
competition from others who require access to common or limited resources, acts of omission 
or commission, and many other factors. It may relate to conditions where unwanted, negative 
outcomes are minimised, or those where intended, positive outcomes are maximised107,108. 
Similarly, 'quality' may refer to the achievement of desired outcomes, the avoidance of 
undesired outcomes, optimised resource usage, reduced hospitalisation, the ability to perform 
at a predicted and reproducible standard or to sustain operations in the face of disruption, or 
many other factors104,109–112. Table 2 lists definitions from the literature that relate to this 
discussion.  
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Safety  “The absence of accidents”104 
“The absence of unwanted events”105 
Safety is a system property rather than a component property106 
Safety I “A condition where the number of adverse outcomes… is as low as 
possible”107,108 
Safety II “The ability to succeed under expected and unexpected conditions alike, so 
that the number of intended and acceptable outcomes… is as high as 
possible”107,108 
Adverse 
event 
“An injury resulting from a medical intervention”101 
Quality “The ultimate test of the quality of a health care system is whether it helps the 
people it intends to help.”111 
“Quality of care is the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are 
consistent with current professional knowledge”112 
Failure “When a component does not satisfy its specified requirements”104 
Reliability “The probability that a component satisfies its specified behavioural 
requirements over time, and under given conditions, i.e. it does not fail”104; 
Reliability is a component property (not system property)106 
Resilience “The intrinsic ability of a system to adjust its functioning prior to, during, or 
following changes and disturbances, so that it can sustain required operations 
under both expected and unexpected conditions.”109 
A system property that enables organisations to understand how to avoid 
failure and achieve success113 
Table 2 Definitions from the literature 
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Interest in healthcare-associated harm has been reported in the published literature for many 
years114, but momentum in PS research has only gathered in recent years. Its development has 
been described in three phases114: ‘sporadic’, with periodic, isolated reports in the literature 
that did not lead to specific action; ‘cult’, where small groups of enthusiasts began tackling 
the problems and illuminating their nature to wider audiences; and ‘breakout’, where concern 
about PS became a mainstream concern for health professionals, politicians and the public at 
large. While not the first study of healthcare-associated harm, the Harvard Medical Practice 
Study was perhaps the first to attract significant public interest with its quantification and 
analysis of potentially preventable harm suffered by large numbers of patients across New 
York State115,116. The later Institute of Medicine publication “To err is human”101 equated the 
number of avoidable deaths in American hospitals to large numbers of aircraft crashing each 
day, and despite their figures relying to some extent upon extrapolation and inference they 
generated substantial public and political interest in this area of study. Subsequent 
publications confirmed the extent of the assertions and began to delineate the broad range of 
harms and potential harms occurring in hospitals. Around the same period, the UK 
Department of Health report “An organisation with a memory”117,118 discussed the extreme 
financial cost of healthcare-associated harm in the NHS, and called for systematic approaches 
to identifying, cataloguing and learning from adverse events in British hospitals. This led to 
'clinical incident’ recognition, recording and investigation becoming a matter of routine for 
NHS clinicians, albeit underreporting and inadequate investigation remains problematic119. 
Various analytical models for investigating such incidents have been described, including 
‘root cause analysis’ and ‘fault tree analysis’120–122. Root-cause analysis is a process of 
adverse incident evaluation that seeks to identify the factors responsible for creating the 
conditions that resulted in the adverse event120. Fault tree analysis provides a similar 
approach, evaluating the various domains associated with an incident and exploring the 
specific situation that led to it occurring122. These techniques often involve retrospective 
analysis of potentially contributory factors to the incident in question. While many 
publications and reports praise their apparent successes, these methods are vulnerable to 
criticism for their historical focus, narrow fields of investigation, and the tendency to produce 
recommendations that are impractical, or not ultimately implemented123–125. 
Attempts to enhance PS often centre upon the recognition and measurement of adverse 
events, with steps taken to reduce potential recurrence or to limit the resulting harm. Most 
NHS PS surveillance programmes rely upon incident logging into central databases, for 
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example Datix126, whose utility for improving safety outcomes remains uncertain127. 
Resources tend to be focused on the incidents arbitrarily graded in the most severe categories, 
and/or those felt likely to recur. It should be noted however that frequent adverse events may 
have a relatively limited impact128, while infrequent events can prove catastrophic; this 
approach may therefore not be the best use of available resources.  
QI methodologies tend to be more firmly grounded in industrial approaches than the 
equivalent PS techniques. Early QI work is often credited to Dening, Toyoda or Ford129. 
During the Industrial Revolution it was felt that “scientific management” (or Taylorism)129 
was the most efficient way to operate; managers would specify while workers mindlessly 
performed tasks. Toyoda recognised the importance of developing this to improve the 
internal working practices within his factories in Japan, and his work developed into what is 
now known as Lean Methodology130. 
More recently the United States Institute of Healthcare Improvement has moved to 
implement QI methodologies in healthcare. A broad range of techniques have been described, 
but notably the UK NHS Improvement Model, which focuses around ‘Plan, Do, Study, Act’ 
(PDSA)131, has gained significant support (figure 3). 
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Figure 3 The NHS Improvement Model: Plan, Do, Study, Act 
The model involves a four-stage approach. First the problem space should be researched, 
with the intention of understanding the issues and recognising targets for intervention 
(‘plan’). Next an intervention should be implemented in the clinical environment (‘do’). The 
impact of the intervention should then be measured and evaluated (‘study’). Modifications to 
the original intervention should be designed, based upon the findings of the measurement and 
evaluation stage; these should then be implemented (‘act’). The four stages should repeat 
until the problem is considered to be addressed. Each revolution is termed a ‘PDSA cycle’. 
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A significant literature base champions the use of PDSA, which is now the dominant model 
for UK healthcare QI projects131. Its simplicity makes it attractive and facilitates its use with 
minimal methodological training; however, this can encourage disordered approaches with 
insufficient strategic oversight and governance, and can cause unforeseen or unintended 
consequences132. It is also common for the “plan” and “do” elements to be done, with less 
attention given to “study” and “act”133. This may partly reflect current requirements for junior 
doctors to conduct QI projects over short timescales134,135. Time pressures could incentivise 
clinicians to overlook more complex problems in favour of those with higher potential to be 
completed more rapidly.  
A further criticism of PDSA and other QI methodologies is their basis in mechanical, 
industrial processes, that are grounded in linear chain causality. Healthcare is an example of 
significant complexity and such linearity is infrequently encountered. The use of ‘simple’ 
methods to tackle ‘complex’ problems may be disadvantageous; this may explain the 
surprising paucity of publications describing successful VA PS or QI projects. Reported 
projects tend to have a narrow focus, for example improving pre-haemodialysis care136; 
haemodialysis nurse education137; or reducing haemodialysis-associated infection138. No 
studies were identified that considered VA services as a whole or accounted for the 
significant clinical complexity described in chapter 1A. 
 
Investigating variation in healthcare 
 
Variation in the delivery of healthcare interventions has been recognised for many years in a 
broad range of clinical specialties. The earliest reports date to the 1930’s when Glover 
demonstrated wide geographical variation in tonsillectomy rates for British schoolchildren139. 
More recently the NHS Atlas of Variation and Dartmouth Atlas Project have shown variation 
across numerous areas of practice in the UK and USA140,141. It is recognised however that 
variation may be desirable in some cases, for example where the degree of illness or patient 
preferences justifiably modifies practice between centres. Several frameworks seek to 
categorise the nature of less desirable ‘unwarranted variation’ with that proposed by 
Wennberg perhaps the most widely recognised140,142,143. He defines ‘unwarranted variation’ 
as that which has no basis in variable illness or patient need between studied populations. He 
categorises it according to: 
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• ‘Effective care’ – where the evidence points to one intervention holding clear benefits 
over others; 
• ‘Preference sensitive’ – where multiple options are reasonably possible but variation 
can arise through patient and professional opinions, with concern about undue 
influence of clinicians’ opinions; 
• ‘Supply sensitive’ – where variation reflects differences in supply and demand for a 
given treatment. 
Reducing or removing unwarranted variation requires an understanding of how and why it 
arises in practice. Greenhalgh and colleagues make a significant contribution to this literature 
through their model for the diffusion of interventions into clinical practice144. This is based 
upon extensive review of a broad literature and considers the influence of the intervention in 
question, the relevant clinical system, and their surrounding contexts. It provides a strategic 
conceptual framework that may explain why some interventions are more readily adopted 
than others in different healthcare settings.  
Panella considered the implementation of new ‘streamlined’ clinical pathways to reduce 
variation across several specialties, and found their successful implementation was associated 
with improved clinical outcomes and metrics such as length-of-stay and the financial costs of 
treatment145. However significant difficulty was noted in actually implementing the pathways 
in practice, and they used a relatively brief observation period of 6 months before and after 
implementation to calculate any effect; this limits any ability to comment on the 
sustainability of their results.  
Interventions have also been designed to tackle variation in specific areas of practice. One 
study describes the successful piloting of an integrated primary and secondary care approach 
to implementing evidence-based treatment for patients with respiratory disease146. Others 
have considered the use of clinical decision aids and guidelines to reduce variation in surgical 
practice, reporting mixed results147. In cancer care, calls have been made to reduce variation 
in screening for common cancers by standardising approaches across cancer types148. In NHS 
primary care a financially incentivised Quality and Outcomes Framework was used to 
improve standards of care across several domains149. It was shown to reduce some variation 
between areas of socioeconomic prosperity and deprivation, but clinical outcomes have been 
modest at best and the proscriptive nature of the programme led to concern around clinician 
autonomy and reduced patient satisfaction150. 
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Financial incentives have also been explored in VA151, as perceived by clinicians working in 
a small sample of renal units in England. Fistula use was reported to be more likely in light of 
financial tariffs incentivising this practice, but this was not borne out in subsequent registry 
data68. Financial motives for facilitating RRT are also referenced in literature pertaining to 
conservative management of ESRF152, with an inference that financial incentives may prompt 
active RRT being offered when conservative strategies could be considered more clinically 
appropriate. Concern has also been raised that financial incentives could paradoxically 
disincentivise other areas of good practice153.  
In the UK registries collate metric data in an effort to reduce variation through the public 
benchmarking of renal units. In recent years the scope of registry data has increased in an 
effort to measure additional variables that may then be subject to improvement efforts154. 
Across the literature variation in care is increasingly recognised; no intervention provides a 
panacea, but the available work provides frameworks with which to begin understanding 
variation, and suggested approaches to improvement. These findings may be of value in this 
study. Using Wennberg’s framework143 VA variation could be categorised under ‘effective 
care’ given the evidence supporting AVF use; also ‘preference sensitive’ given the 
complexities and differences associated with using AVF rather than AVG or TCVC and the 
potential for variable clinical opinion to influence this; ‘supply sensitive’ seems unlikely 
given the geographic confines of NHS Scotland, but also requires consideration. 
 
Complexity 
 
Systems approaches to exploring clinical practice can generate insights that assist clinicians 
within the system, and which enable service redesign in a manner that benefits patients and 
provider organisations155,156. At this stage it is helpful to consider the meaning of 'complexity' 
in the context of systems theory and healthcare, and how applicable it may be to VA. 
Complexity has been an evolving challenge in industry since the industrial revolution, as 
technological advances change the nature of the workplace and expand the possibilities of 
what can be achieved. Complexity can be understood in engineering terms, where an 
environment may be described as ‘simple’, ‘complicated’ or ‘complex’, or in biological terms 
as ‘ordered’, ‘complex’ or ‘chaotic’157–160. 
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In ‘simple’, ‘ordered’ linear sequences, actions are understood as direct consequences of 
preceding activities; these predictably generate subsequent actions in programmed chains of 
events161. If components fail the consequences are the predictable sequelae of that component 
not functioning. ‘Complicated’ systems, e.g. car engines, represent advancement beyond 
linear sequences but the sum of system outputs remains predictable, contained within a 
defined envelope. Modifications to complicated systems can have unexpected effects but can 
ultimately be traced back to their dependent relationships, understood and controlled by 
individuals with sufficient technical expertise. Linear process mapping can enable 
understanding of simple and complicated engineering problems, identifying problems and 
modelling the impact of a component modification. The underpinning assumptions of such 
models – that processes are linear, and operate in predictable, programmed fashions – are 
flawed in the setting of complex systems such as healthcare104,161,162. 
‘Complex’ systems comprise multiple interacting and interdependent components; together 
these elements and their interactions form a whole163. Complex systems are modelled 
hierarchically; each level becomes increasingly complex as a function of ‘emergence’: the 
properties resulting from the predictable and unpredictable interactions of system 
components104. These emergent properties are irreducible and cannot be understood as the 
sum of the component parts104. Emergence may influence system operating properties (e.g. 
modifications to processes based upon previous ‘near misses’); may itself be an endpoint of 
system function (e.g. reaching a clinical diagnosis based upon a clinical history, examination, 
laboratory and radiological tests and a multi-disciplinary team discussion); or may have any 
number of conspicuous or inconspicuous impacts. Chaotic systems are characterised by 
instability and aperiodicity: they never reach a true state of equilibrium and are highly 
sensitive to small disturbances in their environments158,160. Complexity and chaos are not 
mutually exclusive but do not always co-exist; some texts describe complexity as being “at 
the edge of chaos”159. Table 3 compares simple, complicated and complex systems.  
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Simple Complicated Complex 
 
Few elements contained 
within a closed envelope 
 
Usually linear relationships 
between elements 
 
Simple change will have 
predictable impact 
 
Reproductible output 
 
Failures can be traced 
backwards to their origins 
 
Little expertise required 
 
Output equates to sum of 
components 
 
Can be analysed according 
to component parts 
 
(E.g. small electrical circuit) 
 
Many elements contained 
within a closed envelope 
 
Simple change creates a 
describable impact on 
system output 
 
Failures can be traced 
backwards to their origins, 
but this requires technical 
understanding of the system 
 
Some expertise required to 
construct or modify the 
system 
 
Output equates to sum of 
components 
 
Removal of components 
may cause the system to fail 
 
Can be analysed according 
to component parts 
 
(E.g. motor engine) 
 
Many interacting elements 
which are not contained 
within a closed envelope 
 
Unpredictable relationships 
between elements 
 
Simple changes may have 
unpredictable and/or 
inconspicuous impact 
 
Failures cannot reliably be 
traced backwards to their 
origins 
 
System output characterised 
as ‘emergence’ arising from 
element interaction 
 
Adaptable over time, and 
can survive despite 
removing or modifying 
system components 
 
Cannot be analysed 
according to component 
parts; the level of analysis 
should be the whole system 
 
(E.g. an international 
airport) 
 
Table 3 Characteristics of simple, complicated and complex systems158,164–167  
Chapter 1: Introduction 
50 
 
Healthcare contexts, including VA, may be regarded as complex systems characterised by 
their emergent properties rather than simply by their component parts. Sophisticated 
analytical tools are required to understand complex systems, which must be understood as a 
‘whole system’. Reductionist approaches that fragment the system into individual elements 
will potentially miss the central importance of system component interactions which generate 
the systems emergent properties. Complex system analysis should understand how system 
components interact, rather than how individual elements function in isolation.  
The absence of published work analysing VA services as a whole may explain why so little 
improvement has been demonstrated over prolonged periods of registry scrutiny8,9. VA 
problems are also challenging to analyse using existing PS or QI tools. Clinicians may not 
recognise routine, apparently successful, TCVC use as an ‘adverse event’; and the 
fragmented nature of VA care involving clinicians from several specialties, spread across 
multiple hospital campuses, serving a heterogenous and medically complex patient 
population, does not lend itself well to relatively fast moving and simplistic QI techniques 
like PDSA.  
More sophisticated analyses based upon ‘complex socio-technical systems’ theory may be 
better suited to improving VA. The following sections discuss the theoretical basis of such 
approaches. 
 
Sociotechnical systems 
 
Complex systems where humans interact with technologies are termed ‘socio-technical 
systems’. Human involvement in the system brings added complexity with their inherent 
strengths (e.g. ability to adapt, learn and improvise), weaknesses (e.g. fatigability, limited 
concentration) and external influences (e.g. personal ambition, political interests, regulatory 
concerns). Socio-technical systems were first described in the coal mining industry, where the 
addition of new technological tools into working environments traditionally characterised by 
manual labour led to a broad range of unanticipated challenges168. The interaction of humans 
with technologies generate a socio-technical system within the workplace, in which system 
components interact in a manner that is not necessarily predictable, linear or apparent to the 
observer, generating the system’s emergent properties and consequential complexity169. 
Chapter 1: Introduction 
51 
 
Since its earliest descriptions the sociotechnical systems literature has evolved to incorporate 
healthcare settings102,170,171. Clinical environments provide an especially complex substrate 
for study in view of their scale, wide range of variables and potential for very severe harm in 
the event of a negative outcome101. Such highly complex systems are sometimes referred to 
as a 'system of systems', whereby the units within the system are operationally and 
managerially independent but the systems collaboratively function as a whole172,173. For 
example, within a health provider organisation there may be primary and secondary care 
services each providing private and public services; despite their arrangement as discrete, 
standalone units they depend upon and influence one another significantly, and interact at 
multiple operational and strategic levels. 
Sociotechnical systems theory, and the concept of ‘emergence’, provide a window for 
understanding complex interactions in healthcare settings, and a perspective from which to 
investigate and improve clinical systems. Traditional PS and QI approaches consider adverse 
events as discrete episodes that may be understood using retrospective analysis tools; when 
such incidents are instead framed as ‘emergence’ in the context of ‘complexity’, a mandate is 
provided to explore broader system functioning.  
 
Are adverse events 'normal'? 
 
Healthcare adverse events are often considered preventable, and investigations seek to create 
barriers that will prevent recurrence. An alternative perspective considers safety (and its 
absence) as an emergent system property104. Adverse events are thus framed as emergent 
conditions arising from complexity within the system, whereby the adverse outcome 
represents ‘undesirable emergence’ rather than the ‘designed emergence’ the system intends 
to generate.  
This thinking resonates with Perrow’s ‘normal accident theory’, which contends that adverse 
events are an inevitable feature of any complex system174. His studies of complexity in 
various high-risk industries concluded that all complex systems generate emergence of one 
form or another, and the label of ‘positive outcome’ versus ‘adverse event’ was largely a 
matter of perspective. Some criticise what they considered an unnecessarily nihilistic tone 
throughout Perrow’s theories175,176; but acknowledging the nature of complex systems104 it is 
surely inevitable that adverse as well as desired outcomes will occasionally arise from a given 
Chapter 1: Introduction 
52 
 
system. This does not render safety efforts futile; instead the system’s malignant potential 
should be recognised, understood, and efforts made to limit the associated risks177. This 
becomes especially important since public opinion is increasingly intolerant of adverse 
events, even those which are difficult to mitigate178. 
The challenges in providing VA care could be considered examples of ‘normal accidents’: 
despite longstanding variation in AVF use, and large-scale efforts to improve (general) 
clinical quality and safety, there have been few if any objective measures of sustained 
improvement in clinical outcomes179, and no reported studies specific to VA. The apparent 
lack of progress could reflect inadequate tools for change that do not account for healthcare 
complexity. An alternative argument would characterise these issues in the frame of 'wicked 
problems': first described by Rittel and Webber in 1973180, these are problems which can be 
resolved, but not “solved” in mathematical sense, for example those relating to anti-
terrorism181 or climate change182 policy. 
This study could suggest that VA is a wicked problem. This would be consistent with the 
apparent lack of recent progress towards increased AVF use for haemodialysis. Declaring a 
problem to be 'wicked' does not however mean efforts to resolve it should cease; rather, the 
recognition of its ‘wicked’ status should shape the resulting efforts to achieve improvement, 
perhaps with acknowledgement of the limits to what can reasonably be achieved. 
Alternatively, determining that VA does not have the characteristics of a wicked problem 
would be a helpful step towards engaging clinicians and designing service improvements. 
Chapter 11 revisits this issue.  
Table 4 describes the key characteristics of wicked problems. 
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1. It has no definitive 
formulation 
It is not possible to comprehensively document all necessary 
information in order to define the problem, its parameters, and 
the means of solving it. Instead, one’s perspective on a potential 
solution to the problem determines what is needed to understand 
it. 
2. It has no stopping 
rule 
The problem cannot be said to be definitively ‘solved’; attempts 
at resolution end when the individual can no longer focus their 
effort on enacting their solution. 
3. Solutions are ‘good’ 
or ‘bad’, not true or 
false 
Many parties are able to critique solutions to wicked problems, 
but no one has an objective measure of success for a given 
proposed solution. The attractiveness of a proposal relates more 
to its social, political and ideological acceptability than to what 
it might achieve in practice. 
4. It has no immediate 
or definitive test of a 
solution 
The result of an intervention cannot be judged in the short term, 
as it will have many apparent and unseen sequelae that in turn 
generate their own consequences. Only with hindsight and in the 
longer term can a judgement be made about the merit of an 
implemented solution. 
5. Every attempted 
solution has 
consequences 
Solutions cannot be tested without real world consequences, 
which in turn may become integrated into the wicked nature 
problem itself.  
6. They do not have a 
finite set of potential 
solutions 
Whereas logical problems may have a pre-determined number of 
potential solutions, wicked problems can have infinite potential 
solutions that cannot be comprehensively described. 
7. They are unique  Each wicked problem is essentially the first of its kind; it does 
not belong to a recognised category or taxonomy of problems, 
and therefore has no precedent to guide further action. 
8. They can be 
considered a symptom 
of another problem 
The wicked problem is interconnected with many other issues; it 
cannot be seen as a standalone issue that can be tackled as a 
closed system. 
9. Perspectives on the 
problem govern the 
attempted solutions 
An individual’s assumptions, values and beliefs, and the 
solutions they therefore consider to the problem, will determine 
the lens through which the problem is seen. Alternate 
perspectives may be equally valid but not considered by a given 
investigator.  
10. Those proposing 
solutions are compelled 
to be correct 
The impact longevity of any implemented solutions means that 
those designing corrective measures will be held accountable for 
their success or failure. 
Table 4 Characteristics of a wicked problem180,183 
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Latent and active factors in socio-technical systems 
 
Perrow states that adverse events are an inevitable feature of any complex system174. He 
suggests that more tightly coupled systems – those with multiple processes happening in 
rapid sequence, with little opportunity for human intervention – have the greatest risk of 
unwanted emergence174,176. This raises questions about the underlying architecture of a socio-
technical system, and whether certain features of its design are conducive to such incidents 
taking place.  
Reason conceptualises such features as ‘latent conditions’, which include general working 
conditions, policies and other contextual elements. These are then modified by events, actions 
and inactions to ultimately generate emergence184. He further characterises system 
components as ‘types’ and ‘tokens’185,186 that act to generate emergence. ‘Types’ are further 
subdivided into ‘source types’ and ‘function types’: the former describes the tone of strategic 
management decision making, and the latter refer to operational line management decision 
making which leads to the implementation of organisational policy. 
In his ‘Swiss Cheese’ model187, Reason describes how (unforeseen) combinations of latent 
and active conditions can result in the generation of adverse events. This provides a useful 
framework for exploring the circumstances of an adverse event and broadening the scope of 
investigations beyond the incident itself. Various criticisms of the model have been 
published188, including its encouragement of rather linear approaches to examining highly 
dynamic systems189. There is also a tendency to adopt reductionist strategies seeking to 
identify a single ‘root cause’ of a problem124 and investigators may fail to appreciate the 
wider influences of the overall system on the specific incident in question. This has also been 
described as ‘single loop learning’ (where one examines the direct cause of an event) rather 
than ‘double loop learning’, which seeks to explore the underpinning rationale for the 
cause190. Despite these criticisms, Reasons’ model is easily understood and has been used to 
encourage those investigating adverse events in healthcare to consider broader ‘system 
issues’.  
Consideration of these conditions, as they relate to VA, may explain why services function as 
they do, and could illuminate opportunities for improvement. This literature underlines the 
importance of understanding how VA services function at both strategic and operational 
levels, appreciating the roles of senior policymakers and those who implement their 
decisions.  
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System migration 
 
Incident investigations in healthcare and other industries commonly report that checks and 
balances built into a system were bypassed, knowingly or otherwise, by those working within 
it; sometimes this is associated with the adverse event under investigation. Often it becomes 
apparent that such ‘workarounds’ have been in place for some time, perhaps reflecting 
evolution of the system from an original planned state into its current position. This 
phenomenon has been described in terms of 'system migration' by Rasmussen191. His work 
explores the interplay between Reason’s latent and active conditions, and builds upon 
Perrow’s work to describe system migration over time191. He considers shortcuts and 
workarounds employed by staff, intentionally or otherwise, in their efforts to resolve 
perceived misalignments or inefficiencies within the ‘system as designed’. 
Such workarounds may be influenced by external regulations, staff turnover or skill 
development, new technology, or refocusing of system purpose191,192. More subtle 
adaptations arise from individuals within the system seeking to work efficiently, to achieve 
parallel objectives, or perhaps to fit with unrecognised practical or regulatory 
considerations192. Altered working arrangements may involve simply functioning in a manner 
that was unanticipated or can involve active choices to deviate from a specific approach. 
Changes to system elements, intentional or otherwise, can facilitate migration of system 
properties. The system may enter a hazardous state with an increased propensity to generate 
unfavourable outcomes. The system may operate in this hazardous state for a long time 
before adverse events emerge191. Indeed, migration may be inconspicuous, or may be actively 
facilitated in pursuit of perceived benefits. Amalberti conceptualises three stages of system 
evolution where changes occur, stabilise, then the system ‘recovers’ or progresses towards 
adverse events192. 
The concept of system migration is likely to be highly relevant to any comprehensive analysis 
of VA services. AVF and TCVC have been used for many years to provide haemodialysis 
treatment, but VA is not recognised as a specialty in its own right; it is better understood as a 
virtual service comprised of clinicians who usually work across different clinical specialties, 
and in many cases do VA work as part of a broader clinical role. The fragmented nature of 
VA services may result in a vulnerability to system migration, due to dependence upon 
individuals with competing clinical interests. This concept will be explored in detail in the 
present study. 
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Understanding normal system functioning 
 
The concepts of latent and active factors, types and tokens, and dynamic system migration, 
are useful constructs for this study. They emphasise the need to appreciate ‘normal system 
functioning’ to achieve and sustain improvements in quality and safety. This is slightly at 
odds with the retrospective analytical techniques traditionally used in healthcare quality 
improvement, described earlier in this chapter.  
 
Work-as-done versus work-as-imagined 
 
In complex healthcare systems it may be insufficient to simply retrospectively explore the 
circumstances surrounding adverse events. Hollnagel emphasises the requirement to 
understand normal function in order to enhance safety193. He terms the focus on why things 
usually go well ‘Safety II’; in contrast ‘Safety I’ approaches focus on why something went 
wrong193,194. Emphasis on maximising positive outcome is a pragmatic means of exploring a 
system’s operational characteristics and may reveal opportunities to improve efficiency or 
remove unwanted characteristics156,194–196. The value of Safety II approaches is increasingly 
recognised, especially those including comparisons of ‘work-as-done’ versus ‘work-as-
imagined’155. This is a key facet of healthcare resilience engineering, an emerging movement 
that seeks to understand how healthcare systems work and use this knowledge to create safer 
processes156,195,196.  
Hollnagel describes ‘work-as-done’ as ‘how tasks are actually performed’, noting that the 
individual executing the task has awareness of granular details about how the task is done 
that exceeds any written specification for the task; in contrast, ‘work-as-imagined’ presents a 
less granular version of how that task is performed, ‘imagined’ by individuals removed from 
the front-line, who view the process through the lens of filters and metrics197. As an example, 
a phlebotomist will have a detailed understanding of precisely how venepuncture is 
performed at the patient’s bedside (‘work-as-done’); a hospital manager will see this process 
through the prism of policies and data such as phlebotomists’ job descriptions, reports of 
clinical errors, and metrics concerning the number of patients requiring venepuncture in a 
given ward (work-as-imagined). The phlebotomist relies upon the manager to provide the 
necessary working environment and resources to fulfil the task, while the manager relies 
upon the phlebotomist to implement policy in relation to venepuncture. Achieving an 
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understanding of misalignments in their respective perspectives on venepuncture is thus 
important to ensure that the process proceeds optimally. 
 
Positive deviance 
 
‘Positive deviance’ is an interesting practical approach based upon Safety II principles198. 
‘Positive deviants’ –system elements demonstrating unexpectedly good performance – are 
studied with the aim of identifying the reasons behind their apparent successes. Quantitative 
metrics associated with the behaviour are developed and used to generate statistical analyses 
to test the apparent success of the deviant behaviour, which can then be propagated 
throughout the system. This technique has proven highly successful in various areas of 
healthcare and associated fields, with a key strength lying in the fact that the ‘interventions’ 
have, by definition, already proven workable within the contextual factors of the system in 
question198–200. It has been used in the setting of VA: one paper reported its successful use to 
reduce bloodstream infections in American haemodialysis units201. This shows the promise of 
the technique in the VA context, albeit all reported studies had a narrow focus on bacteraemia 
reduction that perhaps fails to recognise additional important aspects of VA care as described 
in chapter 1A. No published works were identified that used positive deviance to address 
these other elements of VA care.  
Criticisms of positive deviance include difficulties identifying positively deviant behaviours, 
the potential for bias when these are self-reported, and the challenges in generating statistical 
metrics to test the effect of the behaviour in laboratory conditions. A key strength however is 
the assumption that good practice already exists within a system and does not therefore 
require to be ‘created’ externally: this provides a useful starting point for exploring VA 
services. There are some barriers to the widespread use of resilient healthcare engineering 
principles. A key challenge is clinicians’ unfamiliarity with non-positivist techniques. 
Positivism is the dominant paradigm in traditional medical research, and clinicians are often 
suspicious of work that cannot provide statistical certainty. Non-quantitative works are 
perceived as being overly susceptible to bias, and factors that cannot be measured are 
disregarded as unimportant or irrelevant; this is termed ‘McNamara’s fallacy’202. Moreover, 
many funded QI and PS programmes require that objectively measurable ‘results’ are 
demonstrated; their absence may cast doubt on the project’s value. Safety II projects, focused 
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upon maximising positive outcomes rather than minimising negative outcomes, do not always 
lend themselves well to these requirements.  
Understanding complex system functioning requires significant time and effort. Many 
medical trainees in UK are mandated to perform quality improvement projects as a 
professional development activity135, and formal programmes have emerged to provide 
training in PS and QI methodologies203.  As such projects become a requirement for career 
progression, individuals are effectively compelled to tackle “quick” problems rather than 
devoting time to more thorough evaluations that might prove more fruitful in the longer 
term204. 
Various analytical tools have been developed to assist investigators wishing to understand 
and improve complex systems. Many are sympathetic to the principles of resilience 
engineering, for example ‘system-theoretic accident model and processes’ (STAMP)161 and 
‘functional resonance analysis method’ (FRAM)156. These sophisticated tools tend to involve 
an in-depth analysis of every conceivable domain that could have influenced a given incident. 
They are seen to generate comprehensive reviews of adverse events, and multiple 
recommendations to prevent future occurrences are typically generated175,205. However these 
thorough analyses come at the expense of considerable time investments; their routine use 
may be unfeasible without dedicated investigative teams194. Additionally, some 
recommendations arising from the analysis may not be within the direct influence of the 
investigator, for example where legislative processes, economic conditions or political policy 
require to be amended. 
FRAM analyses focus upon the manner in which work (or normal system performance) is 
carried out on a routine basis: this is termed ‘work-as-done’155. This is compared with an 
operational view of routine work, or ‘work-as-imagined’. Misalignments in these two 
perspectives facilitate system redesign to realign strategy and operational practice, preventing 
processes, policies and protocols becoming unfit for purpose. FRAM analyses can become 
highly complex and time consuming to conduct but are likely to provide requisite detail and 
recommendations that can be practically applied to the system in question. 
The FRAM tool has been utilised to investigate other areas of clinical practice155,206 and may 
lend itself well to exploring VA services. It is noted however that such an analysis may 
become extremely complicated (and/or complex) in view of the potential for differences 
between individual services. This study intends to explore the configuration of VA services 
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across Scotland, and to make recommendations for practice that are applicable (and 
implementable) by a broad range of clinicians and managers who are not directly connected     
with the project. The FRAM model may be a useful tool for exploring a single VA service 
and comparing it with a gold standard setup; a simpler approach is likely to be better suited to 
this project, both to optimise the illumination of notable practice and to enable the creation of 
study outputs that have meaning and credibility for the clinicians and managers who will be 
expected to implement the resulting recommendations.  
 
Sociotechnical system design 
 
The preceding sections have discussed the nature of complexity and sociotechnical systems; 
tools that enable researchers to understand such systems’ normal functioning; and the 
dynamic migratory changes that can occur over time. The current study will seek to unravel 
these issues as they relate to VA services, with the aim of improving the quality and safety of 
VA care. Since a potential output from this project is VA service redesign, it would be 
helpful to consider whether it is possible to ‘design’ complex sociotechnical systems such as 
VA services.  
Most systems are not genuinely ‘designed’ from the ground up; they evolve over time as 
people and technologies seek to address specified problems. As the organisation changes to 
take on new, emergent states, the original system configuration may no longer be fit for 
purpose. Acknowledging this, design principles may provide a helpful means to understand 
and contrast different systems and could alert investigators to potential pitfalls as system 
changes are contemplated. In this study these principles serve as a useful framework for 
evaluating VA services, and guide the design of the subsequent recommendations.  
Perhaps the most comprehensive approach to the design of sociotechnical systems can be 
found in the work of Cherns, who developed a series of components requiring consideration 
in any (idealised) sociotechnical system207,208. His principles are described in table 5, which 
represents a modified version of Cherns’ original and updated principles of sociotechnical 
systems design.   
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1. Compatibility System design must be mindful of overarching system objectives. 
Social (human) and technical (machinery) roles within the system 
should be designed together and with one another in mind, not simply 
modifying one to better suit the other. 
2. Minimal 
critical 
specification 
Only those rules that are essential to system functioning should be 
defined; rules and restrictions should be limited to those that are 
genuinely necessary to enable system flexibility to adapt.  
3. Variance 
control 
Variances (changes which critically impact upon outcome) should be 
controlled as early in their existence as possible. System elements 
should be given the means to become aware of, and eliminate, 
variance. 
4. Boundary 
location 
Physical, managerial, financial and other boundaries within the system 
should not impede the flow of knowledge, information or learning 
between system elements.  
5. Information 
flow 
Information should be provided to the appropriate person at the most 
appropriate time. Data requiring action should go directly to the 
person who requires to act; reference material should be available only 
if, and when, needed.  
6. Power and 
authority 
Individuals should have the appropriate access and authority to use all 
resources necessary to fulfil their role; in turn, individuals should be 
accountable for their optimal use. 
7. Multifunction The system must have a range of responses that enables it to adapt to 
changing requirements, for example the ability to generate different 
outputs as the environment changes. 
8. Support 
congruence 
System elements should complement one another, sharing 
philosophies and oriented towards achieving the same goal. For 
example, back office functions should be oriented towards supporting 
front-line staff. 
9. Transitional 
organisation 
As systems transit from ‘old’ to ‘new’ states, the transitional version 
of the system should be acknowledged as especially complex: 
redundant processes should be retired, staff retrained or redeployed. 
The manner in which this is done will directly impact upon the new 
system’s success. 
10. Incompletion The system is unlikely to ever reach a truly ‘steady state’ since 
contextual factors are always changing. With this in mind, the system 
and its components must have capacity to think strategically, and to 
intelligently anticipate forthcoming changes. 
Table 5 Principles of sociotechnical systems design (adapted from Cherns’ original and 
revisited works207,208) 
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Some of these principles complement other literature; for example, Ashby’s law of requisite 
variety209 describes the need for systems to match potential inputs with sufficient options for 
output, or exit strategies for dealing with potential scenarios that could be encountered 
through system functioning; this resonates strongly with Cherns’ multifunction 
principle207,208.  
Cherns’ original work has been adapted and updated by more recent authors. Clegg proposes 
a series of meta principles, content principles and process principles210. His meta principles 
advance Cherns’ work by suggesting that system construction is a predominantly social 
(rather than technical) function; his content principles sharpen focus upon problem visibility 
and the need to complement human and technological interactions; while his process 
principles explicitly acknowledge the influence of politics in system design and the 
requirement for specified resources and an evaluation strategy in order to create and operate a 
given system. The last requirement is especially intriguing in the setting of complexity and is 
perhaps an explicit acknowledgement that systems exist within a constantly evolving context 
that includes political, economic, social, technical, legal and economic influences. Indeed, the 
context within which a system exists can be considered infinitely more complex that the 
system itself102.  
Clegg’s principles210 are essentially a modernisation of Cherns’ original papers207,208, 
reflecting updated popular approaches to organisational design and management from 
Taylorist 'scientific management' perspectives129 to those valuing contributions from 
individuals within the system, and acknowledging their power to shape, modify, improve 
(and/or derail) system performance. This resonates with Rasmussen’s model of system 
migration towards and beyond control parameters, and into potentially hazardous states191.  
In his work exploring sociotechnical systems in the setting of security, Fischbacher-Smith 
applies thinking by Cherns and Reason to real world contexts178. His crucial additions to 
Cherns model include a central focus upon ‘consensus’, and grouping of his principles into 
those which heighten system potential and those which defend against erosion of 
performance capacity178. ‘Consensus’ describes the set of attitudes, values and assumptions 
held by those who design, manage and operate a system178. This develops Reason’s types and 
tokens concept185,186 to also account for Rasmussen’s factors influencing system migration. 
These ‘consensus factors’ may be considered the key to generating Reason’s ‘latent 
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conditions’169,187: they collectively form the context within which a system operates and 
generates desirable and undesirable emergence.  
Empirical evidence of this core principle can be seen (at a focused level) in the importance of 
“shared mental models” in healthcare critical events. High profile adverse event analyses 
have shown the consequences of misaligned “shared mental models”211. Other data 
demonstrates the clinical value of working in consensus212. At a strategic level it can be seen 
that the engagement between boards and front-line staff enhances measures of safety and 
patient experience, while reducing staff absenteeism and improving overall organisational 
performance213,214. 
Building upon Clegg’s requirement for a clear evaluative strategy210, and Fischbacher-
Smith’s illustrations of flawed system configuration178, it can be appreciated there is a need to 
explore, refine and adapt complex systems. The process of system adaptation will otherwise 
occur passively – potentially resulting in disastrous outcomes191 – so it appears preferable for 
strategic thinkers to take active control of this process, bearing in mind the potential to 
inadvertently generate adverse events in the process of attempting to avoid them215.  
 
Systems approaches to Vascular Access care 
 
This introduction has demonstrated the complexity associated with caring for patients with 
advanced kidney failure, and who require haemodialysis treatment. Ambiguity often exists as 
to the practically available treatment strategies for a given patient, and which is most 
appropriate for the clinical context. For most patients who require haemodialysis, the means 
of VA used to deliver the treatment is a key modifier of morbidity and mortality, with AVF 
providing substantial survival, cost and morbidity advantage in comparison with TCVC. For 
this reason guidelines recommend that AVF should be used in preference to other VA 
modalities, but registry data suggests wide variation in VA practice between centres in 
Scotland and further afield. This warrants further exploration, particularly to determine if the 
nature of renal units’ VA service structure or function is responsible for this observed 
variation. 
The socio-technical systems literature has also been reviewed and used to frame current 
approaches to safety and quality improvement in healthcare. Many popular approaches to 
safety improvement are limited by their focus upon historical events rather than an 
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appreciation of how things normally work. Commonly used QI methodologies tend to 
encourage narrow, focused views on systems that are contextualised by recognised clinical 
problems or adverse events. More recent techniques take a broader, systems view of such 
incidents and attempt to reconcile them with the normal functioning of the clinical system in 
question. 
Chapter 2 describes the development of a new model to investigate clinical systems, based 
upon the principles of Safety II and sociotechnical systems theory, and sensitive to the needs 
of clinicians wishing to pursue QI work. The chapter goes on to describe its use to explore 
VA services in Scotland and address the research aims noted below. The subsequent chapters 
describe and analyse the data generated from an appraisal of VA services in Scotland.  
  
Research Aims 
64 
 
Research Aims 
 
This study has been prompted by the observation of unwarranted variation in AVF use for 
haemodialysis treatment between renal units in Scotland. It is hypothesised that variation 
between centres may reflect differences in the structure and function of local VA services. 
This work investigates this issue with the overall intention of improving patient care by 
maximising AVF use. 
The specific aims of this study are as follows: 
1. To delineate the structure of VA clinical pathways in Scottish renal units; 
2. To explore the manner in which clinical work occurs within and around these 
pathways; 
3. To quantify the clinical workload associated with VA services; 
4. To illuminate gaps between ‘work-as-imagined’ and ‘work-as-done’ in relation to 
Scottish VA services; 
5. To present the findings in a manner that facilitates quality improvement activities. 
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Chapter 2: A mixed-methods model for exploring clinical systems 
 
Current approaches to patient safety and quality improvement are limited in their ability to 
achieve meaningful change in complex healthcare systems. It is therefore necessary to 
consider alternative approaches, drawing upon the literature described in Chapter 1, and 
accounting for the pragmatic realities of complex clinical systems.  
This chapter describes a novel mixed-methods model for exploring clinical systems. The first 
section describes the theoretical basis for the model, while the second part details its use in 
this study, which sought to understand variation in VA care by delineating the structure, 
function and workload of VA services in Scotland.  
The model was developed based upon the principles below: 
1) Healthcare delivery is highly complex, and provides an excellent context for the 
application of the socio-technical systems literature; 
2) There is significant risk involved in attempts to improve clinical systems, since poorly 
designed changes that do not account for real-world system conditions may inadvertently 
increase the risk of harm; 
3) Clinical service redesign works best when frontline clinicians are engaged with the 
process, take ownership of the improvement process, and show commitment to achieving 
its goals; 
4) Improvement efforts should focus around the needs of patients who use the service, rather 
than the wishes of clinicians or managers within the provider organisation; 
5) Clinicians respond favourably to evidence-based approaches; they may be unfamiliar 
with, or distrustful of, non-positivist methods; 
6) Qualitative methods have the potential to yield powerful insights into the way a system 
functions, the potential hazards it faces, and the practical implications of suggested 
improvements. 
The model frames the delivery of safe, high quality healthcare in the socio-technical systems 
literature. It focuses upon patients’ experience as its central measure of success, and defines 
high quality, patient-centred care as that which is effective, carries minimal risks of 
complications, and which provides an optimal experience of receiving care. The model uses 
quantitative and qualitative data to delineate the normal functioning of the system, to 
challenge aspects of its function, and to facilitate system redesign. It provides a platform for 
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system analysis and improvement, with rapid implementation of changes that are sympathetic 
to the complex environment in which care is provided, and which achieves engagement and 
support from clinicians working in the system. Finally, it facilitates rapid evaluation of 
system changes as they are implemented and encourages ongoing evaluation in the longer 
term. 
 
Elements of the mixed-methods model 
 
There are three main elements within the mixed-methods model. These seek to understand 
the current configuration of the system; to appreciate the current definitions and 
measurements of system “success”; and to appraise the impact of the current system 
arrangement on patients, clinicians and the provider organisation. This three-step process of 
system evaluation provides a means to engage with the clinicians and managers who hold 
operational, strategic and other stakeholder roles within the system.  
The process of determining the realities of system function, and discussing measures of 
successful system operation, facilitates conversations around possible improvements to the 
system, and encourages the development of new metrics which illuminate hidden areas of 
system performance. These new metrics provide further insight into the impact of current 
system configuration and performance, prompting the implementation of changes suggested 
during discussion with system stakeholders. The new metrics then provide a way of 
monitoring the impact of these changes as they become embedded within the system. 
The model is displayed pictorially in figure 4. Each stage is then discussed in further detail 
below. This theoretical discussion is then followed by a description of the practical steps 
employed in this study. 
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Figure 4 Mixed-methods model for investigating clinical systems 
This model takes a three-stage approach to investigating complex clinical systems. The first step is to understand contextual influences on 
system function. These include other systems with which the system interacts or has interdependence; operational parameters; staffing; and 
relevant political, economic, social, technical, legal and environmental factors. Collectively these are the ‘organisational influence’ on system 
function. Next, the performance metrics are considered, including measures of adequacy, early and late complications, and patients’ experience. 
These data collectively describe the system’s ‘organisational impact’ upon the provider organisation, in terms of clinical risk, financial cost and 
clinical outcomes. Together the ‘organisational influences’, ‘performance metrics’ and ‘organisational impact’ frame conversations with key 
stakeholders in an effort to understand normal system function. A Safety II perspective contrasts ‘work-as-imagined’ with ‘work-as-done’. This 
enables the creation of new metrics to fully illuminate system performance and facilitate change. Key stakeholder engagement with the model, 
and hence in the creation and use of new metrics, then facilitates ongoing quality improvement.  
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Understanding organisational influences 
 
The first stage of investigation concerns the context within which the system operates. 
Drawing on the ‘system of systems’ concept described in chapter 1B, the surrounding 
systems that have interdependence with the system in question, must be understood. It is also 
necessary to understand the system parameters, its configuration, the staff who work within 
it, potential external influences on system function and performance, and the routine working 
practices. Together this information creates an impression of the “organisational influences” 
on system performance and frames the subsequent exploration of how the system functions 
on a practical basis. 
 
System parameters 
 
Baseline investigative work is required to understand the context within which the system 
operates, and the boundaries of its activity. In mechanical or technical systems, the 
parameters, feedback loops and control mechanisms that exist to regulate system activity can 
be straightforward to identify. In socio-technical systems the boundaries are often more 
blurred161, particularly in healthcare where an individual patient, member of staff or clinical 
area may be included in multiple systems.  
Control mechanisms in mechanical systems can be regarded as sensors, whose inputs result in 
a decision based upon pre-determined logic. In a complex socio-technical system the control 
mechanisms may include organisational policies, protocols and guidance notes – some of 
which may be known or unknown to individual members of staff, and relevant or irrelevant to 
a specific patient or clinical scenario. 
The boundaries of a clinical system could also be more challenging to define. While a patient 
may attend a clinical service for a specified problem, the nature of healthcare is such that 
there may be an overlap with other related (or unrelated) clinical problems, and there is likely 
to also be an interface with other health and social care services (for example the ambulance 
service, outpatient and inpatient staff, or homecare providers). 
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External influences 
 
Given the nature of healthcare and the need to cater to the whole population, there are a broad 
range of factors external to the healthcare system that may be influential in its routine 
working. These may be highly relevant to the understanding of how the system operates, and 
the ways in which the system may practically be modified. Horizon scanning tools such as a 
‘political, economic, social, technical, legal, environmental’ (PESTLE) analysis216,217 reveals 
several such factors (figure 5). Each of these contextual factors requires consideration in the 
exploration of a complex clinical system, both to understand the influence on system function 
and to consider if, and how, they may be modified with improvements to the system.  
  
Chapter 2: A mixed-methods model for exploring clinical systems 
70 
 
 
 
Figure 5 PESTLE influences on healthcare216,217 
PESTLE (Political, Economic, Social, Technical, Legal and Environmental) is a horizon 
scanning tool which facilitates the exploration of these domains which may act as external 
influences on the system in question. Thorough analysis enables recognition of factors that 
may be relevant to system functioning, which may require to be accounted for in forthcoming 
planned system modifications, or which may prompt the need for system reconfiguration. The 
figure provides examples of the sorts of issues that may be highlighted by using this tool.   
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Political 
Healthcare in the United Kingdom is mostly state-funded, and heavily influenced by national 
party politics. The UK Cabinet’s Secretary of State for Health is ultimately responsible for 
the direction of the NHS in England, while the devolved assemblies in Scotland, Wales and 
Northern Ireland each have a Health Minister (or equivalent) who is responsible for the 
operation of their respective NHS service. The cycle of elections to the UK Parliament and 
the devolved assemblies, cabinet reshuffles, and other political influences, can impact upon 
health system function. While politicians are unlikely to exert a direct effect on a specific 
clinical system at an operational level, political climate influences aspects of system 
functioning including service funding, entitlement to care, demand and capacity. 
 
Economic 
Health and social care funding is highly politicised in the United Kingdom. Only a minority 
of procedures are funded directly by patients or private health insurance. NHS budgets are 
continually discussed in the media. As the population continues to age, patients live longer, 
and more expensive drugs and procedures become possible and desirable, financial pressure 
continues to grow. It remains unusual for funding to impact upon basic decision making 
around clinical investigations and treatments in the NHS, but it does influence organisations’ 
abilities to provide services; occasionally some types of care must be prioritised over others 
to maintain financially solvency.  
In other parts of the world, patients’ ability to pay for treatment, or the extent of their 
insurance coverage, plays a significant role in the overall healthcare journey. Patients may be 
unwilling to engage with expensive preventative strategies without perceiving any personal 
benefits and may only have funds to afford part of an overall treatment package 
recommended by their physician. Payment for healthcare remains a leading cause of 
bankruptcy in the United States of America. 
 
Social 
Patients increasingly expect to have rapid access to clinical tests and treatments and are often 
less able to appreciate the limitations or risks associated with healthcare. As patient 
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expectations expand, clinical practices may become more defensive, and some processes may 
experience changes in clinical demand or in their capacity to perform the same procedure 
safely. Social changes also impact upon the healthcare workforce. 
 
Technical 
As scientific and clinical advances enable more advanced diagnostic tests and treatments, 
further complexity is introduced to the clinical systems into which these new therapies are 
introduced. New processes bring new risks that can be predictable or unpredictable, related to 
the process going wrong or as an unforeseen consequence of the process going well. For 
example, with the advent of highly detailed clinical imaging it has become common to 
identify incidental findings on a scan, which then require further investigations that can lead 
to psychological distress and/or physical harm. Some technical advances have had a 
significant impact upon service configuration, infrastructure and workforce planning, for 
example the introduction of primary percutaneous coronary intervention to treat some forms 
of myocardial infarction. 
 
Legal 
A myriad of legal frameworks governs medical practice in the United Kingdom, including 
formal Acts of Parliament and guidance issued by the General Medical Council and other 
regulatory bodies. Other published guidance is also important, including recommendations 
made by learned societies, and government agencies. The legal context may also influence 
clinical behaviours, for example where clinicians adopt more defensive clinical strategies in 
response to higher risks of litigation218.  
 
Environmental 
The physical healthcare environment can significantly impact upon the practicalities of a 
clinical system, and has also been shown to influence patients’ perceptions of the care they 
receive219. Potential influences include the impact of service co-location on one campus, 
patient transportation and communication between clinicians in person, by telephone, post or 
electronic means.  
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Staffing 
 
The complex staffing matrix of a health service also requires attention. Medical staffing 
comprises those with substantive hospital contracts, and those who are placed in hospitals for 
specified periods of time as part of a specialty training programme. Patient care is directed by 
clinicians who are licensed to practise independently, but patients are highly likely to also 
interface with several other clinicians working under varying degrees of supervision. 
Contractual arrangements vary, including those employed by the hospital in question, those 
employed by third party agencies, and those given employment by the hospital under the 
direction of an authorised training organisation.  
The large number of professional and non-professional staff from a wide range of clinical and 
non-clinical backgrounds; with different experience and variable familiarity with the broader 
organisational context, generates significant potential for human error to be introduced into 
the clinical system. These may arise in the form of “slips, lapses and mistakes”, or 
occasionally as violations or deliberate acts220, as discussed in chapter 1B. 
 
Spatial and temporal factors 
 
Healthcare in the United Kingdom is broadly separated into community-based ‘primary care’ 
and centralised ‘secondary care’ facilities. Secondary care is delivered across district general 
hospitals and centralised teaching hospitals. The former provides a general level of care for a 
range of clinical problems at a local level, whereas more specialised services tend to be 
provided by the latter, which are usually located in major population centres. While the 
distribution of care between primary and secondary care services introduces an obvious 
potential for communication issues, there are other subtler factors requiring to be accounted 
for too. These include the need for sufficient capacity in both primary and secondary care to 
cope with the demand for service; a requirement for robust follow-up arrangements in the 
event that an investigation or treatment is ordered in one setting but has to be delivered or 
otherwise acted upon in another; consideration of transport arrangements for patients; and in 
some cases the need to provide overnight accommodation for patients in view of the distances 
between sites. This particularly affects remote and rural areas. 
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Additionally, patients may need to attend more than one hospital to receive care for the same 
problem, depending upon the clinical expertise, technical equipment and service 
configuration. When patients transit between hospital sites additional considerations are 
required, including the provision of transport and the need for communication between staff 
on multiple sites. Governance arrangements are required to clarify lines of clinical and 
administrative responsibility for the patient at each stage of the journey. 
 
System configuration (‘work-as-imagined’) 
 
It is necessary to establish the formal processes that exist to fulfil the objectives of the 
system. For example, in an outpatient clinic setting there may be processes for appointing 
patients; another used when patients are in the outpatient department; and another for 
managing the clinical administration associated with their appointment: test results, 
correspondence with other health professionals and so on. There may be associated policies, 
protocols, standard operating procedures and other documentation that has been formally 
approved by those responsible for governance in the system. These arrangements represent 
the formal system configuration, and how managers understand its function: ‘work-as-
imagined’. This might form the basis of existing system function or ‘success’ measures; 
understanding this will frame the realities of system working revealed in the subsequent 
investigation. The contrast of ‘work-as-done’ and ‘work-as-imagined’ can provide key 
insights that lead to improved system function196. 
 
Existing performance metrics 
 
Having established the system configuration and how it is thought to function (‘work-as-
imagined’), the next steps are to understand the definition of “success” currently applied to 
the system, and the metrics used to gauge this. Public audit standards, published clinical 
guidance, internal productivity measures, or other measures may be relevant here. 
Understanding the definition of success is important because this is likely to significantly 
influence system functioning and may explain differences between ‘work-as-done’ and work-
as-imagined. 
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Using data to engage clinicians 
 
Having established the system’s parameters, and how managers imagine its function, the next 
step is to explore routine working: ‘work-as-done’. Understanding routine system function, 
adherence to policies and protocols, and workarounds for practical problems, illuminates 
potential levers for system migration191,192. 
Metrics used to describe system functioning can be used to engage clinicians in an 
investigative process that determine the reality of ‘work-as-done’ within the system. 
Credible, quantitative data is used for this purpose, comprising a series of metrics that 
describes the output of the system in question. This may take the form of published registry 
reports, clinical audit data, or the findings of an external review process. The rationale for 
using quantitative data at this stage is twofold: clinicians are typically familiar with 
quantitative methods since positivist research forms the basis for most contemporary 
published clinical studies221; they often have little understanding of the nature, value or 
reliability of qualitative research methods222. Quantitative data is therefore likely to be more 
familiar to the clinicians whose engagement is required for the investigation to succeed and 
for its findings to be implemented. Additionally, the use of system metrics will highlight the 
perceived system inadequacies that may have prompted the investigation to begin with, for 
example: longstanding variation in AVF use for haemodialysis8. It is well recognized that the 
creation of such cognitive dissonance can be a strong motivator for change223.  
 
Determining system impact 
 
Having understood system configuration and performance metrics, the overall impact of the 
current system arrangement in terms of clinical outcomes, patients’ experience and financial 
cost should be demonstrated. This can partly be achieved by the investigator, but system 
stakeholders should also be consulted. To move beyond the investigator’s first impression of 
‘system impact’ will require insights from those working within the system including 
clinicians, managers, and others. The requirements of patients who interact with the system 
are then considered, to provide as rounded a view as possible. New measures of success, 
productivity and so on are then created in conjunction with system stakeholders: for example, 
a clinical system that manages a particular symptom (e.g. “headache”) might consider the 
risk/benefit ratio from using or avoiding particular clinical tests; the clinical outcomes from 
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using or avoiding a particular treatment; and the effect of actively or inadvertently not 
offering that same treatment to a given patient. The intention is to provide a rounded view of 
patient care within the system, using a suite of measures representing the financial, clinical 
and opportunity costs of system function in one form or another. 
This stage is likely to be the most resource intensive. It is necessary to conduct interviews 
with stakeholders; to develop additional metrics to inform these conversations; and to 
consider aspects of the system not previously identified. Measures to limit the potential for 
bias and ensure maximum variation224 are required to maximise the reliability, validity and 
credibility of the process. Confirmation of the investigative process face-validity is also 
required. Using the information gained from existing metrics, new metrics, stakeholder 
interviews and other data sources, a complete picture of system operation can be obtained. 
This can be related to published socio-technical frameworks178,187,191,192,207,208,210 and used to 
identify potential strengths and vulnerabilities of the current system configuration. The 
information provided by the investigation is ultimately used to inform and promote 
improvements to the system. Engagement of clinicians during the investigative process is 
intended partly to inform the investigation, but more importantly to garner support for the 
subsequent design, implementation and evaluation of system improvements. 
 
Quality assurance in qualitative research 
 
The final part of the investigative process seeks to quality assure the preceding steps. 
Measuring ‘quality’ in qualitative research poses significant challenges, in contrast to those 
measures that can be applied to quantitative methodological designs225–228. Measures of 
reliability and validity can be considered markers of quality225–227,229. The following sections 
discuss these issues and describe the steps taken to quality assure this work. 
 
Reliability 
 
‘Reliability’ in qualitative research setting refers to the extent to which a given data collection 
tool would gather the same information, were it repeated by a different researcher on a 
different day, but with the same subject227,230. It can be argued that the interaction between 
interviewer and interviewee is a unique encounter, but for the purposes of ensuring the 
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adequacy of the data collection exercise it is useful to determine whether substantial 
additional information could otherwise have been obtained during the interview process – in 
essence, whether the interview format was fit for purpose and would provide a consistent 
output were it conducted by another researcher. 
 
Validity 
 
The ‘validity’ of a qualitative research project can relate to the adequacy with which the 
methodology investigated the problem space and the congruence of the results with reality 
(‘internal validity’), and the extent to which the findings are generalizable beyond the study 
cohort (‘external validity’)231,232. In quantitative work these can be demonstrated by repeating 
experiments (internal validity); and by careful consideration of sampling and statistical 
techniques (external validity). For qualitative works these approaches are often 
inappropriate225; the nature of qualitative research is such that participants’ opinions, 
perspectives and values heavily influence the data and this cannot be ‘controlled’ in the 
manner of a randomised-controlled trial following a positivist paradigm. The equivalent 
measures of validity for qualitative research include the overall utility of the finished work to 
others (external validity), although this clearly can only become fully apparent once the data 
has been collected and analysed, and the results disseminated to a wide audience, at which 
point little can be done to change the conduct or analysis of the work.  
 
Triangulation 
 
Triangulation225,227 is often used to determine validity and reliability in research projects. 
This refers to the use of multiple techniques, data sources or analytical lenses to confirm or 
refute findings within a dataset. Various categories of triangulation are described233: 
• Method triangulation, where multiple methods are used to explore a given issue;  
• Investigator triangulation, where multiple researchers are involved in a study to 
provide alternative perspectives; 
• Theory triangulation, where different analytical lenses are used to analyse the same 
data; 
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• Data source triangulation, where data is obtained from different ‘categories’ of people 
within a population of interest. 
The concept of triangulation is easily understood, but in qualitative research there can be 
pitfalls with its use. Apparent inconsistencies between data sources do not necessarily 
represent ‘invalid’ or ‘unreliable’ data; such conflicts may illuminate interesting data points, 
suggesting a strength rather than weakness of the methodology234. Similarly, the apparent 
corroboration of data collected from multiple sources does not necessarily confirm the 
accuracy of the data235. A key facet of this study’s methodology lies in comparing 
perspectives of ‘work-as-imagined’ and ‘work-as-done’ in complex healthcare systems; it is 
argued that conflict of opinion and perspective is inevitable and indeed valuable to the 
investigative process, and so the process of data triangulation should not seek to eliminate 
such disagreements within the dataset.  
Other authors have demonstrated the value of triangulation within health research236; to this 
end, the present study employed several triangulation strategies: 
• Method triangulation – a mixed-methods approach was taken comprising semi-
structured interviews and a six-week census of quantitative data (as described later in 
this chapter); 
• Investigator triangulation – an ‘interview panel’ format that included experts in 
nephrology, vascular surgery and interventional radiology respectively, was utilised 
for semi-structured interview data collection and to assist with triangulation during 
the data analysis stages (this is described in more detail in the "interviewers” section 
later in this chapter); 
• Data source triangulation – interviews were conducted with clinicians representing all 
identified stakeholder groups within the VA system, from all ten adult and paediatric 
renal units in Scotland. Quantitative data was also collected from all nine adult renal 
units in Scotland. Pre-existing registry data was also considered in relation to each 
centre, including the incident and prevalent AVF use within each centre (figures 1, 2). 
 
Face validity 
 
A more useful measure of qualitative internal validity lies in its face validity: the degree to 
which participants considered that the methodology achieved its stated aim237 (in this case, to 
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understand the complex clinical systems concerned with the creation, maintenance and 
everyday use of VA for haemodialysis). This is distinct from ‘participant validation’, which 
involves inviting study participants to review the investigator’s analysis of the dataset, before 
the findings are formally reported and disseminated to the outside world. This can be 
hazardous since disagreement between the respondents’ perspectives and the conclusions 
drawn by the researcher do not necessarily imply that the project was invalid238.  
In the context of this study the methodological face-validity was considered most important, 
since the participants form a large part of the clinical audience to whom the eventual findings 
would be most relevant. Moreover, the mixed-methods model relies upon actions being taken 
by those who were engaged by the research process, and this engagement fundamentally 
depends upon participants’ perception that the project’s findings are credible. 
 
 
Justification of model approach 
 
The epistemology of the mixed-methods model is based upon social constructivism227,239. The 
function of any clinical system represents an amalgamation of professional opinions, provider 
infrastructure and governance, and individual patient factors. It is considered essential to 
ascertain the reality of system functioning – ‘work-as-done’ – rather than simply relying upon 
‘work-as-imagined’ which may not reflect reality. The inclusion of multiple stakeholders in 
the investigative process can add time and expense, but a maximum variation approach is 
most likely to provide a realistic idea of ‘work-as-done’, while providing a rich bank of 
examples that can be related to theoretical socio-technical systems frameworks. This 
contrasts a little with ‘positive deviance’ approaches (described in chapter 1) which seek to 
identify ‘unexpectedly good performance’; test its utility in other contexts; and subsequently 
implement the identified ‘deviant’ practice elsewhere. The model is sympathetic to the 
principles of this approach in that areas of existing good practice within the system will be 
identified – but the purpose of this model is not just to identify and upscale examples of good 
practice within complex systems. Rather, it seeks to identify gaps between ‘work-as-
imagined’ and ‘work-as-done’, from the perspectives of the system stakeholders, such that 
improvements can be designed to the system. In the frame of the current study too, it should 
be acknowledged that the complexity of VA care does not lend itself well in practice to 
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statistical comparisons of different processes, which would form part of a positive deviance 
approach. 
Preference is given to understanding routine system functioning rather than focusing upon 
occasions where system function did not proceed as intended, perhaps resulting in an adverse 
event. While it is sensible to remain mindful of hazardous episodes, these are regarded as one 
possible outcome of the current system configuration; it is argued that the finite time and 
resources available for improvement activity are better spent enhancing the resilience of 
everyday function, rather than attempting to prevent recurrence of specific, uncommon, 
scenarios. In this context, the term ‘resilience’ refers to the ability of the system to cope with 
unexpected events or to remain functioning despite deficiencies: for example, the ability of 
clinical areas to function despite computer failures, or when staff are unexpectedly absent.  
The model relies upon metric data and stakeholder interviews to determine system 
configuration and function, but principally orients around patients’ experience of care. If this 
is optimised it is likely that the system is functioning appropriately214,240. The term 
‘experience’ should be distinguished from ‘satisfaction’ and should not be regarded simply as 
a measure of convenience or some other aesthetic consideration. Multiple quantitative and 
qualitative data sources should be used to describe the system from multiple perspectives. 
These may provide contradictory information and might not be strictly “clean data” according 
to the positivist paradigm. This intends to highlight strengths, ambiguities, vulnerabilities and 
areas for improvement. A highly effective strategy for choosing quantitative metrics is to 
consider what might reflect optimised patient-centred care; this might include measures of 
efficacy, adequacy and appropriateness, along with measures of complications (including 
those associated with avoiding particular treatment options). This approach aligns with the 
Scottish Government’s Healthcare Quality Strategy103 which aspires to orient every clinical 
interaction around values relating to patient-centeredness. 
A qualitative approach to describing system function is necessary; the investigation seeks to 
understand normal working practices, but not to test whether one approach is necessarily 
‘better’ than another. Qualitative enquiry remains relatively unfamiliar to medical 
communities but can reveal a substantial depth and breadth of detailed information that is 
difficult or impossible to obtain using quantitative methods. 
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Methods of Vascular Access Appraisal 
 
The previous section described a mixed-methods model to investigate clinical care. This 
section details how this approach was used to explore Scottish VA services, and the 
subsequent quality assurance of the study. 
The mixed-methods model aims to thoroughly explore the workings of a clinical system 
through understanding its strategic alignment, operational realities, and metrics that 
demonstrate the impact of the system’s currently configuration. This is achieved by using 
existing quality measures to frame a series of semi-structured interviews with key 
stakeholders. The interview data is used to generate additional measures of quality and 
productivity. Together these qualitative and quantitative data describe the organisation and 
function of the clinical system; using the lens of socio-technical systems theory it becomes 
possible to analyse the system and design interventions to improve efficiency, quality and 
safety. 
 
Vascular Access system definition 
 
For practical purposes, most clinical systems are designed to serve specific clinical needs and 
are therefore organised according to the requirements of a specific illness, means of treatment 
or patient cohort. This study examines the clinical system concerned with haemodialysis VA, 
as discussed in chapter 1A. It seeks to understand VA as a “whole system” rather than by its 
constituent parts. It was intended that interactions between system elements, and their 
influences upon one another, would be appreciated and understood. The resulting insights 
will facilitate improvements to local services and benefit the broader clinical community 
delivering these services in Scotland and further afield. 
Using the approach described above, a mixed qualitative and quantitative investigative 
strategy was developed to explore the services concerned with the delivery of VA services. 
This was defined as all clinical interactions concerned with the assessment of patients who 
may require VA; the processes involved in VA creation and maintenance; the routine use of 
VA for haemodialysis; and all associated clinical activities. 
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System Parameters 
 
It was necessary to identify the parameters of VA systems, to consider potential external 
influences, and identify key stakeholders whose perspectives could provide insights about 
normal VA system function. It was also necessary to determine what metric data already 
exists to describe the VA service function.  
The basic principles of VA have been described in the introduction. From a systems 
perspective, VA care is concerned with the needs of patients who (may) require VA to 
facilitate haemodialysis treatment. This includes the cohort of patients who may reasonably 
require referral for VA creation; the VA creation pathway; the ongoing maintenance of VA 
(to optimise its patency); and the routine use of VA for haemodialysis. For the purposes of 
this study the processes of care concerned with alternative RRT modalities (including renal 
transplantation and PD), as well as those concerning conservative care strategies, are not 
considered to lie within the VA system boundary. This is in keeping with the author’s 
professional experience of working in renal medicine. It is accepted that system boundaries 
are often dynamic and poorly defined in real-world practice191,192. PESTLE analysis216,217 (see 
figure 5) would suggest that these other approaches to RRT provision could have potentially 
important interactions with VA systems, in keeping with the hierarchical nature of systems 
and the ‘system of systems’ concept discussed earlier172,173. Efforts will therefore be made to 
identify how these systems interact with, and potentially modify, VA services in each unit. It 
is judged however that a full examination of the separate systems concerned with creating, 
maintaining and using each alternative RRT strategy in each unit, in addition to those related 
to VA, would lie outside the scope of this project.  
Figure 6 describes key VA system stakeholders. They include a range of doctors, nurses, 
sonographers and managers, whose activity is focused upon patients who require VA for 
haemodialysis treatment. Doctors include nephrologists with responsibility for managing 
patients’ renal disease and haemodialysis treatment; vascular surgeons who create AVF or 
AVG; and interventional radiologists who maintain AVF or AVG and may be involved in 
TCVC insertion. Nurses include haemodialysis staff and Vascular Access Nurses specialising 
in VA assessment and coordination of VA creation and maintenance. Specialist sonographers 
conduct imaging assessments before and after AVF or AVG creation. Clinical and non-
clinical managers of the various clinical services interacting with the patient have budgetary, 
staffing and resource responsibilities.  
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Figure 6 Key stakeholders in Vascular Access Services 
The key stakeholders in VA services include a range of doctors, nurses, sonographers and 
managers. It should be noted that this diagram denotes the key stakeholders in the VA service 
but does not include the many other clinicians and administrators who are also involvement 
in patients’ journeys. 
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Metrics 
 
The most widely available data about VA services arise from published registry data. The 
annual Scottish Renal Registry report includes a dedicated VA chapter8; similarly, the annual 
UK Renal Registry report includes VA data9.  
The predominant measures of success in VA services relate to the proportion of patients 
whose first ever chronic haemodialysis session is delivered using AVF/G (“incident access”); 
and the proportion of patients within the haemodialysis cohort whose chronic haemodialysis 
sessions are routinely delivered using AVF/G (“prevalent access”)3. These data are published 
in registry reports8,9,11; see also figures 1 and 2. A related measure relates to SAB prevalence. 
Although not exclusive to haemodialysis patients, this cohort accounts for a large proportion 
of the overall SAB burden241. Bloodstream infection rates are published in registry reports 
and are also scrutinised by government agencies. The Scottish Government has instructed 
health boards to reduce SAB episodes39, hence this area receives significant attention at local 
and national level. 
No other measures of VA system function are routinely available in the public domain, 
although it is possible that individual renal units hold unpublished audit data. This may 
include numbers of hospital admissions, numbers of requested and completed procedures, 
and procedure outcomes. 
 
Qualitative data collection strategy 
 
Using the definitions, parameters and metrics described above, a qualitative data collection 
strategy was devised that would gather information on the routine working of VA clinical 
services from the perspectives of all key stakeholders. This was intended to realise aims 1, 2 
and 4 of the study: to delineate the structure of VA clinical pathways in Scottish renal units; 
to explore how clinical work occurs within and around these pathways; and to illuminate gaps 
between ‘work-as-imagined’ and ‘work-as-done’ in relation to Scottish VA services. 
Several means of data collection were considered, including questionnaire-based approaches, 
focus groups, and interviews. Table 6 describes their relative advantages and disadvantages. 
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Means of Data 
Collection 
Advantages Disadvantages 
Questionnaire Inexpensive 
Rapid data collection 
Limited level of detail 
Low response rate 
Focus groups Time efficient 
Group discussion of concept 
Individual views may be over 
or underrepresented 
Controversial views may not 
be expressed 
Technically difficult to 
transcribe 
Structured interview Level of detail limited by 
question design 
Rigid structure creates 
difficulty in exploring new 
ideas 
Semi-structured 
interview 
Rich level of detail 
Balance of standard 
questions with scope to 
explore new ideas 
Time intensive 
Interviewee may feel 
threatened by process 
Unstructured 
interview 
Rich level of detail 
 
Difficult to standardise 
between interviewees 
Relies upon forthcoming 
interviewee 
Table 6 Means of qualitative data collection with their relative advantages and 
disadvantages242–247 
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Questionnaires 
While questionnaires would provide a rapid and inexpensive mechanism for data collection, 
there was concern about the likely response rate and the potential for a lack of detail in 
respondents’ answers.  
 
Focus groups 
Focus groups242,245,247 were likely to provide a rich dataset in a relatively short time; there 
was a risk however that individuals could dominate the conversation while subtle political, 
financial and other influences could be difficult to ascertain. Besides the potential logistical 
and scheduling challenges organising focus groups of this nature, it was also unclear whether 
it would be most productive to hold focus groups involving clinicians representing individual 
renal units, to mix clinicians representing the same specialty in different units, or another 
iteration. Other authors have reported difficulty capturing data during focus group 
interviews242,244,247, and it was preferable to avoid situations where focus groups took place 
but the resulting audio recording was not practically usable. 
 
Interviews 
Interviews243–245,247 seemed the most appealing approach. Structured, unstructured and semi-
structured variants were considered. 
Structured interviews were deemed likely to have similar drawbacks to questionnaire-based 
approaches, with inflexibility for interviewers to discuss emergent issues without risking 
inconsistent data collection between interviews.  
Unstructured interviews were rejected in view of difficulties ensuring consistency between 
interviews, and the potential for interviews to focus on ‘bugbear issues’ rather than exploring 
the breadth of each interviewee’s VA service experience. This was judged particularly 
important since it was planned to interview clinicians from multiple professional 
backgrounds, who would likely hold differing perspectives on VA.  
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Semi-structured interviews 
Semi-structured interviews were considered to provide an optimal format. They would allow 
for individual perspectives to be sampled, using a consistent format between interviews but 
with flexibility to explore issues arising in the discussion using an ‘emergent probing243,248’ 
technique. There was also scope to modify the interview format as the project progressed by 
utilising ‘constant comparison249’ between interviews. 
 
Interview format 
Telephone interviews were considered impractical. The literature suggests telephone 
interviews tend to be shorter, afford interviewees less time to speak, and ultimately have 
reduced data yield, in comparison with equivalent face-to-face interviews250. Audio-recording 
telephone interviews would be difficult without specialist equipment; it would be difficult to 
involve multiple interviewers in the process; and participants’ body language and other 
nuances of conversation would be better appreciated in person. It would also be difficult to 
obtain written interviewee consent for telephone interviews.  
It was considered that face-to-face, semi-structured interviews with key VA stakeholders 
from each renal unit was most likely to yield useful data. From a logistical perspective it was 
considered more practical to visit each renal unit site to conduct interviews, rather than 
inviting participants to a central interview location. 
 
Sampling strategy 
 
Various sampling considerations were necessary, accounting for the need to balance detailed 
investigation with pragmatic concerns around investigator time and financial expense. 
‘Deviant case analysis’251 was considered as an alternative to involving all ten renal units in 
the study. This would involve comparing units considered ‘good’ and ‘bad’ by some 
measure, rather than including every unit in data collection. This could significantly reduce 
the time and cost associated with the study but was judged unlikely to provide a credible 
description of VA delivery across Scotland. Basing the sampling strategy upon a small 
number of existing metrics would involve unsafe assumptions, principally that these metrics 
were true representations of each centre’s organisation and function. Moreover, this would 
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mean basing the study on an arbitrary definition of ‘success’, which would significantly bias 
the methodology. It was therefore determined that a comprehensive interview strategy, 
involving all ten (adult and paediatric) renal units, was necessary.  
A purposive sampling strategy appeared advantageous for this study252,253. This is a non-
random sampling technique whereby specific individuals within the study population – in this 
case, within the VA system – are deliberately targeted to bring their perspective into the 
dataset. In keeping with other literature253, multiple purposive sampling techniques were used 
to maximise data capture: 
• A maximum variation approach224,253 was considered necessary, meaning that every 
perspective from each renal unit would be represented in the study; 
• Snowball sampling253,254 was utilised alongside recruitment via the investigators’ 
professional networks, as described below. 
The result of this process was that semi-structured interviews were arranged with all key 
stakeholders from the VA services in each Scottish renal unit. 
 
Interviewee recruitment 
 
The roles of key VA stakeholders are described in table 7. 
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Team Member Typical Role 
Nephrologist Responsible for overall medical care of the patient with kidney 
failure 
Vascular Surgeon Creates AVF, inserts AVG, and manages associated 
complications 
Interventional 
Radiologist 
Performs x-ray guided procedures including fistulography and 
fistulaplasty 
Sonographer Specialist imaging using ultrasound techniques 
Vascular Access 
Nurse / Coordinator 
Coordination of patients moving through Vascular Access clinical 
pathways; provides expertise in cannulation and troubleshooting 
access problems in RDU 
RDU Nurse Utilises Vascular Access to administer haemodialysis treatment to 
patient 
Table 7 Roles of Vascular Access team members 
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The first potential interviewees were identified using the investigators’ professional 
networks; they were approached via an email invitations. Snowballing254 was then used to 
identify and recruit additional interviewees, with the aim of achieving ‘maximum 
variation’224. Snowballing was utilised at the point of recruiting the original interviewees, and 
at the conclusion of each interview. The interviews continued on each site until all available 
interviewees had been interviewed, or until data saturation224,248,255 was reached.  
A nominated individual on each site agreed to host interview days. Their roles included 
arranging a private interview room, coordinating interview times, and liaising with an 
administrator to confirm interview dates and logistical arrangements. 
For logistical and financial reasons, visits to renal unit sites were planned on dates where 
most interviewees were available. Snowballing254 was used in advance of site visits to 
optimise the interviewee list, and during each interview to confirm that all stakeholders had 
been included in the process. Further site visits were scheduled to meet additional 
stakeholders when necessary. 
 
Interview guides 
 
Detailed interview guides243 (appendix 1) were created to facilitate each interview. These 
served as a reference point enabling the interview to flexibly cover all relevant topics during 
the interview, without requiring rigid adherence to a particular sequence of questioning256. 
They were also used by the lead interviewer and other members of the interview panel to 
make field notes.  
The guide was developed in a manner sympathetic to the published methodological 
literature257,258. The investigators’ prior knowledge of VA and the published VA literature 
(see chapter 1A) was used to create seven general questions that would explore the structure, 
function, productivity, strengths and vulnerabilities of each service. The questions were 
developed with reference to the VA system parameters and metrics described earlier, and 
with mindfulness of socio-technical systems properties, also described earlier.  
In addition to each question, interview guides listed what were considered key issues to be 
discussed within each category. These were intended to prompt the interviewer and to ensure 
consistent discussion of topics with each interviewee while allowing for free-flowing 
conversation. Mock clinical vignettes were appended to the interview guide to stimulate 
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discussion if necessary. These were designed to mimic ‘typical’ patients likely to be 
encountered by VA services, with the intention that interviewees could potentially use these 
mock cases to describe how such a patient could progress through the local VA service.  
It is good practice to pilot interview guides257,258. The nature of VA services, the small 
clinical VA community, and the sampling strategy for this study (see above) meant it was not 
practical to conduct pilot interviews with individuals who were not participating in the study. 
Instead, the first interview date was scheduled around six weeks before the subsequent 
interviews, allowing for the interview guide to be piloted and amended if necessary before 
the main data collection period began. In the event, no major changes were required based 
upon the pilot interview.  
 
Interviewers 
 
The author was present at, and led, every interview. He had previously worked in three of the 
ten renal units (NHS Tayside, NHS Greater Glasgow and Clyde, NHS Lanarkshire) but at the 
time of the study did not have a full-time clinical role. Between one and three additional 
interviewers were also present at each interview. The panel was constructed based upon 
interviewer availability, and in a manner that avoided colleagues who normally worked 
together interviewing one another. A total of six individuals participated in the interview 
panels; one interviewer was also an interviewee, who was recruited to join the interviewer 
panel after being interviewed herself at the beginning of the investigation. 
Traditionally, research interviews are conducted by solo interviewers, but for this study a 
panel interview format was used, using a panel comprising clinician experts in nephrology, 
vascular surgery and interventional radiology. This was considered essential in view of the 
clinical complexities surrounding VA, and to prevent interviews becoming sidetracked by 
uncertainties around technical aspects of VA care. 
Little has been written about panel (rather than solo) interviews in qualitative health research, 
although the technique has been recognised in other areas for decades. The dynamic of the 
interview is clearly different from a one-on-one encounter, but various advantages have been 
cited in the literature: the ability to create less formal discussions; better awareness of time 
and progress through the interview guide; more capacity to ‘observe’ interviewees’ body 
language; and greater overall capacity to gather information from the interview process259,260. 
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In this project, the presence of an expert panel also enabled triangulation of data during the 
interviews, for example to identify and develop points where a key clinical detail was noted 
to vary between interviewees within or between centres.  
 
Interview format 
 
Interviews were conducted in a private room within the interviewees’ host institutions, during 
normal working hours. Only the interview panel and interviewee were present in the room. 
Efforts were made to interview individuals without colleagues being present, but on one 
occasion for logistical reasons it was necessary to interview two vascular surgeons together.  
Interviewees had received written information about the interview in advance of the interview 
date; before each interview the same information was conveyed orally, and the participant 
had the opportunity to ask questions. Written, informed consent was obtained before the 
interview began.  
The lead interviewer opened and led the discussion on each occasion. The interview guides 
were used to guide the discussion, which flowed in a dynamic fashion. Reference was made 
to the mock clinical cases where necessary, for example to illustrate how a patient could 
progress through a clinical pathway. Expert contextualisation was sought from interview 
panel members where necessary, for example to clarify technical aspects of interventional 
radiology procedures.  
Emergent probing261 was used in two ways during the interview. The lead interviewer probed 
issues arising in the discussion that were not featured, or out of sequence in the interview 
guide. When the lead interviewer had concluded the discussion as directed by the interview 
guides, the remaining interviewers were then given the opportunity to ask further questions 
that clarified or expanded upon the issues discussed. In this way the full content of the 
interview guide and any emerging issues were covered.   
All interviews were audio recorded using a laptop computer running Windows Sound 
Recorder (Microsoft Corporation, Seattle, USA). A pocket Dictaphone provided backup 
audio recording. Audio files were stored on a secure drive, for subsequent audio-transcription 
by secretarial staff. Contemporaneous field notes were made by the interview panel, using the 
printed interview guide templates. 
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Constant comparison249 was utilised between interviews, and between site-visits. This 
optimised data capture and enabled the exploration of emerging issues within centres and as 
the project progressed. 
 
Interviews 
 
Between September 2014 and February 2015 all ten adult and paediatric renal units in 
Scotland were visited and interviews conducted with staff. Tables 8 and 9 provide further 
interview details.  
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Renal Unit Number of Interviews Total Interview Duration 
Unit 1 4 2 hours18 minutes 
Unit 2 4 2 hours 57 minutes 
Unit 3 5 3 hours 3 minutes 
Unit 4 1 43 minutes 
Unit 5 5 2 hours 8 minutes 
Unit 6 4 2 hours 21 minutes 
Unit 7 4 2 hours 52 minutes 
Unit 8 9 6 hours 48 minutes 
Unit 9 4 3 hours 32 minutes 
Unit 10 
(Paediatrics) 
2 
1 hour 3 minutes 
Table 8 Number and duration of interviews by centre 
A total of 42 interviews were conducted with a broad spectrum of clinicians in each unit. 
Interviews lasted approximately 45 minutes on average. 
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Specialty 
Number of 
Interviews 
Total Interview 
Duration 
Nephrology 13 8 hours 35 minutes 
Nurses 4 2 hours 42 minutes 
Vascular Access Nurse 7 5 hours 25 minutes 
Vascular Surgeon 9 6 hours 14 minutes 
Interventional Radiologist 8 4 hours 32 minutes 
Sonographer 1 20 minutes 
Table 9 Number and duration of interviews by specialty 
A total of 42 interviews were conducted with clinicians across all ten adult and paediatric 
renal units in Scotland. All but one interview was conducted with a solo interviewee in a 
private room; for logistical reasons, one of the surgical interviews had two surgeons present 
during one interview. “Nurses” refers to nurse practitioners and RDU nurses but does not 
include Vascular Access Nurses, who are counted separately.  
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Interview transcripts 
 
Audio transcripts were typed by a team of secretarial staff, using the interview audio 
recordings, to facilitate thematic analysis of the data. It was considered impractical for 
thematic analysis to be carried out using the raw audio recordings. Similarly, it was not 
feasible for the lead interviewer to transcribe every recording.  
Each typed transcript was quality assured by the lead interviewer. This involved comparison 
of each line of prepared transcripts with every word of spoken audio from each interview. 
Transcripts were amended as required until they fully reflected the recorded interview. Many 
audio files required digital enhancement to remove background noise to facilitate quality 
assurance; this was achieved using freely available software (Audacity version 2.0.6, 
audacityteam.org). The final, combined, quality-assured transcript word count was 
approximately 260,000 words. The quality assurance process took several months to 
complete. 
 
Transcript analysis 
 
The completed, quality-assured transcripts were subjected to thematic analysis262. This 
technique enables the recognition of ‘themes’ emerging from the data in a manner that 
facilitates their presentation and further analysis, and ultimately reach conclusions and 
generate recommendations for practice. The purpose of this study was to delineate the 
structure and function of VA pathways (being mindful of socio-technical systems theory), 
and to illuminate gaps between ‘work-as-done’ and ‘work-as-imagined’ from the perspectives 
of VA system stakeholders (being mindful of healthcare resilience engineering principles). 
To this end it was considered that thematic analysis would provide a revealing analysis of the 
interview data and enable the formulation of conclusions and recommendations for practice.  
Other techniques were considered. Content analysis has many similarities to thematic 
analysis but has a tendency to seek quantitative weighting within the data, potentially at the 
expense of discrediting the analytical process263. Narrative analysis is a process of finding 
meaning by presenting data in a (narrative) story format264. This often requires a degree of 
‘narrative smoothing’, which may be considered as selective reporting of dataset elements to 
enable the final story to coherently fit together. This seemed at odds with the study ambition 
to illuminate ambiguities in VA care. Discourse analysis provides understanding of meaning 
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through analysis of language265; while this may provide interesting insights into  elements of 
VA care, the technique seemed unlikely to fully meet the aims of the study. An ethnographic 
approach would combine interview data with close observation of VA services266. This was 
considered impractical in view of the large number of hospital sites involved, and the 
disparate nature of VA services within a given renal unit (based upon the investigators’ 
professional experiences). Moreover, it is acknowledged that ethnographic approaches tend to 
amalgamate researcher and subject perspectives and do not provide generalisable data; each 
of these factors were considered disadvantageous to this work.  
 
Thematic analysis 
 
Thematic analysis was conducted according to published methodological standards267,268. The 
author became fully immersed251 in the data through leading the interviews and performing 
detailed quality assurance of the audio-transcripts. Initial codes were generated through 
review of the full dataset. Coding was done manually, using qualitative analysis software 
(nVivo 10, QSR International Pty, Melbourne, Australia) to visualise the data, record codes 
as the analysis progressed, and to provide an audit trail of the overall coding process.  
Themes were identified in the data through line-by-line analysis of each transcript, using 
constant comparison249 throughout the process. A ‘theme’ was taken to mean a piece of data 
that seemed important in relation to the research questions. An inductive coding process was 
used, with the intention to provide a rich description of the whole dataset. Themes were 
identified at a latent level, that is, the coding sought not only to locate data of interest within 
the transcripts, but also to consider the assumptions and beliefs underpinning the data.  
All initial themes were considered by the author in conjunction with the other investigators, 
who had formed the interview panels (described earlier). Through a series of meetings, 
further transcript review, and ongoing constant comparison, the perspectives of those 
working in the same unit, those holding similar professional roles in different units, those 
with similar and contrasting views on a topic, and every iteration thereof, were considered in 
detail. This process led to the generation of several themes that were then combined to form 
four axial themes, around which a series of recommendations could be made (table 10). The 
full results of the thematic analysis are described in detail in the results chapters of this thesis.  
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Theme Inclusions 
Creation of Vascular 
Access 
Processes involved in VA creation, including formal, informal and 
workaround processes. Clinicians’ opinions of VA modalities are 
also considered. 
Maintenance of 
Vascular Access 
Processes involved in VA maintenance, including formal, informal 
and workaround processes. VA surveillance is also considered here, 
including clinicians’ opinions and the processes involved for 
centres who routinely perform surveillance. 
Service Performance Issues that were said to impact upon routine function are considered 
here. These include historical and geographical context; clinical 
time and resources; tracking patients’ journeys; unscheduled care; 
timelines; the recording and reporting of clinical outcomes. 
Development Needs Areas for service development are considered here. These include 
the self-reported strengths and weaknesses from each service; 
multi-disciplinary working; strategies for vein preservation; the use 
of electronic health records; barriers to efficiency; and issues 
around team working. 
Table 10 Axial themes arising from the thematic analysis 
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Inevitably with a very rich dataset, the centres where more interview time was possible – 
thought to be a function of unit size and staffing complement – tended to generate more 
coded data (see tables 8 and 9 above). The nature of thematic analysis is such that themes 
cannot be assessed according to a weighting or other form of prioritisation, simply based 
upon their frequency within the dataset. Indeed, analyses where data is weighted according to 
its frequency in the dataset re generally discredited in the literature, although similar 
techniques to identify themes based upon recurring phrases have been described263,267.  
Data coding was exclusively performed by the author. A weakness of this approach is the 
potential introduction of bias into the data coding strategy, however various authors have 
described additional complexities, costs and other challenges associated with multiple 
researchers coding the same dataset269,270. It is suggested the benefits of dual coding lie more 
in the discussion of disagreements in coding rather than simply ensuring both researchers are 
following the same pattern of coding271. With this in mind, and for practical purposes, we 
held a series of informal team meetings throughout the coding process where the coding 
strategy, transcript content, and emerging themes were reviewed and debated. This served as 
a proxy for dual coding, accepting that the absence of formal dual coding was a limitation of 
the methodology used. 
 
Quantitative data collection 
 
This phase of the study was designed to answer research aim 3: to quantify the clinical 
workload associated with VA services. This would supplement existing registry data 
concerned with incident and prevalent Vascular Access8, and inform the development of new 
metrics to better describe VA system function. 
The paediatric centre was excluded from this component of the project, due to the significant 
differences in its patient population and VA-related clinical workload (as described during 
the interviews).  
Quantitative data collection began after the semi-structured interviews had concluded. A 
coordinating clinician on each site was recruited by email or telephone discussion. Data was 
collected using a pre-formatted spreadsheet (appendix 2) provided electronically to each unit. 
This was designed to enable data collection in an efficient manner that struck a balance 
between collecting a sufficiently detailed dataset for analysis, with mindfulness that the 
Chapter 2: A mixed-methods model for exploring clinical systems 
100 
 
coordinators on each site were collecting and providing this data in addition to their usual 
duties at work. 
Each unit was asked to record all VA-related hospital admissions, along with surgical and 
interventional radiology procedures requested or performed during the six-week period 
26/1/15 – 6/3/15 inclusive. The definition of “VA-related” was left at the discretion of the 
coordinating clinicians, within the parameters described on the data collection spreadsheet 
(appendix 2). Coordinators were also asked to indicate whether ‘unusual events’ occurred 
during data collection period, for example staff absence, theatre downtime, extraordinary 
disruptions to clinical services and so on, which could have influenced the quantity of work 
performed during the census period. 
The dates and duration of this clinical activity census were chosen for convenience, avoiding 
major holiday periods, and striking a balance between maximising data returns without the 
process becoming overly onerous for coordinators in each centre. It was judged unlikely that 
many procedures would be requested and performed within the six-week window, hence 
details of both ‘requested’ and ‘performed’ procedures were sought, and efforts made to 
eliminate duplicate entries. This was intended to gauge the volume of procedural activity, 
and, where the date of referral and procedure were available, the indicative waiting times in 
each centre.  
The data-collection spreadsheets were returned electronically to the lead investigator at the 
conclusion of the six-week period. The data were collated to provide a national picture of 
access-related clinical activity across all nine adult renal units. Where data was missing, 
ambiguous or incomplete, efforts were made to resolve this through dialogue with the local 
coordinator at the appropriate renal unit.  
The dataset was analysed using Microsoft Excel 365 (Microsoft Corporation, Seattle, USA). 
Procedure names were coded to ensure consistency between centres. The complete dataset 
was then subjected to analysis and used to contextualise the interview data. 
 
Avoidance of bias 
 
The qualitative nature of this study, and the lack of consensus on many aspects of the clinical 
system in question, emphasised the importance of taking steps to limit the potential for bias 
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during the investigative process. Several techniques were used to protect the process from 
becoming overly influenced by isolated opinions. These are discussed below. 
 
1. Sampling strategy 
A purposive sampling strategy252, augmented by snowballing254, enabled the identification of 
all stakeholders in each renal unit, to provide a comprehensive view of the VA service as 
judged by the others working in that centre. It was highly unusual throughout the interview 
process to encounter the name of a key individual who did not already have an interview 
scheduled, or who had already been interviewed. This sampling strategy prevented bias 
arising from over-representation of a particular group of clinicians, individuals known to the 
interviewers, or those with a particular viewpoint. 
Significant efforts were made to accommodate interviewees. Site-visits were made to twelve 
hospital campuses, with return visits where needed, to meet all the participants. Everyone 
who originally agreed to participate in the study was interviewed. 
The sampling strategy involved every key clinician from VA services in each renal unit. 
While it was not feasible to interview every clinician interfacing with every service, the 
sampling approach provided as near to a full-population sample as was practically possible. 
The large sample size, and the depth of each interview, enabled the reliability of the data to 
be confirmed. By triangulating comments by different interviewees about the same service, it 
was possible to corroborate assertions made. It must be acknowledged however that 
‘perceptions’ of a system, as opposed to ‘facts’, are equally valuable to the analysis225, hence 
assertions that were not triangulated were not discounted from the analysis.  
 
 
2. Interview format 
The semi-structured interview format was advantageous for the reasons described earlier. 
Emergent probing243,248 and constant comparison249 ensured the key points were covered in 
each interview, while the interview panel format prevented important issues being omitted. 
Solo interviewees meant there was less risk of social bias or power gradients influencing the 
interview, at least from within the centre. It is acknowledged that the interview panel was 
composed of senior clinicians; while this may have influenced participants’ willingness to 
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speak freely, investigator familiarity with the context being studied is considered a criterion 
for quality qualitative research235. Participants’ willingness to speak honestly was explored in 
more detail in a face-validity sub-study, described at the end of this chapter. 
 
3. Data saturation 
Interviews continued at each renal unit site until data saturation224,248,255 was reached within 
that unit. The interview panel agreed by consensus when saturation had been reached in each 
centre. This was further confirmed during interview transcript quality assurance. Additional 
site visits were arranged if the scheduled interviews did not result in data saturation being 
reached.  
 
4. Transcript coding 
Each transcript was quality assured before the thematic analysis began, as described above. 
Frequent discussion among the investigator group, and with clinicians from each renal unit, 
enabled sense-checking of ambiguities emerging from the dataset.  
A single investigator performed all data coding during the thematic analysis. This avoided 
potential problems with ambiguous or divergent coding strategies employed by multiple 
coders. The potential for bias with this approach is acknowledged; this was limited by the 
frequent comparison of transcripts from interviews of individual clinicians, those 
representing the same professions on different sites, and those representing the same renal 
units.  
Initial coding was conducted according to the chronological order of the interviews (and 
hence the chronological order with which transcripts became available); however, during the 
several months of data coding each transcript was examined in detail, on several occasions, 
and in random order. 
A summarised version of the coded data within specific themes was created and shared 
within the group of investigators. This document represented the major perspectives from 
each professional group and geographical centre on each coded theme. This ensured that a 
consensus could be reached as to the important points arising within each theme, without 
neglecting unusual or polarised points within the data. 
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Dissemination of findings 
 
The final aim of this study was to present the findings to the clinical community in a manner 
that facilitated ongoing QI. Three strategies were employed to achieve this.  
The findings and associated recommendations for practice were formulated into a written 
report, which was distributed to all project participants and made freely available online.  
A full-day feedback event was convened at the Queen Elizabeth University Hospital in 
Glasgow on 26 November 2015, where members of the VA community from Scotland and 
further afield were introduced to the result, the report, and the recommendations. This event 
was supported and introduced by the Chief Medical Officer for Scotland.  
The third strategy involved the creation of a ‘scorecard tool’, detailed below.  
 
Scorecards 
 
The recommendations arising from the study were intended to facilitate QI across the VA 
community. Being mindful of the large number of recommendations and the limited clinical 
time available within VA services, a novel ‘scorecard’ approach was designed. This aimed to 
present the recommendations in an operationalised format that prompted QI activity while 
enabling units to benchmark their service characteristics against other centres.  
To construct the paper scorecard tool, which was launched at the feedback event and 
published online alongside the report, each recommendation was broken down into simple 
questions that could be answered with a binary ‘yes’ or ‘no’. A total of 68 questions were 
written (appendix 3) using language judged accessible to clinicians and managers alike. The 
original version was subsequently amended for online data collection using the Google Forms 
platform (Google; Mountain View, California) where a third ‘don’t know’ option was added 
to the possible responses. This was added to avoid the scenario whereby respondents were 
unsure about a question but felt compelled to answer ‘yes’ or ‘no’ and therefore potentially 
bias the results. Demographic information was also collected, about the unit being 
represented, respondents’ professional background, and their main role within the local VA 
team.  
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Clinicians and managers representing all specialties in every adult renal unit in Scotland were 
invited to complete the scorecard questionnaire with respect to their own unit. For practical 
purposes the Google Forms platform was used to collect this data, and paper responses were 
not solicited. The invitation to complete a scorecard was first extended to those who had 
agreed to be interviewed for the study; in keeping with the principles of snowballing254 they 
were also asked to forward the invitation to others within their organisation who may also be 
willing to respond. Responses were partly anonymous: demographic information was 
collected to ascertain the location and specialty of the respondent, but not their name or other 
identifying information. Demographic information was ‘required’ but all other questions 
were optional.  
It was intended that the scorecards would provide a ‘map’ of Scottish VA services with 
respect to the implementation of the study recommendations. The first data collection 
exercise would provide a baseline for future comparison. This map would enable 
benchmarking of units and allow colleagues from across the community to consider VA 
service elements missing from their local service, but which were present in adjacent units. It 
was hoped that the process of completing the online scorecard tool would itself bring local 
services together and stimulate local QI activity by effectively providing a menu of ‘things to 
do’.  
The submitted data was collated and analysed at the level of individual units, by professional 
group, and as a whole. These results are discussed in Chapter 10. 
 
 
Face validity of the Vascular Access Appraisal 
 
A sub-study was designed to evaluate the face validity of the semi-structured interviews. Its 
aims were firstly to determine the extent to which interviewees felt able to express their 
views, whether there were additional areas of interest that had not been discussed during the 
interview, and if there were any problems or concerns relating to the interview format. A 
secondary aim was to assess participants’ perceptions of the importance of the VA project, as 
a surrogate of their willingness to engage with any recommendations arising from the project 
findings.  
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Methods 
 
Being mindful that potential participants in this sub-study had already spent considerable 
time being interviewed, efforts were made to minimise further inconvenience while 
maximising the response rate. Anonymity was considered important to increase the chance of 
receiving negative opinions about the methodology. A web-based questionnaire format was 
therefore determined to provide the best format for this sub-study, achieving a balance 
between participant convenience and anonymity, but with the ability to collect meaningful 
data.  
The online survey engine ‘Surveymonkey’ (SurveyMonkey, San Mateo, California) was used 
to host the survey, using a free account.  Questions were designed to capture relevant 
information, without the survey taking an onerous amount of time to complete. The questions 
are in table 11. 
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The purpose of the interview was to hear your experience, and your views, of “how 
Vascular Access works” in your unit. To what extent did the interview achieve this? 
Were you asked leading questions, or did you feel able to answer freely? 
Were there issues you felt unable to discuss during the interview? 
Did the interview cover all of the relevant points? What else should we have asked about? 
Were the interviewers interested in what you had to say? 
Did you feel uncomfortable or intimidated by the interview process? 
Was the interview [about the right length, too short, or too long]? 
Do you think this project is worthwhile overall? 
What did you think of the interview format? Is there anything you would change? 
Did the interviewers make the best use of your time? 
Table 11 Face-validity questionnaire 
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During the interview phase of the study, all participants were invited to provide a contact 
email address after their interview and after audio recording had ended. Their email address 
was noted on the interview guide used to record field notes during that particular interview. 
Participants who provided an email address were sent a single, email invitation to complete 
the online questionnaire. Invitations were sent by the end of the next working day after the 
interviewers had concluded interviews on that site, and only after the interview panel had 
physically departed from the site. The questionnaire was continuously accessible online for a 
period of at least four weeks after the invitation was issued, meaning the final interviewee 
had at least four weeks to respond while earlier interviewees had several weeks longer.  
An individualised email invitation was sent to each participant, but the same response 
weblink was provided to everyone. This meant it was not possible to track who had 
responded to the questionnaire, although the total number of respondents was visible. No 
reminder invitations were sent to avoid ‘pressuring’ non-participants to participate, to avoid 
inconveniencing those who had already responded, and to minimise the risk of receiving 
duplicate responses. 
 
Results 
 
A total of forty-three staff were interviewed across the nine adult and one paediatric renal 
units in Scotland. Every member of staff provided an e-mail address and was invited to 
respond to the online questionnaire. 
A total of forty (77%) respondents completed the online questionnaire. Responses were 
anonymous thus it was not possible to determine respondent demographics. The high 
response rate to the online questionnaire provided assurance that most participant subgroups 
were included in the results.  
All respondents considered the interview had achieved its intended aim (26 “completely 
achieved”, 14 “mostly achieved”): to hear interviewees’ experiences and views about the 
configuration and function of VA in their renal unit. All 40 respondents felt able to speak 
freely, and none felt they had been asked leading questions. Most respondents (37) felt the 
interview covered all relevant points. Suggested additional points included questions around 
the demand for inpatient beds. Most (37) respondents reported there were no issues they had 
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felt unable to discuss during the interview. Two felt that some topics had been missed, and 
one stated there was one topic they had felt uncomfortable discussing.  
All 40 respondents felt the interviewers were “completely” interested in what they had to say 
Most interviewees felt comfortable during the interview process. 33 were “not at all 
uncomfortable”; 5 were “not very uncomfortable”; 1 was “a little uncomfortable” and 1 was 
“completely uncomfortable”. Free text comments included one respondent who felt 
uncomfortable with being audio recorded, and another who felt uncomfortable being asked 
questions that related to their colleagues’ clinical performance. Most (38) thought the 
interview was the right length of time; 1 felt it was too long; 1 felt it was too short. 
Respondents were mostly satisfied with the interview format, although several commented 
that they would have preferred more information about the process in advance. 
Most (38) felt the project was worthwhile. One respondent did not feel it was worthwhile, 
and 1 was unsure. Free-text comments included “this will lead to better collaboration across 
Scotland” and concern about “what clout this [study has]”. All respondents (37 of 40 who 
answered question) felt their time had been used optimally, with many commenting that they 
had enjoyed participating. Many participants additionally used free-text comments to express 
their thanks for being included; their enthusiasm for effecting positive change following their 
interview; and to volunteer their ongoing support.  
 
Discussion 
 
These data suggest that the semi-structured interviews had face validity across a broad range 
of interview participants. While not all interviewees participated, the response rate was very 
high and comparable with similar questionnaire-based approaches to research.  
The typical interview time of around 45 minutes was comparable with reports from the 
literature, albeit some interviews were considerably longer247. It is encouraging that 
interviewees generally felt the interview length had been appropriate to the topic and 
considered their time had been used well. 
It was not intended that participants should feel uncomfortable during the process, and indeed 
this would be disadvantageous to the subsequent workings of this model for investigation 
(where interview participants are actively engaged in implementing changes). The results 
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suggest that the interviewers’ probing for details was probably to an appropriate level, and it 
seems likely that the true ‘work-as-done’ function of VA services was captured from a 
variety of stakeholder perspectives.  
 Some of the reported discomfort may have arisen from participants feeling they were being 
“assessed” rather than interviewed, and indeed it was clear many clinicians felt personally 
responsible for their service and its results, regardless of their practical ability to directly or 
immediately influence it.  
Participants were not pre-briefed about interview content, other than that it concerned their 
role in the local VA service. This was intentional and to avoid participants attending 
interviews with prepared answers; it was judged important that they gave spontaneous 
responses to questions. 
In conclusion the semi-structured interviews appeared, from the perspective of the 
participants, a to have good face-validity as a means of determining the configuration and 
functioning of VA services. 
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Results  
 
Earlier chapters have highlighted the unwarranted variation between Scottish renal units in 
their use of AVF for haemodialysis treatment. VA services have been framed using the socio-
technical systems literature, and a mixed-methods model for investigating clinical systems 
has been described, developed with sociotechnical systems theory and Safety II in mind. This 
model has been used to explore Scottish VA services with the aim of delineating their 
structure, function and workload. The face-validity of the investigative process has been 
assessed, and the resulting data subjected to detailed thematic analysis. The following 
chapters 3-9 describe the study findings. These findings then lead to the development of 
recommendations for practice, which are presented to the clinical community using a 
scorecard tool, described in chapter 10.  
The study yielded a rich tapestry of data. Where possible, findings are illustrated with 
verbatim quotations arising from the transcripts. In some cases the data was best suited to 
presentation by unit and/or in tabulated form; in others the findings were best described in 
summary form across all units. It should be recognised that the findings arising from the 
thematic analysis reflect the coding process and the themes that emerged from the dataset. 
The chapter headings are therefore derived from the findings of the study, rather than strictly 
following the order of questioning in the interview guide, albeit there are obviously broad 
similarities.  
For the purposes of clear presentation, the findings are related across several chapters. It is 
acknowledged however that their separation under discrete chapter headings is somewhat 
arbitrary given the interdependent nature of socio-technical systems, and in keeping with 
systems principles, the results chapters and discussion should be considered as a whole.  
They are presented as follows: 
1. Creation of Vascular Access (chapter 3), including clinicians’ opinions relating to 
different Vascular Access modalities (chapter 4); 
2. Maintenance of Vascular Access (chapter 5), including the surveillance of Vascular 
Access (chapter 6); 
3. The results of the six-week clinical activity census (chapter 7); 
4. Issues affecting Vascular Access service performance (chapter 8); 
5. Development needs for Vascular Access services (chapter 9). 
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The subsequent chapters discuss the findings and associated recommendations for practice, 
and their presentation using the scorecard tool.   
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Chapter 3: Creation of Vascular Access 
 
This study aimed to delineate the structure, function and workload associated with VA 
services in Scotland.  The data were acquired using the mixed-methods model described in 
chapter 2, and subjected to thematic analysis.  This chapter addresses the first research aim of 
the study, relating the first set of results grouped under the theme ‘creation of Vascular 
Access’.  
Perhaps the most obvious finding from the thematic analysis was that no renal unit routinely 
made a distinction between ‘VA creation’ or ‘VA maintenance’ as two distinct processes 
involving separate clinical pathways, different clinicians, and different clinical need. Rather 
the VA service was considered as one entity, with some patients requiring procedures by 
surgeons, and others needing interventional radiology work.  
It was unusual for the VA creation clinical pathway to exist in written form, although 
interviewees could describe how the relevant processes were arranged and how they typically 
functioned.  It is helpful to first consider the formal ‘work-as-imagined’ processes before 
describing the reality of how these processes function. These are considered in the following 
two sections.  
 
Processes 
 
The major elements of the VA creation pathway are shown in figure 7, which represents an 
amalgamation of the clinical pathways used by each centre. Table 12 describes the 
characteristics of VA creation pathways in use by each centre. These should be considered 
alongside the unit-specific VA creation pathway diagrams (appendix 4).
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Figure 7 Generic Vascular Access creation pathway 
This pathway diagram reflects an amalgamation of the clinical pathways in use by each renal 
unit. The pathways used by each individual unit are described in appendix 4.  Several steps 
were identified in the process of VA creation: 1) referral of the patient into the pathway, 2) 
design of a VA approach, 3) a VA procedure, and 4) subsequent follow-up. Patients were 
referred for AVF creation once a decision had been made that they were going to receive 
haemodialysis treatment. The formality and mechanism of referral varied by unit. Patients 
were typically seen in a VA clinic and may require vein mapping and/or further discussion at 
an MDT meeting prior to joining the waiting list for a specified procedure. They were then 
listed for a procedure that would variably proceed dependent upon anaesthetic pre-
assessment, bed availability and treatment time guarantees. They would then enter the VA 
maintenance pathway. Note that post-operative follow-up is considered later in this chapter.   
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Unit 1 2 3 4 5 6 7 8 9 
VA 
Creation 
Policy No No No Yes Yes No No No No 
Referral 
trigger 
eGFR <15 
or 
clinician 
judgement 
Clinician 
judgement 
eGFR <20 or 
clinician 
judgement 
Within 12 
months of 
RRT 
eGFR <15 or 
rapidly 
deteriorating 
eGFR <15 Within 3-4 
months of 
RRT 
Within 12 
months of 
RRT or 
clinician 
judgement 
eGFR 15-
20 or 
clinician 
judgement 
Referral 
mechanism 
VAN 
written 
proforma 
VAN 
email and 
surgeon 
letter 
VA 
coordinator 
informal 
discussion 
during low 
clearance 
clinic 
Written 
proforma 
with email or 
letter to 
surgeon or 
secretary 
VAN written 
proforma 
Surgeon 
and VAN 
letter 
VAN letter 
or written 
proforma 
VAN 
email 
referral or 
letter 
VAN email 
referral 
Referral 
tracking 
Paper Electronic Paper Memory Electronic Electronic Whiteboards Electronic Memory 
Access 
clinic 
Yes No Yes Yes Yes No Yes Yes Yes 
Clinic 
frequency 
Monthly N/A Weekly Fortnightly Fortnightly Informal Twice 
weekly 
Twice 
weekly 
Fortnightly 
Clinic 
attendees 
Surgeon N/A Surgeon, VA 
Coordinator 
Surgeon, 
sonographer 
Surgeon, 
sonographer 
Surgeon VAN VAN Surgeon, 
VAN 
Procedure 
planning 
Surgeon MDT Surgeon Surgeon Surgeon Surgeon VAN MDT Surgeon 
Procedure 
listing 
Surgical 
secretary 
Surgical 
secretary 
VA 
Coordinator 
Surgical 
secretary 
Waiting list 
secretary 
Waiting list 
secretary 
VAN Surgical 
secretary 
VAN 
Table 12 Vascular access creation pathway characteristics, by centre 
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Referral 
 
Prior to the patient being referred for VA creation, it was necessary for a nephrologist to 
decide that the referral was warranted, and to determine the most appropriate timing of 
referral. The referral was typically intended to facilitate the creation of AVF, rather than to 
seek opinion as to the optimal VA modality for that patient.  
Patients were usually attending a renal clinic which was either labelled as ‘general 
nephrology’ or ‘low clearance’ (or equivalent), although some patients would also enter the 
pathway rather more urgently, usually because of late presentation with advanced or ESRF. 
A means of referring the patient into the pathway was required. This could be in the form of 
an electronic referral, a typed letter, or a verbal discussion between colleagues. The referral 
then required to be managed in order that the patient could be seen by those responsible for 
creating VA.  
 
Design of Vascular Access approach 
 
Next, the specific means of VA to be used required consideration. In general terms the VA 
creation pathway was intended for the creation of AVF or AVG, but it was also very 
commonly used to arrange TCVC placement.  
Most centres used an outpatient clinic to review patients referred for VA. A typical setup 
involved a clinic run jointly by a surgeon and Vascular Access nurse (VAN); in some centres 
this also included a sonographer, while elsewhere the clinic was run solely by VAN.  
In some centres the clinic visit would involve a clinical assessment, a duplex ultrasound scan, 
and would conclude with a decision as to the best surgical approach for that patient. In other 
centres the patient would have a clinical assessment, but if imaging was considered necessary 
they would then be referred to radiology (as a separate outpatient visit) for the duplex 
ultrasound scan to be performed. The results of the scan would then either be discussed at a 
multidisciplinary team (MDT) meeting, or at a further outpatient VA clinic visit, where a 
decision about the best approach would be made. In one centre with a VAN-led clinic the 
surgical approach was determined based upon clinical examination and duplex ultrasound 
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scanning; where the best option was not immediately obvious the patient would be listed for 
an ‘explore-and-proceed’ procedure. 
 
Procedure 
 
There was wide variation in the clinical context used to perform VA creation surgery. Most 
centres had some form of designated theatre list for AVF surgery, but the degree of formality 
varied. Larger centres tended to have a specific list (or lists) for such patients, while smaller 
centres tended to book these cases among other vascular surgery cases. 
Most centres used predominantly local anaesthetic to facilitate AVF surgery, but one unit 
reported using general anaesthetics much more commonly. No audit data was forthcoming to 
confirm or refute this assertion. Not all units reported using AVG, but those who did reported 
using general anaesthetics for these cases, and occasionally for some AVF procedures. 
There was variation within and between centres regarding the use of day surgery beds or 
overnight beds for patients having AVF created. In some centres most cases were performed 
as day surgery, while in other centres this was much more variable.  
TCVC insertion was usually performed by an interventional radiologist, although in some 
units a nephrologist would do this on a scheduled or ad hoc basis. No centres had any 
designated interventional radiology slots for any VA procedures, so TCVC insertion would 
be requested in the same manner, and was afforded the same priority, as other routine 
interventional radiology procedures. 
 
 
Post-operative follow-up 
 
It was normal in all centres for patients to be followed-up after their AVF or AVG surgery, 
although the manner of follow-up varied considerably.  
Most patients were invited to attend the VA clinic between 4 and 6 weeks following surgery; 
in some centres there would be a clinical review by VAN, but elsewhere a surgeon would 
assess the patient, and sometimes a duplex ultrasound scan would also be performed. In one 
centre the patient was reviewed thrice weekly in the fortnight following surgery by VAN. 
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Where there was concern about the maturation of a fistula, in some centres patients would be 
discussed at an MDT meeting. Elsewhere, radiology investigations or interventions would be 
arranged via the VA clinic, or the patient would be listed for a further surgical procedure.  
In one centre where the surgeon did not routinely review patients postoperatively, their 
operation note would include recommended steps to take if the fistula failed to mature; this 
directed actions arising from the post-operative assessment.  
 
Function 
 
The above section describes the formal configuration of VA creation pathways. Numerous 
factors were reported to regularly influence the routine functioning of these pathways, and 
these are detailed below. These can be considered in the frame of ‘work-as-done versus 
work-as-imagined’196. The following sections consider the realities of VA creation pathway 
function.  
 
Timing of referral for Vascular Access creation 
 
Considerable uncertainty was seen to exist around the best timing for VA referral. Practice 
seemed to vary considerably between and within units. Many centres reported referring 
patients for VA creation, but who ultimately required haemodialysis treatment before an AVF 
was ready to use. These patients required CVC placement to facilitate haemodialysis until the 
AVF had matured. Similarly, there were many reports of patients having AVF created but not 
requiring haemodialysis treatment for several years, if at all. Almost every interviewee 
reported experience of these cases, albeit reports appeared anecdotal rather than based upon 
audit data. One unit had conducted a limited spot-audit of unused AVF, but nowhere 
systemically audited (or discussed) their rates of (late) AVF referral or complications arising 
from unused AVF.  
 
There was widespread acknowledgement that many patients known to the low clearance 
service require RRT sooner than anticipated, but nephrologists considered this “unavoidable” 
and “unpredictable in the majority of cases”. Nephrologists were generally opposed to 
creating VA that would not ultimately be required; they considered this a worse outcome than 
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a patient requiring haemodialysis before an AVF was available for use. This was particularly 
the case when a patient was perceived to require complex AVF surgery, or where an AVG 
would be required. Nephrologists’ opinions about different RRT modalities are discussed in 
more detail in chapter 4. 
 
Referral timing was generally judged based upon patients’ eGFR and relative rate of decline. 
This was typically assessed at the point of reviewing the patient in a clinic setting, using an 
electronic patient record with the facility to visually plot eGFR against time. No centre had 
created an automated algorithm or equivalent means of predicting the timing of requiring 
haemodialysis. Most nephrologists used an arbitrary eGFR threshold to prompt referral, 
ranging between 12-20ml/min. It was noted that ‘referral for VA’ in many cases really meant 
‘referral for RRT education’; this was considered a prerequisite step to VA creation, and 
effectively delayed patients' entry to the VA creation pathway until their eGFR had declined 
further. 
 
This referral threshold varied within and between centres, dependent upon clinicians’ 
discretion and patient factors. Many VANs described this variation as a major source of 
frustration, both for the receipt of very late referrals (patients considered likely to commence 
haemodialysis before an AVF would realistically be ready to use) and very premature 
referrals (patients who were unlikely to require haemodialysis for several years, based upon 
their eGFR trajectory). It was suggested by clinicians in some larger centres that 
nephrologists who appeared ‘out of touch’ tended to refer patients prematurely, whereas their 
colleagues would refer ‘as late as possible’ to avoid being characterised in this way. 
 
Variations in referrals for VA creation appeared to be attenuated to some degree when 
individual nephrologists had responsibility for a specific patient cohort, or where a VAN was 
able to maintain an overview of the clinic patient population. Where groups of clinicians 
were jointly responsible for the patient cohort this appeared to reduce strategic thinking about 
patients’ illness trajectories, and they seemed more likely to be referred late for access. 
There was little awareness within each centre of the time required for VA creation in a typical 
patient, or the likelihood that a given patient would need multiple procedures to create an 
AVF that would support haemodialysis. No centres were seen to use information of this 
nature to modify referral patterns for VA creation, but individual nephrologists who 
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complained of excessively long waiting times also tended to report earlier referral of patients 
into the access creation process. 
 
Prerequisites for Vascular Access creation referral 
 
Patients were generally referred for VA creation only once their need for RRT had been 
recognised, they had received RRT education, and had reached a decision as to which RRT 
modality they would be treated with. There was a general reluctance to engage with patients 
about the detail of RRT treatments until they had reached an advanced stage of CKD. 
In most centres, RRT education was delivered by a specialist nurse in the low clearance 
clinic. It was common for this specialist nurse to have no other role in RRT delivery, and 
therefore little involvement in other aspects of the patients’ care before or after RRT 
education. Interestingly, no one from this specialist nurse cohort was identified as a member 
of the VA team by other interviewees. The apparent lack of urgency completing the 
education process was considered a difficult challenge, frequently causing delayed referrals 
for access creation. 
In centres without VAN overview of the low clearance patient cohort it was reported to be 
common for patients to be referred for VA creation at a very late stage, in part because of the 
delay introduced between recognition of the impending need for RRT, and the delivery of 
RRT education. 
 
Referral mechanism 
 
The referral mechanism varied greatly within and between centres. In some cases, patients 
were proactively identified and ‘taken’ from the low clearance cohort by a VA coordinator. 
Elsewhere the referral was more formal and required a dictated letter; some centres operated 
a similarly formal referral pathway but used an electronic patient record to generate a referral 
letter including fields automatically populated with the patient’s demographic and clinical 
information.  
In all centres it was common for nephrologists to circumvent the usual referral pathway on 
occasion, whether in an attempt to expedite a particular patient’s referral or for apparent 
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convenience. In these instances, the referral ranged from a verbal corridor discussion, to the 
patient’s details being conveyed via a handwritten sticky note or similar.
 
 
Referral handling and subsequent flow tracking 
 
When patients are referred for access creation, their flow through the pathway is dependent 
upon the sequential referrals for clinic reviews, scans and theatre listing all proceeding as 
planned. Given the clinical complexity of the patients and the relatively large number of 
clinicians involved in the access creation pathways, patients’ progress can be delayed for 
various reasons.  
Tracking patients’ progress through the access creation pathway was assumed by 
nephrologists, surgeons and radiologists, to be a function of the local VAN or equivalent. 
There was little awareness of how this was practically achieved, and most VANs reported 
having limited or no time to fulfil this ‘tracker’ role.  
Regardless of the referral mechanism, most VANs relied upon their memory to move patients 
through the clinical pathway. Some VANs kept track of patients using an electronic database, 
though this was usually in the form of a Microsoft Excel spreadsheet (or equivalent) to which 
only they had access, and its contemporaneity varied dependent upon their competing 
commitments.  
One VA coordinator reported a previous crisis incident whereby they were called upon 
during an unexpected absence to attend their office and retrieve patient details from the 
database on their office computer. In contrast, another centre maintained a ‘VA control room’ 
with several whiteboards upon which active patients’ details were recorded and tracked. 
The oversight of patients transiting through the VA creation pathway was largely internal to 
the VA team, with little involvement from the NHS Boards or centralised waiting list offices. 
 
Imaging 
 
There was general agreement that many patients required imaging before surgery, in most 
cases a duplex ultrasound scan. In some centres this would be performed at the VA clinic; 
elsewhere patients would be referred for imaging via the general radiology service. The lack 
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of designated slots for such scans was considered to cause significant delays, with some 
patients anecdotally reported to wait over six months for an appointment.  
In one unit, VAN performed scans in clinic and had clinical authority to recommend a 
surgical approach based upon the scan, including exploratory procedures where there was no 
obvious ‘best’ approach to pursue clinically. VAN and the vascular surgeon independently 
reported that this had significantly reduced the overall VA creation waiting time. 
Many VANs and surgeons considered that referring nephrologists should be more involved in 
patients’ clinical assessment for VA, and that this could enable better prioritisation of those 
requiring imaging before listing for AVF creation. It was reportedly common for patients to 
be referred for VA creation without any details of their blood vessel suitability, or details of 
relevant past medical history that might impacted upon their vasculature. 
 
Multi-disciplinary discussion 
 
‘MDT discussion’ features in the VA creation pathway in most centres, but it was unusual in 
most units for patients to be discussed at the MDT before listing for their first VA creation 
procedure.  
Most centres reported that the surgeon or VAN would determine the most appropriate 
procedure at the VA clinic. This was particularly the case when a ‘one-stop’ clinic operated, 
with at least a surgeon and VAN in attendance. Where additional imaging studies were 
required before a patient could be listed, the imaging results were usually passed to a surgeon 
for a decision about the most appropriate approach. Most centres had one surgeon who acted 
as the ‘lead AVF surgeon’, but this was usually a de facto rather than formally allocated title. 
They usually determined the surgical approach for each patient in their cohort.  
It was unusual for a radiologist to be consulted in advance about the intended VA strategy for 
a given patient. They would more typically only become involved once a patient was referred 
for TCVC insertion, and effectively functioned as technicians in such cases. In almost every 
centre, the decision to refer a patient for TCVC was usually made by a nephrologist, with the 
VAN performing an administrative and coordinating role. The surgeon would usually have 
no role in this discussion and would usually be unaware of the TCVC referral. 
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One centre reported using the MDT to discuss the majority of patients requiring VA creation. 
VAN would meet the patient in a clinic, and the surgeon would first meet the patient on the 
day of surgery. The MDT discussion would focus around potential problems with the 
proposed surgical approach and consider if additional investigations were needed before the 
day of surgery. The MDT was also used as a mechanism for identifying patients with 
TCVCs, for whom AVF or AVG surgery could be attempted. 
In other centres the role of the MDT was largely focused around the maintenance of VA, 
(discussed in chapter 5). 
 
Procedure scheduling and waiting list management 
 
Scheduling VA procedures was reported as a significant source of frustration to VANs and 
others in the clinical team in almost every centre. Slot availability on surgical or IR lists was 
unpredictable, relying upon external factors including competing clinical demands, and the 
availability of surgeons and support staff including anaesthetists and theatre nurses. 
Slots were usually made available via administrators external to the VA team; this was 
reported to be a relatively passive process that did not often account for patients’ clinical 
needs. It was difficult for VANs or others to influence slot provision as there was no clear 
managerial oversight: the patients were considered to be under nephrology care, but the 
procedure was proposed by a surgeon or radiologist working in another directorate with its 
own management structure and priorities.  
The ideal scenario envisaged by most centres was the ability to allocate patients to specific 
theatre slots at the point of deciding which procedure to attempt. This was possible in some 
units, usually where there were allocated VA theatre slots. This enabled patients to be listed 
via MDT meetings or at the VA clinic. However, in most cases this was not possible, and 
instead VANs required to liaise with waiting list administrators to optimally use the available 
capacity. 
Where slots became available at short notice it was often impossible to use them for VA 
procedures in view of patients’ medical complexity, a lack of inpatients beds on an 
appropriate ward, the challenge of fitting ongoing haemodialysis treatment around the 
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proposed procedure, and logistical challenges where procedures were performed on another 
hospital campus.  
The apparent lack of transparency with regard to waiting lists greatly frustrated nephrologists. 
They often described referring patients for AVF creation, but several months later needing to 
separately arrange TCVC insertion because AVF surgery had not been forthcoming within 
the necessary timescale. This was often perceived as a failure of the VA team to create 
access, without acknowledgement of the parameters within which they had to work. 
 
Bed booking 
 
Some centres considered issues relating to bed booking as absolute barriers to creating VA, 
while for others it was more of an inconvenience. While this may partly reflect the degree of 
team cohesion within the centre, it could also be a measure of the potential options available 
to VANs requiring beds for VA procedures (table 13). 
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Unit Transcript data 
1 “Beds are booked, but they are just being absolutely farmed [out] everywhere and I 
just think it is unsatisfactory.” (Consultant Surgeon)  
2 “I just tell [surgical secretary] who needs booking in and they do the booking” 
(Vascular Access Nurse) 
3 
 
“No, it is very difficult, that is one of the worst things recently is trying to get beds.”  
“Sometimes they can [be] admitted and decanted around the hospital” (Vascular 
Access Coordinator) 
7 “They normally do find something and it’s very unusual to cancel surgery 
due to the lack of beds.” (Vascular Access Nurse) 
8 “What often happens is they don’t end up being admitted; they end up coming up to 
the day ward and recover in there for 4 or 6 hours, then the surgeon will come and 
see them and see if they’re happy for them to go home.”  (Nurse Practitioner) 
9 “I think there is an element of a bed situation, so it’s again not an ideal situation. 
You can be in a situation where there is no beds, because they tend to keep the 
patient overnight and there is just no beds to keep them.”  (Associate Specialist 
Surgeon) 
Table 13 Bed booking for procedures 
(No data was coded under this theme for units 4, 5 or 6)  
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Various bed ‘categories’ were utilised for VA creation procedures. Some units used day 
surgery beds; others admitted every patient to hospital, variably into beds formally allocated 
to vascular surgery, general surgery or renal medicine. Where ‘day surgery’ beds were used, 
these were sometimes within the main hospital day surgery unit but could also be situated 
within a ‘short stay medicine’ unit or a renal ‘day area’.  
Where day surgery beds were available, these tended to be used for the least medically 
complex patients and procedures. More complex patients, or higher risk procedures, would 
usually require that the patient was admitted to hospital. Reserving beds for VA procedures 
was problematic in most centres, particularly where patients were being admitted to areas that 
did not otherwise take elective admissions, and which therefore had no formal bed booking 
facility. While electively-admitted patients account for a large proportion of surgical wards’ 
workload, this is unusual in medical wards and centres using renal medicine beds tended to 
report the greatest difficulty.  
Even when beds could be found within acute renal medical wards, patients undergoing VA 
surgery tended to be vulnerable to being ‘boarded’ to another ward in the event of bed 
pressures. In addition to the inconvenience to patients and staff, boarding was said to 
contribute towards suboptimal postoperative management and unnecessary delays in 
subsequent discharge home. 
Surgeons and radiologists who performed VA procedures tended to prefer when their patients 
were admitted to renal medical beds rather than to other parts of the hospital. They reported 
feeling more confident that patients’ specific perioperative needs would be attended to: for 
example, close observation of blood pressure with appropriate, timely intervention. The 
ability to efficiently book a bed in what was perceived as an appropriate area of the hospital 
was seen to facilitate efficient scheduling of VA procedures. It probably also encouraged 
surgeons and radiologists to tackle more challenging cases. 
 
Treatment time guarantee 
 
The Patient Rights (Scotland) Act272 affords patients a legal guarantee as to the maximum 
time they will wait for a particular diagnostic test or therapeutic procedure. This is commonly 
known as the ‘treatment time guarantee’ (TTG). It serves as an umbrella target for all 
procedures and is specified by statute rather than taking account of clinical timelines. 
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Patients awaiting AVF creation are subject to TTG from the point at which their name is 
added to the waiting list for a specified surgical procedure, rather than the point of 
nephrology referral for access creation. All centres reported that the TTG was not practically 
relevant for patients requiring AVF creation since the pre-dialysis clinical timeline was 
almost always significantly shorter than the TTG time. In practice, the TTG was more likely 
to delay AVF surgery as it was a commonly cited cause for VA cases being postponed for 
non-clinical reasons. 
The centres whose published registry data suggested highest rates of incident and prevalent 
AVF usage8 tended to report formal or informal prioritisation of VA surgery over other cases. 
(The registry data are not reproduced here to protect anonymity.) In Unit 3 all such cases 
were afforded “urgent” priority, while in Unit 2 it was reported there was sufficient capacity 
to perform AVF surgery within one week, albeit this prioritisation was informal. In larger 
centres the lack of formal protection, coupled with “routine” priority, was reported to 
regularly cause VA cases to be delayed in favour of other cases that were less clinically 
urgent, but which were approaching a TTG deadline. 
 
Anaesthetics involvement 
 
Most VA surgery was reported to be performed under local anaesthetic. Centres varied in the 
proportions of patients reported to undergo general anaesthetic procedures. In Unit 6 this was 
highly unusual, whereas in Unit 9 it was said to be very common. Cases involving general 
anaesthesia were said to be more complex or involving AVG insertion. No audit data was 
available to support these assertions. 
 
Some centres routinely sent patients for anaesthetic pre-assessment prior to listing for 
surgery, even where their procedure might not require general anaesthesia. In many cases 
patients could wait several weeks for pre-assessment, which would often then be ‘failed’ 
owing to their clinical complexity. They then had to wait for a further appointment with an 
anaesthetic doctor. 
 
Surgeons who did not work with a regular anaesthetist on their VA cases reported that it was 
common for surgery to be cancelled on the day if the individual anaesthetist felt 
uncomfortable performing the general anaesthetic for a patient with renal failure or associated 
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comorbidity. The best strategy for minimising cancellations appeared to be where a small 
group of vascular anaesthetists (or equivalent) dealt with these theatre lists, with a pre-
assessment process that accounted for the clinical complexity of this patient cohort. 
 
Documentation of surgical procedures 
 
All patients undergoing a surgical procedure have an operation note documented as a routine 
practice. For VA cases, it was common practice for the operation note, or an abridged 
version, to be duplicated in the (renal) electronic patient record. In most centres this 
administrative task was usually performed by VAN or equivalent.  
In Unit 1, at the point of initial surgery, the surgeon routinely recommended the actions to 
take if the AVF failed to adequately mature. This served as direction to VAN during the post-
operative period and was said to expedite referrals for interventional procedures that became 
necessary. No other centre routinely documented this information, although some units 
reported having easy access to a surgeon who could discuss the case if problems were 
identified.  
 
Post-operative follow-up 
 
While there was general agreement that all patients should be reviewed postoperatively, there 
was variation as to how this occurred. The process is described in figure 8. This represents an 
amalgamation of the pathways in use in each centre; appendix 5 contains diagrams with the 
specific pathways in use by centre for comparison. 
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Figure 8 Generic post-operative Vascular Access follow-up pathway 
This pathway diagram reflects an amalgamation of the clinical pathways in use by each renal 
unit. The pathways used by each individual unit are described in appendix 5. When a new 
AVF or AVG was created every centre had an arrangement to review the patient 
postoperatively. This assessment was usually conducted by VAN or surgeon. If the review 
was satisfactory the patient would then enter the VA maintenance pathway. Otherwise the 
patient could re-enter the VA creation pathway, or be re-listed for an alternative operation, 
or sent for investigations, or discussed at an MDT meeting. Practice varied significantly by 
centre. 
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In some units the purpose of this review lacked clarity; elsewhere it was clearly designed to 
assess AVF maturation and arrange corrective action where necessary. 
Most centres appointed patients to attend the VA clinic 4-6 weeks after their operation. In 
Unit 9 the patient was reviewed on a total of six occasions during the first fortnight following 
surgery, and not thereafter. This appeared to stem from the timing of scheduled 
haemodialysis sessions for those already attending for haemodialysis, but also applied to 
patients not yet undergoing haemodialysis treatment. 
The commonest outcomes from postoperative reviews were either that no action was 
clinically indicated, or that an IR procedure was required to assist maturation. Occasionally 
patients needed further surgical procedures, or a further attempt to create a new AVF. No 
centres provided designated interventional radiology slots for this purpose. In some units the 
radiology service seemed able and willing to prioritise these cases, but elsewhere patients 
were said to face lengthy waits. It was reported that the waiting time for interventional 
procedures could at times mean the AVF was unsalvageable by the time the procedure date 
arrived. 
As with other elements of VA creation there was no audit or statistical data relating to 
postoperative reviews.  
 
Discussion 
 
This section has illustrated idealised VA creation and postoperative review pathways, along 
with their practical realities and limitations in each unit. The success of VA creation 
pathways is likely to be reflected primarily in the published proportion of ‘incident’ patients 
using AVF or AVG for haemodialysis in a centre. The following sections consider challenges 
in the VA creation pathways identified by the thematic analysis. 
 
Referral timing  
 
Variation in practice and difficulties predicting the timing of needing an AVF resonates with 
the literature. There are many VA articles published describing this issue, and attempting to 
solve it with a variety of calculators and algorithms273–275. This study adds a systems 
Chapter 3: Creation of Vascular Access 
130 
 
perspective and demonstrates additional service characteristics not necessarily recognised by 
existing audit standards and guidelines.  
There was marked variation in waiting times between centres for AVF creation surgery (see 
chapter 7). This was seen to be a function of local process, resource availability and 
competing demands from elsewhere in the organisation. It was notable that waiting times 
were not published internally despite their central importance to nephrologists’ judgement as 
to when patients should be referred for surgery. 
It was also appreciated that AVF surgery had a relatively high rate of technical failure, but no 
data was available at local, regional or national level to enable proper scrutiny. It is unknown 
if success rates or failure rates varied significantly between centres. The literature and clinical 
community has acknowledged this in general terms, but this study is perhaps the first to 
illuminate the inadequacy of current recording and scrutiny of procedural outcomes. It is at 
odds with Department of Health guidance117,118 and the need for change is emphasised by the 
unexpectedly high volume of VA procedures (see chapter 7). It is recommended that renal 
units routinely publish their waiting times, success rates and repeat procedure rates for AVF 
creation surgery. The product of these values should be used to guide the timing of future 
AVF referrals.  
 
AVF planning 
 
It was clear that clinical evidence was lacking in many aspects of VA creation. There was 
uncertainty surrounding the ‘best’ VA modality (i.e. TCVC or AVF or AVG) for a given 
patient, partly due to a lack of robust published outcome data to guide treatment decisions. It 
was unclear which surgical approach was technically best for AVF creation, and little 
consensus as to what constituted suitability for AVG insertion rather than attempted AVF 
creation. Further studies should evaluate these questions. 
Resource utilisation varied substantially between centres. In one centre patients were listed 
for surgery following clinical assessment by VAN; elsewhere the same patient required 
appointments with VAN, a subsequent appointment for a vein-mapping scan, followed by 
MDT meeting discussion, before eventually being listed for surgery. It is not asserted that one 
strategy is better than another, particularly in the absence of published outcome data, but 
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these divergent approaches to AVF planning require further investigation to delineate the 
clinical, financial and opportunity costs of both approaches. 
Variation in the use of general anaesthetics for AVF creation is striking between centres. 
Notably, Unit 6 almost never used general anaesthesia, whereas Unit 9 routinely sent patients 
for anaesthetic pre-assessment whenever AVF creation was contemplated and were unable to 
quantify how frequently operations proceeded with just local anaesthesia. Similarly, the 
differences in financial cost, patient-experience and resource use between centres who 
typically perform VA procedures as day cases, versus those who normally admit patients 
overnight for similar types of operation, deserves closer study. 
 
Vascular access clinic 
 
The VA clinic varied in almost every regard between units. Its function included evaluation 
of new patients before VA creation, postoperative assessment of those who had recently had 
VA creation surgery, assessment of problematic VA, or a combination thereof. The staffing 
and location also varied greatly; in some centres this was a VAN-led clinic held in a general 
outpatient area, but elsewhere it was staffed by VAN, surgeon and sonographer and was 
hosted in a vascular lab or ultrasound department.  
The possible actions following VA clinic review were limited in many centres. It is suggested 
that designated IR and imaging slots are required if this clinic is to successfully evaluate 
postoperative patients or those with problematic VA. Otherwise there appeared to be little 
realistic prospect of a clinic visit resulting in a meaningful attempt to salvage failing VA. 
The role of the clinic surgeon also requires definition. In some centres every patient is seen 
by a surgeon preoperatively, while in others it seemed possible for the patient to only meet a 
surgeon for the first time immediately before their AVF operation. It may be that surgical 
time is more optimally used with the latter approach, but further study is required before 
formal recommendations can be made. 
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Treatment time guarantee 
 
The impact of TTG provides a useful example of healthcare complexity in action. The 
intention of the TTG272 was to guarantee that patients would not face excessive waits for 
treatment. In the context of VA however, clinicians reported in this study that TTG had the 
effect of reducing the likelihood that a patient would have their VA surgery within a 
clinically appropriate time.  
A lack of ringfenced resources was said to render VA operations vulnerable to the competing 
demands of higher volume, but perhaps clinically less important, procedures. Varicose vein 
surgery was often cited by interviewees as regularly displacing VA work, despite the former 
being essentially ‘routine’ or even ‘cosmetic’ in nature, while the latter has potential to 
impact upon patients’ survival.  
In seeking to enhance the general NHS patient experience, TTG may have had the unforeseen 
consequence of creating an additional barriers to high quality VA care. 
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This study aims to delineate the structure, function and workload associated with VA services 
in Scotland. It is hoped that this will illuminate opportunities for improvement, in the context 
of observed unwarranted variation in AVF use for haemodialysis between Scottish renal 
units. A novel systems approach (described in chapter 2) has been used to conduct the study, 
sympathetic to the socio-technical systems theory and Safety II approaches to quality 
improvement described in chapter 1B.  
Chapter 3 considered the structure and routine functioning of VA creation pathways. Among 
many barriers to VA creation, it was clear that in many units referral for VA creation was 
often delayed until the referring clinician felt haemodialysis was imminent. This chapter 
explores this ‘clinician discretion’ in greater detail and considers clinicians’ opinions about 
the various VA modalities. These opinions are important, in view of the literature presented 
in chapter 1 around ‘consensus’ and ‘latent factors’178,186,187,276.  
It was clear that clinicians’ opinions varied considerably regarding the potential role of the 
available VA modalities, within centres and within each professional group (table 14).  
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Unit Transcript Data 
1 “There is a cohort of patients that we have looked at… and said look we have got 50 central catheters and I am saying 20 I don’t want to know anything about… 
There are 20 or 30 that are either refuseniks because they are perfectly happy, or they could have something done but they just haven’t properly gone through the 
system.  Now hopefully there is none of the people that aren’t being properly assessed it is just people refusing and that need a bit more work done on them.” 
(Consultant Surgeon) 
“I do keep stats and I know the patients that haven’t been referred so then I hound the consultant” (Vascular Access Nurse) 
“The fact is they have to start. If, occasionally you’ll get one and you think: ‘well they’re really urgent’ so you will obviously try, if you can, you will try and put 
them first, to get them the fistula… once they have been reviewed and once they have had their duplex. … if you are asked you can try and rush them through. You 
will not always have that option so at the end of the day they will start with a catheter.”  (Vascular Access Nurse)  
“I would get a letter from one of the nephrologists. ‘This patient has to start, and I have referred them and asked for a catheter’, so then that is where I take over: 
after they have been referred.” (Vascular Access Nurse) 
“How soon are the nephrologists referring the patients to the Vascular Access and how soon are they landing up in the low clearance?  That again is our 
responsibility, so if we aren’t doing it on time then obviously the surgeon can’t do anything more than that. Of course, the surgeon can only start working from 
the day you ask the surgeon to do something so that is all our responsibility.” (Associate Specialist Nephrologist) 
“Well, we actually have a number of line patients that present problems when they come back for repeated lines, with poorly functioning lines, migrating lines, 
patients with central venous stenosis, they are actually quite difficult to manage, as I’m sure you are well aware. Clearly patients with recurrent stenosis despite 
repeated venoplasties, so, just the problems every unit will face.” (Consultant Interventional Radiologist) 
2 “I don’t think there’s anybody… yes there’s maybe one person at the moment who might… we might have given up on, in terms of native access” (Consultant 
Nephrologist) 
“It’s always difficult when you have a death in somebody who is relatively frail and you think, ‘ah should we have done a done a fistula’ or, ‘they could have got 
line sepsis’” (Consultant Nephrologist) 
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3 " I think the fewer lines they have, the fewer problems they have with central stenosis and problems later on. So we try and prevent them having lines really 
because we think that is the best, fewer sepsis and fewer central stenosis later on." (Vascular Access Coordinator) 
“[TCVC are] used as a bridging access if their fistula failed and we haven’t been able to save it. We never look at them as a permanent access. We have just got 
one patient that I can think of that is a permanent access.” (RDU Nurse) 
“It is there as a temporary procedure, all lines are temporary, tunnelled or not! [laughter] They are not allowed to call them anything other than temporary, until 
we get [a] fistula.” (Vascular Access Coordinator) 
“Nope, so I think in [Unit 3] we don’t, as a rule I would think, any Nephrologist talks about lines with their patients, on the basis that we, I think, pretty much 
universally don’t believe there is anyone who can’t be dialysed in another fashion.” (Consultant Nephrologist) 
“I have never had a conversation with somebody that needed to start on a line because no other access in my whole time here, you know as a first access.” 
(Consultant Nephrologist) 
“If someone is dying of cancer we will put them in a graft, you know if we think they are going to die within 6 months, to get a line out quick and give them a 
better quality of life we will put in a graft. There is one or two I can think of two patients we did that to rather than have a line in.”  (Vascular Access 
Coordinator) 
“I think there is a very good buy in both from renal and vascular, I think we all see that in actual fact just sticking lines in and saying ‘we’ll think about a new 
fistula next week’ just makes more work in the long run.” (Consultant Nephrologist) 
4 “I am not sure that we would actually be able to improve much on our incident fistula rate, but we are reasonably happy using permcaths [TCVC] for a short 
period bridging to a fistula.” (Consultant Nephrologist) 
5 “I think the more central lines we’re accessing per week, the greater risk of SABs we have and then, you know, the mortality, the morbidity and mortality 
associated with SABs is worrying.”  (Vascular Access Nurse) 
6 “Most of the time the folk will end up having dialysis with a line coming from the pre-dialysis setup are the ones who had fistulas done, they are not matured, they 
have clotted, they needed multiple surgeries, those are the ones…” (Consultant Nephrologist)  
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“If I were counselling, I would give them the options of both and I will obviously tell them that fistula is better for various reasons and obviously it’s their choice. 
Thankfully, we have not come across many patients who insist that, ‘oh I don’t want a fistula’”. (Consultant Nephrologist) 
7 “Now if there is a thrombosed fistula in an outpatient, yeah they might well get involved in organising the permcath [TCVC] to prevent the admission to take keep 
things moving.” (Consultant Nephrologist) 
“…very elderly, frail people who can’t survive their line sepsis, so we don’t see that as a reason not to try and get a fistula. You sometimes have a, patient… who 
prefers not to have a fistula, but not for comorbidity reasons.” (Consultant Nephrologist) 
8 “In particularly elderly patients as well because maybe, I think sometimes we have that emotional thing of ‘poor old soul, poor wee soul’ or ‘they don’t need a 
fistula’, I think we’ve all been guilty of that. But I think the longer I have been doing this job and the more education that I’ve learned about it and the value of 
good access comparison to lines because I have seen patients with so many awful problems.” (RDU Nurse)  
“Older in age seem to like the lines and don’t want [AVF], I think because they know their veins are frail… they just say they’ll stick with the line long-term 
now… there’s quite a number of patients who would say ‘not for any further access at this time – patient’s choice’.” (Nurse Practitioner) 
“I have got a lot of patients who have had lots and lots of access issues, who have had fistulas, they have failed, they have ruptured, some of them have nearly 
died because their fistulas have ruptured so there is just no way that they are ever going to be persuaded…some patient’s lines, they are always absolutely fine, 
we don’t really have any problems with them and they’ve had them for a long time, other patients, their lines are, they just, they are problematic, difficult flows, 
sometimes they reverse the lines, get urokinase locks, get intra-dialytic urokinase, tends to be the same.” (RDU Nurse) 
“The problem is, most of these crash landers, they need dialysis there and then and so we don’t have access to someone in the PD unit, we don’t have an 
emergency Tenckhoff insertion, whereas we can put a line in right away and dialyse them that night and know that it will be fine…… well, it will be controlled.” 
(Consultant Nephrologist) 
“It’s a dreadful shame to have a pre-emptive live donor [transplant] 3 months after having a fistula made. That’s a bit of a waste and if we can be more confident 
that it’s likely to happen… but again that needs to be pushed as well and that often doesn’t happen, and they end up having dialysis.” (Consultant Nephrologist) 
“They will put a temporary line in. They’ll do nothing else. It’s just left on my desk for when I come back.” (Vascular Access Nurse) 
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“I think more and more, based on what I’ve been hearing from research done by the Vascular Access Team here, that if this is a patient just presenting and 
they’ve got a reasonably good chance of getting a transplant in the future, there’s a strong case for pushing PD more and preserving their central veins.” 
(Consultant Nephrologist) 
“Our default tends to be, in most places it tends to be haemodialysis. It shouldn’t necessarily be so. … PD probably has more of a role in difficult Vascular 
Access then we use it for…  PD … patients can do pretty well.” (Consultant Nephrologist) 
“We’ve had one or two situations of people having catheters in for 8 months because people thought they were ready to start, but in actual fact, things were okay, 
left the catheter in and in one of those cases they had severe peritonitis that may have contributed to their death.” (Consultant Nephrologist)   
“I would be reasonably keen that we do more PD, particularly in difficult access patients. A PD catheter is probably better than a TCVC.” (Consultant 
Nephrologist) 
9 “I think they would get a line. Most of them would get a line straight away and we have a problem with that… They get a line and after they get the line then they 
think about creating a fistula.” (Associate Specialist Surgeon) 
“We know no-one should ever get a line in unless it’s an absolute extreme. No-one should get a line in, end of story. All my problem cases are line related. You 
know, I spent the best part of three hours yesterday ploughing my way through someone’s superior vena cava simply because she had a whole pile of line-related 
problems. All avoidable if possible.” (Consultant Radiologist) 
“We have only started doing grafts so that isn’t an option at the moment. So therefore it would have to be a tunnelled line until I could get, and, although at that 
point in time I would be asked to get more permanent access, it would have to be a line that they would be put on to the list for AVF.” (Vascular Access Nurse) 
10 
(Paed
iatric
s) 
“Recurrent issues of line and infection risk, we don’t generally, that is medically, don’t get involved as much as say [nurse] would.” (Consultant Nephrologist) 
“We have had a period up to maybe about a year ago that we hadn’t had an infection for a long time, and [specialist nurse] will be able to give you the figures. 
But latterly we have had quite a few, with similar patients, and there’s more a hygiene thing.” (Consultant Nephrologist) 
Table 14 Clinician opinions about Vascular Access modalities
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Views appeared to be influenced by several factors including: 
• Anecdotally reported personal experience with each modality; 
• Perception of the morbidity and mortality burden associated with each modality; 
• Practical availability of each modality within the centre;  
• Perceptions around surgeon and radiologist enthusiasm and technical skill; 
• Appreciation of what was technically possible and achievable for a given modality in a 
particular patient group; 
• Perceived transplant availability and likelihood of success for a specific patient. 
The following sections detail clinicians’ opinions about the use of TCVC, AVF, AVG and 
PD for RRT. It was clear that opinion was almost exclusively based upon the above factors, 
and there was a conspicuous absence of data-driven opinion. Anecdotes and local experience 
appeared to significantly influence clinicians’ views and would be cited as rationale for 
taking one clinical approach over another. It was also striking that clinicians appeared to 
consider “haemodialysis with a line”, “haemodialysis with a fistula” and “haemodialysis with 
a graft” as a single modality with some technical differences, instead of separate treatments 
with divergent associated burdens of morbidity and mortality. 
The most contentious opinions related to the use of TCVC. Clinicians working in centres 
with higher TCVC use tended to give more detailed opinions about them. It was apparent that 
centres where TCVC were used frequently, and where TCVC insertion required challenging 
logistical arrangements, this would occupy a substantial portion of the available VAN time. 
In centres where TCVC were mostly inserted by IR, this task occupied significant volumes of 
clinical IR time, and was often viewed negatively by individual radiologists. 
It was apparent that TCVCs were more difficult to access in some centres than in others. In 
some units, a designated nephrologist would insert TCVC, usually during a scheduled weekly 
list. It was more common however for TCVC to be inserted by radiologists. Interestingly, the 
apparently easier availability of TCVC in nephrology-led centres did not seem to 
significantly increase their usage, so long as other nephrologists in the centre were bought-
into the value of AVF or AVG as the preferred alternatives. This may have reflected the 
reduced TCVC-related workload for radiologists, who could then devote their time to the 
maintenance of AVF and AVG. 
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There was a clear difference in attitudes towards lines between centres, and less so, between 
individuals and professional groups within a given centre. TCVC were variably considered as 
temporary, bridging measures, to being long-term “necessary evils” required in order to 
deliver haemodialysis treatment. The difference in views was most apparent when 
considering the language used by clinicians to describe NTCVC and TCVC: the centres with 
lowest TCVC use referred to “non-tunnelled” and “tunnelled” lines, while centres with higher 
use tended to use the terms “temporary” and “permanent” to describe the same VA devices. 
Many staff would also refer to TCVC by the brand name “Permcath”; some appeared to think 
this was a clinical term meaning that the patient had a “permanent catheter” and were 
unaware “Permcath” was in fact a brand name for a particular type of TCVC.  
PD is generally seen as a favourable option. Some clinicians felt it was not offered it as 
readily as it could or should be. The driver for that seems to be mostly historical rather than 
being based upon data. 
AVGs are afforded ‘special’ status which perhaps limits their use. They were sometimes 
considered as an alternative to a TCVC, although interestingly this was not the case in the 
unit with the lowest TCVC and highest AVF usage. There was significant uncertainty about 
the frequency of AVG surveillance, the required actions when imaging anomalies were 
identified without corresponding clinical signs, and the infrastructure required to rapidly 
manage emerging clinical problems. There was also significant budgetary concern about 
AVGs, as in many cases these required to be funded on a named patient basis. Financial 
issues were not a specific consideration for other VA modalities. Clinicians almost 
universally expressed a wish for additional clinical evidence and 'normalisation' before AVG 
were used on a wider scale. It was also apparent that RDU nurses felt inexperienced and 
unsupported using AVGs, and there was a clear need for further training.  
 
Unit 1 
There was a realisation that significant historical reliance upon TCVC would leave a legacy 
of significant clinical problems for some time to come. It was recognised that for some 
patients it would now be very challenging to find alternatives to TCVC for clinical reasons; 
in some cases, it was also thought that patients would simply refuse to consider alternatives to 
TCVC in view of their previous experiences.  
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The heavy TCVC reliance is reflected in the VAN role, which almost completely revolves 
around coordinating TCVC insertion or replacement. VAN had clear ownership of this 
process, contrasting with the AVF / AVG pathway. It was clear that TCVC coordination 
consumed the vast majority of her working time, partly because of the required complex 
logistical arrangements as TCVCs were inserted on a separate hospital campus. This raised 
various problems, including ambiguity as to who was clinically responsible for patients who 
were in transit or on the other campus. 
There was a sense that patients requiring VA have a very limited timescale before 
haemodialysis treatment would commence. This may have reflected a tendency for patients to 
be referred for VA creation late in the progression of their kidney disease, without 
mindfulness of the likely timeline involved in the process. It was clear that while VAN had 
an overview of the patients who would soon require VA, the patient required to be formally 
referred by their nephrologist before any action could be taken. 
It was described as almost impossible for a patient to navigate the AVF pathway before 
starting haemodialysis, and it was ‘normal’ to start haemodialysis with a line and attempt to 
transit to AVF later. There was little discussion of the potential to utilise AVG in patients 
who were referred late, although the vascular surgeons considered them logistically difficult 
to organise in view of the need for a general anaesthetic (whereas most other procedures 
simply required a local anaesthetic). 
There was some awareness from nephrology that late referrals impeded VAN’s ability to 
push a patient through the AVF pathway. It was inferred that this insight did not extend 
throughout the clinical team. There was awareness of TCVC-related complications such as 
sepsis and central venous stenosis, but they were regarded as being inevitable within 
haemodialysis patient cohorts. This was in stark contrast with other centres. There was also 
insight into the need to increase AVF use. Some patient education initiatives had been 
undertaken to this end, but little had been done to engage other clinicians in the unit with the 
problem.  
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Unit 2 
It was considered that AVF or AVG should be achievable for all patients, although as in other 
centres there was uncertainty about how appropriate this would be in frailer patients. TCVC 
were considered a bridge to AVF, and there was widespread recognition of the associated 
infection risks. There was less awareness of central venous stenosis as a longer-term risk, but 
in keeping with the very low TCVC use this was very uncommon. Where TCVC were needed 
they are usually inserted on the same day by IR, and this required minimal involvement of 
VAN. TCVC were historically inserted by vascular surgeons, but their available time was 
now considered better spent creating AVF. There was no nephrology-led TCVC list. 
All patients with a TCVC in-situ were discussed every week at the VA MDT meeting, until 
alternative access was in use. This was reported as a highly successful strategy to maintain 
awareness of such patients, and as a mechanism to migrate them onto AVF or AVG.  
AVG were used infrequently. They were spoken of as an option if there was no feasible AVF 
option, but for patients referred late for VA it would be more likely they would start 
haemodialysis via a TCVC and subsequently have an AVF fashioned, than to have an AVG 
used to avoid the use of the TCVC.  
 
Unit 3 
In Unit 3 it was clearly felt that lines equated to short-term sepsis and long-term central 
stenosis, both of which were seen to outweigh any potential convenience benefits. AVF and 
AVG were considered ‘a better option’ than a line, rather than a line being ‘easier’ to obtain 
and use. Action to expedite or salvage an AVF or AVG was considered action that would 
“save a line from being used”. This strategy of line avoidance was used to justify actions that 
would perhaps appear unwarranted or over-the-top in other centres, for example coordinating 
out-of-hours surgeons, radiologists and theatre staff to attempt to de-clot an AVF. This 
strategic approach was consistently observed between professional groups in the centre.  
NTCVC or TCVC are inserted in emergency situations but both are considered ‘temporary 
lines’. This language prevents staff or patients thinking these are ‘permanent’ access 
strategies. Lines are not offered as an elective access option when patients are receiving pre-
dialysis education.  
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It is believed that AVF or AVG (or peritoneal dialysis) are viable options for all patients; this 
contrasts with opinion encountered elsewhere. When patients decline AVF they clearly 
communicate their belief that this is a bad decision. If an AVF option was not apparent they’d 
then discuss AVG or PD rather than going to a line. An example was cited of a patient with 
needle phobia who had counselling and psychotherapy rather than settling for a line. 
There is enthusiasm to use AVG when AVF are not feasible in a given patient. Vascular 
surgeons were mindful of the need for closer surveillance than AVF, and the significant 
uncertainty around the most appropriate action following the detection of a stenosis without a 
clinical event. There was also concern about the need to rapidly manage any clinical events to 
prevent graft loss, with some doubt expressed about the ability of the local infrastructure to 
reliably cope with this. RDU staff felt there was a need for greater expertise to be developed 
for optimal cannulation and assessment of patients with AVG.  
Nephrologists considered that the overall morbidity burden and quality of life with AVG 
favoured their use above TCVC, particularly for patients with a short life expectancy. This 
contrasted sharply with the opinions voiced in other centres.  
Patients do still occasionally start haemodialysis via a TCVC. This can prove logistically 
difficult since their infrequent use means there is no established process for expedited referral 
to a radiologist who can insert one. It is generally thought that having as few patients as 
possible dialysing with a TCVC probably means less overall work for interventional 
radiology. 
 
Unit 4 
It was stated that many patients commenced RRT with unpredictable timing. This was said to 
explain why so many patients commenced haemodialysis using TCVC. There was reluctance 
from nephrology to refer patients for AVF or AVG until it was beyond any doubt that 
haemodialysis treatment was required. It was considered better for a patient to commence 
haemodialysis without an AVF or AVG than to ultimately not require haemodialysis but have 
had an AVF or AVG fashioned. In addition, nephrologists were reluctant to refer patients for 
AVG insertion as this was thought to remove options for future AVF creation. 
They share VA surgery and IR services with Unit 5 and enjoy short waiting times for creation 
and maintenance procedures. It was considered that TCVC were an acceptable 'first modality' 
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when it was possible to convert patients to using AVF or AVG within a few months of 
commencing haemodialysis.  
 
Unit 5 
In Unit 5, TCVC use was ultimately considered to represent a SAB risk. Minimising TCVC 
usage was the main factor used to prioritise patient referrals to their VA service.  
New patients were offered an AVF as a default first access option, with AVG as the fall-back 
if AVF were not technically feasible. Patients 'crash-landing' on RRT tended to start 
haemodialysis with TCVC, but it was reported that the assessment process for AVF creation 
would begin during the index admission unless this was not possible due to the nature of the 
patients' acute illness precipitating the need for dialysis treatment. There was usually a 
presumption that all patients should be assessed for AVF, and TCVC used only as a bridging 
solution or if no feasible alternative was identified. AVG were available but their use was 
limited to specific named patients, and clear criteria for their use had not yet been identified. 
PD was offered to new patients as an alternative means of RRT, but not normally as a line 
avoidance strategy. Staff reported PD was increasingly offered to 'crash landing' patients 
although haemodialysis using a TCVC was still the most common outcome.  
TCVC insertion was generally nephrologist-led, with a scheduled list in the IR department 
performed by a nephrologist, with 3 patient slots per week. While this meant TCVC insertion 
was readily available, in practice the effect was to reduce overall TCVC usage as more IR 
time was available for AVF maintenance. It was notable that VAN spent almost no time 
coordinating TCVC insertion, in contrast to other centres where this occupied significant 
proportions of VAN time.  
There was a general sense that 'home therapies', whether home haemodialysis or PD, should 
be offered to any appropriate patient, and it was reported that the uptake of PD was 
increasing. 
 
Unit 6 
They tended to discuss AVF and AVG with patients as their preferential VA modality, but 
would also offer TCVC as part of the discussion. It was felt that AVG were the best option 
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for patients with poor blood vessels (who would otherwise have needed TCVC), although 
TCVC were preferred for urgent access or for those presenting late with ESRF.  
AVG were considered technically challenging by the surgeons so they would only be 
considered for selected patients, and on an elective rather than emergency basis. There was a 
sense that nephrologists viewed AVG as 'special procedures' not in routine use. It was also 
recognised that RDU staff had limited experience with AVG cannulation, while VAN had 
limited experience of AVG surveillance and subsequent management of problems. There was 
also uncertainty about whether the patients required anticoagulation.  
It was reported to be straightforward to have a TCVC inserted since two nephrologists would 
routinely do this. This did not tend to result in large numbers of TCVCs being used, as the 
local vascular surgeon was enthusiastic about creating AVF and had the capacity and 
willingness to fit such patients into operating lists at short notice. The lack of interventional 
radiology on-site limits the ability to manage acute AVF problems, and TCVC were largely 
considered a by-product of this deficiency, rather than an equivalent to AVF. 
It was clear that the VAN role primarily oriented around AVF creation and maintenance, in 
contrast to other units where it was more oriented around TCVCs. The relatively low TCVC 
use meant there was less clinical experience of TCVC-related problems; while the 
nephrologists who regularly inserted TCVC were mindful of the associated morbidity, this 
may have been less apparent to others.  
There was no clear timescale for AVF creation in the unit, although it was not felt to be a 
protracted process. The uncertainty about timescales may however have resulted in 
inappropriately early or late referrals for access creation.  
 
Unit 7 
The overall focus of the VA team is on achieving a functioning AVF for the patient. It was 
reported to be difficult to obtain a TCVC in practice, as there was no dedicated IR resource 
for this and no nephrologists routinely inserted them. There had also historically been little 
attention paid to creating a robust TCVC pathway as the VA strategy in the unit was 
concerned with minimising TCVC use and maximising AVF use. The difficulty obtaining 
TCVCs was said to result in delayed patient discharges. There was a reluctance to improve 
the TCVC process as it was perceived that this would increase the overall TCVC use at the 
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expense of AVF. When TCVC are required it was reported to be normal practice for VAN 
and nephrologists to liaise with IR, to optimise the TCVC location in order to prevent the 
compromise of future potential AVF sites. If an AVF presents a problem they make several 
attempts to preserve it rather than just abandoning and settling for a line.  
Staff reported being aware of the likely timelines involved in TCVC insertion or AVF 
creation. While striving to maintain AVF, they would also attempt to expedite TCVC if the 
alternative would be admission to hospital because of a thrombosed AVF.  
AVF were considered preferable to TCVC in frailer patients. Their approach to AVG 
appeared less aggressive than in other centres. Whereas other centres reported using AVG 
specifically to prevent TCVC use, in Unit 7 it appeared that AVG were reserved for a more 
selective patient group. It was suggested that AVG use would likely increase once a better 
evidence base existed for them. NTCVC practice appeared very clinician-dependent, with 
little standardisation across the unit.  
VAN reported concern that it was possible for patients to effectively 'disappear' within the 
outpatient RDU setting. For example, if a patient had started haemodialysis using a TCVC 
and had not already been referred by their nephrologist for AVF creation, it was unusual for 
RDU nursing staff to prompt this referral. It was also said to be common for patients to have 
an AVF ready for use, but for RDU nursing staff to continue providing haemodialysis via 
their TCVC (and therefore prolong the duration of TCVC use).  
PD is used relatively infrequently, and appears to run as a standalone service, with a different 
surgical team and different nursing staff.  
 
Unit 8 
In Unit 8 many nephrologists and RDU nurses considered TCVC to be preferable for frail 
and elderly patients. There was a perception that AVF or AVG use would involve procedures 
that were unnecessarily invasive in this patient cohort. Indeed, there was a focus upon the 
need for a surgical procedure to provide haemodialysis via an AVF or AVG, whereas TCVC 
were considered less invasive.  
It was notable that clinicians tended to refer to "permanent lines" rather than "tunnelled lines" 
or similar, whereas in other centres the language associated with CVCs reflected their 
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technical status (tunnelled or non-tunnelled) rather than their perceived longevity (temporary 
or permanent).  
There was a perception among RDU staff that AVF exposed patients to significant burdens of 
morbidity, including seemingly minor skin irritation through to catastrophic bleeding and the 
likes. In contrast, TCVC-associated problems were viewed as coincidental, chance 
occurrences rather than predictable events. It was notable that when AVF or AVG problems 
arose, the overall access strategy for the patient was considered to have failed; whereas 
TCVC-related problems tended to be labelled as challenges with a particular TCVC rather 
than the strategy of ‘haemodialysis via TCVC’.  
A recent clinical trial had provided substantial experience of AVG use. They were viewed by 
nephrologists and vascular surgeons as excellent alternatives to for patients who would 
otherwise have required TCVC for haemodialysis treatment.  
Clinicians across the VA team reported a significant lack of resources for VA maintenance, 
and some acknowledged that this was likely to contribute significant to the perception that 
AVF and AVG were troublesome. IR were particularly mindful of this, and the need for 
significant investment to adequately maintain AVF and AVG.  
Nephrologists and VAN noted that TCVC use had become habitual within some satellite 
RDUs. It was reported that when higher proportions of patients were dialysing using TCVC 
within a given satellite RDU, it became progressively more difficult to convince patients or 
staff that AVF or AVG was a better alternative. Nephrologists were mindful of the longer-
term risks associated with TCVC, particularly central venous stenosis. They considered that 
PD could provide a better alternative to haemodialysis with a TCVC, but thought it 
reasonable for patients to take time deciding upon their preferred RRT modality while using a 
TCVC. PD was reportedly less easy to access in the acute setting, whereas it was perceived 
that NTCVC or TCVC were easily obtained.  
As with other units there was a sense that the patient group with high historical TCVC use 
would have accumulated irreversible morbidity, and for VA purposes they should be 
considered a separate cohort to other patients attending the centre.  
Unit 8 is a transplant centre, with a large cohort of patients who have successfully been 
transplanted. It was perceived that the availability of transplantation had effectively selected 
out a frailer, more comorbid group of patients who would then require haemodialysis or PD. 
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Much of the morbidity and mortality in this patient group was said to relate to this high 
degree of comorbidity, with less emphasis placed upon their respective VA strategies. 
It was said that RDU nurses had limited support in cannulating AVF or AVG, some of which 
would prove technically challenging. It was perceived that technical difficulties with AVF or 
AVG reflected 'failure' on the part of the RDU nurse, rather than a physical problem with the 
AVF or AVG that required interventional maintenance activity. RDU staff were said to prefer 
using TCVC as they were technically much easier, and whenever problems arose they could 
be managed using a simple protocol or would require onwards referral to the nephrology 
service.  
Staff reported that it was common for existing VA to fail without a fall-back plan existing. 
Usually the patient required NTCVC or TCVC insertion, and it was rare for the patient to 
transit directly onto another AVF, AVG or PD. When NTCVC were required, this usually 
precipitated an acute hospital admission to await replacement with a TCVC. 
There was considerable uncertainty in the unit about the absolute and relative waiting times 
for different procedures. Nephrologists were reluctant to consider AVF or AVG in patients 
for whom transplantation was perceived to be imminent, while accepting that sometimes the 
transplant was then not forthcoming. 
It was apparent that nephrologists had a perspective of the relative merits and risks of each 
VA modality, but this was not shared with the wider VA team or among the broad range of 
individuals who could influence patient choices, such as RDU nurses, ward nurses, and 
interventional radiologists. Anecdotes and opinion appeared to guide access planning for 
individual patients, rather than data-driven evidence.  
As was the case in other centres, there was no formal policy about preferred NTCVC site or 
duration for a given clinical scenario, nor was there a formal VA policy for patients requiring 
chronic RRT. It was perceived by some that VA was not always a high priority for clinicians 
who weren't directly involved in the VA team. 
PD was considered under-utilised, and there was an appetite among nephrologists to explore 
the possibility of increasing PD use. Logistical difficulties are still a challenge with PD 
catheters. On one hand it was said to be relatively common for them to be inserted long 
before they were needed, but it was sometimes difficult to have one placed at very short 
notice. 
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It was reported to be much easier to have a PD catheter inserted than to have an AVF created 
for a given patient. This was thought to reflect the relatively low usage of PD in comparison 
with haemodialysis.  
 
Unit 9 
TCVC were considered inevitable for patients 'crash-landing' on haemodialysis, or those with 
no feasible AVF options. NTCVC or TCVC were considered appropriate access modalities 
for the short term and AVF could be created at a later date – however in many cases this 
never ultimately happened. The perceived inevitability of CVC use was borne out by recent 
quality improvement efforts in the unit, which had focused upon reducing TCVC-associated 
infections rather than upon increasing AVF use. 
As seen elsewhere, CVCs were referred to as "temporary" (NTCVC) or "permanent" 
(TCVC), reflecting that for many patients a TCVC would be the only VA modality on offer. 
There was a nephrology-led TCVC list held fortnightly in the renal unit, offering 2 slots per 
fortnight. It was viewed as a means of converting NTCVC to TCVC more rapidly (and so 
facilitating patients' discharge from hospital), rather than a mechanism to maximise IR time 
for AVF maintenance.  
There were significant logistical difficulties reported in accessing vascular surgery or IR, 
since both services were based on another campus. This seemed to result in TCVC being a 
default access modality, at least for those starting haemodialysis treatment. Significant VAN 
clinical time was occupied by coordinating TCVC insertion. 
AVG usage was reportedly very low. They were not routinely inserted by the vascular 
surgeons, RDU staff were unfamiliar with them, and there was no clear process for their 
surveillance and maintenance. Their use also caused significant uncertainty around internal 
funding for the AVG device and associated maintenance costs, since nephrology, vascular 
surgery and IR sat within three separate directorates with different managers, different 
budgets, and many other competing priorities. The logistical, practical and financial issues 
meant AVG were not considered achievable options for most patients. 
PD was considered underutilised by nephrologists, who showed interest in increasing its use. 
It was offered to patients as an alternative modality to haemodialysis but was not considered 
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a means of avoiding 'haemodialysis with a TCVC' if no AVF option existed. It was 
considered easier to achieve PD catheter insertion than to have an AVF created in most cases. 
 
Unit 10 (Paediatrics) 
In the children’s renal unit there was a notable focus upon TCVC as the default means of VA 
for haemodialysis. Staff reported it had been several years since a patient last dialysed in their 
unit using an AVF.  
For some very young patients, for whom TCVC insertion was not physically possible, PD 
would be offered. PD was also offered to patients who lived far away from the centre, but it 
was not offered routinely to patients whose vessels were suitable for a TCVC but not for 
AVF creation. PD was not considered a strategy for preserving central vessels. 
The complications of TCVC use were not readily acknowledged by clinicians. TCVC-
associated infections were often attributed to a lack of patient hygiene rather than as a 
recognised complication of treatment. There was a lack of awareness of central venous 
stenosis as a late complication of TCVC use. It was said to be highly unusual for their 
patients to develop this under paediatric care, when patients typically dialysed (and thus 
required VA) for only short periods before receiving a transplant; central venous stenosis was 
more typically seen in these patients many years later when they attended adult services.  
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Discussion 
 
This chapter has considered clinicians’ opinions relating to the different VA modalities. 
Overall the data suggested that viewpoints on VA modalities varied by unit rather than by 
professional background. The historical context of each unit is likely also relevant.  
It would be overly simplistic to suggest that clinicians’ values were the only contributor to 
the relative utilisation of each VA modality in each centre: clearly there are many other issues 
including resource availability, local technical expertise and other factors discussed 
elsewhere in this thesis. However, clinicians’ opinions define many of the assumptions and 
values that underpin the function of the VA service, and given the relative power gradient 
that exists with patients it may be argued they must also influence clinical decision making 
and the consent process. These opinions may be considered ‘source types’ or ‘function 
types’, dependent upon perspective185,186. Cherns’ sociotechnical system design rules207,208, 
modified by Clegg210, and updated by Fischbacher-Smith178,would position them as central 
‘assumptions’ that are key to system functioning. Amending these assumptions through 
education or by other means, may hold the key to changing VA clinical practice. 
Current audit standards measure the proportion of patients receiving haemodialysis using 
AVF within a given centre3. It is apparent that this figure could be ‘unfairly’ influenced by 
the availability of alternatives such as AVG and PD, and access to transplantation. In turn, 
this may be modified by clinicians’ opinions about these modalities and their suitability for 
specific patients. Centres who make proportionally higher use of PD, AVG or transplantation 
may be unfairly disadvantaged by current audit standards. A suggested alternative audit 
standard is ‘the proportion of patients in a given centre whose RRT modality is haemodialysis 
delivered using a TCVC’. As well as generating a more comparable dataset between centres, 
this also characterises ‘haemodialysis with TCVC’, ‘haemodialysis with AVF’ and 
‘haemodialysis with AVG’ as discrete RRT modalities, characterised by their unique and 
divergent burdens of morbidity, mortality and financial cost.  
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Chapter 5: Maintenance of Vascular Access 
 
This chapter describes and analyses the processes used to maintain VA in Scottish renal units. 
Since all VA modalities may fail over time these processes are considered essential to any 
VA service. It is likely that VA creation pathways (chapter 3) and clinicians’ opinions of VA 
modalities (chapter 4) influence the proportion of patients who receive their first 
haemodialysis with an AVF; however, the proportion of patients who receive ongoing 
haemodialysis with AVF is likely to reflect how well existing VA is maintained. This study 
aims to understand variation between centres in this regard, and to design improvements; 
understanding each unit’s maintenance processes is therefore vital to achieving the study’s 
aims. 
As with VA creation pathways, it is helpful to explore the formal processes involved in the 
VA maintenance pathways (‘work-as-imagined’) before considering their routine functioning 
(‘work-as-done’). 
It has been acknowledged in earlier chapters that centres varied considerably in the extent to 
which VA pathways were formally recognised as distinct entities. This was notable for VA 
creation, and strikingly apparent for VA maintenance. The pathway elements, the language 
used to describe these elements, and the nature of clinical interactions across the pathway, all 
vary considerably between centres and, in some cases, between satellite haemodialysis 
centres associated with the same renal unit.  
 
Processes 
 
The major elements of the VA maintenance pathway are described in figure 9. This 
represents an amalgamation of the pathways used by each centre; Table 15 describes 
components of the pathways in each centre; these should be read alongside appendix 6 which 
contains diagrams with the specific pathways in use by each centre for comparison. The 
stages are detailed below. 
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Figure 9 Generic Vascular Access maintenance pathway 
This pathway diagram reflects an amalgamation of the clinical pathways in use by each renal 
unit. The pathways used by each individual unit are described in appendix 6; they vary 
considerably between units. In most centres the patients’ VA was assessed at the time of 
haemodialysis sessions, using dialysis indices, and/or by transonic measurement. VAN would 
be informed if there was concern based on these findings or for any other reason. 
Investigations and/or intervention would then follow, sometimes arranged via an MDT 
meeting. In cases of clotted AVF most centres relied upon a combined IR and surgical de-
clotting procedure, although in many cases this proved impossible to facilitate with a 
clinically appropriate timeframe. If VA failed the patient would then enter the VA creation 
pathway (see chapter 3).  
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Unit 1 2 3 4 5 6 7 8 9 
Protected IR 
slots? 
No No No No Informal No No No No 
AVF history 
used in 
planning AVF 
interventions? 
Yes Yes No Yes Yes No No Yes No 
Declotting – 
usual practice 
Surgical IR Surgical Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Variable IR 
Declotting – 
unit’s 
preferred 
practice 
Surgical Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Combined 
surgical / 
IR 
Unknown IR 
Table 15 Vascular access maintenance pathway characteristics, by centre  
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Surveillance 
 
Surveillance of VA, and what this means in different centres, forms a major component of 
VA maintenance. For clarity of presentation, chapter 6 is dedicated to this issue.  
 
Clinical assessment 
 
VAN and RDU nurses in all units considered the VA clinical assessment to be a routine part 
of the clinical activity associated with all outpatient haemodialysis sessions. No units 
routinely recorded this assessment, and no unit had a written protocol (or equivalent) 
describing this assessment in any detail. Clinicians who were not directly involved in the 
delivery of haemodialysis sessions had limited awareness of this assessment. 
Clinical assessment also involved nephrologist review of haemodialysis indices on a monthly 
or three-monthly basis, although this was not usually performed directly alongside the 
nursing staff responsible for delivering haemodialysis treatment. 
 
Referral of clinical concern 
 
In most centres, VANs acted as the first contact point for any VA-related concerns. VANs 
expressed frustration at the variable timing of such referrals: on one hand, it was common for 
AVF problems to be referred at the point of AVF failure, despite a lengthy prodrome being 
retrospectively apparent in the haemodialysis indices; whereas other patients were often 
referred to VAN with apparently trivial problems, for which no remedial measures had been 
tried by RDU staff before referral. 
There appeared to be no clear distinction between the role of VAN and RDU staff with 
respect to identifying and managing clinical problems, or coordinating more complex 
management such as referrals to surgeons or IR. 
Referrals to VAN were largely informal, with little formal documentation required by the 
referring clinician. No unit had a written policy describing the conditions in which a patient 
should be referred, or the actions that would be taken following referral. 
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Interventional radiology 
 
Most patients with identified AVF problems were said to require fistulography imaging 
and/or fistuloplasty. No units had IR slots formally designated for VA work, although some 
units informally protected some slots for this purpose. In Unit 5 slots informally designated 
for VA were allocated to named patients during the VA MDT meeting (discussed below). In 
Unit 2 there was sufficient capacity and engagement from IR such that cases were usually 
appointed within one week. Elsewhere, patients were placed on the general waiting list for 
any patient awaiting an IR procedure; it was said that many patients’ AVF would then fail 
irreparably before their IR procedure was appointed, although no audit data was forthcoming 
to support this assertion.  
In most centres it was normal for fistuloplasty to immediately follow fistulography, during 
the same procedure, where it was indicated; however, in Unit 9 patients were appointed first 
for diagnostic fistulography, and where fistuloplasty was required they would receive a 
further appointment to attend for this on a later date. 
 
Vascular surgery 
 
A small patient cohort required surgical maintenance procedures. This was in addition to 
those who were thought to require a new AVF creation, in which case the VA creation 
pathways would be followed (see chapter 3). VANs reported it was more straightforward to 
schedule surgical maintenance cases (rather than IR cases) since they occupied the same 
theatre lists used for VA creation. 
 
De-clotting 
 
The approach to patients presenting with clotted AVF varied considerably between centres, at 
different times of day, and occasionally between clinicians in the same team. Most units 
aspired to providing combined surgical / IR de-clotting procedures, but this was not routinely 
possible in many units. Various barriers to providing this service were described, including: 
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• Lack of available theatre space; 
• Lack of available (non-medical) theatre staff out-of-hours; 
• Non-co-location of the renal unit (and hence the patient) with interventional facilities; 
• Variable clinical engagement by individual surgeons and radiologists providing out-of-
hours cover.  
In some centres it was common for a radiologist or a surgeon to attempt a de-clotting 
procedure, but not working together. Surgeons and radiologists both expressed frustration 
with such procedures, which were considered technically challenging and likely to prove 
futile. 
The benefits of combined approaches seemed most apparent to surgeons and radiologists 
working in centres where this was normal, routine practice. These were also the centres that 
tended to describe aggressive, early intervention strategies for problematic AVF.  
Staff in Unit 2 maintained a specific ‘AVF history’ that detailed interventional procedures 
and other relevant clinical details; this was used to inform decision-making in the event that 
an AVF developed problems or failed altogether. If an AVF was considered to be failing, 
new VA would be created before original AVF failed. Similarly, in Unit 5 it was reported that 
patients whose AVF began to show signs of failing would be listed for a new AVF procedure. 
In both centres it was highly unusual for patients to present with a thrombosed AVF without 
an alternative access strategy in place. 
The centres with closer teamworking between vascular surgery and radiology, where 
combined procedures were more common, also tended to report performing the fewest de-
clotting procedures – although as with many other aspects of VA practice, no audit data was 
available to corroborate this. The benefits of combined procedures were least likely to be 
discussed by nephrologists in centres with more passive surveillance programmes and where 
combined de-clotting procedures were not routinely available.  
 
Function 
 
Multi-disciplinary team meetings 
 
The term ‘MDT’ was familiar to all clinicians interviewed in this study. The term was 
understood in most centres to refer to the “multi-disciplinary team [meeting]”, but also 
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referred to the concept of a multi-disciplinary approach or to the broader concept of 
teamworking.  
The generic VA team composition includes representation from nephrology, vascular 
surgery, IR, VAN, sonographers, and administrative support. Substantial variation was seen 
between centres in the extent to which each clinical group engaged with MDT meetings, and 
with the broader VA service. In some centres a surgeon and VAN informally discussed VA 
patients without any regular input from nephrology, IR or others. Elsewhere there were 
weekly meetings attended by multiple representatives of each clinical group. The purpose, 
composition, frequency and impact of these MDT meetings also varied between centres. In 
some units meetings were infrequent and poorly attended; elsewhere they formed the 
cornerstone of the VA service. Meetings were conspicuously absent in Unit 6, yet the MDT 
functions described elsewhere were clearly evident and were said to be facilitated by 
effective interdisciplinary co-operation and regular, albeit ad hoc, communication about 
shared patients with VA problems.  
 
No unit clearly articulated the specific role of the MDT meeting. There was an implicit 
assumption in all centres that the MDT meeting would be the forum for discussion of any VA 
issues, whether clinical, operational or strategic. In practice, most MDT meetings focused 
efforts upon improving secondary patency, that is they managed problematic VA within the 
prevalent HD cohort. The role of the MDT in the creation of new VA (for new patients not 
previously known to the team) was less clear. Similarly, it was apparent that MDT meetings 
were not typically concerned with more strategic approaches to improving the proportion of 
patients dialysing with AVF or AVG. There did not appear to be a natural forum for 
discussion of these issues.  
 
Surgeons and radiologists placed more value on the MDT meeting process than 
nephrologists, but nephrology involvement was regarded by surgeons and IR as being key to 
the meeting’s success. Surgeons and radiologists appeared more familiar than nephrologists 
with MDT processes, from the other aspects of their clinical roles. Nephrologists had with 
limited insight into the value with which surgeons and radiologists held their opinions. Some 
regarded themselves as passive participants in the MDT, whose role was to refer patients into 
the clinical pathway rather than being involved directly in the ensuing discussion. Overall it 
was clear that face-to-face contact between members of the team was a key attribute of a 
successful service, and regular MDT meetings usefully facilitated this.  
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Co-location of nephrology, vascular surgery and radiology units, along with the provision of 
protected job-planned time to attend meetings and manage the associated clinical issues, 
seemed to strongly influence individual clinicians’ ability to engage with MDT working.  
The importance of MDT meetings appeared as much about building interpersonal 
relationships between clinicians as with the specific clinical discussions that took place. 
Some units credited the mutual trust established by MDT working with the development of 
efficient clinical processes, for example VAN listing patients for theatre, without direct 
surgeon involvement, at the VA clinic. Some centres clearly regarded the MDT as the 
cornerstone of their VA strategy, crediting it with better clinical outcomes for patients and 
substantial reductions in unscheduled VA care. In centres without a functioning MDT it was 
common for clinicians to be unfamiliar with the names of colleagues working in other parts 
of the service; in some units they reported never having met one another in person.  
Important prerequisites for a successful MDT meeting appeared to be as follows:  
• Availability of a comprehensive patient list for discussion;  
• Reliable presence of all stakeholder groups;  
• Administrative support to record and disseminate decisions and to book procedures;  
• Available slots to be allocated to named patients who require radiological or surgical 
procedures. 
 
Table 16 describes MDT meeting characteristics in each centre. Table 17 demonstrates 
quotations from interview transcripts describing the MDT meetings. The function and 
capability of the MDT meeting is then discussed in detail. 
 
 
 
  
 
.   
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Unit 1 2 3 4 5 6 7 8 9 
MDT 
meetings 
Yes Yes No Yes Yes No Yes Yes Yes 
Meeting on 
renal unit 
site? 
Varies Yes N/A Yes Yes N/A Yes Yes No 
Regular or 
on request 
Regular Regular N/A Regular Regular On request Regular Regular On request 
Meetings per 
year 
12 39 0 12 17 0 26 52 12 
MDT 
frequency 
Monthly 3 weeks in 4 N/A Monthly 3 weekly On request Fortnightly Weekly Monthly 
Who attends Surgeon, 
VAN, 
sometimes 
nephrology 
IR, surgeon, 
nephrologists, 
VA nurse, 
sonographers 
n/a Nephrology, 
IR, possibly 
others? 
IR, surgeon, 
nephrologist, 
vascular lab, 
VA nurse 
Informal Nephrologist, 
IR, surgeon, 
VAN, RDU 
staff 
Nephrologist, 
Surgeon, 
VAN, IR 
Surgeon, IR, 
occasionally 
VAN and 
nephrologist 
Job planned Yes Yes n/a Unclear Yes No Yes Some No 
Time 
protected 
Yes Yes n/a Unclear Yes No Yes Yes No 
Table 16 Multi-disciplinary team meeting characteristics by unit
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Unit Transcript Data 
1 “We do have a forum for Vascular Access discussion which is barely used. But again, you know, I 
don’t like to say ‘you must come to this meeting to discuss patients’ when, you know, I take as much 
responsibility as them for not turning up to the MDT sometimes” (Consultant Surgeon) 
“No, it is just a general Vascular MDT so there is no specific renal MDT… it is just a case of 
discussed ad hoc at that meeting, again there is no ring-fenced time, it is just part of the general 
meeting.” (Consultant Radiologist) 
2 “We are a relatively small place. On occasion, people can’t come… and you notice that you do suffer 
when … you want the advice of a renal physician… but by and large it runs well.” (Consultant 
Surgeon) 
“We still have difficult patients and there are still failures. We’ve had a few patients who needed a 
few attempts to get an access going but just sharing that around helps a lot.” (Consultant Surgeon) 
3 
“it’s most useful because it allows the interventional radiologists to be engaged with a case and 
take on something that they might not have been very keen to do, or they may have just not done 
what was wanted” (Consultant Surgeon) 
“I think the structure was better, the overall management picture was better when we had the 
MDT because everyone was involved and even a simple fistulogram that was done was discussed 
and there was an MDT approach … there was a structure previously and that was good and I 
think it would be useful if we could go back to that.” (Consultant Radiologist)  
4 “We have got a monthly Vascular Access meeting in the team meeting so that’s looking at planning 
but also surveillance results and intervention planning mostly from that meeting.” (Consultant 
Nephrologist) 
5 
“When I used to go to other centres in Scotland, they didn’t have specific Vascular Access MDTs. 
They didn’t have surveillance. I strongly believe that, having seen it here, that it works very well 
having a specific MDT to only discuss Vascular Access cases, having surveillance programme 
with interested sonographers running it and having some protected slots to some extent.” 
(Consultant Radiologist) 
6 “We tried to set up a MDT meeting, but our patients, which are so few, that is wasn’t worth it and to 
be fair, phone calls or corridor meetings are just as productive really.” (Vascular Access Nurse) 
“We see each other pretty well every day, so it’s not difficult.” (Consultant Surgeon) 
7 “MDTs have been very good in terms of, you know, not even just about the discussion. The discussion 
can be quite really boring, because we’ve actually sorted things out but it actually brings everyone 
together and we discuss other aspects of problems.” (Consultant Surgeon) 
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8 “The MDT meetings which we don’t go to, it’s difficult to go to them. But there is some nephrologists 
who do go, I have been to them before, but particularly in [this unit] they’re so big, that the majority 
of the patients will not be relevant to me, and my influence in them may not be particularly useful for 
most of the patients.” (Consultant Nephrologist) 
“I think that’s not well attended by all the groups, to my understanding, and possibly not even well 
attended within the groups if you follow, so even the groups who come along, there are 
individual who are clearly driven to get involved and there are others who are not. But there is a 
formal MDT yeah.” (Consultant Radiologist) 
“It doesn’t really work, currently. It runs on alternate weeks on different days. So it’s not weekly, and 
which day of the week varies. It’s done in lunch time slots in a day when we [are often on offsite 
clinics]. The radiologists sometimes are unable to make it because they are [offsite]. So it doesn’t 
really work as well as we would like it to. It would be much better if there was a more consistent way 
of protected time.” (Consultant Surgeon) 
9 “There is a vascular MDT meeting that I infrequently manage to get to” (Consultant Nephrologist) 
“[Nephrologists] used to come [to the MDT meeting] and they do come every now and then to the 
meeting. Not very regularly, but equally enough not all the 3 vascular people are in, but there 
will be a representative.” (Associate Specialist Surgeon) 
“[Nephrologists] do [attend the MDT meeting] when they can. But again, because of your two sites, 
it’s actually easier, we tend to have it just before the vascular MDT meeting so timing wise we’re all 
on site at [campus]. It would be much easier to have the nephrologists present” (Consultant 
Radiologist) 
Table 17 Multi-disciplinary team meetings 
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Unit 1 
Unit 1 has a monthly MDT meeting that is almost never attended by consultant nephrologists 
or interventional radiologists. Meetings were said to be short, infrequent and poorly attended. 
One staff grade nephrologist tries to attend but other timetabled clinical commitments can 
hamper attendance. Functionally the MDT is mostly an informal discussion between the 
surgeon and VAN in the RDU, where the surgeon attends on at least a weekly basis. All 
interface between surgery and IR occurred through the general vascular surgery MDT 
meeting, without direct nephrology or VAN involvement.  
 
Unit 2 
There was a weekly MDT coordinated by VAN and well attended by all specialties. The 
agenda was formed using an ‘active patient’ list including all those using TCVC or with other 
VA creation or maintenance issues. The meetings were the mechanism for clinical referrals to 
surgeons and radiologists. Clinical decisions were assisted by VA intervention records 
maintained by sonography staff, who also attended each meeting. This enabled timely 
planning of maintenance for problematic AVF, or new VA creation if this seemed more 
appropriate.  
Patients were listed by VAN for the relevant surgical or IR procedure directly from the MDT 
meeting. VAN also prioritised theatre lists and scheduled further discussion of patients at the 
next meeting following their procedure. Ad hoc emergency referrals were normally 
accommodated between meetings, but the bulk of clinical activity arose from the meetings; 
this was said to benefit all parties. Strategic service issues were discussed separately in an 
annual review meeting.  
The meeting’s value was widely appreciated. Radiology considered that the meetings had all 
but eliminated clinically inappropriate procedure requests, while surgeons credited them with 
successfully reducing unscheduled VA care. 
 
Unit 3 
The MDT was previously viewed as a useful forum for discussing problem cases, but 
meetings had become infrequent and it was now common for VA issues to be discussed at the 
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general vascular surgery MDT meeting. The surgeons felt meetings enabled closer MDT 
working than was otherwise possible, while radiologists suggested this helped them feel more 
involved in the overall care of the patient, rather than simply acting as technicians. 
 
Unit 4 
The monthly MDT meeting was a forum for discussion of elective VA creation, intervention 
planning and problems identified during surveillance imaging; most of the agenda arose from 
their surveillance programme.  
 
Unit 5 
Unit 5 held a well-attended MDT meeting every three weeks, and it was unusual for the 
meeting to be cancelled or rescheduled. There was broad buy-in from clinicians representing 
all specialties. Cases could be listed for discussion by VAN or by the vascular lab; RDU staff 
could send patients to the vascular lab via liaison with VAN, or for scheduled routine 
surveillance imaging. The meeting was used to plan forthcoming surgical or IR intervention 
on the existing AVF cohort. Where IR intervention was planned it would be scheduled 
directly at the meeting and was usually completed in time for further discussion at the next 
meeting, three weeks later.  
Radiologists particularly valued having a VA-specific MDT that was not subsumed by the 
general vascular surgery MDT. They considered that the VA service generally functioned 
well because of the face-to-face discussions, scheduling and overview of the active patients 
that was facilitated by the MDT.  
 
Unit 6 
It was reported that attempts to establish a regular MDT meeting had been unsuccessful as 
there was insufficient workload to justify the time commitment. Clinical issues were 
managed on a case-by-case basis; clinicians reported that this was straightforward in view of 
their proximity to one another within the small hospital, and their mutual enthusiasm for VA 
work. It was acknowledged that this did mean there was limited strategic overview of the VA 
service.  
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Unit 7 
The MDT meeting was considered a good use of time. It was seen to streamline the patient 
experience, provide a forum for discussing clinical challenges, and enable new access 
creation when maintenance of an existing strategy was proving difficult. The MDT meeting 
was thought to reduces the overall VA workload, albeit there was no audit data to confirm or 
refute this.  
Meetings were generally well attended, but geography and pressures of service delivery were 
cited as reasons for some clinicians having difficulty attending. Regardless of attendance, all 
MDT meeting decisions were circulated to the nephrologist responsible for the patient after 
the meeting.  
Surgeons viewed the MDT as a helpful forum in which to review recent interventions and 
newly fashioned AVF, but considered the most important element to be the bringing together 
of each profession and the face-to-face contact. 
 
Unit 8 
There was an established MDT meeting, but attendance was variable. RDU nurses were 
effectively unable to attend for logistical reasons, and it was said that they were expected to 
attend in their own time (i.e. on a day off) if they had issues to discuss. 
Some nephrologists referred to “meetings to review the radiology” rather than discussions 
around individualised VA planning. They did however recognise the MDT meeting’s 
potential to tackle complex VA problems. They did not consider meeting attendance a good 
use of their time as most patients being discussed were not under their care.  
The referral pathway for patients to be discussed at the meeting was not clearly defined. 
Meeting outcomes were recorded on patients’ electronic health records but were not directly 
distributed to the referring clinician. Some nephrologists felt these outcomes lacked 
credibility, stating it was common for agreed actions to not be successfully carried out.  
Meeting agendas were populated using an Excel spreadsheet with details of patients who had 
recently undergone VA interventions. Ad hoc VAN referrals could also be discussed. It was 
reported that many ‘routine’ cases were listed for discussion: typically patients who had 
attended for vein mapping in advance of AVF creation. Some clinicians felt the meeting time 
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could be better utilised by removing these cases. In common with many other centres, there 
was no time at the meeting for strategic service discussions. 
 
Unit 9 
The VA MDT meeting was held on a different hospital campus to the renal unit, immediately 
before the general vascular surgery MDT meeting. It was logistically challenging for VAN to 
attend, and impossible for the nephrologist to attend in view of competing clinical demands 
before and after the meeting, on the renal unit site. It was noted that VA cases were usually 
not discussed if VAN or a nephrologist did not attend.  
MDT meetings did not have a formal agenda, and the discussion would usually focus upon ad 
hoc cases raised by VAN. It was not normal practice to review all patients who had recently 
undergone VA intervention or who had other active VA problems pending resolution.  
 
 
Discussion 
 
VA maintenance is essential if patients are to successfully use AVF for haemodialysis 
treatment. The success of maintenance pathways may thus be reflected in the proportions of 
‘prevalent’ patients using AVF for ongoing haemodialysis treatment. This section has 
considered the configuration of maintenance pathway and their practical limitations in units 
across Scotland. An idealised pathway has been described, and comparison with current 
models of practice have generated many recommendations for practice. These have 
considerable overlap with other areas of VA care; for ease of presentation the 
recommendations are described in chapter 11.  
 
Clinical resources 
 
The interview transcripts suggested there was a significant, unmet demand for VA 
investigations and procedures, ultimately with the potential to modify patients’ life 
expectancy. This assertion is supported by the findings of the clinical activity census, which 
demonstrated a very high workload across VA service over a short time period (this is 
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reported fully in chapter 7). This contrasts starkly with the lack of any designated resources to 
meet these needs, as described in this chapter.  
Specific adverse events arising from this unmet clinical need were not directly identified by 
this study, but it was also notable that no audit data existed as to the exact demand for, and 
capacity to perform, VA procedures, or any consequential morbidity and mortality. Further 
work should examine this issue. It is interesting also to note that the Safety II approach taken 
by this study has served to highlight the scale of the potential clinical need; it is possible that 
Safety I oriented investigations, focusing upon discrete adverse events, may not have detected 
this lack of resource with such detail. Understanding the normal functioning of VA 
maintenance pathways, including the clinical workload has also enabled estimations to be 
made of the resource gap in each unit (see chapter 7). 
 
Team working 
 
Multi-disciplinary teamworking seems vital to effective functioning of VA maintenance 
pathways, perhaps even more so than with VA creation pathways. Cherns’ principles207,208 
(and updates178,210) concur with the central relevance of the team and its core values, 
assumptions and beliefs. The VA clinical context presents a wide range of clinical, technical 
and logistical challenges, and team members must be adequately equipped to deal with these. 
The importance of the multi-function principles is evident when contemplating these myriad 
presentations. Similarly, the need for proper information flow (e.g. the prompt availability of 
a fistula intervention record); support congruence (e.g. test requesting systems that are 
synchronised across all hospital campuses); power and authority (e.g. VAN-led test 
requesting or discussion with IR) are all highlighted in these pathways.  
The sense of ‘team’ within each service also seemed to influence clinicians’ perceptions of 
their own role. Where the team functioned well it was clear that individuals felt empowered 
to make decisions with confidence that colleagues would support them. A notable example 
related to VAN-led discharges from hospital following AVF surgery. In Unit 2 this was 
perceived as patient-centred care being delivered by the most appropriate member. In 
contrast, the VAN in Unit 9, whose postoperative discharge role was very similar, felt 
vulnerable and ‘left to get on with it’ with little support from other team members. 
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Clinicians working in units where teamworking appeared strongest also seemed to take more 
‘ownership’ of VA clinical pathways and accepted more personal responsibility for patients 
within the service. The existence of a regular MDT meeting, and the degree of clinical 
engagement with this, tended to signify how involved individuals were with the VA service. 
It should be noted though that staff in Unit 6 appeared to work as a strong team without 
having a formal MDT meeting.  
Perhaps the simplest marker of teamwork was the extent to which interviewees named others 
in the team as they discussed the processes. In the centres where ‘ownership’ did not appear 
to be a problem it was common for individuals to name one another through the course of 
their respective interviews; whereas in other units it was more common to refer to colleagues 
by job titles or by other impersonal descriptors. In other cases, individual clinicians expressed 
frustration with others’ apparent lack of interest in the service or spoke of difficulties 
identifying who was responsible for a given patient as they transited through a VA pathway.  
Table 18 demonstrates transcript data, which is then discussed by unit in the following 
sections. 
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Unit Transcript Data 
1 “So I don’t take any ownership of who requires priority from that point of view. I will let the 
nurse in conjunction with the nephrologist” (Consultant Surgeon) 
“What the nephrologist needs to do if they want any Vascular Access at all, there is a paper 
referral form and that, I don’t do anything until I have got that… As soon as we do the 
referral form that’s the ownership over to their work” (Vascular Access Nurse) 
“I am not personally aware, to be honest they are managed pre and post by surgical staff, we 
don’t routinely see them” (Consultant Radiologist) 
“I don’t know who this patient belongs to… we are probably leaving the whole monitoring 
and everything down only to the Vascular Access nurses” (Associate Specialist Nephrologist) 
“Our Vascular Access nurses, who presumably link between nephrology and surgery and 
they link between nephrology and surgery and interventional radiology as well.” (Consultant 
Surgeon) 
“I would imagine the process, generally, is it is discussed with [the surgeon] who would then 
make the decision whether the referral was made for fistuloplasty, so that is probably the 
pathway that is taken.” (Consultant Interventional Radiologist) 
 “The rest of the team is very intermittent so usually it will be left to us even though the 
patients like you know belong to [another dialysis shift]… but then you have to deal with the 
access issues” (Associate Specialist Nephrologist) 
2 “Not sure we’ve ever thought that anyone in particular has ownership, bit of shared 
responsibility, I mean, if a patient needs an access or a revision I think the surgeon takes 
charge of that process… I think the renal physicians feel over all they are in charge of the 
care of the patient. I think we essentially agree with that.” (Consultant Surgeon) 
“We are all part of one big team and we have all got a role to play… a small part, a large 
part of this and we work together.” (Vascular Access Nurse) 
“You have to remember this is very much a team-based process… everybody has an input, 
and everybody has a voice… I think that attitude, I think that is the crux of why it works so 
well is that we have such a good set-up with the MDT and with the teamwork.” (Consultant 
Radiologist) 
“I have two colleagues… the one that does fistuloplasties won’t put lines in whereas the one 
who won’t do fistuloplasties does put lines in. And then I do everything.” (Consultant 
Radiologist) 
“I think [named surgeon] is probably an important factor” (Consultant Nephrologist) 
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“There is a bit of an issue with radiology as well because it’s really essentially [named 
radiologist] who’s taking the interest and he’s the only one who comes to the MDT… so that 
service is single handed which is not ideal.” (Consultant Surgeon) 
3 “I think… you have got to make it easy for the surgeons. We admit all the patients, we 
prepare them for theatre, the surgeon sees them… we get them all ready and organise their 
diabetic treatment, warfarin and they come and see them in our ward and take them to 
theatre… I am aware that I just, you know if something needs done I will just do it rather 
than, you know, it is quicker than trying to hassle some others to do it.” (Vascular Access 
Coordinator) 
“They are our responsibility and you need clear areas of who is looking after this patient… I 
do it because it’s the right thing to do.” (Vascular Access Coordinator) 
“Usually within 3 or 4 hours we will get a vascular person over to have a look and they could 
be in theatre that night if it’s starting to fail.”  (RDU Nurse) 
“One of us can’t really take the lead: half the time I’m here, and half the time I might not be 
here” (Consultant Radiologist) 
4 “If we get a problem on dialysis then they are usually accessible instantly to have a look at 
the scan either to see if there is an active problem, or simply to indicate a point the nurses 
can needle. So that’s a very good service and so from identifying a problem with a fistula to 
getting a scan is usually same session and often is, if it requires interventional radiology, that 
that happens the same day.” (Consultant Nephrologist) 
5 “It’s the ethos rather than one person, it’s the ethos of the whole, the way it runs and this is 
important… I think that’s probably what’s running the place.” (Consultant Radiologist) 
“We’re very comfortable with our vascular lab … I mean all of the way in which I do a 
fistulas presuppose the Duplex is going to be correct, and it almost always is” (Consultant 
Radiologist) 
"So I suspect some of…how units work has much more of an impact than what they actually 
do when they find something." (Consultant Radiologist)  
6 “I have full faith in that bunch around the corner, they’re fine people and we get on really 
well, and if they say it needs doing, then we will do it.” (Consultant Surgeon) 
“We’re a happy family, we talk to each other… we don’t need quite so many rules because, 
you know, we’ve got more flexibility.” (Consultant Surgeon) 
7 “It’s a really good team: our Vascular Access team are brilliant! We nominated them for the 
[health board awards] team of the year.” (Consultant Nephrologist) 
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“I think that the complications of Vascular Access are our problem and I think that we have, 
we are kind of the patient’s guardian in a way aren’t we?” (Consultant Nephrologist) 
8 “I feel just now there’s no one person responsible and that causes issues… that causes delays 
that probably don’t need to be there.” (Nurse Practitioner) 
“I’d say that that’s not them all but there are certainly some who just don’t think it’s 
appropriate [for a nurse to make a referral] and I don’t know whether it is or not.” (Nurse 
Practitioner) 
“There is a whole bunch of people, if you like, doing the selection process, it seems to me, I 
think they outnumber the people doing the delivery process!  Clearly the renal physicians are 
involved, we have got renal nurse practitioners who are often the interface between us and 
the competing priorities during the day.” (Consultant Radiologist) 
“I will phone down because we have good rapport, I would contact nursing staff where I 
guess the surgeons would go directly to the radiologists… sometimes it feels like they’re 
doing you a favour.” (Nurse Practitioner)  
“I don’t think there is a clear trail of who is responsible but I’m not sure whether that has 
much of an impact clinically.” (Consultant Surgeon) 
“Yeah that’s the problem, because see if I get somebody that comes in with ‘Oh their fistula’s 
clotted’, oh that’s a medical problem. And we’re like that, ‘well no it’s a surgical problem’. 
And you’re like that, ‘it’s the patient’s problem – they’ve now got no access, could somebody 
do their access please!’” (Vascular Access Nurse) 
“It is difficult to know who the responsible nephrologist is…you can look at letters from 
[clinics] and see six different consultant nephrologists have been seeing the patient and none 
more than anywhere else. So you never quite know who to write to.” (Consultant Surgeon) 
“It all floods into an MDT and goes out to other people you don’t really know” (Consultant 
Nephrologist)   
“I bet [RDU nurses] feel very unsupported… we have to do some serious diplomacy work 
when people have written in [the electronic health record] ‘nurses unable to do such and 
such’” (Consultant Nephrologist) 
“It’s a group of people ultimately headed by [surgeon]” (Consultant Nephrologist) 
 “I can do as much as I need to and then it’s handing over, it’s other people from them on” 
(Consultant Nephrologist) 
“Once they go on the list for surgery that’s my bit done” (Vascular Access Nurse) 
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“It just gets blocked and you have to kind of push it… it just does keep bouncing back and if 
it is not happening, you have to keep pushing it. You have that feeling all the time.” 
(Consultant Nephrologist) 
“If it’s something that they think: ‘well this patient could get a temporary line, they don’t 
need to be dealt with today’, then it will just be ‘on you go with them’” (Nurse Practitioner) 
9 “There has to be someone feeling the ownership of the patient and this patient needs to have 
so and so. This patient needs priority of so and so, but it’s like I am not the direct clinician 
looking after this patient, it’s the renal physician, if they want something, they come to us. 
Unfortunately we do not have a lead renal access surgeon and I think that’s the problem…. 
My view, this has to be a surgical lead, a radiology lead and a nephrology lead, with [VAN], 
these people to be the arc of the renal access” (Associate Specialist Surgeon) 
“I just give you an example, in a different scenario. Diabetic patient, coming in with diabetic 
septic foot, ulcers. They have the podiatry clinic, there is a diabetic consultant and there is a 
vascular surgeon. I say why you don’t apply the same to the renal!” (Associate Specialist 
Surgeon) 
“I hope that is the case, [VAN] feels there is no barrier, that she can phone me, and she 
knows that if she needs me to see the patient today, I see the patient at the end of the day. She 
might not feel, and I will be very honest here, she might not feel the same thing of 
communication may be with radiologists, but I think she is trying to work around that.” 
(Associate Specialist Surgeon) 
“We have an informal duty of care to renal patients… I think each element external to 
nephrology has a technician role to some extent” (Consultant Radiologist) 
10 
(Paediatrics) 
“We don’t specifically put in the access as it’s the surgical role, so we make the decision of 
when the child needs haemodialysis” (Consultant Nephrologist) 
“Recurrent issues of line and infection risk, we don’t generally … get involved as much as 
say [nurse practitioner] would.” (Consultant Nephrologist) 
“It tends to be the nursing staff that kind of, I would say leads, apart from the actual 
connection between the surgeon and the consultant for permission formally, the nurses, we 
do most of the rest of it.” (Nurse Practitioner) 
Table 18 Teamworking 
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Unit 1 
There was a striking lack of ownership of VA processes, and little evidence of collaborative 
working in the centre. The surgeon and nephrologist had struggled greatly to engage others 
within the centre and were aware of difficulties streamlining patient care arising from this. 
Without significant ongoing contact with other members of the team, the radiologist adopted 
a passive ‘technician’ role and did not feel responsible for VA care. 
Teamworking was considered necessary to cope with the complexity of patients requiring VA 
work, but nobody appeared to lead the VA team, and clinical activity essentially depended 
upon individuals doing what they felt able to do, with variable support from others. There 
was uncertainty as to the specifics of clinical processes in the centre, and poorly defined lines 
of clinical responsibility for patients attending the offsite IR department for TCVC 
procedures. 
There was an apparent lack of interest from the wider nephrology team. The service did not 
seem to focus upon patients’ needs, but instead viewed the clinical pathways as technical 
processes. 
 
Unit 2 
There was a strong sense of team and striking lack of hierarchy. Team members referred to 
one another by name and as colleagues, rather than as “the surgeon” or “the nephrologist” as 
heard elsewhere. It was perceived that nephrology had overall charge of the service, but in 
the context of a flat hierarchy. 
There was clear ownership of the VA patient’s clinical problems, and a desire to provide 
patients with the best possible service. Flexible working arrangements were seen to work in 
patients’ and the service’s favour. Each clinician reported feeling able to fulfil their role 
without requiring to be responsibility for other areas which were outside their area of clinical 
expertise. As was seen in other centres, this mutual support was felt to enable team members 
to tackle clinical problems they would otherwise be reluctant to take on. Interestingly, one 
clinician referred to another (non-VA) clinical role, where he felt less engaged with that team 
because he was treated as a technician rather than a clinician in his own right.  
Chapter 5: Maintenance of Vascular Access 
173 
 
It was acknowledged that the collaborative approach did rely to some extent on individuals’ 
personalities and enthusiasm, and that this made the service vulnerable in the event of 
unplanned absence.  
 
Unit 3 
The VA coordinator was clearly identified by all interviewees, including herself, as the key 
person with ownership of the VA service. The configuration of their team enabled an 
individual to maintain an overview, while other clinicians retained awareness (and overall 
responsibility) for their individual patients. This was said to allow everyone to function 
optimally. Her view is that patients requiring VA ultimately have a nephrology problem and 
should therefore be primarily cared for by a nephrologist. She sought to optimise patients’ 
journeys by enabling others to participate in the service, or where this is not possible by 
solving the problem herself. Others in the team valued having one individual motivated to 
lead and coordinate the team. Her success in this role was attributed to maintaining a good 
relationship with the key players across the multidisciplinary team.  
One surgeon was particularly visible within the VA team, and due to their interest in the 
service there is a responsive surgical involvement that responds to patient needs. Surgeons 
valued having someone else to coordinate the overall process, dealing with medical issues 
and liaising with others. Radiology seemed dislocated from the main service, but they too 
valued teamworking and appreciated the clinical imperative for patients.  
On a broader scale the “Scottish Renal Nurses Strategy Group” was cited as a useful forum 
for general renal nursing collaboration. This was not restricted to VA issues, but staff valued 
having a safe place to canvass opinion and share ideas with colleagues. 
 
Unit 4 
It appeared that all members of the VA team were committed to the service, and problems 
were thus usually addressed effectively. Patients were said to receive an excellent service in 
view of the collaboration between vascular lab and radiology. Identified problems were 
managed by the most appropriate person without any requirement for ‘permission’ to be 
granted by another member of the team.  
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Unit 5 
There was a clear sense of team and each clinician appeared to enjoy VA work. The sense of 
sharing this clinical interest with colleagues was thought to generate a shared feeling of 
ownership over the service. There was a very strong, supportive engagement between 
radiology and the vascular lab. Team function was also recognised as a key element of 
successful VA clinical outcomes.  
 
Unit 6 
All team members expressed a sense of responsibility towards patients, but nephrology 
appeared to have overall ownership of the VA pathways and maintained an overview of the 
clinical situation. This allowed others to contribute their expertise without feeling overly 
burdened with the nephrology aspects of patient care. It was perceived by others that the renal 
team valued and benefited from this approach. 
Close working proximity seemed important, and there was a sense of team with a common 
goal, characterised by accessible team members who could be relied upon contribute 
whatever was necessary to meet patients’ needs. 
In contrast with other units where collaboration appeared to be lacking, interviewees tended 
to use open language and the focus of discussion was about what could be achieved for 
patients instead of what felt impossible. There was also a degree of humility and enthusiasm 
for learning from others; this was not always apparent in centres where clinicians did not 
seem to have such a strong sense of team.  
 
Unit 7 
There was a sense of collegiality between team members. Nephrologists considered that they 
had primary responsibility for VA problems, but the VAN team was supported and resourced 
to manage and coordinate clinical problems on a day-to-day basis. Team members were 
familiar with one another and referred by name to colleagues in their own professional groups 
and in other parts of the service. It seemed important that each component of the service 
(surgery, IR, VAN, nephrology) had a number of individuals contributing to the team; this 
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meant nobody was over burdened with clinical workload, and there was not a dependence 
upon a single individual for the service to remain functional.  
 
Unit 8 
There was a sense that nobody owned the overall VA process. Individual clinicians felt they 
lacked permission to take control of the service, and there was no one clinician or manager 
who had an overview of the service. Unlike other units, it was highly unusual for specific 
individuals to be named as key team players. There were many references to unidentified 
third parties who were considered responsible for managing a clinical problem. This 
contrasted with other centres, where interviewees usually expressed an ability to manage such 
problems themselves. There was also a feeling of hierarchy, which inhibited team working. 
This was perhaps most apparent in IR, where it was said that some radiologists refused to 
discuss clinical cases with VAN or other senior nurses. 
The lack of clinical leadership was particularly evident in the IR team, where referral 
handling appeared chaotic and variable. Staff felt they had to coerce the IR team to perform 
VA procedures, rather than these being core clinical activities. Radiologists also viewed their 
involvement with the service as being quite separate from that of the surgeon and considered 
that VA accounted for a considerable volume of work that was unrecognised in their job 
plans. 
The lack of clear VA team working was also apparent in surgery and nephrology. Scheduling 
of cases was haphazard and it was said to be difficult to solve problems unless specific 
individuals were available. There was no definition as to which clinician would deal with 
problems, and it was apparent that team approaches to VA problems were unusual.  
The lack of proper teamworking reduced the VA team’s credibility in the eyes of the wider 
clinical team in the unit. This also left RDU nurses feeling isolated and often led to conflict 
within the team, that would further add to the workload associated with the VA service. 
A lack of collaborative working between clinicians meant there was no collective sense of 
shared responsibility for providing optimised patient care. Problems tended to be managed 
reactively, with little evidence of forward planning. There was mixed understanding of how 
clinical problems were ‘normally’ managed. One individual was named as being the key 
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driver of clinical activity across the VA service, but it was felt that their contribution could 
only go so far. 
 
Unit 9 
Nephrologist and VAN transcripts from this centre had a conspicuous lack of any references 
to teamworking or collaboration. One nephrologist described themselves as de facto VA lead, 
but without the necessary time or resource to optimally fulfil this role. As a result, most 
clinical leadership was effectively delegated to VAN, who also lacked adequate time, 
resource and authority to fulfil this role; this was especially problematic during periods of 
leave, as colleagues would not backfill in her absence.  
The surgeon was aware of the leadership vacuum and recognised the need for a more patient-
centred approach. His attempts to provide leadership to the team were limited by his being 
based on another campus. He felt excluded from VA clinical decisions, treated more as a 
technician than as a properly qualified clinician in his own right. He contrasted this with 
positive teamworking he enjoyed in other, non-VA, parts of his job. He was aware that the 
service provided by IR was often haphazard, and that VAN was often left in a difficult 
situation because of this. 
IR described informal involvement with the VA service, without any formally responsibility 
for the patients. Overall, the radiology team felt disconnected from the wider VA team. This 
may have been influenced by their lack of designated clinical resources for VA and being 
based on another campus. They did recognise that clinical leadership was needed across the 
VA team, and that VA work had to become a routine part of their jobs instead of the current 
ad hoc ‘voluntary’ service. They echoed the surgical view of feeling reduced to technician 
status, rather than full members of the team. It was unclear if this was considered a cause or 
effect of the current way of working. 
There was some awareness that the current service was not delivering care within a clinically 
appropriate timescale. An idealised VAN role was described, but there seemed little 
awareness of how this might be achieved.  
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Unit 10 (Paediatrics) 
It was seen that collaborative working was required to deliver optimised patient care, but in 
the paediatric centre the ad hoc, low volume, nature of VA work meant it was difficult to 
build close working relationships to achieve this. The nephrologist viewed herself more as a 
coordinator rather than the person in overall charge of VA clinical processes. Nurses view 
themselves as patients’ advocates, and felt they had greater ownership over VA as a key 
factor in caring for a patient requiring haemodialysis.  
Chapter 6: Surveillance of Vascular Access 
178 
 
Chapter 6: Surveillance of Vascular Access 
 
This study seeks to delineate the structure, function and workload associated with VA 
services in Scotland. Using a systems and healthcare resilience engineering approach, the aim 
is to highlight gaps in ‘work-as-imagined’ versus ‘work-as-done’ (see chapter 1B), with the 
intention of generating recommendations for practice that will stimulate ongoing QI efforts in 
this area. Thus far chapter 1 has introduced the study context: of marked, unwarranted 
variation between Scottish renal units in relation to their use of AVF for haemodialysis. This 
is despite clear evidence of a morbidity and mortality benefit from using AVF, and various 
guidelines mandating their use. Chapter 2 described the development of a mixed-methods 
model to investigate complex clinical systems, and its use in this study. Chapters 3 and 4 
have described the manner in which VA creation pathways are structured, how they function, 
and explored how clinicians’ opinions on the various VA modalities influence this process. 
Chapter 5 has described the structure and function of VA maintenance pathways. Several 
challenges were encountered including poorly defined clinical pathways, a lack of designated 
resources for maintenance activity, variable MDT working that was at times dysfunctional, 
and reliance upon key individuals with unrealistic workloads to coordinate clinical activity. 
This chapter considers VA ‘surveillance’ practice, as a discrete set of findings arising from 
the thematic analysis.  
VA surveillance is closely allied to VA maintenance, but it was apparent that clinicians in 
different centres were referring to different things when using the term. Similarly, it was clear 
that some units considered surveillance an essential component of the overall VA service, 
while others regarded it as essentially a waste of resources. This chapter discusses these 
issues, which should be considered in the context of guidelines that recommend routine 
surveillance of VA3,89. 
The term ‘surveillance’ was generally considered to be the ongoing process of monitoring 
existing VA, but it was also used to describe: 
• postoperative reviews in the days or few weeks following AVF creation surgery;  
• routine VA assessment performed by RDU nurses immediately before, during and after 
outpatient haemodialysis sessions;  
• routine nephrologist review of haemodialysis indices, not necessarily involving clinical 
examination;  
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• Transonic or duplex ultrasound imaging with or without any of the other measures. 
It was widely recognised that patients with existing VA were a different cohort, in terms of 
their requirement for clinical assessment, to those in the immediate postoperative period 
following AVF creation surgery. In Unit 9 this distinction was not clearly made, and the term 
"surveillance" was generally applied to postoperative reviews. 
The formality and timing of surveillance varied considerably within and between centres 
(table 19). This partly reflected the available resources, geographical considerations and the 
prevailing opinion within the centre about the financial and clinical efficacy of such activity 
(table 20).  
  
Chapter 6: Surveillance of Vascular Access 
180 
 
Unit 1 2 3 4 5 6 7 8 9 
Routine Yes Yes No Yes Yes Yes No No Yes 
Location RDU RDU Vascular lab Vascular lab RDU and 
vascular lab 
RDU N/A N/A RDU 
Transonic Yes Yes No No Yes Yes No No Yes 
Sonosite No Yes No No No No Yes No Yes 
Clinician VAN RDU nurses Sonographer 
or surgeon 
Sonographer Vascular lab RDU nurse N/A N/A VAN 
Frequency Monthly Monthly 
(quarterly in 
satellites) 
3 monthly 4 monthly 6 monthly Monthly N/A N/A 4 monthly 
Table 19 Surveillance practices by unit 
The location, frequency and nature of surveillance varied considerably between centres. Some centres did not have a routine surveillance 
programme, while another had a programme that varied between the main RDU and satellite RDUs.
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Unit Transcript Data 
1 “It can vary between 2 weeks and 6 weeks. It just depends how busy they are. Because obviously they 
don’t have a designated time slot for renal” (Vascular Access Nurse) 
“That is when I would refer them on to [surgeon]... Only two people actually do the referrals, 
because there were some mix-ups… we will go and highlight there’s an issue and discuss what it is 
and they will see yeah ok that warrants a duplex or a fistulogram.” (Vascular Access Nurse) 
“[Surgeon] would generally see the referrals and then refer on to IR as appropriate, and that is just 
done through the [electronic requesting system], there is no pre-discussion this is just requested as a 
radiological procedure if you like, a fistuloplasty or whatever.” (Consultant Radiologist) 
“Again, that is something we are not involved in in radiology. I am sure there is a surveillance 
programme but the details I don’t know” (Consultant Radiologist) 
2 "We have reduced [unscheduled care] dramatically, we think by having our MDT and in particular 
having our sort of surveillance scan programme and scanning all problematic AVFs so the majority 
of our workload now is elective which is great" (Consultant Surgeon) 
3 “There is a number obviously who [surgeon] is seeing for regular surveillance, there is a number 
who come through for regular, who just go straight to radiology regularly for fistulograms and 
plasties, you know recurrent stenosis and stuff.” (Consultant Nephrologist) 
“We have a very small number of patients on high risk grafts who are going to the vascular lab for 
some surveillance. The main method of surveillance, there is also another small group of patients who 
we deem to be very high risk who will come back to that clinic… if we had a little more formal 
support from them, for example I would probably want all the grafts in a surveillance programme. 
Although it is still a dilemma what to do with them when you find a stenosis. No one knows what the 
best thing to do is.” (Consultant Surgeon) 
4 “It’s usually 4 monthly vascular scans and there is a dedicated person that does that and again it is 
the routine scans, but if we get a problem on dialysis then they are usually accessible instantly to have 
a look at the scan either to see if there is an active problem, or simply to indicate a point the nurses 
can needle. So that’s a very good service and so from identifying a problem with a fistula to getting a 
scan is usually same session and often is, if it requires interventional radiology, that that happens the 
same day.” (Consultant Nephrologist) 
5 "I get the feeling that our surveillance programme has identified… failing AVFs… early before 
they’ve failed, and we intervene and maintain AVFs. We seem to have been maintaining a large 
number of AVFs by repeat angioplasties or stents, and creating less." (Consultant Surgeon)  
"I think it’s probably the identification of what you’re supposed to do is the important thing and 
places that have, you know do maybe lots of thrombectomies are probably not identifying those AVFs 
that are just about to go down in a satisfactory manner, in my view." (Consultant Radiologist)  
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6 "As far as AVGs are concerned, we are sort of still feeling our way because I haven’t done very many 
of them, so we probably would do scans now and again just so that we’ve got an idea of what’s 
happening." (Consultant Surgeon)  
7 “Well, actually we don’t do a great deal of surveillance work ourselves. You know, surveillance is 
taken care of by the vascular lab. So we hear from them once they’re running into difficulties and then 
[VAN] or somebody will come round with a Duplex scan” (Consultant Radiologist) 
“Then in the back of my mind I’m thinking I’ll go and speak to [radiologist]. Hopefully we can get a 
fistulaplasty done in three or four weeks. So I’m sort of thinking about then.” (Vascular Access 
Nurse) 
“New fistulae get planned surveillance. Established fistulae get reactive surveillance at the first hint 
of any trouble at all. We don’t have a kind of planned, just routine scanning” (Consultant 
Nephrologist) 
8 "Why on earth would you start doing surveillance when you can’t even do the very basics when 
somebody clearly doesn’t have an AVF there! It is definitely not working because it’s not there!" 
(Consultant Nephrologist)  
9 "There is no point in us creating more AVFs if we are not going to look after them properly and deal 
with a problem, which we can’t." (Consultant Nephrologist) 
Table 20 Surveillance of Vascular Access 
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Some centres credited high prevalent AVF use and low rates of unscheduled VA care with 
robust surveillance programmes. This was most apparent in centres maintaining records of 
individual patients' VA, where there was rapid access to fistula intervention, and very low 
rates of unanticipated fistula thrombosis requiring de-clotting procedures. Others thought 
surveillance activities offered poor value for money; these views were typically held in 
centres that also reported having little available resource to manage the clinical problems 
identified through surveillance activities. Surgeons tended to hold favourable views of 
surveillance, but nephrologists were less certain of its utility.  
There was agreement that AVGs probably required surveillance beyond that considered 
adequate for AVF. It was unclear what represented ‘optimal’ AVG surveillance and there was 
considerable uncertainty about the threshold for interventions, especially if imaging 
suggested an AVG problem without this being clinically apparent. 
 
Unit 1 
Unit 1 reported performing regular ultrasound surveillance imaging for all patients with an 
AVF, including those on ‘night shift’ haemodialysis and who attended outlying satellite units. 
Surveillance was coordinated (and largely performed) by VAN and was said to generate a 
considerable workload.  
There was no formal vascular lab facility available to perform formal duplex ultrasound 
imaging; patients who required this were referred to the echocardiography department, and 
appointments for formal scans were said to have considerable waiting times. There was no 
forum for routine discussion of such patients with an interventional radiologist, since there 
was no regular MDT meeting. 
When fistulography or fistuloplasty was considered necessary based upon surveillance 
imaging, VAN was unable to directly request this or to allocate specific radiology slots to 
patients; these requests had to come from a nephrologist or a surgeon. 
 
Unit 2 
The surveillance programme in Unit 2 varied considerably between patients attending the 
main unit or an outlying satellite centre for their haemodialysis treatment. Patients had 
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monthly (three-monthly in satellite units) transonic readings, supported by informal RDU 
nurse-led assessment at each haemodialysis session and a patient education programme. 
Patients who lived in the very remote parts of the catchment area had no routine VA imaging 
as no transonic machine was available.  
Potential AVF problems were usually referred by VAN directly to the sonographer. 
Similarly, the sonographer could directly refer patients to IR when duplex imaging 
demonstrated a problem. It was said to be common for patients to attend for routine 
surveillance and end up undergoing fistuloplasty on the same day. Patients from very rural 
areas with identified problems would slot into the same clinical pathway, with air ambulance 
transport being provided to and from the main unit.  
The sonographers maintained an ‘AVF intervention history’ for each patient. This was said to 
inform MDT discussions, and would often prompt the creation of alternative access in 
patients with increasingly problematic AVF. It was felt that the combination of intensive 
surveillance and subsequent MDT working had brought large reductions in unscheduled 
access work. 
 
Unit 3 
Unit 3 reported informal AVF surveillance performed by RDU staff as part of routine 
haemodialysis patient care. This was supported by a formal renal competency training 
programme for haemodialysis nursing staff. Plans were in place for a scheduled AVF 
imaging programme in the form of duplex ultrasound scans performed by RDU nurses; this 
had not been formalised and no start date had been agreed.  
The small cohort of patients with recurrent VA difficulties were known to the VA 
coordinator. They tended to have more regular, scheduled fistulography and fistuloplasty 
rather than attending for screening duplex ultrasound imaging. It was said to be normal for 
these patients to have new VA created pre-emptively before the existing AVF failed.  
Patients with AVGs had more formal surveillance on a scheduled basis. There was 
considerable uncertainty around the management of AVG problems identified on surveillance 
in the absence of a clinical issue.  
  
Chapter 6: Surveillance of Vascular Access 
185 
 
Unit 4 
There was no formal strategy for routine clinical AVF assessment in the RDU, but there was 
some interest in establishing parameters to guide this. Patients were invited to attend 
scheduled vascular lab AVF imaging every four months. If this identified a problem, the 
sonographer liaised directly with IR to arrange fistulography and fistuloplasty. USS-guided 
AVF cannulation was also possible via the vascular lab if an AVF was proving difficult to 
cannulate in the haemodialysis unit.  
 
Unit 5 
A comprehensive surveillance programme was described by Unit 5. All patients with AVF 
underwent regular transonic scans during haemodialysis sessions, supplemented by routine, 
scheduled duplex ultrasound imaging in the vascular lab. Additional scans were arranged 
following any AVF interventions. 
Vascular lab imaging was performed by a highly skilled operator who had a higher degree 
qualification along with substantial clinical and technical experience imaging AVF. 
Radiologists said this had largely replaced the need for diagnostic fistulography.  
It was felt that the early identification and management of AVF problems had significantly 
reduced the number of patients in the prevalent haemodialysis cohort who required repeated 
surgical AVF fashioning procedures, or unscheduled hospital attendances for emergency de-
clotting procedures.  
 
Unit 6 
RDU nurses performed clinical AVF assessment and regular transonic scans as part of 
routine haemodialysis patient care. Formal duplex ultrasound imaging could be requested by 
VAN, and appointments were said to usually be available within the week. Patients who had 
had an AVF fashioned, but had not yet commenced haemodialysis treatment, did not have 
regular AVF surveillance beyond the initial post-operative checks.  
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Unit 7 
The main feature of surveillance was reported to be the monitoring of haemodialysis indices. 
Formal imaging was not normally requested without a clinical problem being apparent; but 
when such problems arose there were regular opportunities to discuss patients at the VA 
clinic or MDT meeting, and requests for imaging or IR tended to be readily accommodated.  
 
Unit 8 
Surveillance mostly took the form of informal observation by RDU staff during routine 
haemodialysis care. The nurses were not formally trained to assess AVF or AVG, there was 
no formal scheduling of surveillance activity, and no formal parameters for identifying or 
managing potential clinical problems.  
Patients with suspected AVF problems could be referred to the VA clinic. Imaging was 
performed here by VAN, before discussion at the MDT meeting or direct referral for 
fistulography, fistuloplasty or a surgical procedure. It was reported that IR imaging and 
procedures often had waiting times exceeding several months, during which time it was 
common for patients to represent with AVF thrombosis. There was a strong sense throughout 
the team that most VA problems were predictable and preventable, but when patients 
presented with AVF thrombosis there was no capacity to deal with this as a medical 
emergency.  
Clinicians were interested in the possibility of formalising surveillance and introducing a 
regular VA imaging programme. Some however worried this would compromise VA creation 
activity, by displacing patients from the same limited imaging resources.  
 
Unit 9 
RDU nurses assessed AVF at each haemodialysis session, and VAN performed four-monthly 
transonic measurements. It was said there was no capacity for formal duplex ultrasound 
imaging to investigate potential problems, and very limited access to IR or vascular surgery 
for intervention. This was considered a significant barrier to increasing AVF usage.  
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It was said that almost every clinical concern or question relating to patients' existing VA was 
directed to VAN; this generated an unmanageable clinical workload and distracted from other 
important aspects of the VAN role.  
Normal post-operative AVF monitoring involved significantly more clinical contact than in 
other centres; VAN would assess new AVF three times per week in the fortnight following 
surgery, whether or not a patient was already attending the hospital for outpatient 
haemodialysis. As was described with the general surveillance programme in Unit 9 there 
were very limited resources available to intervene when problems were encountered during 
these postoperative checks.  
 
Discussion 
 
Several aspects of the described surveillance practices are helpfully contextualised by the 
socio-technical systems literature. 
Clinicians’ subjective opinions about the utility of surveillance may significantly influence 
local practice, including at the most basic level whether formal surveillance happens at all 
within the unit. Reason would characterise this decision making in the manner of ‘source 
types’, and arguably the variations in practice within and between centres as ‘function types’. 
These together create some of the latent factors that could enable the generation of 
subsequent adverse events. Some would argue that consequential adverse events would 
include opportunity costs of surveillance, if the resources used for surveillance led to capacity 
problems elsewhere in the VA service. It is suggested that further clinical studies are required 
to ascertain the utility and value of VA surveillance, and to determine the intensity of such 
activity that provides the best balance of clinical outcomes relative to resource use.  
Several of Cherns’ (modified) sociotechnical system principles178,207,208 are also illustrated in 
this data (table 21). These issues are considered in more detail in chapters 8-11. Chapter 7 
describes the clinical activity associated with current VA services; this emphasises the 
‘system impact’ of current VA creation, surveillance and maintenance practices as per the 
model described earlier in figure 4.  
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Information flow Without regular MDT meetings it is more difficult to efficiently 
share information about potential VA problems between VAN, 
sonographers, nephrologists, surgeons and radiologists (see also 
chapter 5); 
Reference to an AVF intervention history when planning future 
interventions was associated with pro-active creation of new VA 
before existing strategies failed, and fewer unscheduled care 
episodes generated by failed access. 
Power and authority Functional MDT working enabled rapid intervention when 
clinical problems were detected (e.g. Unit 2 sonographer could 
liaise directly with a radiologist, rather than waiting for the next 
MDT meeting). 
Support congruence In units with the most ‘active’ surveillance programmes VAN 
and sonographers performed imaging studies; IR support 
corrected identified AVF problems; surgeons created new VA 
before existing strategies failed; and nephrologists maintained an 
overview of dialysis indices in the context of the patients’ 
overall care. The absence of any of these elements appeared to 
limit the potential of surveillance activities to contribute 
positively to AVF use.  
Multifunction principle Surveillance programmes increasingly require to accommodate 
patients with AVG, which had different (and uncertain) needs in 
terms of imaging frequency and actions resulting from abnormal 
results.  
Table 21 Cherns’ principles applied to Vascular Access surveillance 
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Chapter 7: Clinical Activity Census 
 
This study aims to delineate the structure, function and workload associated with VA services 
in Scotland. It seeks to illuminate gaps between ‘work-as-imagined’ and ‘work-as-done’, and 
to present recommendations for practice in a manner that facilitates ongoing QI work. The 
preceding chapters 3-6 have described the operational structure and function of VA creation 
and VA maintenance pathways. This chapter contextualises these findings by quantifying VA 
clinical workload, in the first reported clinical activity census of its kind. The methodology is 
described in chapter 2.  
It is considered important to quantify clinical workload for several reasons. The data 
illustrates patient throughput using the pathways described in earlier chapters and facilitates 
benchmarking between centres. Does clinical activity correlate with incident and prevalent 
AVF use? This chapter also provides a baseline for further comparative work, and for others 
to consider the financial and other resource implications of running their VA service. 
The collective chapters 3-7 set the scene for subsequent chapters that discuss the strategic 
issues influencing VA service performance, and their development needs. 
 
Results 
 
All nine adult renal units in Scotland provided data concerning every investigation and 
procedure related to VA creation or maintenance during the census period, which was 
Monday 26/01/2015 – Friday 06/03/2015 inclusive. Investigations and procedures that were 
requested or performed during the census period were recorded.  
All units confirmed they had provided a complete dataset, except for Unit 5. Unfortunately, it 
was not possible to obtain this missing data. Most units struggled to record data relating to 
emergency hospital attendances and admissions related to VA, and this was felt to have been 
significantly under-reported.  
In this six-week period 429 patients were noted to have undergone a total of 550 procedures, 
of which 118 procedures required an overnight stay of at least one day, and 331 procedures 
were undertaken as day cases.  
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A total of 150 surgical procedures and 400 radiology procedures were reported during the 
six-week clinical activity census period. The volume and activity varied by centre. There 
were considerably more TCVC-related than AVF-related procedures. Tables 22 and 23 
present the surgical and IR procedures respectively.   
Chapter 7: Clinical Activity Census 
191 
 
Procedure/ Unit 1 2 3 4 5 6 7 8 9 Total 
AVF Creation 6 3 5 5 7 2 17 23 4 72 
AVF Ligation 0 0 0 1 0 0 1 4 0 6 
AVF De-clotting 1 0 4 0 1 1 1 3 0 11 
AVF Revision 4 3 1 0 0 2 9 7 0 26 
AVF Maintenance 0 0 4 0 0 1 1 0 0 6 
AVG Creation 1 1 3 0 2 1 1 4 0 13 
AVG Ligation 0 0 1 0 0 0 0 0 0 1 
AVG De-clotting 0 0 0 0 0 0 0 5 0 5 
AVG Revision 0 1 0 0 0 0 0 0 0 1 
AVG Maintenance  0 0 0 0 0 0 0 1 0 1 
PD Catheter Insertion 0 0 1 3 3 0 0 0 0 7 
PD Catheter Exchange 0 0 1 0 0 0 0 0 0 1 
Total 12 8 20 9 13 7 30 47 4 150 
Table 22 Surgical procedures by unit 
150 surgical procedures were reported during the six-week clinical activity census period. 
There were considerably fewer surgical than radiology procedures (see table 23). (Note that 
unit 5 submitted an incomplete dataset.)   
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Procedure / Unit 1 2 3 4 5 6 7 8 9 Total 
TCVC Insertion 5 7 5 5 10 0 14 34 4 84 
TCVC Exchange 0 0 0 0 5 0 3 10 0 18 
TCVC Removal 4 1 0 0 0 0 0 5 0 10 
TCVC Declot/ Strip 0 1 0 0 0 0 1 0 0 2 
NTCVC Insertion 0 0 8 1 1 0 5 8 4 27 
AVF Fistulogram 0 6 6 0 4 1 0 4 4 25 
AVF Fistuloplasty 3 7 0 0 0 0 7 3 8 28 
AVF Fistulogram and Plasty 0 0 7 5 0 5 0 16 0 33 
AVF Fistulogram, Plasty and Stent 0 0 0 0 1 0 0 2 0 3 
Venogram 0 1 1 0 3 0 0 2 0 7 
Lineogram 0 0 0 0 0 0 0 0 3 3 
AVF Stent 0 2 0 0 0 0 0 0 0 2 
Clinical Science USS 0 0 0 0 0 0 63 0 0 63 
Departmental Duplex USS 0 24 1 0 0 26 0 25 0 76 
Vein Mapping 0 6 0 0 0 3 0 10 0 19 
Total 12 55 28 11 24 35 93 119 23 400 
Table 23 Interventional radiology procedures by unit 
400 interventional radiology procedures were reported during the six-week clinical activity 
census period. There were more TCVC-related than AVF-related procedures, and many more 
radiology than surgical procedures (see table 22). (Note that unit 5 submitted an incomplete 
dataset.)   
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The Scottish Renal Registry publishes the size of the haemodialysis and total RRT cohorts, 
respectively, from each renal unit13. These data are not reproduced here to avoid directly 
identifying units, given the sensitive nature of the semi-structured interviews. Nonetheless it 
has been possible to use these published cohort sizes to perform some analyses of the data to 
estimate annualised activity within each centre. Tables 24 and 25 respectively show these 
analyses for surgical procedures and IR investigations. The data are presented as the number 
of events recorded during the 6-week period 26/1/15 – 6/3/15 alongside the respective HD 
and RRT populations in that unit (from registry figures13). To facilitate comparisons between 
centres the ‘total procedures’ are then standardised as a value per 100 patients, and this is 
extrapolated from 6 weeks to 52 weeks, to provide an estimate of annual activity per 100 
patients in each centre.   
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Unit 
Total 
procedures 
HD 
population 
RRT 
population 
Surgical 
Procedures / 
100 HD 
patients / year 
Surgical Procedures / 
100 RRT patients / 
Year 
1 21 137 310 132.85 58.71 
2 17 92 252 160.14 58.47 
3 33 217 535 131.80 53.46 
4 15 148 292 87.84 44.52 
5 29 186 422 135.13 59.56 
6 7 54 130 112.35 46.67 
7 30 283 780 91.87 33.33 
8 104 602 1718 149.72 52.46 
9 12 192 423 54.17 24.59 
Table 24 Surgical procedures in proportion to the haemodialysis and renal replacement 
therapy cohort sizes, by unit 
‘HD population’ and ‘RRT population’ are taken from published registry figures13. ‘HD 
population’ includes all patients from a given centre who undergo hospital haemodialysis or 
home haemodialysis, while ‘RRT population’ includes all patients from a given centre who 
undergo hospital haemodialysis, home haemodialysis, peritoneal dialysis, or who have a 
functioning renal transplant. ‘Surgical procedures / 100 HD patients / year’ = ((Total 
Procedures / (HD population / 100)) / 6) x 52; ‘Surgical procedures / 100 RRT patients / 
year’ = ((Total Procedures / (RRT population / 100)) / 6) x 52 
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Unit 
Total 
Investigations 
HD 
population 
RRT 
population 
Interventional 
Radiology 
Investigations / 100 
HD patients / year 
Interventional 
Radiology 
Investigations / 100 
RRT patients / Year 
1 3 137 310 18.98 8.39 
2 46 92 252 433.33 158.20 
3 15 217 535 59.91 24.30 
4 5 148 292 29.28 14.84 
5 8 186 422 37.28 16.43 
6 35 54 130 561.73 233.33 
7 70 283 780 214.37 77.78 
8 62 602 1718 89.26 31.28 
9 15 192 423 67.71 30.73 
Table 25 Interventional radiology procedures in proportion to the haemodialysis and renal 
replacement therapy cohort sizes, by unit 
‘HD population’ and ‘RRT population’ are taken from published registry figures13. ‘HD 
population’ includes all patients from a given centre who undergo hospital haemodialysis or 
home haemodialysis, while ‘RRT population’ includes all patients from a given centre who 
undergo hospital haemodialysis, home haemodialysis, peritoneal dialysis, or who have a 
functioning renal transplant. ‘Interventional Radiology Investigations / 100 HD patients / 
year’ = ((Total Investigations / (HD population / 100)) / 6) x 52; ‘Interventional Radiology 
Investigations / 100 RRT patients / year’ = ((Total Investigations / (RRT population / 100)) / 
6) x 52 
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The data suggested some variation between centres as to the number of VA surgical 
procedures performed, but this was largely proportional to cohort size with correlation co-
efficients 0.96 (annual procedures vs HD population) and 0.96 (annual procedures vs RRT 
population) (figure 10). 
 
There was significant variation in IR investigations by centre that wasn’t proportional to the 
cohort size. Correlation co-efficients were 0.52 (annual procedures vs HD population) and 
0.59 (annual procedures vs RRT population). This may have been skewed by the incomplete 
dataset provided by unit 5, or by variable TCVC use between centres (figure 11).  
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Figure 10 Scattergram: surgical procedures / 100 patients / year, by unit 
Correlation coefficient for surgical procedures / 100 HD patients / year = 0.96; correlation 
coefficient for surgical procedures / 100 RRT patients / year = 0.96  
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Figure 11 Scattergram: interventional radiology investigations / 100 patients / year, by unit 
Correlation coefficient for interventional radiology investigations / 100 HD patients / year = 
0.52; correlation coefficient for interventional radiology investigations / 100 RRT patients / 
year = 0.59 
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Eighteen unscheduled hospital admissions and 26 unscheduled day case hospital attendances 
were reported during the six weeks, with significant variation between centres. In some cases, 
the need for admission and prompt for the VA procedure may have been the same, for 
example in the case of a bleeding AVF. In others it may have been easier to facilitate an IR or 
surgical procedure as an inpatient rather than as an outpatient. Table 26 describes these data.  
Eight ‘unexpected events’ were also logged during the six-week period. These are described 
in table 27. These data were originally collected in an effort to understand whether the 
reported activity was ‘atypical’ due to disruption to services. It was apparent that major 
service disruption was relatively common.  
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Unit Day Cases Admission 
1 Pus from needle site 
SAB associated with AVF 
(x3) 
 Blocked TCVC  Blocked TCVC (x4) 
2  Steal syndrome 
3  Stenosed fistula 
  Blocked TCVC 
6 New AVF with no thrill or bruit Ruptured AVF 
7  Thrombosed AVF 
8 Blown fistula Thrombosed AVF (x2) 
 HD post fistuloplasty Aneurysmal AVF 
 Blocked TCVC (x2) Blocked TCVC 
 Blister at TCVC site Steal syndrome 
 
Unsecured TCVC 
AVF swelling (x2) Failed fistuloplasty 
 AVG Haematoma  
 AVG swelling  
 Wound at TCVC exit site  
 TCVC replacement (x2)  
 AVG infection (x3)  
 AVF review (x3)  
 Steal syndrome  
 Aneurysmal AVF (x2)  
 Possible AVG infection  
Table 26 Reasons for day area attendance and admission, by unit 
Forty-four VA emergencies were recorded during the six-week activity census period. 
Twenty-six of these patients were assessed and managed via a day area, while 18 required 
hospital admission. It was not possible to distinguish between patients who were admitted 
because of their VA problem, or who were already inpatients for other reasons. The data is 
understood to significantly underreport the number of emergency presentations, and no data 
was supplied by units 4, 5 or 9; the actual number of attendances and admissions may be 
significantly higher. 
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Unit Unexpected Events 
Unit 1 Theatre list cancelled as surgeon on call 
Unit 2 VAN on long term sick leave 
Unit 3 Vascular scanner broken 
 All Vascular Access clinics cancelled for month of March 
Unit 8 
No sonographer available for booked Vascular Access ultrasound list (2 
occasions) 
 
Patient's AVG surveillance appointment changed, but patient not 
informed; patient attended on original date 
Unit 9 AVF Creation cancelled as no surgeon available 
 Patient cancelled planned AVF creation 
Table 27 Unexpected events logged by unit 
Eight ‘unexpected events’ were logged during the six-week period. Some were issues that 
limited the ability of the service to function, while others reflected morbidity or critical 
incidents associated with a specific patient’s Vascular Access or procedure. (No data was 
supplied by units 4, 5, 6, 7.)  
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It was possible to estimate the waiting time for investigations and procedures in each unit. 
Variable information was provided about each request; where a full dataset was available the 
information included the date of request, date of being added to the waiting list, and date of 
investigation or procedure as appropriate. Investigations or procedures with no waiting time 
data, or that were requested but not performed during the census period, were not included. 
Tables 28 and 29 show these data for surgical and IR procedures respectively.  
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Unit 
Number of 
procedures 
Median waiting 
time: referral to 
surgery (days) 
Median waiting 
time: listing to 
surgery (days) 
Range: referral 
to surgery 
(days) 
Range: listing to 
surgery (days) 
1 12 39 26 0-204 1-75 
2 8 21.5 21.5 1-145 1-145 
3 20 10 1.5 0-272 0-29 
4 9 41 32 13-129 12-96 
5 13 102 66 1-788 0-649 
6 7 3 3 0-115 0-35 
7 30 41 22 1-384 0-168 
8 47 91 49.5 9-290 5-86 
9 4 36.5 6.5 13-54 3-39 
Table 28 Waiting times for surgery, by centre 
It was apparent that waiting times for surgical procedures were highly variable within and 
between centres. The waiting time was often excessive and potentially clinically 
inappropriate in the context of VA creation and maintenance. Values are expressed as 
number of days waiting. Only procedures that were performed during the 6 week period 
26/1/15 – 6/3/15 (inclusive) are included in this analysis; procedures requested during this 
period, but not carried out, are excluded.   
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Unit 
Number of 
procedures 
Median waiting 
time: referral to 
procedure (days) 
Median waiting 
time: listing to 
procedure (days) 
Range: referral 
to procedure 
(days) 
Range: listing 
to procedure 
(days) 
1 12 13 5.5 1-25 1-101 
2 55 2 16 1-3 0-390 
3 28 3.5 1 0-10 0-35 
4 11 (no data) 22 (no data) 7-83 
5 24 5 3 0-35 0-34 
6 35 (no data) 13 (no data) 0-68 
7 70 (no data) 19 (no data) 0-63 
8 119 3 20 0-19 0-170 
9 23 2 14 0-12 0-35 
Table 29 Waiting times for interventional radiology procedures, by centre 
It was apparent that waiting times for IR procedures were highly variable within and between 
centres. The waiting time was often excessive and potentially clinically inappropriate in the 
context of VA creation and maintenance. Values are expressed as number of days waiting. 
Only procedures that were performed during the 6 week period 26/1/15 – 6/3/15 (inclusive) 
are included in this analysis; procedures requested during this period, but not carried out, 
are excluded. Incomplete data was available for units 4, 6 and 7.  
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Discussion 
 
These data represent the first reported clinical activity census for haemodialysis VA in 
Scotland. A substantial workload is demonstrated with significant variation between sites in 
both the volume and nature of the work.  
The data suggests surgical workloads are broadly proportional to the haemodialysis and RRT 
cohort size, whereas only around half the variation in IR workload is explained by the 
haemodialysis cohort size. Most variation in IR workload relates to the overall RRT cohort 
size, likely a function of the procedures required to maintain large numbers of patients on 
TCVC (e.g. TCVC insertion, imaging and intervention related to central venous stenosis).  
These data may reflect the existence of protected slots for surgical procedures in most 
centres, and the lack of protected IR slots for VA work. In the absence of designated slots 
clinical activity may vary depending upon competing demands elsewhere in the hospital, 
referral patterns, and operator willingness to take on what is effectively ‘unpaid’ VA work. 
It is clear that significant numbers of procedures are being performed to create, maintain and 
revise VA. The data demonstrate substantial waiting times from initial referral to having 
procedures performed, with significant delays between referral, listing and the eventual 
procedure. Some of these delays may be clinically deliberate, for example postponing 
planned AVF creation in view of apparent stabilisation of renal function. Intercurrent illness 
may also have caused delays, for example deferral of AVG insertion in the context of a sepsis 
episode. It seems implausible however that these explanations account for the majority of 
delays documented above. 
The data collection strategy employed here has several advantages. Data collected by local 
VANs was likely to be accurate given that their jobs are concerned with the coordination of 
such clinical activity. It is apparent they are the clinicians in the VA team most likely to have 
knowledge of such referrals and procedures, including any managed outside the usual referral 
pathway within the centre. A six-week period of data collection outside of major holiday 
periods, and at a time of year without significant risk of adverse weather, is likely to provide 
at least an indicative snapshot of the ‘business as usual’ clinical workload. Collecting data 
concurrently in each centre enabled fair comparison to be made. 
There are also limitations to collecting data in this way. One centre’s dataset was 
acknowledged to be incomplete; it is possible that other parts of the dataset are incomplete, 
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which may underestimate the workload and/or proportions of investigations and procedures 
by each centre. This data was not routinely collected outside of this exercise, and procedures 
may have been incorrectly recorded by local data collectors or coded wrongly during 
amalgamation with other centres’ data. The investigation or procedure performed may have 
differed from what was initially requested, and this may not have been reflected in the 
submitted dataset. A significant volume of data relating to referral and procedure dates was 
missing, which could have influenced the accuracy of apparent waiting times.  
Despite these potential disadvantages, these data suggest significant variation in waiting 
times for VA procedures across Scotland. Surgical workload seems proportional to RRT 
cohort size, yet registry figures8 suggest this volume of work is insufficient, given the 
consistently low proportions of patients who begin and remain on haemodialysis treatment 
with AVF or AVG. Wide variation is also seen with IR procedures, possibly reflecting local 
clinicians’ interest and capacity to perform procedures. It is hypothesised that the provision of 
designated IR resources for VA could enable more robust AVF and AVG maintenance, 
positively impacting on incident and prevalent AVF and AVG use. 
This clinical census exercise has illuminated the ‘system impact’ of maintaining VA services 
in the configurations described in chapters 3 and 5. There would be merit in periodically 
repeating this clinical activity census, or tracking such clinical activity in real time, for 
several reasons. First, the dataset provides an estimate of clinical activity across Scotland. 
This is helpful for individual centres and could facilitate regional or national collaboration to 
share the workload, managing peaks and troughs in demand. Next, it enables units to 
anticipate the likely interventional capacity required to accommodate different proportions of 
patients using AVF and AVG within their centre. Finally, it allows boards to document the 
workload associated with this relatively niche area of clinical practise, which should facilitate 
better provision of designated clinical time with which to perform VA procedures. 
Recognition of the clinical workload should also prompt discussions about the measurement 
of procedural outcomes, alongside the morbidity and mortality associated with individual 
procedures and the VA service in general. 
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Chapter 8: System Performance 
 
This study seeks to understand variation in AVF use across Scottish renal units. The aims are 
to delineate the structure, function and workload in each VA service, to highlight 
inconsistencies between ‘work-as-imagined’ and ‘work-as-done’, and to present 
recommendations for practice to the clinical community in a manner that facilitates ongoing 
QI in this area.   
Chapters 1 and 2 respectively introduced the study context and methodology. Chapters 3 and 
5 respectively related the structure and function of VA creation and maintenance pathways 
from an ‘operational’ perspective, based upon thematic analysis of interview transcripts (see 
chapter 2). Chapter 4 considered whether clinicians’ opinions influenced their use of different 
VA modalities, relating this to published models of variation and the impact of ‘consensus’ 
on sociotechnical system function143,178,186. Chapter 6 explored variations in VA surveillance 
practice, which the thematic analysis had suggested as a potential influence on VA 
maintenance activity. Chapter 7 concluded the operational analysis of VA services by 
quantifying clinical activity through the pathways over a six-week census period.  
This chapter takes a strategic view of VA service performance. Earlier chapters have 
described how VA services are structured and their function; this chapter addresses findings 
from the thematic analysis that could explain why services are configured, and operate, as 
described. It draws upon Cherns’ work describing sociotechnical system function178,207,208,210, 
and Reason’s work around types and tokens. It considers strategic elements of VA services in 
relation to system performance: service context; the allocation of clinical time; scheduling 
and tracking of clinical activity; and measures of process and outcome. This chapter 
considers these strategic challenges around system performance arising from the thematic 
analysis; the subsequent chapter 9 discusses VA services’ development needs identified 
through thematic analysis. Together these chapters lead into the development of 
recommendations for practice.  
 
Service Context 
 
Each renal unit can be considered a product of history, local health service configuration, and 
the various improvement activities that have taken place at local, regional and national levels. 
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This section discusses the context of each VA service, focusing upon events attributed by 
clinicians to generating the unit’s current position (table 30). 
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Unit Contextual factors Changes instituted Transcript data 
1 VA pathway bottlenecks 
Patients dialysing with TCVC without 
attempts to create AVF 
Haphazard referrals to VA service 
Education programme  
VAN trained in ultrasound 
imaging techniques 
Standardised referral form 
“Patients sitting with catheters for a long, long time and not being addressed. There 
was an acute education programme set up for that reason.” (Vascular Access Nurse) 
“I have taken responsibility for some of the things like education of the staff and you 
know teaching cannulation skills, teaching them like, the Vascular Access Nurse the 
scanning skills so that we don’t have to wait for duplex scans, things like that.”  
(Associate Specialist Nephrologist) 
“There is a referral form which is [completed]… I put it on [EHR]… it was so 
haphazard that I was trying to streamline that a little bit” (Associate Specialist 
Nephrologist 
2 Recognition of MDT meeting value 
Strong team function 
Annual service review meeting 
Regular MDT meetings with 
wide stakeholder involvement 
“Well the [MDT] meetings started off with just a vascular surgeon, a nephrologists and 
myself. Expanding to include the sonographers, the interventional radiologists was a 
huge, huge change … we have a yearly Vascular Access service meeting, so if there is 
anything we feel we want to take forward, which is like joining [national EHR].” 
(Vascular Access Nurse) 
“When I came it was just something I sort of took on. I didn’t realise actually, when I 
got here, that it hadn’t happened before. I just sort of – they just told me there’s a 
Renal/Vascular MDT so I used to turn up and do it. And it’s just grown into the role” 
(Consultant Radiologist) 
3 Sense of competition with other 
centres 
Utilisation of vacant theatre 
slots for VA work 
“We never thought we could get over 90% and it is only when the Japanese did it that it 
upset [surgeon]: he said well we should have a shot at that and so we started going for 
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Recognised importance of maintaining 
secondary patency 
Historical strong working relationship 
between nephrology and surgery 
Aggressive efforts to salvage 
thrombosed AVF 
 
 
it and he took over extra lists and you know it was hard getting it up there!” (Vascular 
Access Coordinator)  
“We were doing transplants and things initially so we were two wards down from the 
vascular surgeons so we were up and down there all the time and the relationship is 
crucial.” (Vascular Access Coordinator) 
4 High bacteraemia rates Working alongside 
microbiology colleagues to 
reduce infection rates 
“We have got very interested microbiologists … with their help and us putting in place 
bundles … we have managed to get, I think this might actually be our fifth month with 
no bacteraemias.” (Consultant Nephrologist) 
 
5 Staffing crisis in neighbouring health 
board 
High proportion of patients dying with 
unused AVF 
Joint working between health 
boards to improve capacity 
Development of conservative 
care programme 
 
“In the past when [neighbouring unit] lost their radiologist… [these] patients were 
coming here… and in fact they are now on a vascular network between here and 
[neighbouring unit] and they do some cross cover for emergencies and elective stuff.” 
(Consultant Nephrologist) 
“We now have about 25% of our low clearance clinic population choosing supportive 
care … we’re not placing fistulas in the … elderly or population that thought they might 
want it and then when dialysis comes they actually don’t [want it]” (Vascular Access 
Nurse) 
6 Reliance upon visiting radiologist 
from another board 
Surgeons trained as 
interventional radiologists 
“We used to have somebody come from [neighbouring unit] but he decided to go to 
[elsewhere]… we found somebody in Ireland that would train us [in interventional 
radiology]; so we persuaded the Health Board to hire a locum for a year [to enable us 
to do so]” (Consultant Surgeon) 
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7 Relatively slow approach to managing 
failed AVF 
Recognition of redundant steps in VA 
creation pathway 
Lack of funding for capital investment 
More aggressive joint surgical 
/ radiological interventions for 
thrombosed AVF 
VAN was empowered to list 
patients directly for AVF 
surgery based upon her sole 
assessment 
Introduction of VAN 
secondment programme 
Use of endowment funds for 
capital investments 
“I think there’s been a stepwise improvement in… the way that we deal with [failed 
AVF] …. down to communication and particularly with the surgeons … expedient 
treatment, both you know surgical and to [radiologically] delineate the cause of the 
underlying thrombosis; … I think that has certainly been… a sea change I’ve 
experienced” (Consultant Radiologist) 
“The idea is to get … a junior nurse who will come around for a period of about 6 – 12 
months, who can learn obviously from me and my colleagues and then would back and 
share her knowledge with the dialysis staff” (Vascular Access Nurse) 
8 Straightforward access to 
transplantation may reduce the pool of 
patients requiring haemodialysis to 
those with less adequate veins 
Historical amalgamation of two units 
into a single unit, without maintaining 
proportional staffing and procedure 
slot numbers 
Consideration of using same 
mindset for AVF as for 
transplant 
Business case developed for 
specific sonographer training 
in AVF imaging 
Attempts to ‘optimise’ 
working with a single VAN as 
a consistent point of contact 
 
“One thing that has improved things is our pre-emptive transplant … [but] that can 
remove the … and the easier proportion [for creating AVF].” (Consultant 
Nephrologist) 
“We’ve … never cancelled a live donor transplant. We’ve cancelled many, many 
fistulas and people need to be thinking that, under many circumstances, a fistula is as 
lifesaving, or a graft, is as lifesaving as live donor transplant.” (Consultant 
Nephrologist) 
“I’ve recently been very fortunate, I can probably give more information as to the [VA] 
process now because I have just done a secondment with [VAN]” (RDU Nurse) 
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Use of VAN secondment 
programme to effectively 
increase VAN capacity 
 
 
9 High bacteraemia rates 
Skin irritation from soaps within the 
RDU, which may have contributed to 
infection rates 
Previous co-location of nephrology, 
surgery and radiology had enabled 
team working 
New processes for AVF 
preparation for haemodialysis 
sessions, including patients in 
the process. 
Investigation of products used 
in the RDU to eliminate 
potential sources of infection 
risk. 
“We did a lot of work…we started to look at our processes and how we cleaned lines”; 
“We changed the whole process. We’re [doing] the same steps but we do them in a 
different way. We do them thoroughly.”; “We gave every patient a letter, we told the 
patient what we had to do [to clean AVF before haemodialysis].” (Vascular Access 
Nurse) 
“We found that some of our soaps are perfumed, which they shouldn’t 
be and patients were starting to get reactions and itching and things.” (Vascular 
Access Nurse) 
“I was on site 5 days a week. Then … [surgery and radiology] moved back to [another 
campus] … They had day to day contact and I learned a lot around renal access and 
nephrology that I hadn’t appreciated before.” (Consultant Radiologist) 
Table 30 Contextual factors by unit
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Unit 1 
The Unit 1 team reported making changes in response to awareness of clinical pathway 
bottlenecks. VAN undertook training in duplex ultrasound scanning to reduce lengthy waiting 
times. A one-stop clinic staffed by a VAN and surgeon was being set up to reduce the need 
for multiple clinic appointments about VA creation. In recognition of the high proportion of 
patients who presented late (and therefore missed the usual pre-dialysis education programme 
delivered via the outpatient clinic setting) an acute education programme was developed 
specifically for this patient group.  
While there was no formal 'lead VA nephrologist', one found himself the de facto lead 
because his office was located close to the haemodialysis unit, and he was therefore regularly 
asked about VA issues. He introduced a standardised access referral form in an effort to 
streamline what he considered a haphazard referral process. He had overcome initial 
resistance from colleagues using this form by instituting a policy of only accepting VA 
referrals conveyed using this form.  
 
Unit 2 
Unit 2 was unique in holding an annual, formal review of the VA service. This was said to 
provide a useful forum for strategic discussion and was credited with facilitating moves 
towards more effective use of an electronic health record system.  
The establishment of a weekly MDT meeting was lauded as the key element in the unit's 
consistently good performance regarding incident and prevalent AVF rates. This had evolved 
from a series of ad hoc meetings between the nephrologist and surgeon into a formal meeting 
with broad specialty representation (including sonographers), a formal agenda, and detailed 
record keeping in relation to AVF interventions. Each of these elements was said to 
contribute to the unit's success.  
Strong team working was also credited with success. It was recognised that each team 
participated in a manner that minimised 'waste' elsewhere in the service: for example, IR 
recognised their willingness to place occasional TCVCs meant surgical slots were not 
‘wasted’ on this purpose. The surgeons were mindful that regular MDT discussions and a 
policy of early, aggressive intervention for clinical problems had substantially reduced 
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unscheduled VA care. The efficient MDT had also enabled surgeons to remove the pre-
operative clinic visit, which reduced their overall time commitment to the VA service.  
 
Unit 3 
In Unit 3 it was reported that the primary driver to improve the service was a sense of 
competition with other centres. Local surgeons aspired to equal or exceed reportedly high 
proportions of incident and prevalent AVF use in Japan (historically). Various strategies were 
described for achieving this, including the utilisation of vacant theatre slots, and an 
enthusiasm for salvage procedures when a patient presented with a clotted AVF.  
They actively sought out vacant operating theatre slots, for example when a surgeon was on 
leave and the theatre nursing team and anaesthetics staff were otherwise available. These 
slots would then be used to perform additional VA procedures, often at relatively short 
notice. They also recognised the importance of secondary AVF patency to maintain high 
prevalent AVF use, so took an aggressive approach to de-clotting thrombosed AVF.  
Various aspects of teamworking were also credited with their VA successes. A good working 
relationship existed between local nephrologists and vascular surgeons, attributed to their 
historical transplant centre status. The VA coordinator’s unique perspective was also 
considered highly influential in their success: her background differed from every other VA 
coordinator as she was a doctor rather than a nurse; her clinical training also contrasted with 
that of most other nephrologists, since she originally trained in psychiatry and general 
practice before working in renal medicine. All interviewees from the unit considered her 
highly skilled at coordinating clinical services and fostering a team approach. She reported 
success using clinical audit and data presentation to engage colleagues with the VA service. 
 
Unit 4 
Discussions about historical service context here focused around efforts to improve VA-
associated bacteraemia. Successes in this regard were attributed to ongoing clinical audit, 
data-driven improvements in clinical processes, and engagement with key external 
stakeholder groups including microbiology and infection control teams.  
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Unit 5 
Various improvement drivers were reported by clinicians, including clinical audit, 
networking with neighbouring health boards in the context of staffing crises, and innovative 
approaches to releasing effective clinical time for IR and vascular surgery. 
It was said to be common historically for patients to be referred for AVF creation, but not to 
go on and receive haemodialysis treatment. Clinical audit had demonstrated this problem and 
had led ultimately to the development of a conservative care programme. 
A robust approach to AVF creation and maintenance was partly attributed to joint working 
with clinicians from a neighbouring health board, which had been prompted by a staffing 
crisis in the other board. Surgeons considered that this process had brought together a group 
of radiologists with a collective interest in renal VA. They had also found success in 
negotiating with management to reserve 'urgent' theatre slots for AVF cases; previously when 
lists had been designated 'routine' they were unable to find slots within a clinically 
appropriate timeframe for AVF cases. 
 
Unit 6 
The major historical difficulty was the lack of on-site IR support. They had previously relied 
upon a infrequently visiting radiologist from another health board. Two vascular surgeons 
underwent formal endovascular IR training to mitigate this problem. This had required a 
considerable financial investment by the Board and substantial effort on the part of the two 
individual surgeons. When they launched the surgical IR service they found colleagues were 
reluctant to complete the appropriate referral paperwork (to comply with radiation 
legislation), but similarly to Unit 1, they had successfully instigated a policy of only 
accepting referrals that used the approved paperwork and process. 
 
Unit 7 
Clinicians reported that their recruitment of radiologists with an interest in VA had facilitated 
increased AVF maintenance activity. Surgeons felt better supported by a more proactive IR 
team, and reported that this made them more willing to consider complex or higher risk cases. 
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Nephrologists credit engaged clinical and non-clinical managers, and their investment in a 
comprehensive VAN team, with much success. Having several VANs had enabled them to 
function optimally without having an overwhelming workload. In common with other 
centres, the lead VAN had been recruited from another clinical discipline (vascular surgery); 
this was felt to provide useful alternative perspectives on VA processes, in comparison with 
more traditional 'renal' views. She had introduced a 'VAN secondment' programme to foster 
RDU awareness of VA problems; this was widely regarded as a successful project. 
Surgeons had removed their usual clinic review before AVF surgery, having observed the 
VAN team’s abilities and in discussion with colleagues in other centres. This released 
additional clinical time and substantially reduced theatre waiting times for patients. 
There was little formal audit of the VA service, but there was enthusiasm to change systems 
to improve clinical outcomes. For example, a postoperative review clinic had been 
established in an effort to enhance AVF maturation. Similarly, there had previously been a 
coordinated 'sweep' of all outpatient haemodialysis units seeking to identify patients dialysing 
with TCVC, for whom AVF could be a viable option.  
It was reported that endowment funds were regularly used whenever capital investment was 
required in the service, for example to purchase an ultrasound machine for the VA clinic.  
 
Unit 8 
Nephrologists in Unit 8 felt their VA figures were inadvertently disadvantaged by having 
easy access to transplantation. They considered that most relatively fit patients received renal 
transplants within short waiting times, hence only the frailer and more technically 
challenging patients required ongoing haemodialysis VA. They thought other centres might 
have higher proportions of 'healthier' patients receiving haemodialysis treatment, who would 
potentially have already been transplanted in Unit 8. 
Nephrologists, VAN and surgeons all felt that VA surgery was becoming more technically 
complex, perhaps as a function of the haemodialysis cohort having fewer ‘straightforward’ 
patients, as above. There was admiration for the technical skill and tenacity of surgeons in 
pursuing an AVF or AVG despite technical difficulties in some challenging patients.  
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A recently established VA fellowship post was considered hugely beneficial, particularly by 
nurses. This provided a single point of contact for VA surgical review, ensuring patients with 
VA problems had access to an interested clinician who could rapidly make decisions. There 
was concern about succession planning for this post beyond the incumbent post holder.  
The radiology department reported a heavy pressure on their service to perform VA imaging 
studies. They recognised that significant volumes of clinical IR time was used for duplex 
scanning (in the absence of an adequately trained sonographer), reducing the available time 
for 'radiologist only' procedures like fistulograms and fistuloplasty. This was particularly 
problematic due to the recent increase in AVG use following an in-house clinical trial; these 
patients had more intensive imaging requirements than the equivalent patients using AVF. A 
business case was being drafted to create new sonographer posts to manage this problem. It 
was noted in Unit 8 and elsewhere that there was no recognised means of training 
sonographers in the subspecialty of VA imaging, and this obstructed service development. 
The service in Unit 8 had historically existed as two separate 'north' and 'south' clinical units. 
It was reported that, before the units amalgamated, some surgical theatre slots were 
informally reserved for VA work; some of these had been lost when the units merged on to 
one hospital site. Staffing ratios and clinical slots for VA had not been specifically addressed 
when the units merged, meaning there was now one VAN left to manage the combined 
patient cohort. This seemed to be a disproportionately high workload in comparison with the 
equivalent arrangements in other centres. It was felt that having a single VAN did carry some 
benefit as she was the single and consistent contact point for all VA related enquiries.  
 
Unit 9 
The Unit 9 service had utilised government targets around SAB episode reduction to frame 
the overall need to improve their VA offering. A pragmatic approach was described, largely 
attributed to the non-renal (emergency department) background of the VAN. Simple 
interventions had brought great success: these included purchasing large clocks for RDU to 
facilitate adequate AVF washing time before use, and an investigation of soaps used for 
washing AVF that identified an undeclared perfume ingredient causing skin irritation.  
They credited their efforts to empower patients and to engage with clinical and senior 
managers, with previous successes. They considered that a VAN secondment programme for 
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RDU nurses had been highly successful in improving awareness and skill level in relation to 
VA problems among the RDU staff. 
The power of team working was also recognised, particularly by the radiologists. They noted 
that a previous service configuration had allowed radiology and nephrology teams to work in 
close proximity, before a reorganisation (separate from VA) moved the IR service to another 
hospital campus. It was felt that more frequent personal contact between clinicians had been 
useful to facilitate clinical decision making in challenging VA cases.  
 
Geographical influence 
 
Having considered the historical context of VA provision, this section discusses the 
geographical context of services, including those serving remote and rural communities, 
those with larger and smaller catchments, and the national paediatric renal unit serving the 
whole of Scotland from a single unit.  
In general, the data suggest that geography is mostly a problem for VA services when 
elements of the VA service for one unit are physically separated from one another. This 
caused difficulties bringing the clinical teams together, and it was notable that no centres 
regularly used telemedicine (or equivalent) to facilitate clinical, MDT or service strategy 
meetings. Centres serving large catchment populations, or covering broad geographical areas, 
or remote and rural areas, did not consider that their territorial geography posed a significant 
problem. Rural areas did consider their patients were hospitalised for logistical reasons more 
often than in other centres, but this was not considered a barrier to providing adequate care. 
(Table 31.) 
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Unit Transcript data 
1 “So, the interventional radiologists providing a service are [name] and [name]. But sadly, that is an outside service down at [another campus] which is 
one of the issues.” (Consultant Surgeon) 
2 “It’s one of the difficulties working in such a rural community.  You know, even the guys from [rural area], they can take 4 hours to get here. [Other rural 
area] the same, and that’s in the summer.  Or maybe a day to get here, a lot of them.  So, one of the problems we have with fistuloplasties is that - in the 
afternoons - is transport.  It’s getting the folk back to wherever they’ve come from after a fistuloplasty.  So sometimes they have to get admitted if there’s a 
problem [with transport].” (Consultant Radiologist) 
3 “Obviously having everything on one site makes things geographically much easier, it’d be more challenging without that.” (Consultant Nephrologist) 
4 “Usually [VA work is] all [done] here. So out of hours or if there’s holiday cover things then sometimes patients 
will go up to [neighbouring unit]. Mostly it gets done here.” (Consultant Nephrologist) 
5 “We have low clearance in [peripheral and central sites] and our consultants and registrars and nurses go out to the clinics from here and see the more 
rural patients and we also offer education at home so a nurse goes out to the patient’s home and will see family members.” (Vascular Access Nurse) 
6 “It’s really good having everything in proximity. I mean we’ve got the renal unit there, you’ve got us, [surgeon]’s office is right beside this and the 
vascular lab is 20 metres that way so it’s all very close together.”  (Consultant Surgeon) 
7 “The trouble is that nobody wants to go [to peripheral hospital] and that’s the issue we have. But it’s funny, the patients 
that are in [remote areas] will travel … they haven’t got an issue at all.” (Vascular Access Nurse) 
8 “Obviously there’s one dialysis unit on site; the rest are [very far away]. I never get around them” (Vascular Access Nurse) 
“One of the problems we have [here] compared with a lot of big centres is we don’t have a central dialysis hub. It’s not a hub and spoke model it’s a 
model of scattered small units. That sort of surprised me when I came up here for pre-interview visit.” (Consultant Surgeon) 
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“The renal service is regional in [this unit], but the interventional radiology service is not, so that’s part of the issue where the capacity is at, and I am 
very aware that there are [radiology] units around the [catchment] who don’t provide fairly basic imaging support for fistula.” (Consultant Radiologist) 
9 “We are a two-centred area: [radiologist] tends to do fistulograms here but then they’ve got to go [to another campus] for a fistuloplasty. I can’t get 
it……there’s no intervention done [here]. I can get a line, I can get a line stripping done here and… I can get a dialysis line put in but I can get no 
intervention done here because we don’t have any Vascular Access surgeons here. … Within probably the last 2 years I’ve had patients that have waited 
up to 6 months by the time they’d got a fistula done and then a fistuloplasty.” (Vascular Access Nurse) 
“It’s very difficult when you’ve got to travel. It can take you, at 9 o’clock in the morning, the best part of an hour and ten minutes to travel here. And should 
that influence your decision making? No. But does it? Of course it does. I am sitting here today thinking if I don’t get away from here today round about 
4.30 it will take me an extra three quarters of an hour to get home and that’s just a fact of life. So hopefully that answers that question.” (Consultant 
Interventional Radiologist) 
10 
(Paediatrics) 
“Particularly for patients who require only haemodialysis, then they have to not only, travel some families have to relocate. We’ve had families who’ve 
needed to relocate from… anywhere around Scotland. That’s a major undertaking for a family.” (Consultant Nephrologist) 
Table 31 Geographical influences on service provision 
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Unit 1 
The Unit 1 team cite the non-colocation of nephrology, vascular surgery and interventional 
radiology as a key problem. It was apparent that VAN spent a considerable proportion of her 
clinical time coordinating logistical matters arising from the need to transfer patients between 
sites. The lack of physical proximity was also seen as a barrier to swift decision making and 
problem resolution. 
 
Unit 2 
The satellite RDUs serving Unit 2 were very remote from the main unit, limiting VAN’s 
ability to visit more than twice per year. Clinicians in the unit felt that rural patients perhaps 
encountered more AVF problems than those attending the main unit, but this had not been 
formally audited.  
In an effort to minimise patients' time in hospital, efforts would be made to create or maintain 
AVF for rural patients when they were in hospital for other reasons, and this meant they 
would sometimes not benefit from formal discussion at the MDT meeting, that other patients 
would have.  
The hospital had a formal policy for accommodating patients who attended from rural areas 
for IR procedures but whose transport home was then unavailable. This was said to prevent 
cancelled procedures simply on the basis of where the patient lived.  
Patients who lived in the very remote areas of the catchment did not have haemodialysis as a 
treatment option in view of the logistics that would be involved. PD was offered to these 
patients instead. 
 
Unit 3 
In Unit 3 patients are brought to the main centre in the event of a VA clinical problem. While 
this creates some inconvenience for the patient, the distances are not seen as a barrier to 
providing care. For more routine queries they correspond by email or telemedicine with 
peripheral RDUs. Attempts are made to feedback to peripheral staff about outcome of clinical 
problems as a means of educationally engaging with them across a remote area.  
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Unit 3 also provides renal services for two rural health boards. Patients who live in one rural 
health board area are seen by a visiting nephrologist who flies there on a regular basis, while 
those living in the other rural health board area are flown to the main hospital for routine 
consultations. This is largely dependent upon the service-level agreement. Patients from very 
remote areas were said to have disproportionately long hospital admissions, for example 
requiring overnight accommodation after late procedures where they could otherwise have 
travelled home.  
Co-location of nephrology, vascular surgery and interventional radiology was cited as a key 
reason for their service appearing to function so well. 
 
Unit 5 
The Unit 5 team held outreach clinics in peripheral clinics in an effort to reduce 
inconvenience to their patients in remote areas. Efforts were made to provide care on an 
equitable basis, for example those in rural areas would still have home visits for pre-dialysis 
patient education. 
 
Unit 6 
Most of the catchment area served by Unit 6 is remote and rural. When patients from outlying 
areas required to be admitted this did cause inconvenience in relation to transport 
arrangements, but geography was not described as a barrier to providing care. 
 
Unit 7 
Patients were said to often be reluctant to travel to peripheral centres for elective AVF 
procedures. This was sometimes challenging as more procedure slots were available in the 
peripheral centre. Emergency cases were also less likely to displace scheduled procedures in 
the peripheral centre, whereas this was a common problem in the central hospital. Patients 
who lived in rural areas tended to be more amenable to travelling further distances for clinical 
interventions. 
Chapter 8: System Performance 
223 
 
Correspondence with peripheral units was usually done by email. It was noted that 
geographical distance was a barrier to MDT meeting attendance for some team members. 
They had not considered using telemedicine to manage this problem. 
 
Unit 8 
The large number of peripheral RDUs in Unit 8 created difficulties for the solo VAN to 
adequately cover staff and patients attending each centre, in addition to managing new 
patients and inpatient problems. The historical service configuration was also a challenge: 
nephrology had become a regional service covering the whole health board area (which itself 
represented an amalgamation of several older health boards); however, the IR service on the 
hospital campus where the renal unit was situated was resourced only for the equivalent 
nominal catchment area of that hospital. IR perceived that this meant they received requests 
for interventional procedures that were grossly disproportional to local capacity.  
 
Unit 9 
The lack of nephrology, vascular surgery and IR co-location was cited as the biggest problem 
affecting the service. This caused difficulties discussing patients and scheduling procedures, 
and patients were often reluctant to travel between sites for procedures. The lack of on-site 
surgery made it difficult to have VA problems in the RDU assessed and managed timeously.  
Confusion was reported in relation to the types of surgical and radiology procedures that 
could be performed on one site but not another. Surgeons typically performed AVF 
procedures in the middle of a general surgical operating list, but the use of a day surgery 
theatre list could lead to a procedure being cancelled if the patient was deemed unsuitable for 
day surgery. It was difficult to utilise vacant theatre spaces when the surgeon, patient and 
nephrologist were often not in the same location. 
There were significant problems reported in transporting patients between sites. Ambulance 
transport was said to be unreliable, and when a patient moved from the renal unit for an IR 
procedure on another site there was no obvious clinician responsible for the patient while 
they were there. There was also nowhere for such patients to go within the offsite hospital if 
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they became unfit to travel back to the renal unit, or (more commonly) if transport was 
unavailable before the IR department closed.  
The need for clinicians to travel between sites influenced clinical decision making: 
 
Unit 10 (Paediatrics) 
The paediatric unit provides care to the whole of Scotland. Patients requiring RRT were 
offered PD but if HD was chosen (or was the only practical option) families had to move 
home to facilitate regular outpatient hospital attendance. This was said to be a relatively 
common occurrence, and it seemed preferable for families to relocate for HD than to pursue 
PD because of geographical concerns. 
 
 
Job-planned time 
 
This section considers the availability of formally allocated clinical time for VA services, and 
clinicians' opinions as to the amount of time typically spent delivering the service.  
Across Scotland, and across most of the relevant clinical professions, it was unusual for VA 
service delivery to be formally job planned. It was also unusual for clinicians to have a 
genuine sense of the time commitment currently used to deliver the service, or what would be 
required to do this.  
The commonest event in the VA calendar to be job planned was the MDT meeting, but 
usually only one or two clinicians present would have this in their job plan; others would 
effectively be attending in their own time, or when timetabled to be doing something else. 
One centre reported an MDT meeting that commenced before the start of normal working 
hours for most of those who attended. Most centres had either a dedicated vascular surgery 
operating list, or dedicated slots on specific list, for VA work. It was said to be common for 
these cases to be usurped by competing non-clinical and clinical demands. No centre had 
VA-specific IR lists, and no radiologists had specific time allocated for VA work.  
It was clearly perceived by almost every clinician in the study that most other clinicians also 
performed VA work in their free time, sandwiched between other clinical commitments. 
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Clinicians reported participating in VA activity out of a sense of professional duty; from a 
belief they could improve clinical outcomes; or in an effort to improve the efficiency of their 
overall service. Nobody had a clear idea of others' job plans or how they related to VA. There 
was considerable uncertainty as to what work colleagues performed as part of their core role 
or as peripheral activities, and it was clear that most VA work was considered to be done ‘as 
a favour’ rather than as part of contracted clinical work.  (Table 32) 
(It should be noted that consultant job planning in the NHS is a confidential process; as such 
it was deemed inappropriate to directly ask interview subjects to provide details of their 
individual job plans.) 
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Unit Transcript data 
1 “I wouldn’t like to tell you when I was last properly job planned, but it is part of my job plan that I handed into them for discussion: that I need the time to do that” 
(Consultant Surgeon) 
2 “MDT is actually in people’s job plans but its slightly fudged, partly to… its one of the things that makes the books balance a little bit.” (Consultant Nephrologist) 
“If I have got the time.  Because obviously being 0.5 of a post… if you are working away in the background, some people often forget that you are already [doing] 
0.5 of the post so you can’t [fit additional commitments in].” (Vascular Access Nurse) 
3 “I try and plan it ahead. I have the list, a huge list saying this is what I think might be coming up and I email it round to [surgeon] and some of the other surgeons 
saying look I need this, this and this within the next 2 – 3 weeks, this one within the next 4 – 5 weeks when you are planning and I try and get one of the physicians 
to take some responsibility for it so that there is somebody for contacting as well. It can be a problem for them.” (Vascular Access Coordinator)  
4 “Interviewer: Do you know what their [VA clinicians’] approximate time allocation is for renal/Vascular Access?  Response: I don’t know. I don’t know. 
Interviewer: And how much time, in the real world, how much time roughly speaking do they spend on it? Response: I honestly don’t know. It seems like we take up 
a lot of their time but I’m not sure we do.” (Consultant Nephrologist) 
5 “I have one session for doing the tunnelled lines and I think I put in times for…. we have 3 weeks, an MDT, with most of the people I mentioned, and then there’s 
other sort of bits, of course!” (Consultant Nephrologist)  
“That’s the only allocated time for Vascular Access in the job plan. It’s the clinics, Vascular Access MDM and theatre time is just general theatre time.” 
(Consultant Surgeon) 
6 “No dedicated time as such. So they have not got sessions or anything, it is all just kind of ad hoc, as and when.” (Vascular Access Nurse) 
7 “We have tried to be very honest in our job planning and we try and work out how many of the meetings in a year you would actually make it to, and annualise 
that. But… there is a bit of you know, there’s a kind of a collegiate feel to it as well.” (Consultant Nephrologist) 
8 “The difficulty is that that’s not what they’re paid to do. So they go and ask and again it’s a please, please, please. It can’t run like that!” Consultant Nephrologist 
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“I don’t think that if you gave me more time, specifically for the Vascular Access issues of the patients that I look after, it would make any difference. I think, in the 
time I’ve got, that I’ve described there, I can do as much as I need to do and then it’s handing over… it’s other people from then on. My impression is that there 
isn’t enough resource within the service, but I don’t know whether that’s the lack of human time from a sort of medical point of view. I think that there’s a lack of 
time in terms of nursing. I think we don’t have enough nursing time allocated to it specifically.” (Consultant Nephrologist) 
9 “In terms of intervention – we have actually no fixed sessions allocated to renal” (Consultant Radiologist) 
[Asked about the required time commitment for VA service:] “when you speak to [VAN], it’s just 5 minutes. I mean, I wouldn’t have thought it would be a session.” 
“[VA clinical problems] do need to be pushed forward. I guess they’re our patients aren’t they, so probably one of us [should do it]. You could argue it’s me. I 
don’t have a session for it though.” (Consultant Nephrologist) 
Table 32 Job planned time and Vascular Access services 
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Unit 1 
VA work was described as being counted within the overall vascular surgery consultant job 
plan, including operating time and one hour per month for MDT discussions. It was reported 
that this was not reflective of the time actually spent visiting the RDU and liaising with VAN 
and others.  
There are two whole-time equivalent VANs. There was no job planned IR time for VA. The 
nephrologist who acted as de facto nephrology lead for VA was a member of the team largely 
because his office's proximity to RDU, meaning he was frequently asked VA related 
questions; this meant however that no formal clinical time was allocated for VA and this was 
absorbed within his overall allocation of clinical time. He estimated spending around 4 hours 
per week on VA work. 
 
Unit 2 
The MDT was said to be job planned but was timed to begin before normal working hours for 
some attendees. If individual clinicians were on leave their role in the MDT was not 
backfilled. This had caused previous problems in the event of prolonged sickness absence.  
VAN was employed nominally on a 0.5 whole time equivalent basis, with another 
unconnected 0.5 time commitment in another role in the unit. In reality however, it was said 
that the vast majority of her time was spent attending to VA, possibly to the detriment of the 
other role.  
 
Unit 3 
There was no formal clinical time allocation for IR to attend MDT meetings, perform 
procedures, or otherwise participate in the VA service.  
The VA coordinator estimated spending 5 hours per week dealing with VA work, including 
clinical and administrative functions along with attending meetings. There was however a 
significant degree of unmeasured activity that is likely to greatly exceed this time 
commitment including clinic attendances to meet new patients, ad hoc scheduling enquiries 
and so on. She described having to anticipate and plan ahead during periods of annual or 
study leave, providing clear instructions for nephrologists and surgeons to follow in her 
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absence. She sometimes struggled to find a nephrologist willing to backfill her role during 
planned absences, in part because they would have little experience of coordinating the 
service.  
The degree of formally allocated time for VA surgery was unclear. Surgeons reported slotting 
VA work into their general vascular theatre lists to prevent lengthy waiting lists developing 
and thus impacting upon other elements of their service.  
 
Unit 4 
The clinician interviewed in this unit was unclear about how much clinical time was formally 
job planned for VA services, or how much time was routinely needed to deliver the service. 
 
Unit 5 
The Unit 5 VA team had a clear idea of the available and required time allocation to maintain 
their current level of working. There was one nephrology session per week allocated to 
TCVC insertion, plus around 0.5 sessions allocated for MDT discussions and administration. 
It was reported that the TCVC list usually had spare capacity; this effectively provided a 
buffer for procedures that would otherwise go to IR, meaning the available IR time was then 
protected for AVF maintenance.  
While IR time was not formally job planned there was an informal designation of specific 
slots for VA work in the department, with several operators performing the procedures. The 
flexibility of this approach was welcomed by IR but did mean there was no formal 
measurement of clinical activity at an organisational level. 
Vascular surgeons have 0.5 sessions per week to attend the VA clinic and MDT. Operating 
time was included within their general operating job planned time, and they estimated this 
equated to approximately 0.5 sessions per surgeon per week.  
VAN has a 0.8 whole time equivalent time commitment, but found she often required to work 
significantly beyond this to achieve the necessary results, often in her own time.  
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Unit 6 
While there was no formally job planned vascular surgery time for VA, there was relative 
freedom to book VA cases during an allocated endovascular theatre day. There was no formal 
nephrology time allocation. There was no radiologist employed within the board who could 
perform VA work. IR procedures were usually conducted by the vascular surgeon, who was 
also trained in endovascular procedures more traditionally performed by a radiologist. It was 
considered normal practice that VA work would be fitted around other clinical commitments, 
whether by VAN, sonographers or surgeons.  
 
Unit 7 
MDT attendance was job planned for radiologists and nephrologists. It was said that some 
nephrologists could not reliably attend MDT meetings in view of geography and other 
commitments, but colleagues tended to discuss patients on their behalf in this case.  
VA was considered part of caring for HD patients and was hence accounted for within this 
part of nephrologists' job plans. There was no reference to time allocations for managing VA 
issues in the low clearance clinic cohort, nor for strategic service development.  
Surgeons reported recent success using electronic job planning tools. This was said to allow 
more specific allocations of time that reflected their usual clinical commitments. It was hoped 
this would reduce the impact of ad hoc VA scheduling that would sometimes require 
utilisation of emergency theatre space for elective or semi-elective VA work. 
 
Unit 8 
Nephrologists reported that some job planned time was designated for MDT attendance, but 
not for the associated administration or clinical activity. It was estimated that each 
nephrologist spent 1-2 hours per week attending to VA related issues, including inpatients, 
outpatients and HD patients. They estimated there was probably one WTE nephrologist 
spread across the whole unit by the time all the access issues are dealt with, but no individual 
had sufficient time to properly attend to VA. It was common for nephrologists to circumvent 
established pathways in an effort to expedite a particular patient's case. There was a strong 
perception that VA work was largely “done as a favour”. 
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It was considered best to focus the available time allocation for one or two clinicians to take 
ownership of the service, rather than spreading this among all nephrologists in the centre.  
Nephrologists considered that several additional VAN roles were necessary for the service to 
be adequately resourced. There was one whole-time equivalent VAN for the whole service.  
RDU VA link nurses were considered a highly valuable resource within RDUs and by VAN. 
Link nurses reported rarely having time at work to devote to VA, and in fact could not recall 
the last shift that had been genuinely protected for VA work alone. They were expected to 
absorb VA into their already full working day, and attendance at MDT meetings or strategic 
involvement with the service had to be done in their personal time.  
A significant proportion of the overall inpatient workload was attributed to VA emergencies 
and other VA problems. Ward nurses and inpatient nurse practitioners were said to spend a 
lot of time managing the associated logistical issues, but this had never been formally 
measured. The designated VA theatre lists were insufficient to meet the clinical demand, and 
surgeons tended to utilise emergency theatre to get through the necessary VA work. 
Radiologists had job planned time to attend the VA MDT, but no protected time to deal with 
the subsequent clinical workload. It was suggested that significant proportions of clinical IR 
time was spent on activities that could be performed by other members of the team, for 
example by sonographers. There were often logistical problems impacting upon radiologists' 
ability to cover VA work in practice, in view of their requirement to cover multiple clinical 
sites and provide an emergency on-call service.  
 
Unit 9 
There was some ambiguity as to the available job planned VA time in Unit 9. Surgeon's 
operating time was job planned, and the VA clinic was also thought to be job planned 
although this was unclear.  
The only nephrology job planned time for VA was a nominal TCVC insertion list. The 
clinician who usually performed this list did not have any other role within the VA team and 
the list was often cancelled. It was also reported that nephrologists already had fully 
committed job plans and thus had no spare capacity for VA issues.  
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IR reported having job planned time to attend a VA MDT but not for the resulting clinical 
activity. It was unclear if this was job planned time specifically for VA MDT since this was 
said to almost never go ahead in practice. The radiologist stated that VA clinical work was 
performed almost exclusively within their professional development time, meaning procedure 
lists were unreliable and not backfilled in the event of absence.  
 
 
Scheduling and tracking 
 
This section considers the means of scheduling and tracking VA clinical activities (table 33). 
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Unit Transcript Data 
1 "We do everything within a day, like you know the same day the Vascular Access Nurse gets details, on the same day the access form is done … and we fill in the 
request on [electronic requesting system] on the same day, but then it stops there until you hear from the interventional team, so that depends on how free they are 
and how busy they are." (Associate Specialist Nephrologist) 
“I would say they would be once every fortnight [there is] a situation where you have to prioritise somebody” (Associate Specialist Nephrologist) 
2 “…our sonographers, if they notice that there’s a critical stenosis or there may be thrombus within the fistula or what have you, they will just bring the card directly 
to one of the interventionalists… we just get on with it. Sometimes we get them done that day.” (Consultant Interventional Radiologist) 
“They certainly get priority over, well the venous work, some of the ischaemic legs, so it usually works out okay. We’re usually able to fit them in at very, very 
short notice because most of our vascular work is that sort of same thing that will come – ischaemic legs, aneurysms needing to be worked up. So it works quite 
well.” (Consultant Surgeon) 
“Theatre time is definitely an issue, but we have times where there have been issues about theatre space and it has impacted, as we might have had to wait three 
weeks to get a fistula and you know [surgeon] and [surgeon] are both about and we still can’t get space in theatre to do it.” (Consultant Nephrologist) 
3 “We have got two main interventionalists… if one of the experienced ones are off it is problematic to get them in, and the person who organises it all is away for 
three weeks… it is the organisational aspects that can be difficult in getting messages to somebody who, you know there is nobody sort of taking that over then it 
can be difficult.” (Vascular Access Coordinator) 
“I think having one person in charge of that is the key, and I think also having flexibility so that I trust that [she] will arrange for my patient to get a fistula just as 
much as any of my other renal colleagues… she talks to us all about it: ‘can I cancel this one and do this one’, … so it is done on a clinical need for the 
population.” (Consultant Nephrologist) 
4 “I am not sure how frequently their lists are, but there is certainly we have access to a list once a week at least… it would be at least once a month because we 
never have difficulty getting people on to those lists really.” (Consultant Nephrologist) 
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“Incident access doesn’t generally come through [the MDT] meeting unless prioritising the waiting list for PD access and fistula creation which is a very small 
part of the meeting.” (Consultant Nephrologist) 
5 “You talk about job planning time – there isn’t any, but that makes it more efficient for me because I can then you know put two fistulas into three lists for every 
three weeks, depending what… who is around, so you just get swallowed up by the rest of the work. There’s no official time.” (Consultant Interventional 
Radiologist) 
“We feel, or I feel, it’s the renal physicians that need to advise us of the running order of how we should and when we should do operations … we just are unaware 
of what priorities and pressures [there] are.” (Consultant Surgeon)  
“One of our patients had a fistula planned for Tuesday and he got called for a transplant on Sunday night. So then on Monday when I came in, I was scrambling 
about in my low clearance… who, because we have to swap like for like, so if the surgeon was going to do a [radiocephalic fistula] I can only put a [radiocephalic 
fistula] in that space because that’s all he’s got space to do.” (Vascular Access Nurse) 
6 “We get a reasonably good service from the radiology department wherein [they] can find a slot within 48 hours or so. Occasionally it might take 3 – 4 days. It is 
usually because of multiple things like me not being free when they are free and vice versa. But usually it’s ok. We feel quite comfortable, you know, screening 
when doing the procedure and things.” (Consultant Nephrologist) 
7 “There is some slack built into the system towards the end of the week. We don’t book electives in every single slot…. we recognise that by the end of the week you 
are going to accrue a various amount of emergency work. That’s across the board – that’s vascular, hepatobiliary, all of those things.” (Consultant Interventional 
Radiologist)  
“What I would love to happen is, I see a patient in clinic… and I could offer him a date for surgery… I’d love to say, ‘these are the dates we’ve got, you choose 
what suits you’.”  (Vascular Access Nurse) 
“It’s very fragmented because there is a waiting list office and they will say ‘we can give you so many slots’, and it’s out of, I mean it’s out of my control. I don’t 
know what I am going to do, you know, I’m at the mercy of the waiting list coordinator, and so Vascular Access will say ‘well we have only been given, you know, 
two or three slots, this is what we… can you add another patient in?’ So then they come up to myself or any of my colleagues to just add it on to that, and then they 
will email the waiting list office to say ‘right I’ve added more fistulas’. It’s not ideal.” (Consultant Surgeon) 
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“The problem is it’s not a priority, because what’s happening is these patients get their fistulas, and a lot of it is through my colleagues’ good will. You know, 
‘yeah we will do it, stick it on the end of the list’, and in fact the priority is this three-month target that’s come up, and that’s actually swung things to the detriment 
of the renal patients. And that’s a real issue, and you can fight with it till you go blue in the face, but you know, ‘no sorry this is our priority, this is, you know the 
patient, this patient’s gonna trip’ and you know the politics behind that!” (Consultant Surgeon) 
8 “I go down to try and get a space for a renal patient and I go down, I’m a nurse and I’m standing next to one of the consultant vascular surgeons down asking to 
have an angioplasty done, and I want an angioplasty done. Who do you think the radiologist is going to do?  Who are they going to give that space to?” (Vascular 
Access Nurse) 
“There’s so little spaces, and it was robbing Peter to pay Paul a little bit, you know. ‘So and so’s name is more important than someone else’s name’, so they are 
going to take you off the list, or put [you] down the list because you have got nothing but you can wait. And even though your [fistula] is about to actually collapse 
and fail dramatically, you might need yours first cause you need [procedure], it’s one of those scenarios.” (RDU Nurse) 
“[Some surgeons] will only put renal patients on when they’ve got an empty list, cancellations, and it’s last minute, and then trying to get patients last minute – 
they don’t want to come, or there’s a problem, they need to dialyse or whatever.” (Nurse Practitioner) 
“There’s usually an immediate referral made to radiology probably, quite timely – I would say within the sort of first hour of the patient being there it’s established 
what the problem is and if it needs to be referred to radiology… and is it a clotted fistula? And that’s where the hold-up then really happens, because if radiology 
can’t fit them in then the patient sits all day waiting to hear. Because radiology will often tell us, ‘we’ll try and fit them in’ … and then the patient sits all day and 
quite often at 4 or 5 o’clock when a phone call comes to say, ‘we’ve ran out of time’, and then that leaves us to deal with the problem late on into the on-call hours 
because either then we need to get a temporary line put in if their bloods aren’t safe, or they have to be admitted, or they get discharged. They go away and come 
back the next day, and they have to revisit and then we go through the whole performance again of waiting while the patient sits in a room.” (Nurse Practitioner) 
“The radiologists, certain ones won’t speak to nurses, they have a wee bit of an issue… I had an issue with [radiologist] where I went down, and the radiologist 
turned up and said ‘I don’t speak to nurses’. And I said, ‘well there is nobody else’. I kind of stood my ground and eventually he spoke to me but that’s not always 
the case… [VAN], because they’re familiar with her, they maybe won’t discuss the case but they’ll allow the [radiology nurses] to kind of liaise with her and sort 
things out you know. Usually if it’s an emergency, something that needs done in a hurry [VAN] will often say it will have to be a medic that goes down to discuss it 
if you want it done there and then.” (Nurse Practitioner) 
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“Some individuals seem to be really focused on this, and for other individuals this is clearly not a priority and I know that I see the same faces come down to speak 
to me or engage with me and then for other faces, you don’t see them at all… and I don’t know whether that’s because they have other commitments, it could well 
be, I don’t know that, but you just don’t see them so you don’t get that engagement. The more engagement you get, the better, particularly when you get into the 
marginal cases.” (Consultant Interventional Radiologist) 
“They may say ‘come speak to us’, but it’s not easy because I’ve done it. I’ve really tried to do it and as you know I’m quite happy to wander round and speak to 
anybody I can find in order to get things done, so it’s not that I’m averse to it, but I cannot find them. Now if you’ve got an emergency or whatever, then you know 
you’re forced use your phone and stamp your feet!  But there isn’t somewhere I can go and think, how can I speak to a radiologist and say this is the situation, 
what can we do.” (Consultant Nephrologist) 
“One of the problems when you do a list of just fistulas is if you have, say five or six fistulas on the list, you know that one of them is going to have awful vessels 
and just won’t work, that the other one that you do that doesn’t work very well and you fiddle around with it for a bit to try and get it going better, and the other 
three will probably be fine. But if the two bad ones, the first and second patients on the list, your day is ruined, and the rest of the day is entirely miserable!  So, for 
that reason I don’t like a list with five fistulas; I like to put a bit of general surgery in too, for my own sanity.” (Consultant Surgeon) 
“A one-step [clinic], that would be ideal, but even if there is a 2-step, there’s no point in seeing the surgeon before they get mapped. They will see the surgeon first 
of all, then they get vein mapping, then they see the surgeon again, then another surgeon does it and does something completely different!” (Consultant 
Nephrologist) 
“So that depends which route you want to use. So, either you fill in the screen in the same way that I usually do and set them off into dialysis in whatever unit 
they’re doing, and then wait, wait, and wait – or you go and nobble a surgeon!  And say ‘come down, this person’s got reasonably good veins. Do you think you 
can fit them in sometime!’” (Consultant Nephrologist) 
“There’s a handful get referred informally, particularly people who are currently inpatients on [the renal ward], someone will speak to us and you can fit them in 
somewhere. And that creates a problem in that we don’t, there’s no-one tracking that and there’s no prioritisation of that so that’s a particular problem area.” 
(Consultant Surgeon) 
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9 “Yeah, I’d go back into my head and jiggle about, and obviously I’ve got people sitting on the waiting list, so I’d look at that and try and see, well, who can I see” 
(Vascular Access Nurse) 
“We have our waiting list, so I then get emails from those secretaries to say [name] is on annual leave, study leave, etc. So I know what planned dates we have, I 
know what procedures they are going for and whether it’s a one slot or two slot. So I then just have to try and… and also we work at the moment with, one theatre 
session is in day surgery and it’s day surgery protocols, the other two sessions are in the main theatres, so the protocols are slightly different …. it affects the 
patient as in, they are being, sometimes their diabetic status etc, so I do have to do a wee bit of juggling around to see which patient actually goes where.” 
(Vascular Access Nurse) 
“The way that we sell ‘come to [another campus]’ is that that’s where our vascular surgeons are; if something were to go wrong, you’re better… it’s safer for you 
to be there and vascular surgery theatre is right beside us, so it is, there’s that connection.” (Consultant Interventional Radiologist) 
“And again, that’s what having someone whose job it is to look after the kind of quality clinical part of it and somebody to co-ordinate. They’re different things. We 
try to make it…. we’re asking one person to do everything and she’s doing the best she can but it’s plate spinning.” (Consultant Interventional Radiologist) 
Table 33 Scheduling and tracking Vascular Access clinical activity
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VA scheduling was viewed as a cumbersome process requiring knowledge of the clinical 
priority, decision making as to the specific procedure to be scheduled, with the clinical (and 
technical) authority to book slots within the surgery or radiology system. Multiple convoluted 
steps were often involved in scheduling a specific procedure and it was common for multiple 
administrative staff to be involved in the process.  
Effective scheduling required available slots designated for VA work, and where VANs or 
other members of the VA team were afforded direct booking rights to allocate specific slots 
to named patients.  
It was apparent that no unit had designated clinical slots or formally protected time for VA 
services across nephrology, surgery and interventional radiology. Most centres had some 
formally protected surgery slots, but relied upon additionally unprotected slots to manage 
clinical demand. There were no formally protected radiology slots in any centre.  
It was highly uncommon for procedures to be scheduled directly within the MDT meeting; 
just one centre routinely did this, and only for IR procedures. In several centres formal 
radiology requests would require to be submitted following MDT discussion, and the requests 
were subsequently vetted and processed through waiting lists and other back office 
administration. In some centres MDT discussion was required before a request would be 
considered, but MDT meetings were reported to occur too infrequently for this to be 
practical. 
Scheduling procedures and the associated logistical arrangements tended to occupy 
considerable amounts of clinical time for VANs, particularly in units with high TCVC usage 
or where the renal unit was not geographically co-located with vascular surgery or radiology.  
It was also said to be common for theatre lists to be cancelled at short notice, for operators to 
be redirected to performing an alternative clinical activity, or for there to be mismatches 
between operator and theatre space availability. These issues all required VA procedures to 
be rescheduled. It was also apparent that processes were necessary to manage technical 
failure of a procedure, for example AVF that failed to mature. Most centres recognised the 
importance of being able to reschedule procedure lists to accommodate emergency cases at 
short notice, but practice between units varied considerably: some described proactive 
planning to counteract anticipated AVF problems, while others were reliant upon reactive 
last-minute approaches that often precipitated unscheduled hospital admission. 
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Unit 1 
In Unit 1 there was reported to be a day surgery list available for VA procedures, and this 
was heavily utilised for elective work. There was said to be a considerable additional surgical 
workload that required to be slotted around other commitments into non-protected slots. The 
surgeon found considerable benefit from regularly visiting the RDU but this was not during 
designated clinical time, and so was not backfilled when he was on leave, on-call, or 
otherwise unable to attend. VAN could allocate surgical theatre slots to named patients within 
broad parameters. 
There were no designated IR slots for VA work and no allocated time for MDT discussion. 
The VA team described having almost no ability to influence the scheduling process for IR 
procedures, the majority of which related to TCVC insertion. 
The logistics of transferring patients from the renal unit on one site, to either the surgical unit 
or radiology service on another site, occupied a lot of VAN time. While inpatient VA 
problems were not formally part of VAN's role, they did tend to become involved with these 
cases too in view of the common logistical challenges.  
It was said to be common for clinicians to be asked to reprioritise waiting lists to 
accommodate emergency clinical problems or to utilise newly available slots. This typically 
meant displacing an existing planned VA procedure in favour of one that was more clinically 
urgent. 
 
Unit 2 
The ethos in Unit 2 was clearly to focus upon patients’ individual needs to provide optimal 
VA. They adopted a team approach and held a weekly MDT meeting where forthcoming 
surgical and IR slots were allocated. They were flexible such that urgent clinical problems 
could be addressed without waiting for the next MDT meeting.  
Patients who lived in geographically remote areas tended to need customised ‘one stop’ 
approaches, but this was not seen to be a significant problem. All VA cases were afforded 
‘urgent’ priority status, and there was willingness to accommodate cases at short notice.  
There was no formal protection of IR or surgical slots for VA work. Enthusiastic operators in 
both departments meant slots were readily available when required, although there were 
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sometimes mismatches between operator and theatre space availability. Surgeons tended to 
allocate patients to ‘vascular’ rather than ‘general’ theatre spaces to ensure a vascular 
anaesthetist would be present. 
VAN booked patients for procedures following the weekly MDT meeting. She had authority 
to prioritise the waiting list, and maintained an overview of surgeons’ availability. It was 
normal to create a follow-up plan at the point of planning an intervention, to facilitate 
rescheduling when required. The weekly MDT meeting agenda consisted of an ‘active patient 
list’, which served as a means of tracking ‘active’ patients. There was also a policy to actively 
discuss any patient currently dialysing with a TCVC until they had successfully moved over 
to using an AVF or AVG. 
 
Unit 3 
There were reported to be designated theatre slots for VA work, and it was perceived by other 
team members that these were readily accessible for VA patients. Surgical on-call 
commitments would occasionally result in a cancelled VA list, since the operator would be 
unavailable to perform the procedures.  
The nephrology team (and the VA coordinator in particular) scheduled all VA procedures, in 
liaison with a named surgical secretary. A nephrology secretary would book an inpatient bed 
where required. The VA coordinator was empowered to allocate specific surgical slots to 
named patients, without them needing to meet the operating surgeon until the day of surgery. 
There tended to be a reliance upon one administrator, and a small number of operators with 
the technical skills to perform procedures, which could occasionally cause difficulties. 
Patients seen in the VA clinic are allocated a specific surgical slot. Patients who present late 
tended to have VA creation surgery scheduled before leaving hospital during the index 
admission, for a date as soon as possible thereafter. The VA coordinator matches operators 
with cases based upon their relative experience and case complexity, taking account of their 
general workload and any planned absences. She maintains a running order of patients 
awaiting procedures, to facilitate scheduling and reorganisation if a patient could not utilise a 
particular slot. Her overview of the active patient cohort, coupled with empowerment and 
ability to prioritise, were considered a key element of success.  
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Unit 4 
In Unit 4 the MDT was the forum for decision making, prioritisation and scheduling of VA 
procedures, including the placement of PD catheters where appropriate. There was 
uncertainty as to the number or availability of protected slots, but it was considered that 
patient throughput was prompt and appropriately timed for the clinical context. It was noted 
that Unit 4 and Unit 5 operated a shared surgical and IR network for the purposes of VA. 
 
Unit 5 
Unit 5 had easy, rapid access to a TCVC insertion list designated for renal VA work. This 
was performed by a nephrologist and was considered an effective means of limiting NTCVC 
use.  
The weekly VA clinic appeared to function well, although it was not backfilled in event of 
planned or unplanned staff absence. Clinic attendance was prioritised by VAN, and it was 
possible to directly allocate specific IR slots to named patients at the MDT meeting. Some IR 
slots were informally designated for VA work, with an intended three-week turnaround 
period such that patients were appointed at one MDT meeting, and their IR procedure 
outcome discussed at the subsequent meeting three weeks later. IR think this works well 
albeit the lack of protected slots could make the service vulnerable to external pressures.  
It was not possible to directly allocate patients to surgical slots, and instead their names 
would be added to a surgical waiting list from the clinic or MDT meeting as appropriate. 
There was no dedicated surgical theatre time for VA work; this was considered a key 
problem by VAN and surgeons alike since VA cases could be usurped by other patients who 
required their theatre slot for an unrelated clinical problem.  
Once a patient had been added to the surgical waiting list it was not possible for VAN to 
further influence the timing of their procedure, beyond swapping one case for another on an 
already published theatre list. This could only be done on a like-for-like basis, meaning only 
patients awaiting the same procedure could be swapped. The surgeons were comfortable with 
this process and would perhaps have welcome further flexibility with their lists, based upon 
the clinical imperative indicated by other members of the team. 
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Individual surgeons were flexible as to which patients they operated on; it was not necessary 
that they had personally met the patient in the clinic before the scheduled theatre date.  
It was noted that VA procedures were given ‘routine’ priority for the purposes of the surgical 
waiting list, while procedures for other non-VA indications were afforded ‘emergency’ 
priority despite having a similar level of clinical urgency. 
Surgical and IR rescheduling tended to be reactive, and there was no described process for 
maintaining a ‘reserve list’ of patients on standby for a late availability slot.  
 
Unit 6 
Unit 6 described having adequate capacity to schedule VA procedures at short notice, without 
requiring designated slots to be available for this purpose in advance. It was usual for duplex 
ultrasound to be performed within one day, and for theatre cases to be listed either as 
emergency procedures or electively scheduled within 1 month. While the weekly 
endovascular theatre list was not formally designated for VA procedures, this was the usual 
list for VA cases and the surgeons were enthusiastic about listing them.  
Difficulties in obtaining IR imaging or procedures tended to reflect a lack of slot availability 
at short notice, but the workload was not judged sufficient to justify the designation of 
specific slots for VA work. 
 
Unit 7 
A major component of the VAN role was to prioritise and reschedule theatre lists, and 
optimising slot utilisation by maintaining an overview of active patients. They maintained a 
‘control room’ with various whiteboards to facilitate this aim. 
There were no designated slots for VA work in IR, although VAN tended to use this as a 
means of limiting TCVC use within the unit. There were some slots informally available for 
VA use, although these were in the form of slots at the end of each week that were purposely 
left vacant to accommodate emergency work from earlier in in the week. 
Radiologists found VAN very helpful in prioritising VA patient throughput, although when 
patients were directly referred to them by a nephrologist (for example as an inpatient) they 
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had difficulty assessing the degree of urgency of the requested procedure. There were also 
some inefficiencies identified in that individual nephrologists would request IR procedures 
for their patients following an MDT meeting, rather than these being allocated directly during 
the meeting. 
Surgery slots were available with at least 1 month notice and VAN allocates individual 
patients to slots. It was not possible to allocate specific theatre dates to patients during their 
clinic consultation, but this was something they aspired towards doing. VAN was reliant 
upon the surgical waiting list office providing an appropriate number of slots, a process 
which could be frustrating for the whole VA team.  
The only dedicated access slots were in a peripheral centre, and surgeons wanted additional 
protected theatre time. It was common for surgical cases to be postponed because (non-VA) 
cases required the theatre space, often because of an impending waiting list target rather than 
for clinical reasons. There was little dialogue with the waiting list administration, and despite 
informal agreement that patients could be listed onto any available surgical list, many cases 
were said to rely upon goodwill to be done within a clinically appropriate timeframe.  
There was local agreement that a patient did not require to be seen in an outpatient clinic by a 
surgeon in order to be listed for an AVF creation procedure. Instead, VAN could assess the 
patient in their clinic and then list for a specific procedure, or in the event that adequately 
sized vessels were not identified on imaging, they would be booked for an exploratory 
procedure. This was said to be highly successful. 
 
Unit 8 
Unit 8 reported having a regular nurse-led TCVC insertion list. While this list was often 
oversubscribed, there were said to be strict criteria defining the patient cohort suitable for the 
service and in practice many patients were deemed ‘unsuitable’. There were no other 
protected slots in IR for VA associated procedures relating to TCVC or AVF. The lack of 
slots was described as having reached a critical juncture where crisis management had 
become the normal day-to-day experience for staff in the unit.  
IR did try to accommodate VA cases amongst their other workload, but frequently had to deal 
with other (non-VA) clinical emergencies, displacing VA cases. They maintained a diary and 
whiteboard with the names of ‘priority patients’, but considerable difficulty was reported in 
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persuading radiologists to prioritise VA cases above the other clinical problems of the day 
and it seemed many people awaiting IR VA procedures had already reached ‘emergency’ 
status hence it had become impossibly difficult to genuinely prioritise urgent cases. 
There were some scheduled VA surgical theatre lists, but these were said to be insufficient to 
cope with the clinical need. Other slots often become available at short notice, but many 
patients were not available to attend with such little warning. It was also common for non-VA 
cases to usurp renal patients, particularly for ‘higher profile’ procedures like transplant 
surgery. It was felt that VA cases would only become a priority when it was impractical for 
other sorts of cases to utilise the available theatre space. This meant there was variable patient 
throughput and at times operators with limited AVF experience would be performing most of 
the necessary procedures.  
Nobody across the clinical team had any certainty about the available clinical time for VA 
work, and it was therefore said to be difficult to ‘demand’ spaces for their patients’ cases. 
Nobody had job planned time to attend the VA MDT, which was often cancelled or poorly 
attended. When the MDT did happen, patients would be added to a surgical waiting list for a 
named procedure, but it was unknown at the point of the MDT meeting how long it would 
take for a slot to become available. The uncertain lead time for procedures also led to 
uncertainty, if a patient was thought likely to receive a transplant in the near future, perhaps 
soon after AVF creation. 
The convoluted scheduling processes, involving test requesting, waiting for slot allocation 
from a waiting list, and no real-time tracking or allocation, meant it was difficult for anyone 
to maintain an overview of the service, or track individual patients’ journeys. When 
procedure slots did become available there was no organised means of identifying the next 
patient on the waiting list. This seemed chaotic, particularly since a significant proportion of 
the overall VA workload was scheduled in this way. 
It was felt that AVF had not been afforded the urgency of other procedures, and that this was 
increasingly necessary. It was recognised that AVF procedures often failed, but there was 
little fall-back planning for this occurrence. 
Convoluted booking processes were described for both surgical and IR procedures. For IR 
cases technical difficulties with the booking system that meant VAN could not personally 
request VA procedures, as these required to be ordered by a doctor. Listing a patient for a 
procedure required liaison between the radiology booking office, VAN and RDU, to 
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coordinate logistics. Without allocated slots, and with low priority being given to emergency 
access issues, it was felt that patients’ needs were not well served by IR. 
It was apparent that last-minute scheduling was a significant challenge, and often an element 
of luck was needed for a referral to be accepted. It also appeared that urgent cases were more 
likely to be prioritised by radiologists if they were presented and discussed with them by a 
doctor rather than by a nurse. 
Radiologists felt detached from the clinical decision-making process, with little involvement 
unless another clinician specifically sought their opinion. Nephrologists however expressed 
frustration at the difficulty in finding a radiologist to discuss VA cases. 
Access surgery was considered technically frustrating by some surgeons, and they were at 
times uncomfortable performing procedures that had been listed by colleagues. Some were 
also uncomfortable with day surgery arrangements where they would not have met the patient 
before the day of surgery. Nephrologists, however, questioned the utility of patients routinely 
meeting a surgeon in clinic before theatre.   
The convoluted VA referral systems had made it common for nephrologists to make informal 
referrals that circumvented the usual process. Surgeons found this frustrating and considered 
that it ultimately hindered the service.  
 
Unit 9 
In Unit 9 the lack of protected radiology time, and the need to transfer patients to another 
campus for IR or surgery procedures, were cited as key challenges. Radiologists reported 
performing VA procedures exclusively during professional development time rather than 
clinical time. VAN reported significant variability in whether procedures would occur on any 
given week, which led to considerable difficulties. There were further difficulties in that VA 
cases would be given similar priority to other cases, despite the potential time-sensitivity of 
VA cases. Many slots that did become available were used for TCVC insertion as there was a 
high proportion of patients dialysing in this way. This meant that almost no IR time was used 
for AVF maintenance, and so there was a reluctance to invest in the IR service.  
There were protected slots for surgical procedures and a scheduled VA surgical clinic. These 
were usually on another campus from the renal unit, and the surgeon who usually conducted 
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the clinic did not personally perform any VA surgical procedures. The operating surgeon 
would only hear about the patient upon their arrival on the day of surgery, although it was 
unusual for an operation to be cancelled at that stage. Neither surgeon had an overview of the 
whole patient cohort including those waiting for clinic or operation appointments, and those 
who had recently had an operation. The standard surgical TTG was applied to AVF surgical 
referrals, but it was acknowledged that this was a ‘routine’ surgery target that was often not 
clinically appropriate for patients requiring VA. 
Nobody had an overview of the current waiting list size or lead times for procedures. The 
allocation of individual patients to specific slots relied mostly upon VAN’s memory rather 
than an organised and accessible waiting list system. VAN was unable to allocate named 
patients to specific theatre slots beyond a small number that were made available at short 
notice. There was no formal or informal managerial involvement in this process, and little 
acknowledgement of the difficulties generated by multi-site working. 
There was an awareness that the VAN workload was unrealistic for one individual. It was 
acknowledged that mutual trust and agreement was needed between different members of the 
clinical team to facilitate optimal utilisation of the available clinical slots.  
 
Unscheduled care 
 
The approach to managing unscheduled care was significantly different between units. In 
some centres the discussion focused upon emergency access presentations, while others were 
more concerned about other, non-renal, unscheduled clinical work, and its impact upon 
displaced VA work (table 34). 
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Unit Transcript data 
1 “We don’t have emergency services over the weekend so that is another thing that an additional pair of hands would probably be helpful for” (Associate Specialist 
Nephrologist) 
2 “I can’t remember a fistula requiring de-clotting since I’ve been here, presumably because of the surveillance. You know if someone has a problem.” (Consultant 
Surgeon) 
3 “There is no Vascular Access clinic this week but if there is somebody I desperately need seen, I will buttonhole a surgeon and take the patient to them or do 
something” (Vascular Access Coordinator) 
“Usually within 3 or 4 hours we will get a vascular person over to have a look and they could be in theatre that night if it’s starting to fail. They usually do try and 
attempt to see, even if it was stopped completely they will go to theatre and try and rescue if it’s just happened.” (RDU Nurse) 
“A lot of the challenge is in the out-of-hours work in ensuring that the cases are appropriately assessed, and the correct decisions are made and people, you know 
bear in mind just the long term and not just the short-term fix…. We don’t always have adequate cover out-of-hours in interventional radiology and it causes a 
huge logistic problem in terms of the staff because we need staff from theatre, so when you do that it stops the emergency list, and you need the interventional staff, 
including the nurses who also cross-cover cardiology, their interventional suite, so you have got three different lots, four different lots of on call people all trying to 
get into the same place at the same time and not being somewhere else” (Consultant Surgeon) 
4 “So out of hours or if there’s holiday cover things then sometimes patients will go up to [neighbouring board]. Mostly it gets done here.” (Consultant 
Nephrologist) 
5 “I am very aware of Vascular Access theatre slots having to be postponed if emergencies happen. You know, because we are on the receiving end of that. That will 
be the one to go if a vascular emergency comes in, it will be Vascular Access that gets [postponed]” (Vascular Access Nurse) 
“It’s more what’s coming in through the doors that can bump Vascular Access patients, sadly.” (Consultant Surgeon) 
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“As I said, one of the things is because of surveillance, fistulas just turning up thrombosed is not that often for us. Unexpected thrombosis of fistulas which is what 
I have seen in other centres where I was training, where they more often than not, the fellow used to do the last fistuloplasty thrombectomy of the day – it doesn’t 
happen here. It’s very rare.” (Consultant Interventional Radiologist) 
6 We [have a] contingency plan [for clotted fistulas] that we would either wait until the Monday or we will try and deal with it on emergency theatre at the weekend.  
Yeah.  It doesn’t happen that often.” (Vascular Access Nurse) 
“If it is urgent, urgent, then [surgeon] tries to squish them in, even in the emergency theatre list he will try and do them for us.” (Vascular Access Nurse) 
7 “You know, you can be in clinic and you’ve got the bleep going off continuously, you’ve got a blocked fistula coming in from [satellite centre], and when a blocked 
fistula comes in that’s my responsibility to sort out.” (Vascular Access Nurse) 
8 “It’s like crisis management, so people who have got the most need get the space and somebody who maybe isn’t, I don’t mean is not important but their access is 
still ticking along and you know, it’s not failed yet. They will not have the priority over someone whose access has fell out, the fistula’s collapsed and it’s not 
working and it needs to go back to theatre, you know, wait to get new access in to plan, so it was a bit of a vicious circle the whole month I was there, plans were 
changed and changed and changed every day.” (RDU Nurse) 
“Occasionally interventional radiology wouldn’t be able to do what we should be able to do with a fistula, like a fistuloplasty. And I think salvaging the fistulas, 
you know, is a big effort.” (Consultant Nephrologist) 
“They put them on a list and then an emergency does come in, and radiology will tell us to make a choice: that you’ve got two routines booked in tomorrow or two 
patients on the waiting list, but if you want your fistula that’s clotted done, you’re going to have to postpone them and reappoint. So, then they get bumped, and 
they might get bumped for 2 weeks or 3 weeks, so that the emergency can get done. So it can be at the end of that time most of them reappear and they become the 
emergency and then the patients get bumped so the circle… the vicious circle goes on.” (Nurse Practitioner) 
9 “You can be operating in theatre and then someone phones you, and you feel very, very bad about it because you can be in an aneurysm that can take 3 hours or so 
and they are waiting for you and the patient might have had the dialysis already and needs to wait sometimes, not very common. By the time I go across to see 
them, maybe it’s about 4 o’clock – 5 o’clock and they are waiting for me. So it’s not the ideal situation.” (Associate Specialist Surgeon) 
Table 34 Unscheduled Vascular Access care
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Unit 1 
There were no emergency cover arrangements at weekends. There was no additional data 
around unscheduled VA care in this unit. 
 
Unit 2 
There was often a reliance upon an individual surgeon to deal with AVF problems out of 
hours, but when a new patient presented or an AVF thrombosed at the weekend it was normal 
to insert an NTCVC in the first instance. The need for unscheduled care among existing VA 
patients was said to be very uncommon, and this was attributed to the achievements of the 
close-knit MDT team. 
 
Unit 3 
There was a focus upon managing problems as rapidly as possible. Surgeons considered that 
out-of-hours there could be inconsistency of approach, where clinicians who are not normally 
part of the VA team could encounter AVF problems.  
 
Unit 4 
Emergencies arising out-of-hours would be sent to the neighbouring health board, with which 
they shared surgical and IR services for VA.  Most VA problems were considered to be 
managed locally however, although there was no audit data to support or refute this.  
 
Unit 5 
It was said to be common for non-VA emergencies to displace VA cases.   Radiologists noted 
that emergency fistula procedures were uncommon and attributed this to a robust surveillance 
programme that preventing this from arising. 
 
 
Chapter 8: System Performance 
250 
 
Unit 6 
Unscheduled care was not reported to present a significant problem. It was normal to slot 
additional emergency cases into the normal working day if clinically required.  
 
Unit 7 
The main challenge was reported to be the need to juggle emergency issues during the 
working day around the existing ‘routine’ workload. As described earlier, there was 
additional radiology capacity made available for VA (and other) emergency cases, to prevent 
significant delays in their management.  
 
Unit 8 
There was a sense of crisis, with the service felt to be operating at the very limit of its 
capacity. Nephrologists did not feel they had sufficient IR support to maintain fistulas, and it 
was reported that a large proportion of IR referrals related to unscheduled emergency care 
rather than routine maintenance activity. The feeling of crisis was said to be perpetuated by 
an inability to fix clinical problems within an appropriate timescale, resulting in problems 
escalating.  
 
Unit 9 
There was a nominal on-call IR service, but in practise VA patients tended not to have rapid 
access to it. There was reasonable access to an on-call surgeon, but they were based off-site 
hence any clinical review tended to be delayed by several hours.  
 
 
Knowledge of timelines and processes 
 
It was apparent that nobody had a complete overview of the VA service within their unit. 
Most clinicians had an appreciation of the processes relevant to their specialty, and most 
VANs and equivalents had a command of the other operational aspects of the service such as 
slot availability, pathways, and workarounds required to get things done. However, there was 
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no managerial oversight of the service or strategic overview of the overall VA service, its use 
of resources and the outcomes delivered. 
Most clinicians assumed that VAN had access to an array of VA metrics and statistics, but in 
reality this was not available. The operational components of the VAN job appeared to 
occupy the whole working day, often significantly beyond contracted hours, and there was 
little potential to add strategic components to the role without substantially increasing staffing 
complements.  
I am 30 hours but 30 hours officially, but I’m here a lot more than that… I kind of 
probably work an extra day in amongst all that….  Just hours over my time coming in 
on days off to facilitate Vascular Access.” (Vascular Access Nurse, Unit 5) 
It was clear that waiting times and clinical processes were almost never discussed across the 
broader VA team, and almost never with a management representative. There was no internal 
or other publication of waiting times, which created difficulty in accurately timing when 
patients should be referred for VA creation, and anticipating how long a patient was likely to 
wait for a requested test or procedure. There was a lack of data about postponed or cancelled 
tests and procedures. Individual clinicians referred to ‘being able to dig out the data’ when 
asked about their local throughput and service statistics, but it was clear that this information 
was not routinely reviewed or used to improve service performance.  
 
Procedure outcomes, morbidity and mortality discussion 
 
There was a lack of discussion around VA clinical outcomes, and there appeared to be no 
formal managerial oversight of VA care in any centre.  
There was no agreed definition of ‘morbidity’ relating to VA. Individual specialties would 
occasionally discuss cases relating to VA work at a local meeting, for example in the event of 
a theatre mishap which happened to occur during an AVF procedure. There was no VA-
specific morbidity and mortality meeting held in any centre, and discussion of major adverse 
events was typically limited to a once-off review.  
It was striking that IR and surgical operators were often unaware whether their interventions 
resulted in a positive subsequent clinical course for the patient concerned. Their view on the 
utility of VA procedures was governed mostly by the volume of repeat work they were asked 
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to perform on the same patients. No units routinely measured their volume of clinical 
procedures or their outcomes. Only a few surgeons and radiologists could produce logs of 
their VA clinical workload, and where these existed they were not tethered to outcome data, 
for example the survival of a new AVF.  
“We were doing a fair bit of de-clotting and, you know, it was soul destroying. We 
had to look at it and just say right, what difference are we making here with this? 
Considering this procedure takes 4 or 5 hours to do, takes out pretty much the whole 
day in intervention to do one patient. Let’s have a look at our figures. And our figures 
were just appalling. This is not worthwhile doing. Let’s have a look. Let’s see which, 
let’s try and decide which patients would be worth attempting to open it and which 
ones are [not].” (Consultant Radiologist, Unit 2) 
It was highly unusual for VA complications to be associated with morbidity and mortality 
data. Unscheduled care episodes, unusable AVF and similar episodes were not routinely 
recorded or discussed. Similarly, NTCVC use was not normally recorded in any searchable 
database. Associated complications were not routinely considered ‘morbidity’ or logged for 
regular review. There was some awareness of the approximate proportion of patients within 
the centre who dialysed via TCVC, but there was no means of tracking which specific 
patients used them, or their status with regard to AVF or AVG planning. The one exception 
was Unit 2, where the weekly MDT meeting did feature a real-time list of all patients 
currently dialysing with TCVC. Part of the standing agenda at this meeting was to plan an 
exit strategy from the TCVC for these individual patients, and their names would remain on 
the meeting agenda until the TCVC was removed.  
Across most centres, the role of tracking clinical outcomes and individual patient journeys 
was considered a part of the VAN portfolio. It seemed however that the VAN, who was often 
a solo clinician, typically funded for less than one whole-time equivalent salary, couldn’t 
realistically hope to achieve this in addition to their multiple other roles.  
A further striking finding was the ad hoc nature of any clinical audit relating to VA. 
Typically this was performed in the context of a medical student project or equivalent. VA 
clinical audit was not taken seriously by any health board, and no administrative or analytical 
support was available to help achieve this. This was at odds with the support that was said to 
be available for other areas of practice such as ‘infection control’, and the detailed analyses 
reported to took place when patients developed VA-associated SAB episodes.   
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Chapter 9: Service Development Needs 
 
This study aims to delineate the structure, function and workload of VA services in Scotland, 
in the context of unwarranted variation in AVF use for haemodialysis. Moreover, it aims to 
highlight inconsistencies between ‘work-as-imagined’ and ‘work-as-done’, using these to 
generate recommendations for practice that are then used to stimulate QI activity.  
Earlier chapters have contextualised the study and its systems-based methodology (chapters 1 
and 2). Results chapters 3-7 described the structure, function and workload of VA services 
from an operational perspective. Chapter 8 considered strategic findings from the thematic 
analysis related to how VA services perform, from a systems perspective. This chapter relates 
further strategic findings from the thematic analysis, about VA services’ development needs. 
The findings reported here reflect clinicians’ perspectives on the strengths and vulnerabilities 
of their service; barriers they face to working effectively; their use of EHRs; and strategies 
they have adopted to preserve veins for AVF creation. The chapter is particularly important 
in view of the final research aim of this study – to present recommendations for practice to 
the clinical community in a manner that facilitates ongoing QI. Creating these 
recommendations in light of clinicians’ own reflections about their aspirations for service 
development will surely enhance the likelihood of their implementation.  
 
Self-reported strengths 
 
Clinicians in all centres recognised several strengths and weaknesses of their service (table 
35). 
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Unit Transcript data 
1 “We usually write two or three options, you know [fistula approaches] so if what we do doesn’t know, 
we are happy with the blood pressure and all that sort of stuff, they just get listed for the next 
procedure.” (Consultant Surgeon) 
“I quite like the surveillance programme over here. The nurses are doing a very good job over here 
so that I think is a good thing that other units can learn from that.” (Associate Specialist 
Nephrologist) 
“We recently started one patient who… had a fully working fistula you know before he started 
dialysis, so that story is quite welcome and we are happy to see that but unfortunately that is not very 
often.” (Associate Specialist Nephrologist) 
2 “It’s because we all play a part. A small part, a large part of this and we work together. And we work 
quite well together.” (Vascular Access Nurse) 
“I think we can do it quite well because the number – we do roughly I think it’s about 140 
fistuloplasties a year… we’re doing it with a number of interventional radiologists that is less than a 
lot of places, but then if you look at somewhere like [large unit] you’ll be having to do a helluva lot 
more fistuloplasties which makes it more sort of difficult to fit it into the working week.” (Consultant 
Radiologist) 
“I can’t imagine us doing this sort of work without an MDT. It organises the work, it brings everyone 
together to give an opinion so I think that is key to have an organised and well attended MDT.” 
(Consultant Surgeon) 
3 “I think if you are going to work together it is absolutely crucial that you have a good working 
relationship and excellent communication so that, you know, we can pick up problems and you know 
with each others work and try aim for the best for the patient.” (Vascular Access Coordinator) 
“We are not too big so the whole thing is kept under the control of [VA coordinator] and me really, 
they are the main players in making sure things happen and without that it would probably all fall to 
pieces, you would have to formalise everything. If the [unit] gets too big then we won’t be able to 
cope with the numbers anymore without being more formal arrangements” (Consultant Surgeon) 
“If there is failing fistula, early intervention I suppose, and people who are dealing with the fistulas 
they pick up problems quickly…I think most of the fistulas that we deal with, the failing fistulas, or 
even the clotted failed fistulas we deal with, we do have pretty good results” (Consultant Radiologist) 
4 “I think what works well here is that we get on with and speak frequently with the Vascular Access 
surgeons and interventional radiology, and the surgeons and interventional radiology are committed 
to our service. So we never have a problem convincing them of the importance of procedures and 
access and part of that, I think mostly, that is the personalities involved because they seem to enjoy 
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the renal service and patients enjoy their interaction with the surgeons and particularly with 
interventional radiology.” (Consultant Nephrologist) 
5 “I think the fact that we meet and we talk and, you know, I certainly feel that we’re a team. I think 
having access to a vascular laboratory is fab and even if we’re struggling to get needles in and we 
can’t see why, [sonographer] will take the nurse and the patient along and scan the patient with the 
nurse there.” (Vascular Access Nurse) 
“We seem to have been maintaining a large number of fistulas by repeat angioplasties or stents, and 
creating less.” (Consultant Surgeon) 
“It works very well having a specific [MDT] to only discuss Vascular Access cases, having a 
surveillance programme with interested sonographers running it.” (Consultant Radiologist) 
6 The major advantage for us is we have a really friendly approachable surgeon… this is a small 
hospital wherein the theatre space and the surgeons availability… even if there is no space, [surgeon] 
finds a space and people will go out of their way to help him because he helps them.” (Consultant 
Nephrologist) 
“We’re a happy family, we talk to each other, it’s I don’t think the rules… we don’t need quite so 
many rules because you know we’ve got more flexibility.” (Consultant Surgeon) 
7 “I think the main thing is you are quite comfortable with your colleagues of what, how they do 
things” (Consultant Surgeon) 
8 “The referral process in is fairly good. I think that the units outwith know how to contact in now 
because I think in the past it was all a bit up in the air about who they contacted, but certainly having 
a Vascular Access nurse on site they will either contact her directly or they will contact the nurse 
practitioners.” (Nurse Practitioner) 
“There are surgeons now who will keep going in theatre until they make something and that is very 
commendable… I think someone like [surgeon] should be viewed as an expert and we should be 
referring people in for you know end stage access transplant requests and Vascular Access requests 
because there probably is a role for people building up experience in these sorts of things.” 
(Consultant Nephrologist)  
9 “We’ve done a lot of work on SAB reduction; we’ve not had a … SAB in a temporary line for over 3 
years. And we’ve not had one in a tunnelled line for over 2 years.” (Vascular Access Nurse) 
Table 35 Self-reported strengths 
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Unit 1 
Significant benefit had been found by their surgeon's willingness to anticipate future 
difficulties when designing a VA strategy for a given patient. It was normal to explicitly 
document several potential surgical approaches to AVF creation, facilitating early relisting of 
the patient for a further attempt in the event that an AVF failed to mature. This was said to 
have prevented many delays.  
The surveillance programme and attempts to pre-emptively detect AVF problems was said to 
be highly effective. Similarly, they reported having an effective patient education programme 
about AVF care.  
Curiously, it was also suggested that a recent patient who had begun haemodialysis treatment 
with a functioning AVF in-situ was a 'success story'; it appeared unusual for this to occur.  
 
Unit 2 
There was a strong sense of team working, and individual clinicians worked semi-
autonomously without requiring colleagues’ approval to escalate clinical problems. 
It was clear that all clinicians felt responsible for patients’ VA, and the MDT format appeared 
collegial and functional. The success of the weekly meetings, routine use of detailed clinical 
records, and proactive approaches to VA problems, had substantially reduced unscheduled 
care episodes associated with VA. 
Clinicians felt that the workload was well balanced to enable operators to maintain their 
skills, without being overwhelmed such that other services were adversely impacted.  
 
Unit 3 
In Unit 3 good relations between nephrology and surgery were seen as the key to success, 
with nephrology mostly directing patient flow through the service, supported by surgeons 
with technical expertise and a willingness to fit VA cases around their other workload. They 
also saw significant benefit in having a nominated individual, equipped with the appropriate 
clinical knowledge, skills and authority, to coordinate the service. It was recognised that this 
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worked well with the current patient cohort size but could potentially fall down in the event 
that patient numbers were to substantially expand.  
A further strength was recognised in their usual approach of early and aggressive intervention 
whenever a clinical problem was detected with VA. This was seen to helps maintain the 
prevalent fistula numbers within the patient cohort, by avoiding access failure and prolonging 
secondary AVF patency.  
 
Unit 4 
Effective communication between team members was regarded as enabling the service to 
function optimally. The vascular lab was seen to act in a flexible manner that provided rapid 
access to imaging for patients, and prompt escalation of problems to IR. 
 
Unit 5 
Regular MDT meetings were said to enable scheduled AVF intervention planning. The 
meetings were held with sufficient frequency that additional cases rarely required discussion 
between meetings. The use of a dedicated VA MDT forum, with sufficient clinical autonomy 
to directly appoint patients into timed slots, both reduced the risk of VA being displaced by 
other issues and prevented VA from disrupting other clinical activities. 
The vascular lab was considered especially useful in providing practical help with needling 
AVF and for surveillance imaging. The degree of accuracy from the USS imaging was said to 
have effectively removed the need for diagnostic fistulography in IR. Their surveillance 
programme was considered highly effective in extending AVF secondary patency, in part 
because of the high quality, responsive sonography service. Radiologists also considered that 
having a regular, nephrology-led TCVC list, was a significant strength: it effectively focused 
IR VA time on AVF rather than TCVC.  
 
Unit 6 
The small, local feel of the hospital was said to enable collaborative working without the 
need for formal processes and meetings to facilitate this happening. Regular renal unit 
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business meetings, and relative autonomy from senior management over budget control, were 
said to enable the optimisation of resource use. This, combined with a flexible approach from 
all clinicians who contributed to the service was said to enable efficient patient care without 
the need for regular, formal MDT meetings.  
It was felt that having one, dual trained operator who could perform both surgical and 
interventional radiology procedures had eliminated any potential disputes as to who should 
manage a particular clinical problem. It was recognised however that with this strength came 
the limiting factor that this individual had to be present in the hospital for any VA 
interventional activity to occur.  
 
Unit 7 
The VAN team was said to be highly visible within the unit, with delegated authority to 
manage most aspects of VA, and with sufficient staffing to cope with staff planned and 
unplanned leave.  
MDT working was credited with facilitating good communication between clinical specialties 
and had fostered an environment where clinicians felt comfortable with one another’s 
judgement and decision making. 
 
Unit 8 
A key reported strength was the presence of significant expertise in the surgical team, which 
enabled management of complex patients. There was also said to be better access to 
‘emergency transplantation’, which was unlikely to be so forthcoming in other (non-
transplant) centres. 
RDU staff enjoyed considerable autonomy in their ability to directly refer VA problems to a 
clinic without requiring VAN to first review the patient. The single point of contact (VAN) 
was also considered a strength by RDU staff, albeit the VAN felt overwhelmed with the vast 
number of referrals and enquiries she received.  
The presence of a day area was also considered a strength; this provided a reservoir of beds 
that limited the impact of bed capacity problems on day case VA activity.  
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Unit 9 
Patient engagement was cited as the reason for substantial reductions in SAB episodes. There 
was otherwise a striking sense of underachievement among transcripts from this centre, with 
surprisingly little cited as a positive example of good practice. 
 
Self-reported weaknesses 
 
Many weaknesses were perceived by clinicians in every unit (table 36). 
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Unit Transcript data 
1 “I think that if everyone bought into the referral form and the Duplex scanning happened 
quite reasonably in terms of time and we actually had a bit more access to theatre, then the 
way the service is set up would run quite smoothly. It would work very well. But it doesn’t 
quite run as smoothly as we would like. Even if I stopped and thought about it and tried to get 
a handle on it.” (Consultant Surgeon) 
2 “We don’t have on-call intervention. We can’t have patients staying around in our 
department after 5 o’clock. And everyone knows that here, so they’ll just, they usually come 
back here and [VAN] will assist with transport. Sometimes it’s a taxi and… It can make it 
difficult for organising stuff. We don’t like to do a fistuloplasty as the last case for the 
afternoon unless they’re an inpatient just because of that reason.” (Consultant Radiologist) 
“We’d like an audit base, a database.”  (Consultant Surgeon) 
3 “The posts are there, we just can’t get anybody to apply, it is the same with all our registrars 
and trying to get staff to come up here is not easy” (Vascular Access Coordinator) 
“[VA coordinator] retires next year, so I think for our service you know… there are many 
things [she] does for the renal unit that I don’t even know I suspect! And when she goes there 
will be a whole load of stuff on everyone’s desk, for want of a better term, which hasn’t been 
recorded.” (Consultant Nephrologist) 
“I am worried when [VA coordinator] goes because she plays such a key role” (RDU nurse) 
“A lot of the challenge is in the out-of-hours work, in ensuring the cases are appropriately 
assessed and the correct decisions are made and people, you know bear in mind just the long 
term and not just the short term fix.” (Consultant Surgeon) 
“So it is also an issue for seccession planning when she retires next year, we will have to 
replace [VA coordinator] with about 3 specialist nurses I think.” (Consultant Surgeon) 
4 “I would have more robust team planning rather than individual clinicians maintaining their 
own lists. That is our intention. And that will rely on the new IT which we can’t deal with 
currently, not easily. We have tried with various Excel lists but they tend to duplicate and be 
overwritten.”  (Consultant Nephrologist) 
5 “[I would use additional resources for] dedicated theatre time, where our patients wouldn’t 
get bumped for complex vascular cases, so that our access could happen smoothly… and a 
vascular anaesthetist who would, you know, take on these crumbly patients that, you know, 
require block or GA. Maybe another Vascular Access nurse. I’m only me and I’ve got 185 
haemo patients and all the low clearance clinic patients that we’re dealing with as well.” 
(Vascular Access Nurse) 
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“Well, there’s one thing that we don’t have and that’s some sort of central intelligence on 
Vascular Access. We don’t have a Vascular Access manager so … renal manages its own bit. 
Vascular lab manages its own bit, we manage our own bit and radiology manages its own bit. 
Nobody actually has an overview” (Consultant Surgeon) 
“I’m towards the end of my career, need to get other people involved to take that over so 
there isn’t a dip when I do go, whenever I do. And I suppose the same applies to the vascular 
lab as well. I think that’s a big challenge.” (Consultant Radiologist) 
6 “Paradoxically, we are about to build a new hospital and the renal unit is not going to be in 
it!” (Consultant Surgeon) 
“I think it will be massively crippled when [surgeon] retires unless they get a proper 
replacement.” (Consultant Nephrologist) 
“We want [a] vascular interventional radiologist to be honest with you, wherein, if we had a 
difficult line or a difficult fistula, which needs immediate attention, so we can go to somebody 
to do it.” (Consultant Nephrologist) 
7 “And I also realise that as I have been talking I have been focusing on fistulae and the 
management of [them], and I think [what works much less well] is permcath placement.” 
(Consultant Nephrologist) 
“I prefer a written letter anyway. A sticker’s not appropriate at all. I mean that’s just 
ridiculous. And I think stopping me in the corridor, you know, I forget, you know I prefer 
something documented. We do sort of try and insist that all referrals come in properly you 
know, so we’ve got a trail back and you can look.” (Vascular Access Nurse) 
“I used to do a lot of fistulas in the [emergency] theatre, if it was empty I would just do it and 
then I got my knuckles wrapped saying I really shouldn’t be doing this because this is for kind 
of true emergencies.  So that doesn’t happen as much.” (Consultant Surgeon) 
8 “I come in and I’ve got 60, 70 emails after a weekend. And I’ve got a clinic on Monday 
morning. (laugher) I’m like that, okay, that all waits until I’ve been to clinic. I’ve got an 
MDT, I’ve got to action the MDT for 3 pm before I even start answering any emails.” 
(Vascular Access Nurse) 
“Yeah that’s the problem because see if I get somebody that comes in with ‘Oh their fistula’s 
clotted’.  ‘Oh that’s a medical problem’. And we’re like that, ‘well no it’s a surgical 
problem’. And you’re like that, it’s the patient’s problem – they’ve now got no access, could 
somebody do their access please!” (Vascular Access Nurse) 
“We’re all in a slightly difficult situation because when you go complaining to someone else 
that their service is not good or our service is not good, then there’s a tendency for that to be 
taken personally.”  (Consultant Nephrologist) 
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“I think smaller [satellite RDUs] have more time to give. I think the bigger units struggle 
because they’ve just got so many patients and their staffing levels are different… we certainly 
seem to see less referrals coming in from [smaller units] … I don’t think the surveillance is as 
good in [larger] units.  Patients often get here, and they look back and [they’ve had] months 
of high venous pressures and needling problems and low pump speeds and you think ‘well 
why were they not referred’?  It’s a kind of frustration that you think why have they got left to 
this point?” (Nurse Practitioner) 
9 “We have no dedicated radiology time whatsoever for our patients, which is a problem. I 
would say that is probably the weakest part of our service. They are great, don’t get me 
wrong. They would do emergency stuff and they are very helpful on the phone, we’ve got no 
problems with the radiologists themselves and it’s just that we have no time dedicated for 
when we need it. The more fistulas we have, you know yourself, the more problems there are 
going to be.” (Consultant Nephrologist) 
“My view, this has to be a surgical lead, a radiology lead and a nephrology lead. At the 
moment, the renal service is compartmentalised. Each compartment is sequestrating in their 
own compartment. Surgeons, fistula, do the fistula, nice operation, do it. But what are we 
trying to achieve? Where are we going ahead with it? Where are we among the rest? No. 
Physician, nephrologist, refer. See, anaesthetist yes, we do this, we don’t do that. It’s 
compartmentalised and that’s a problem.” (Associate Specialist Surgeon) 
“I think, to be honest, we are doing the bare basic for a fistula… I don’t think we are 
providing a service that I should be really proud of.” (Associate Specialist Surgeon) 
“We are slightly dislocated from the surgical side of the things unless there’s a hybrid 
procedure requiring to be done or the surgeons wish some ancillary investigation prior to 
creating a fistula. If we are speaking candidly I would say that we perhaps need to improve 
that…” (Consultant Radiologist) 
10 
(Paediatrics) 
“I don’t think [management] really knows how difficult it is dialyse a 4 month year old child 
or a 5 year old child, I don’t think they have any concept of, you know, as soon as the dialysis 
is finished we can move this nurse to them, that would be finished, are you sure can’t manage 
with less nurses?” (Nurse Practitioner) 
Table 36 Self-reported weaknesses
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Unit 1 
There was a notably nihilistic tone in the interview transcripts: the surgeon asserted that he 
was unable to change anything; the nephrologist felt that his unit was underperforming, and 
the radiologist stated he was unsure that his unit had any good practice to share with others. 
Passivity and lack of interest from colleagues were cited as particular problems, in addition to 
the significant waiting time for any investigations or theatre slots to become available, and 
the geographical separation of the renal unit from vascular surgery and IR.  
 
Unit 2 
A major difficulty in this unit was the coordination of logistics for patients who lived in rural 
areas and required an IR or surgical procedure. It was also noted that despite high AVF 
utilisation, there was very limited data available relating to clinical outcomes of VA creation 
and maintenance procedures in the centre. 
 
Unit 3 
The team was heavily dependent upon two individuals to fulfil most of the VA workload: the 
VA coordinator and one surgeon who performed the bulk of access surgery. There was 
concern about difficulties in succession planning, in a broader context of challenges 
recruiting staff at all levels across the wider medical and nursing workload. This was a 
particular concern as the VA coordinator had indicated they were planning to retire in the 
near future.  
Concern was also voiced about the limited capacity of the surgical service, as one surgeon 
performed the bulk of the work, but this was increasingly impractical given the required time 
to attend clinic, have MDT discussions and perform the operations, when there was little 
formally allocated time to do this. Out-of-hours the approach to VA problems was said to be 
very variable, based largely upon the degree of interest in VA held by whoever happened to 
be on-call when a patient presented to hospital.  
It was recognised across the service that most VA work was done outside of formal job plans 
and so there was difficulty in reconciling the time and skill requirements for any individuals 
being recruited to replace incumbents.  
Chapter 9: Service Development Needs 
264 
 
Unit 4 
Clinicians in this unit did not typically take a team approach to the VA service, and instead 
individual clinicians were said to refer, manage and navigate their own patients through the 
access creation and maintenance pathways. Service data recording was said to be unreliable 
and a robust IT solution was wanted to improve this. 
 
Unit 5 
Lack of protected clinical time was a concern, particularly when this meant that relatively 
urgent VA work could be displaced by non-urgent (but protected) clinical activity.  
The vascular lab was a key element of their service, but little succession planning had been 
done prior to the recent retiral of one of the sonographers. Similarly, one radiologist was 
anticipating retirement in the next few years, and it was proving difficult to plan for this. 
There was little strategic overview of the VA service. This role had historically fallen to 
VAN, but in reality her 0.8 WTE job was already overwhelmed by operational clinical work, 
and it had become normal for her to work an additional (unpaid) day per week to cope with 
the volume of work.  
 
Unit 6 
There was awareness that low patient numbers and relative lack of VA-related complications 
could reduce RDU nurses’ vigilance. It was felt that education was important to prevent this, 
but the available time to deliver this was limited.  
Since one individual surgeon performed both the surgical and IR service there were 
occasional delays in accessing either service, albeit this was not said to be a significant 
problem.  
A future challenge was anticipated in that a proposed new hospital development would lead 
to radiology and surgery moving to an offsite location; this was expected to hamper the 
strong sense of teamworking the unit currently enjoyed.  
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Unit 7 
The VAN team was key to the VA service in Unit 7 but had no interaction with inpatients; 
this was said to cause difficulties whenever an inpatient required a TCVC placed.  
There was said to be considerable variation between clinicians as to their VA referral 
practice, and many referrals were very informal and circumvented the published referral 
pathway. For example, it was not uncommon for VAN to be given an addressograph label in 
a brief corridor discussion, and for no additional details to be forwarded about the patient and 
their requirements.  
There was little theatre time allocated to VA surgery in the main centre, and surgeons 
reported being censured previously by management when they attempted to utilise 
emergency theatre space for this work.  
 
Unit 8 
A lack of resources was a key challenge in this unit. The individual VAN reported having a 
workload far in excess of what one person could reasonably be expected to contend with, 
with limited support for professional development and no real contact with the board 
management structure. Technical issues with the test ordering system also prevented VAN 
requesting some routine investigations that formed a key part of her role.  
The large size of the unit was also considered a barrier to some clinical activity. It was 
difficult for clinicians to attend MDT meetings due to the geography of the unit and its 
outlying satellites. Some were disinclined to attend due to a perception that much of the time 
would be spent discussing patients for whom they were not directly responsible.  
There was uncertainty relating to when patients should be referred for VA creation, 
particularly when the timescales varied significantly without any apparent clinical reason. It 
was unusual for follow-up plans to be documented at the point of AVF creation, so in the 
event of primary (or secondary) AVF failure it was difficult to expedite a further procedure.  
There was a reported tendency for RDU staff to ‘nurse problems along’ rather than escalating 
them when first identified. When problems were highlighted, staff reported it being normal to 
lose the AVF during the excessive waiting time before a maintenance or salvage procedure. 
There was a substantial mismatch between IR capacity and clinical demand, in part because 
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the regional renal unit relied upon an IR department that was only resourced for a local 
hospital’s needs, rather than to support a regional service.  
There was little team cohesion within the centre. Nephrologists report difficulty finding 
radiologists to speak with, while radiologists reported frustratingly little contact with 
nephrologists. VAN and nurse practitioners often feel usurped by doctors when requesting 
emergency IR procedures, and some radiologists were said to be unwilling to speak with 
nurses about clinical matters altogether. 
 
Unit 9 
A lack of designated surgery and IR resource was compounded by the geographical 
separation of these departments from the renal unit. This hampered attempts to hold MDT 
meetings, which were held irregularly if at all; consequently, the team lacked cohesion, with 
individual clinicians working largely independent of one another with no genuine lead 
surgeon, radiologist or nephrologist.  
The lack of IR time was said to delay inpatient discharges and led to increased NTCVC use 
in patients awaiting TCVC. Staff described having to ‘beg’ for IR space, and considered that 
procedures were done as personal favours, rather than as properly scheduled clinical 
activities. There was also said to be reluctance from a sonographer with expertise in AVF 
imaging to share this expertise with VAN or other RDU staff.  
The non-co-location of renal, surgical and IR services created challenges in identifying a bed 
and nominating a responsible clinician whenever a patient required to move outside the renal 
unit for a procedure to be performed. Surgery was commonly cancelled due to patient illness, 
and last-minute surgical spaces were hard to utilise as there was no easy way to identify the 
next patient waiting in the queue. There was said to be a relatively high procedure 
cancellation rate because of confusion around patients’ inpatient or outpatient status, 
particularly when ‘day surgery’ theatres were being utilised for inpatient VA procedures. 
The surgeon who runs the VA clinic does not personally perform the subsequent operations 
and plays no other part in the service.  
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Unit 10 (Paediatrics) 
The low clinical workload made it difficult to justify regular, programmed VA activity, but 
the potential value of formal pathways was recognised. Clinicians had very limited awareness 
of VA complications, especially those that emerged in the longer term such as central venous 
stenosis. There was little management insight into the complexity and logistical requirements 
of VA. 
 
Vein preservation 
 
An adequately sized artery and vein are required for the surgical fashioning of an AVF. 
Without these, the procedure is technically impossible. Veins can be damaged by repeated 
venepuncture, so limiting their potential use as an AVF. In this study it seemed very common 
for surgeons to have encountered patients whose veins had been rendered unusable by recent 
venepuncture. In some cases, it was suggested that alternatives had been available but not 
utilised for phlebotomy or intravenous cannulation. This was an almost universal source of 
frustration amongst VA clinicians. 
Many units reported issuing patients with ‘alert wristbands’ that identified the arm where an 
AVF was planned, maturing or in use. These were typically funded from charitable funds 
rather being directly provided by the NHS organisation. It was also uncertain whether anyone 
outside the renal services recognised these wristbands, or their significance.  
Most units reported ‘educating’ patients about vein preservation but there were no formal 
policies in relation to this. It was reported to be extremely common for veins that were 
potentially useable for AVF creation to be rendered inoperable by clinic venepuncture or 
intravenous cannulation. Patients requiring venepuncture outside the renal ward were said to 
be at the highest risk. (Table 37.) 
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Unit Transcript data 
1 “They get their wee red bangles now and stuff like that, so I mean we still get people fistulas about 2 weeks before they’ve had IV therapy put through the labelled 
vein” (Consultant Surgeon) 
2 “It is very, very difficult and we try to educate medical students, because the renal educator goes and does talks to medical students… Phlebotomists, we try to 
teach and we also try to educate GP practices as well, but obviously some people are quite set in their ways.” (Vascular Access Nurse) 
3 “[I] tell the patient [which arm to ‘protect’] and we put it in the computer system and when the junior doctors start here you tell them, try and use the veins at the 
back of the hand, unless if it is a cardiac arrest they can put a venflon in that [arm]” (Vascular Access Coordinator) 
“All patients have got a white board beside their bed with their fluid restriction and no needles in whichever arm” (Consultant Nephrologist) 
4 “We have had quite a few problems with cannulation of things, usually A & E, but other admissions: medical admissions, surgical admissions, they usually identify 
the patients that need to preserve veins and so it has not been too bad a problem…we have input to the doctors’ induction, so all grades, and that includes A & E, 
surgical and so we explain to them about dialysis patients and venous access so that they all get that and we haven’t had major problems with it.” (Consultant 
Nephrologist) 
5 “We educate the junior medical staff but no, not the phlebotomists really. I suppose we rely on the patients…I think the patients are generally clued up [about 
preserving veins]” (Consultant Nephrologist) 
6 “When I see somebody in the Vascular Lab I usually say we’re going to make a fistula on this side. If anybody wants to take blood we ask them to use the other 
side. So it’s usually addressed when I meet the patient” (Consultant Surgeon) 
7 “…that is purely because veins have been battered. They have that band thing, ‘fistula, do not use’, but still in the community it happens…two or three weeks ago I 
had a patient who had like…..you know….who’d come in for a [AVF] and they had just been recently, the day before, in the community they had blood taken from 
the vein” (Consultant Surgeon) 
8 “…in general terms really we don’t [discuss vein preservation] because you’re going to have to embark on the discussion about renal replacement therapy. Which 
is pretty time consuming and very upsetting for them.” (Consultant Nephrologist) 
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“The difficulty is, a lot of our patients are frail and have cognitive impairment and they’re not going to remember! ... The difficulty is they don’t get admitted to our 
unit, they get admitted to half a dozen other hospitals. I think it’s really hard.” (Consultant Nephrologist) 
9 “We do have the red rubber wrist bands… elderly people are not that keen about wearing them; I would say [60% of our patients] will wear them.  If they are on 
the ward for any reason they have the band on, or they have on their board above their bed ‘do not use’, we find a bit more of an issue if they are outliers” 
(Vascular Access Nurse) 
Table 37 Vein preservation
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Unit 1 
Red armbands are issued to patients to signify which arm to avoid for venepuncture. Despite 
this it is said to be common that patients attend for AVF creation surgery, whose veins have 
been needled in the recent past. There is no formal patient education programme, although 
efforts are made informally to tell patients about protecting specific vessels. This is most 
commonly done at the point of AVF creation or when a patient is established on 
haemodialysis, rather than in the earlier pre-dialysis and clinic stages.  
 
Unit 2 
There had been some problems with staff engagement in vessel preservation, which limited 
efforts aimed at staff education. Problems with primary care phlebotomy had been partly 
negated by the renal team supplying smaller butterfly needles for venesection, to reduce the 
risk of large needles being used in an antecubital fossa vein. 
 
Unit 3 
Renal inpatients have a whiteboard at the bedside which includes a description of which arm 
to avoid for venesection. Attempts are made to identify the most likely vessels for AVF 
creation at an early stage, and patients are taught to protect this arm from venesection. The 
proposed or existing AVF site is referred to as the patients’ ‘lifeline’. 
 
Unit 4 
There was a reliance upon staff education and patient empowerment to protect vessels. There 
was little formal thought as to which vessel was most likely to accommodate an AVF, and it 
was said to be common to find that a ‘preserved’ vein is inadequate at the point of requiring 
AVF creation. 
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Unit 5 
The key strategy for vein preservation was to inform the patients about which arm they 
should avoid having blood taken from. This was felt to be as successful as more extensive 
strategies would be. 
 
Unit 6 
Vein preservation efforts were focused around empowering patients to protect the specific 
vessels from venepuncture. It was common for patients who attended the renal service to be 
accommodated within the renal ward whenever they were inpatients for any reason; vein 
protection for VA purposes was an unintended benefit of this policy.  
 
Unit 7 
The VA team anticipate the need for AVF creation and use wrist bands to assist vein 
preservation. It was very common to encounter a patient with essentially unusable veins.  
 
Unit 8 
There was a reluctance among nephrologists to discuss vein preservation with patients early 
in the course of CKD. It was considered that holding this discussion “too early” might cause 
unnecessary distress and lead to difficult discussions about future needs for RRT, when this 
may not realistically occur for many years. 
There had been some effort to informally train ward and clinic phlebotomy staff about vein 
preservation. However, many patients were exposed to other settings where there was no 
oversight of vein preservation: non-renal clinics, inpatient admissions under other specialties, 
or attending for blood tests in primary care.  
 
Unit 9 
Wristbands are offered for vessel preservation, but it was reported that many patients 
declined to wear them.  
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Electronic Health Records 
 
EHRs are seen to have considerable potential to improve clinical quality in nephrology and 
other areas of practice277–279. Little has been written specifically about EHR use in the setting 
of VA. Across Scotland every renal unit reported using an EHR, but none was seen to utilise 
this to more effectively to manage the VA service. Various software programs were in use, 
and most were unable to effectively interface with software used by other specialties. All 
centres were seen to rely heavily upon email communication, with subsequent copying/ 
pasting of information into a clinical record. In practice, most ‘EHRs’ were really collections 
of static data points such as copied email chains, rather than live records that could practically 
be used to assist decision making or facilitate detailed clinical audit. There was variable IT 
support available within units to develop EHRs or to generally support the VA team. No unit 
consistently recorded the insertion of NTCVC, and it was highly unusual to consistently 
record other VA episodes of care, clinical outcomes or adverse events in an auditable, 
electronic database (table 38). 
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Unit Transcript data 
1 “I know of [EHR]s existence and my information gets put on it but not by me. So, I mean I think I was 
given a code, a password, a long time ago. But I just bring the information to [VAN] and she just 
plonks it on to her vascular operations. I don’t use it for any sort of audit.” (Consultant Surgeon) 
2 “Some of it is on an electronic record. A lot of it is on my computer, where I keep electronic records. 
But here isn’t a named database as such.” (Vascular Access Nurse) 
“We make up a list, you know, simple spreadsheets for the MDT. That information… there isn’t really 
a fool-proof system.” (Consultant Surgeon) 
3 “We have got a space now [on the EHR] and we have been doing that maybe for a year or two… it 
comes up at the top of the report, Vascular Access plan.” (Vascular Access Coordinator) 
“The trouble is [peripheral unit A] are on [national EHR linkage system] but I think we have now got 
that linked. We are trying to get [peripheral unit B] linked to our [national EHR linkage system] as 
well so that we can run the reports and pick up [peripheral unit B] patients and we haven’t managed 
that.” (Vascular Access Coordinator) 
4 “We have had [electronic] low clearance lists but around about 2008… it was abandoned as too 
chaotic and that never got replaced.” (Consultant Nephrologist) 
“We have never [consistently] recorded [clinical data] and so that’s because of the way other 
individuals use IT, so it’s actually quite difficult.” (Consultant Nephrologist) 
5 “I copy and paste the clinic letter into [EHR] and then when they’re going to theatre, I get that from 
the waiting list secretary so that goes into [EHR]… once we get the discharge letter from the surgeon 
that goes into the patient’s record on [EHR] as well” (Vascular Access Nurse) 
6 “I receive an email, the system is called [name] … as soon as there’s something in the [EHR] there’s 
an email in my account … it just shows me a list of people who have been referred to me.” 
(Consultant Surgeon) 
7 “We have got a database and we do keep a list of all the patients we’ve put on [waiting lists], but we 
are very much in the office, we have got like three massive big white boards and all the information’s 
on there. A bit of both really [paper and electronic record keeping]” (Vascular Access Nurse) 
“At the moment, not very much because [old EHR] hasn’t been developed in a very long time because 
as you know, we are moving over to [new EHR] [soon].” (Consultant Nephrologist) 
8 “The idea [is] that anybody, everybody puts the information in the same place… individual access 
episode specific, all the information and that no matter where you are in the service, even if you’re at 
home, you can read the latest information about the Vascular Access, whether it’s from the surgeon, 
[VAN], nephrologist, nurse, I think that’s a real strength … that’s involved a big culture change over 
several years.” (Consultant Nephrologist) 
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“We have got a paper and an electronic diary because paper is much easier to use than electronic 
diaries.” (Consultant Radiologist) 
“We have… an electronic kind of spreadsheet, but everybody that’s referred goes on to the front page 
which is just the referral and all the waiting list dates and as they’re appointed they move on to 
whatever date, and then [VAN] does her MDT list she just pulls through all the dates in the last week 
to look up the last and see who’s all been seen by radiology” (Nurse Practitioner) 
9 “We did have what was all in my head basically, but now we put it on to this waiting list on [EHR 
separate to main renal EHR]” (Vascular Access Nurse) 
Table 38 Electronic Health Record systems 
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Unit 1 
The EHR was viewed primarily as an audit tool, and the VA surgeon didn’t routinely use it. 
VAN kept records on the EHR but had to manually enter data into the EHR, rather than using 
the EHR to generate a referral. An electronic test requesting system was used for VA 
procedures; this was considered more robust than previously used paper referral forms. 
Unfortunately, the renal unit campus used a different system to the one used on the campus 
where IR and surgery were based, and no interface between the systems existed. This was 
said to cause confusion, and it was common for procedures to be mistakenly requested on the 
wrong system  
 
Unit 2 
An EHR was reported to be in use for the general care of renal patients, but not specifically 
for VA. A simple spreadsheet was used to track ‘active’ VA patients and to guide MDT 
discussions. VA issues weren’t formally documented in the main renal EHR, but there were 
plans to move onto an updated EHR in the near future.  
 
Unit 3 
The VA plan appears at the top of the electronic patient report. Access creation and 
significant events were recorded, but the process for doing so was relatively labour intensive 
and relied upon manual data input. There had been technical difficulty utilising the EHR for 
patients who lived in other health board areas, for whom they provided renal services.  
Telemedicine is used to support remote RDUs, for example photographs of AVFs could be 
send by email for review in the main unit.  
 
Unit 4 
Electronic patient tracking had previously been in use, but its widespread use had been 
abandoned a number of years ago. This was attributed to inconsistent recording of data by 
different clinicians within the unit, and the emergence of a chaotic database that was not 
practically useful.  
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Unit 5 
The EHR was a compendium of access-related activities and decisions. The data was almost 
all manually input by VAN, who copied/pasted clinical letters and other relevant data. This 
amounted to a large volume of work, and the resulting database was not practically usable for 
audit purposes or for strategic review of the unit activities. 
 
Unit 6 
New referrals to the VA surgeon were made electronically. These would generate an email 
alert to the surgeon, and the patient was usually allocated a specific theatre slot within a day 
of referral. This system helped facilitate rapid attention for emergency cases.  
 
Unit 7 
The team used a mostly paper-based tracking system, but also maintained an electronic 
patient database and inserted MDT outcomes as free-text comments within the main EHR. 
There was no centralised recording of NTCVC insertion.  
 
Unit 8 
The EHR has a VA section that is used to refer patients for VA creation; an accompanying 
letter, email, telephone call or other message to VAN prompts her to read the referral. The 
VA screens could be updated in real time but there was no software functionality to track 
‘active’ patients. A VA spreadsheet is used for this purpose, but this data seemed to be 
accessible only to VAN, and there were questions as to the accuracy of the data. The EHR 
was widely used by nephrology, VAN, RDUs, surgery and radiology, albeit mostly as a 
reference tool rather than for active scheduling of appointments. There were no clinical 
decision aids within the EHR, for example predictors of when a patient should be referred for 
incident VA creation.  
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Unit 9 
An electronic clinic management system was used to organise a VAN clinic. This did not 
interface with the main renal EHR and could not be used to carry clinical details or otherwise 
assist in patient prioritisation. No other use was made of the EHR for VA purposes. 
 
Barriers to effective working 
 
It was acknowledged across every unit that there were several barriers to providing an 
effective VA service for patients. There was variable insight into the challenges faced by 
each unit, but in general the units who appeared to have the most significant hurdles to 
overcome tended to have more insight into their difficulties than others. A nihilistic 
perspective was frequently encountered when discussing these barriers, and there was often a 
clear sense that ‘nothing can be done’. Phrases like “sadly this happens…” were used 
frequently to lead into this part of the discussion (table 39). 
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Unit Transcript data 
1 “If you were a surgeon taking on an operation then you should be looking after the patient at 
the time of surgery and after the operation. I struggle to do that because I’m not on site… 
having your vascular service and your interventional radiology service in different hospitals 
is not good planning… having a single handed surgeon providing the service is not good 
either.” (Consultant Surgeon) 
“I don’t think the nephrologists really had much interest in access. It was somebody else’s 
problem… they didn’t seem to take a really big interest in what happens, or liaise closely 
with the access nurse” (Consultant Surgeon) 
 “We do everything within a day, like you know the same day the Vascular Access Nurse gets 
details on the same day, the access form is done on the same day and we fill in the request on 
[IR system] the same day, but then it stops there until you hear from the interventional team 
so that depends on how free they are and how busy they are.”(Associate Specialist 
Nephrologist) 
“Me , [surgeon], all of the nephrologists are asked [to the MDT meeting], [specific 
nephrologist] is probably the best attender; the rest don’t bother.” (Vascular Access Nurse) 
“The logistics of getting people across from [campus A to campus B] is such that we can’t 
really meet that requirement. And there are a number of temporary lines going in, sadly, for 
that reason.” (Consultant Interventional Radiologist) 
“We have all the problems of a small centre really and I am not sure we have got any key 
excellent points. Unfortunately, I would only see the downsides of the geography and 
relatively small numbers of procedures and IRs offering intervention. I am not sure we have a 
lot to teach the rest of Scotland.” (Consultant Radiologist) 
2 “Probably the biggest challenge I suppose is the interventional radiology, whether you can 
fix that. It’s a sort of small hospital but I always get the impression that they are most 
pressurised within the whole system.” (Consultant Nephrologist) 
3 “There is one [surgeon] who it is very difficult to get him to do anything.  It is not his area of 
interest so he will do about two a year, but it causes problems if he is on when an emergency 
happens.  The chances are that [the fistula] won’t be retrieved. So it is trying to get 
consistency, so that the same thing happens when there is a problem every time isn’t easy” 
(Vascular Access Coordinator) 
“I think we are highly dependent on individuals in vascular surgery and radiology” 
(Consultant Nephrologist) 
“We have a huge problem with our interventional radiology service here in terms of capacity 
and recruitment and retention of radiologists” (Consultant Surgeon) 
Chapter 9: Service Development Needs 
279 
 
“The only grief I get [from surgical colleagues] is when I tell them that they need to sort their 
own ones out, so if they are on call and they have an access problem I say right you sort it 
out.  You sort out the definitive access don’t dump it back on me, that’s the only grief I get!” 
(Consultant Surgeon) 
4 “We’re still getting late presentation of patients even from other specialties who hold on to 
patients until they’re at the brink of dialysis and there’s maybe nothing we can do other than 
put plastic in them. And GPs also, some of them refer late which is frustrating” (Consultant 
Nephrologist) 
5 “Vascular access patients – if we have emergency vascular, urgent fistula, major arterial 
cases coming in, we don’t have dedicated Vascular Access theatre, so these patients will be 
knocked out of their theatre slots just as varicose vein patients are in order to make space… 
It’s more what’s coming in through the doors that can bump Vascular Access patients, 
sadly.” (Consultant Surgeon) 
“If you get an anaesthetist outside our usual 4 vascular anaesthetists, you can run into 
problems with inexperience for putting blocks or being uncomfortable with anaesthetising 
patients close to or in renal failure.” (Consultant Surgeon) 
“With the former PD surgeons we had a problem in that they were always leaking. We tried 
to set up a meeting with them and it’s really difficult.” (Consultant Nephrologist) 
“Having let maybe three members of staff hit retirement with nothing relating to succession 
planned for these individuals… you have to grow your own vascular lab technician, as we 
can’t find them (laughter) in the papers, we are a bit under pressure” (Consultant Surgeon) 
6 “Putting a graft in, I haven’t really been able to do that very a-traumatically. Let’s put it that 
way. People have often ended up with quite a lot of bruising… they’re used immediately in 
some places but, maybe we’ll get around to [that] some day” (Consultant Surgeon) 
“I have spoken to [administrator] and she promises she will email me, but I mean she has got 
loads of other things to do as well, and you can’t always rely on her, so yeah, I do a bit of 
chasing.” (Vascular Access Nurse) 
“Most of our community team or the support team are part-time. So that’s when the problem 
comes, wherein they are not been followed up and things are not getting done purely because 
nobody is there to do it” (Consultant Nephrologist) 
7 “A lot of academic consultants will, you know, will refer the patients about 2 years before 
they need a fistula” (Vascular Access Nurse) 
“[Interventional radiology] is a side of our service that runs less well. Definitely. Now that is 
because the pressure is on their system” (Consultant Nephrologist) 
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8 “The renal service is regional in [this centre], but the interventional radiology service is not, 
so that’s part of the issue where the capacity is at. I am very aware that there are units 
around [this area] who don’t provide fairly basic imaging support for fistulas…we are faced 
with fistulae coming in from other areas for venography… and those other centres are really 
capable centres, … so you know, a bit of re-distribution wouldn’t go amiss.” (Consultant 
Interventional Radiologist) 
“All of them have got interventional radiology that could probably do some of these things. 
They argue that they’ve got no back up vascular surgeon if something goes wrong.” 
(Vascular Access Nurse) 
“We are always displacing people and I am not judging one against the other, but I think, no 
I would be reticent to improve the service for one area, on patient group, if it would but 
impacted very adversely on another patient.” (Consultant Interventional Radiologist) 
“Honestly, it never stops. It never stops. Because it’s like: I tried to phone you and couldn’t 
get you so I’ve emailed you. You know?  I’ll come in, and I’ve cleared my emails, and when I 
go back there’ll probably be about 30 emails and I’m not kidding.” (Vascular Access Nurse) 
9 “When we drew up the plan to re-vamp the Vascular Access service, everything was in it, so 
there was [VAN]’s post, there was a fistula clinic planning clinic, the fistula surveillance 
programme. Everything that we thought we might need, including, we worked out how many 
sessions of theatre we would need based on the guidelines that we used at the time, and also 
there were guidelines for how much radiology time you would need, and there was a number 
of functioning fistula and patients on dialysis. And we would put that in and it made this, the 
budget, the business case so expensive that the managers just took that out. So we have no 
dedicated radiology time whatsoever for our patients, which is a problem. I would say that is 
probably the weakest part of our service. They are great, don’t get me wrong. They would do 
emergency stuff and they are very helpful on the phone, we’ve got no problems with the 
radiologists themselves and it’s just that we have no time dedicated for when we need it. The 
more fistulas we have, you know you yourself, the more problems there are going to be.” 
(Consultant Nephrologist) 
“If we had a system in place to stop the guys getting on the treadmill, we wouldn’t have to try 
and catch them as they’re falling off. So if we get this part sorted out, we will able to save in 
that part, but we can’t do that, because we can’t do that. We’ve got to invest to look after 
these patients.” (Consultant Radiologist) 
“It would be defining what, in terms of resources, to find out what we need to support a good 
quality service and I think there’s a gap between what we need to support the service. 
Because we’ve got a gap, we’ve come up with all these compromises and fill-ins etc.” 
(Consultant Radiologist) 
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“No, I think the last time [any radiologists and nephrologists in this unit] met [in person] 
was at a meeting [organised by a third party]” (Consultant Radiologist) 
10 
(Paediatrics) 
“My last emergency cases, you are phoning around various different people coordinating, if 
you can’t get hold of someone or you’re leaving voicemails, messages, then you have to wait 
for them to get back. You can’t plan until you have everybody in place. So it certainly could 
be smoother but that’s the way it is.” (Consultant Nephrologist) 
I think as long as the service is progressing and moving on and there’s not too many issues, 
people don’t look too far beyond and that’s where I feel that we could do with some more 
audit too” (Nurse Practitioner)  
Table 39 Barriers to effective working 
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Unit 1 
Several problems were reported in this unit. Fundamentally there was a lack of clinical time 
allocated to the service and no designated procedure slots for VA, compounded by multi-site 
working and a perceived lack of buy-in from the wider nephrology team. 
The VA team consisted almost exclusively of individuals who had no formal job planned 
time to participate in the service. There was no named radiologist to liaise with the VA team, 
and any contact between VAN or surgeon with radiology was reserved for ‘special’ cases. 
The radiologist interviewed for the study was unable to name any nephrologists and could not 
recall having ever met a nephrologist in person. One surgeon performed all VA procedures 
with no provision for backfilling his time in the event of absence. One staff grade 
nephrologist attempted to contribute to the team but had no time or administrative support to 
fulfil this role.  
It was perceived that nephrologists were disinterested in VA, while the broader surgical, 
radiology and sonography teams perhaps failed to appreciate the complexity of the VA 
service beyond the technical aspects of the relevant clinical procedures.  
There were no scheduled MDT meetings besides informal discussions between the surgeon 
and VAN in the RDU. These were fitted around the surgeon’s other commitments and in 
practice it was not possible for patients attached to some haemodialysis shifts to see the 
surgeon during their scheduled haemodialysis sessions. 
The non-co-location of nephrology, surgery and radiology on one campus caused substantial 
inconvenience to patients and the service. Specific challenges include the logistics of moving 
patients between sites, ambiguity as to who was clinically responsible for the patient at 
different stages of the VA journey, and managing clinical uncertainties when patients with 
complex renal illness require to stay as inpatients on the other campus (with no on-site 
nephrology cover), and ambiguity as to who is clinically responsible for the patient at any 
given stage of their VA journey. Most surgical intervention was scheduled offsite as bed 
pressures prevented patients from having their operation and being accommodated in the 
renal unit. The lack of onsite surgery or IR meant it was not possible to aggressively manage 
patients who presented with an acute VA problem such as AVF thrombosis. The difficulty 
accessing IR was said to result in high NTCVC use. 
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VAN appeared overwhelmed with the workload involved in organising the logistics of patient 
transfers to the IR site, coupled with the need to book beds, issue instructions for patient care 
(e.g. regarding the administration of peri-procedure antibiotics), and attending to the vast 
array of enquiries about these patients’ care. VAN was also unable to order some VA-related 
tests and needed a nephrologist to countersign requests, which added to delays in pushing 
patients through the system. There were two parallel interventional radiology requesting 
systems in use (one on each campus) and it was said to be common for miscommunication to 
result in tests being requested on the wrong system and therefore being missed.  
Referrals for new VA creation were said to be haphazard. Clinicians varied in their thresholds 
for referring patients, and variably bought into using the referral documentation. It was 
typical for referral to be deferred until a crisis point was reached, with little 
acknowledgement of the timelines involved in new AVF creation. Much of this delay was 
outside the control of the VA team, but was not routinely measured or published internally.  
Patients were not actively discouraged from TCVC use, and staff felt that using TCVC early 
in a patient’s experience of RRT might reduce their enthusiasm for transiting onto an AVF.  
It had become normal for patients to wait over three months for ‘urgent’ VA procedures, 
sometimes remaining an inpatient for large proportions of this time. New patients had almost 
no hope of having an AVF in place they required haemodialysis, and when this did happen it 
was lauded as a major achievement rather than being considered normal practice. 
 
Unit 2 
The major barrier to optimal working was said to be a lack of designated IR resources for 
VA. There was a highly enthusiastic radiologist in post in the unit, but most of the VA related 
activity was seen to be discretionary. There was some concern that if IR ceased to continue 
providing their current, intensive, level of service, this would have serious consequences for 
patients and would impact greatly on surgical and nephrology services.  
 
Unit 3 
The main active challenges related to capacity in the radiology department, which was a 
particular challenge due to difficulties in recruiting and retaining consultant radiologists. It 
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was acknowledged that while the service functioned well, there was a dependence upon one 
or two key individuals in each unit. Out-of-hours it was difficult to ensure consistency of 
approach to managing access problems, and there was at times a tendency for any VA 
problems to be referred back to one or two clinicians who were not resourced to provide the 
whole unit’s VA service. 
 
Unit 4 
Late referral into the renal service was said to be a major problem, frustrating efforts to create 
timely VA. There was limited data to support this assertion, and it seemed that a lack of audit 
data to support practice was perhaps a more important barrier. This was partly because of 
reluctance among the wider renal team to effectively utilise the EHR system, hence limiting 
the ability to collect meaningful data. 
 
Unit 5 
A major reported challenge here was in succession planning, as several established members 
of the VA team were planning to retire in the coming year or so.  
There was also some difficulty in maintaining ‘urgent’ status for VA work, and other clinical 
problems frequently usurped VA cases for non-clinical reasons. Occasionally there were also 
difficulties encountered when anaesthetic staff who were unfamiliar with VA work were 
asked to help in a theatre case: non-vascular anaesthetists tended to be less comfortable with 
renal patients’ comorbidity, so were more likely to cancel the surgery. 
Historical difficulties with PD catheters had proven particularly difficult to address; the high 
frequency of PD fluid leaks had been thought partly a function of operator technical skill. In 
the absence of robust local (or national) audit data it had been impossible to raise this issue 
with the surgeon concerned.  
 
Unit 6 
The major challenge in this unit related to AVG. Their insertion was considered a significant 
technical challenge by surgeons, and there was considerable uncertainty as to how they 
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should be monitored thereafter. RDU also struggled to needle grafts, which was said to reflect 
a general need to improve skills with AVF cannulation. Educational opportunities were 
relatively lacking in view of their geographical situation and low patient numbers.  
A large part of VAN’s role involved chasing administrative staff to push patients through 
clinical pathways; there seemed to be sufficient work for a part time VA administrator role 
alongside that of VAN. 
The VA team collaborated informally with one another; while this worked well in the 
existing setup, the lack of formality and designated clinical resource was a risk that staff 
changes, or other external events, could impact upon the service.  
 
Unit 7 
The major challenge reported here was the variable timing of referrals into the service for VA 
creation. While some clinicians tended to refer patients very early, others would refer 
significantly later in the illness trajectory. There was little appreciation within the nephrology 
group as to the likely timescale of creating a functioning AVF. There was concern that 
patients referred too early in the course of their CKD may occupy slots that would be better 
used for more urgent cases. They may have an AVF created and require considerable ongoing 
maintenance work prior to its eventual use, or it may ultimately not be required. 
There were several technical barriers, for example VAN was unable to directly request 
several imaging tests and procedures; these had to be countersigned by a nephrologist. In 
addition, there was a reliance upon administrative staff who were not part of the VA team, 
who controlled access to theatre slots. This was a particular issue when urgent AVF creation 
was required. 
There were no designated IR slots for VA, which could cause delays. TCVC insertion was 
not considered ‘urgent’ hence an inpatient with NTCVC may wait a considerable time before 
this can be converted to a TCVC. The designated VA surgery slots tended to be offsite, but 
patients were often unwilling to travel there for their procedure. 
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Unit 8 
There were several major challenges in Unit 8, principally focused on the IR service, AVF 
surveillance and VAN workload. 
There was a significant lack of IR slots for VA, and limited buy-in from senior radiologists to 
enable service development. This was partly because of a mismatch between the IR 
department funding (for the needs of one local hospital) versus the regional catchment of the 
renal unit, which generated a disproportionate volume of IR work. This generated 
considerable discontent and was possibly perceived by some team members as disinterest in 
patients, rather than inability to accommodate the large volume of requests.  
It appeared that no one in the centre had an idea of the likely timeline for a given procedure, 
which could sometimes be done within hours of the request and other times would require 
several months wait. Many clinicians reported having a sense of radiology ‘doing them a 
favour’ whenever a VA case was performed.  
It was reported to be common for semi-elective IR referrals to evolve into clinical crises. 
Urgent procedures that required out-of-hours radiology would only be considered once the 
out-of-hours period began, which caused further uncertainty and delay. A consequence of the 
inability to maintain AVF was a large patient cohort with longstanding TCVC use resulting in 
central venous stenosis, which brought a further large workload to the IR department.  
Significant chunks of IR resource were utilised performing routine ultrasound vein map 
scans, as there were no sonographers available to do this work. It was said to be common for 
this imaging list to be cancelled at short notice if the radiologist was required elsewhere. The 
vascular lab was a separate entity from radiology, with no capacity to record images on a 
central database, and with no direct interface with IR in the event of a problem being 
encountered. Radiologists also had a high TCVC-related workload: the nurse-led service’s 
exclusion criteria effectively excluded most potential (renal) patients, and when the nurse-led 
service was operating a radiologist was required to be in close proximity, further limiting 
their capacity for other clinical tasks.  
IR feel disengaged from the renal and VA teams and feel a duty to consider all renal and non-
renal patients equitably. 
VAN and RDU staff encountered significant difficulty in maintaining surveillance or 
education programmes in view of the high patient numbers, large numbers of satellite units 
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spread across a wide geographical area, and high staff turnover. Staff were often reluctant to 
discuss VA with patients, particularly since they had little confidence that a candid discussion 
of AVF benefits would then be supported by the service being able to create an AVF for that 
patient. Many RDU staff were also underconfident cannulating AVF.  
It had become common for clinicians to circumvent the usual VA clinical pathways for 
patients with urgent clinical problems, in part because the routine pathway was not 
considered credible by the wider clinical team. The difficulty accessing IR encouraged ‘just 
in case’ referrals instead of waiting until it was clear a patient needed a particular procedure.  
There were various governance problems within the unit. Nephrologists worked on a ‘team’ 
rather than ‘named patient’ basis, and colleagues often struggled to identify the nephrologist 
responsible for a given patient. It was said to be difficult to obtain senior surgical opinion 
during the working day, and decision making tended to be deferred until ward rounds in the 
late afternoon when there was then little prospect of actioning any decisions that day. 
VA was not afforded ‘urgent’ priority status. It was regularly displaced by transplant and 
other vascular emergencies, as there are no designated VA slots and these procedures were 
performed by the same group of surgeons. 
The workload for the solitary VAN in the centre was far in excess of what could realistically 
be achieved. The flow of incoming enquiries seemed overwhelming, and the lack of 
dedicated surgical or IR resource limited her options for addressing any identified problems. 
In common with other centres, it was reportedly common for referrals to contain inadequate 
clinical information, while technical issues prevented VAN requesting radiology tests or 
procedures which were fundamental to her role. There was also very limited training or 
clinical support available for VAN, which frustrated efforts to develop the service. 
 
Unit 9 
A key challenge in this centre was the lack of designated clinical time for VA work. It was 
reported that a business case had previously been submitted to senior management in an 
effort to secure dedicated IR resources, but for cost reasons this has been declined. All IR on 
the renal unit site was said to be performed during the radiologist’s professional development 
time, hence it was unreliable and not backfilled in the event of absence. Offsite IR was more 
reliably operational, but logistical difficulties made this extremely difficult to access. 
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Sonography availability was also variable, and there were reported personality clashes that 
impeded development of this service in the RDU.  
Surgical time was similarly under-resourced. Besides a fortnightly theatre list, the surgeon 
had no other clinical time to attend to VA problems, and was not otherwise based on the renal 
unit site. He would see urgent referrals effectively in his own time at the end of the working 
day. There was interest in increasing the use of AVG as a strategy to reduce TCVC use, but 
the lack of infrastructure to maintain grafts had frustrated this. 
There was very little formal nephrology involvement in the VA service, which predominantly 
relied upon VAN. The lack of regular MDT meetings, and the situation of IR and surgery on 
another campus meant that the VA team almost never met with one another. There was no 
insight into the volume of pending clinical activity or the current waiting times for 
procedures.  
Clinical pathways seemed inadequately designed. The VA team was not made aware of a 
patient until they had chosen haemodialysis as an RRT modality; this decision was often 
made late, without due regard for what was technically possible for that patient, and without 
awareness of the timelines involved. The VA clinic was run by a surgeon who did not 
actually perform any access surgery; it was common for the surgical assessment to effectively 
be repeated by the operating surgeon on the eventual day of surgery. It was also very 
common for patients to be referred for anaesthetic pre-assessment, which typically resulted in 
their planned surgery being cancelled, even when general anaesthesia was not being 
contemplated. 
 
Unit 10 (Paediatrics) 
It was apparent that the logistical difficulties involved in arranging a VA procedure were very 
time consuming; this was ultimately seen as a barrier to doing things unless absolutely 
necessary. Little effort was made to audit clinical activities and there was very limited 
awareness of patient outcomes, particularly later outcomes that became apparent once the 
patient had transited from paediatric into adult care. 
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This study sought to explore the structure, function and workload of Scottish VA services, in 
the context of widespread variation in AVF use between centres (see chapter 1). Principles of 
sociotechnical systems theory and healthcare resilience engineering were used to design a 
mixed-methods model that was then used to explore the structure, function and workload of 
VA services across Scotland, and comparison of ‘work-as-imagined’ and ‘work-as-done’ 
from the perspectives of all key VA stakeholders in Scotland (see chapter 2). The findings 
collectively enable the generation of recommendations for practice: practical steps units 
could take to improve their VA service, with an overarching aim of improving AVF use.  
This chapter reports the results associated with the final two research aims of this study: to 
illuminate gaps between ‘work-as-imagined’ and ‘work-as-done’, and to present 
recommendations for practice in a manner that facilitates ongoing QI. These results are 
presented in two main sections: recommendations for practice, which reflect the identified 
gaps arising from the data; and VA scorecards, the means of presenting the recommendations 
and stimulating QI. The subsequent chapters discuss the study and suggest avenues for 
further study.  
 
Recommendations 
 
The recommendations were generated from the study findings, which arose from detailed 
thematic analysis of interview transcripts (chapters 3-6, 8-9), consideration of field notes, and 
analysis of the six-week clinical activity census data (chapter 7). These findings were 
contextualised in the sociotechnical systems and healthcare resilience engineering literatures, 
and a Safety II perspective focusing on ‘why things go well’ rather than ‘why things go 
wrong’ was adopted. 
In writing the recommendations a balance had to be struck between providing a sufficiently 
detailed statement of recommendation, with the need for this to be practically useful to the 
VA community. Similarly, there was a need to accommodate a mixture of large and small, 
rural and city-based units, accepting that a ‘one size fits all’ approach was unlikely to be 
helpful. The language used was judged accessible to clinicians and managers alike, while 
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each recommendation was written in a way that its implementation could be gauged 
objectively using the scorecard tool (see below).  
The recommendations, and their rationale, are presented in table 40. 
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 Recommendation Explanation 
1 ‘Haemodialysis with 
TCVC’, ‘haemodialysis 
with AVF’, ‘haemodialysis 
with AVG’ should be 
considered as three 
discrete RRT modalities 
with varying associated 
burdens of morbidity, 
mortality and financial 
cost.  
The data suggested clinicians considered different VA 
modalities as merely technical considerations of how 
haemodialysis was delivered. The literature suggests 
significant divergence in the morbidity, mortality and 
financial costs profile of each modality. This 
recommendation seeks to reframe VA modality selection 
and enable patients to make better informed choices about 
RRT. (See chapters 3 and 4.) 
2 Variation in TCVC use 
should be used to study 
variation in VA between 
centres.  
The data suggested clinicians were interested in increasing 
usage of PD and transplantation. Current guidelines 
recommend ‘maximising AVF use’ as an audit standard for 
VA services; this perhaps fails to recognise the potential 
benefits for patients of other RRT strategies. This 
recommendation suggests ‘minimising TCVC use’ – 
encompassing greater use of PD, transplantation, AVF and 
AVG – would provide a much clearer picture of quality in 
VA services, and potentially stimulate greater use of other 
RRT modalities. (See chapter 4.) 
3 Efforts should be made to 
understand and measure 
patients’ experience of 
Vascular Access services.  
Chapters 3 and 5, and appendices 4-6, suggest markedly 
variable clinical pathways, uncertain waiting times, and a 
frustrating clinical course for many patients. Chapter 7 
suggests patients are also subjected to large numbers of 
tests and procedures. This recommendation seeks to 
encourage units to consider their patients’ experience of 
the VA service, in keeping with Scottish Government 
strategy103. 
4 Clinical time should be 
allocated to delivering 
patient education about 
Vascular Access 
modalities, and vein 
preservation strategies, to 
The data suggested some patients are unable to have AVF 
created due to overzealous venepuncture (see chapter 9). 
This recommendation seeks to acknowledge and address 
this challenge, being mindful that this issue is not 
necessarily within the gift of the local VA service to fix. 
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all patients for whom 
haemodialysis is being 
contemplated.   
5 Patient education about 
Vascular Access should 
continue throughout their 
time on haemodialysis 
treatment. Patients should 
be encouraged to self-
report potential access 
problems. 
The data suggested patient education was delivered as a 
once-off session prior to commencing haemodialysis, and 
variable surveillance activity (chapters 3, 6). This 
recommendation seeks to empower patients regarding their 
Vascular Access in the hope this will facilitate smoother 
entry and processing through VA maintenance pathways. 
6 A ‘personal access 
strategy’ should be 
documented by 
nephrologists for each 
patient who may plausibly 
require haemodialysis 
treatment. This should be 
done with mindfulness of 
local timelines for access 
creation, which should be 
published regularly. 
The data suggested variable clinician opinion about using 
AVF, late referral for AVF creation, shared clinical 
responsibility for patients, and uncertain internal timelines 
for VA creation (chapters 3, 4, 8). This recommendation 
encourages nephrologists to anticipate the need for 
Vascular Access, to document a clear plan about this, and 
to initiate referral into the local VA creation pathway with 
sufficient time for there to be a realistic chance of 
commencing haemodialysis using an AVF. 
7 A written clinical pathway 
for Vascular Access 
creation and maintenance 
should exist in each renal 
unit. This should include 
clear processes for referral 
into the pathways for both 
new access creation, and 
when problems are 
identified with existing 
access. 
The data suggested poorly defined clinical pathways, and 
poor clinician awareness of local pathways (chapters 3, 5, 
8). This recommendation arises from these findings, and is 
in keeping with the Safety II emphasis on “why things 
usually go well” to design and document a clear, 
unambiguous pathway. 
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8 Electronic health records 
should be routinely used to 
streamline and track 
patient flow through 
Vascular Access pathways. 
The data suggested all units had access to EHRs but did 
not routinely use them for VA purposes (chapter 9). This 
recommendation arises from this and mindfulness of the 
sociotechnical systems literature around ‘information flow’ 
(see chapter 1B). 
9 A suitably trained 
sonographer, with 
adequate clinical time and 
resources, should be 
available to all Vascular 
Access services. 
The data suggested a clear lack of clinical imaging 
facilities for Vascular Access creation and maintenance 
purposes (chapters 3, 5). This recommendation aims to 
reduce the reported reliance upon consultant radiologists to 
perform such imaging, which was said to reduce their 
available clinical time for other VA activities. 
10 Patients with a clear option 
for AVF creation should 
be listed directly for their 
operation without 
requiring additional clinic 
attendances. If there is 
uncertainty about the best 
AVF creation approach, 
patients should have 
access to a one-stop clinic 
for access planning. 
Appropriate clinical 
review, imaging and a 
decision for theatre should 
be available at a single 
appointment.  
The data suggested decisions about AVF creation were 
regularly delayed or thwarted by patients having to attend 
multiple outpatient appointments. There were also 
difficulties in tracking patients’ progress through the 
pathways, and it was said to be common for patients to be 
lost in the process. Units in which patients could be 
directly listed for surgery by VAN or equivalent, or who 
operated a one-stop clinic for this purpose, tended to report 
higher AVF use. (See chapters 3 and 8.) This 
recommendation aims to share these areas of good practice 
from the study findings. 
 
11 AVG should be available 
to any patient with a 
clinical requirement for 
one. This may require 
regional or national 
collaboration to provide a 
tertiary specialist service. 
The data suggested AVG were only practically available in 
centres where there was an interested and technically 
skilled surgeon, supported by responsive interventional 
radiology services to maintain graft patency. Patients who 
did not have access to AVG would otherwise dialyse using 
TCVC. (Chapters 3 and 4.) This recommendation seeks to 
reverse this finding and is in keeping with clinical 
guidelines3,89.  
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12 Designated vascular 
surgery and interventional 
radiology slots should be 
available for Vascular 
Access procedures. These 
should be available to 
book on both a routine and 
emergency basis. 
Clinical activity data suggested a substantial workload 
associated with VA services, while interviewees almost 
universally complained of inadequate slot provision for 
surgical or IR VA procedures. Access to the available slots 
was limited by difficulties booking elective or emergency 
cases with sufficient notice. (See chapters 3, 5, 7, 8). This 
recommendation seeks to resolve this problem.  
13 Vascular access 
procedures should be 
afforded ‘urgent’ or 
‘emergency’ status. They 
should not be subject to 
displacement by other 
cases for non-clinical 
reasons 
 
The data suggested VA cases were usually given 
‘routine’ status and were often subject to displacement 
for non-clinical reasons. This was said to commonly 
mean VA cases were not managed within clinically 
acceptable timeframes. (Chapters 3, 8). This 
recommendation seeks to resolve this problem.  
14 A plan for further 
intervention should be 
documented at the time of 
any access creation or 
maintenance procedure. 
This should guide further 
action in the event that the 
procedure proves to be 
unsuccessful.  
The data suggested many VA procedures were 
unsuccessful, but patients had to then join a waiting list for 
a clinic visit before further procedures could be scheduled. 
One unit routinely documented the next steps to take with 
each access procedure, expediting listing for a follow-up 
procedure if the first attempt failed. (Chapter 3.) This 
recommendation seeks to share this good practice and 
resonates with Chern’s model in relation to ‘information 
flow’ (see table 4). 
15 All patients should be 
assessed by a suitably 
trained clinician between 
2-4 weeks following an 
access creation or 
maintenance procedure. 
This review should be 
supported by provision of 
designated procedure slots 
Variation in postoperative review practice was described 
between centres. All sought to review patients within 4 
weeks of AVF creation, but in one centre this review was 
performed six times within a two-week time window. 
Steps to remedy identified problems were said to be 
practically difficult in view of the lack of available urgent 
surgery or IR slots. (Chapters 3, 5, 6.) This 
recommendation seeks to address these challenges by 
focusing clinical resources upon a single postoperative 
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for further work that is 
found to be needed. 
review followed by direct access to a procedural slot for 
any required maintenance procedure. 
16 Vascular Access 
Coordinators should be 
empowered to directly 
request tests and allocate 
slots to named patients for 
Vascular Access 
procedures, in keeping 
with the clinical 
confidence of other team 
members. 
Interviewees suggested that key VAN roles were to request 
VA tests and prioritise procedures for patients. It was said 
however that they often lacked authority to book tests 
without a doctor’s countersignature, and often had to defer 
to a third-party administrator to procedure slots to patients. 
This recommendation takes account of these findings in 
light of Chern’s model, in relation to ‘power and authority’ 
(see table 4). 
17 Units should maintain 
‘priority lists’ that 
identify the next 
patient to have a 
procedure performed, 
should additional 
capacity become 
available. This should 
be accessible by all 
relevant members of 
the team.  
The data suggested chaotic patient flow tracking and 
reliance upon memory, or databases that were inaccessible 
to key team members. It was said that ‘spare’ procedure 
slots were often ‘wasted’ as staff had difficulty identifying 
the next patient on the waiting list. (Chapters 3, 8, 9.) This 
recommendation seeks to resolve these challenges. 
18 Patients should have 
access to vascular surgery 
and interventional 
radiology services that are 
co-located with the renal 
unit. 
The data suggested non-co-location of renal, surgical and 
IR services often impeded patient care (chapters 3, 5, 8, 9). 
This recommendation is made to resolve this problem, 
mindful that its implementation is likely to be challenging 
within the wider hospital context.  
19 A vascular-access specific 
morbidity and mortality 
meeting should be held on 
a regular basis, with 
The data suggested an almost complete absence of clinical 
audit, discussion and publication of VA outcomes, 
morbidity and mortality. There was also sporadic 
awareness within centres of other barriers to effective 
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involvement from all 
members of the team. 
Meetings should discuss 
procedure outcomes and 
cancellations; 
administrative delays; 
deviation from normal 
clinical pathways; 
emergency Vascular 
Access provision in 
patients with established 
kidney failure; access 
patency; unanticipated 
failure of existing access; 
complications including 
central venous stenosis, 
steal syndromes and 
infections. 
clinical care (such as deviation from the usual clinical 
pathway, administrative delays and so on). (Chapters 3, 5, 
8, 9.) 
This recommendation seeks to provide scrutiny of VA 
clinical outcomes. It is also hoped that a morbidity and 
mortality meeting would provide a helpful forum to discuss 
other relevant service issues such as administrative delays, 
or where colleagues appeared to be deviating from the 
usual clinical pathway.  
20 A Vascular Access-
specific multidisciplinary 
team meeting should be 
convened on a regular 
basis, with a frequency and 
duration reflecting the 
patient cohort size. All 
clinicians with 
responsibility for patients 
receiving haemodialysis 
should have clinical time 
to contribute to this 
meeting. At least one 
nephrologist, surgeon, 
interventional radiologist 
and VAN should attend, 
and administrative support 
The data suggested that multidisciplinary teamworking was 
necessary for effective VA care. Reported barriers to this 
process included the inadequate provision of clinical time, 
no administrative support and poor attendance from 
colleagues. (Chapter 5.) This recommendation seeks to 
equip units with the reported prerequisites for effective 
multidisciplinary working. 
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should be provided for 
each session. 
21 The Vascular Access 
service should be 
adequately resourced with 
job planned time. This 
should include backfilling 
in the event of long-term 
absence. 
The data suggested almost no VA clinical work was 
performed during formal job planned time, rendering 
services vulnerable to staff absences. (Chapter 8). This 
recommendation seeks to remedy this issue. 
22 A meeting to discuss 
strategic aspects Vascular 
Access services should be 
held on a regular basis. 
This should be kept 
separate from clinical 
discussions about 
individual cases.  
 
There was a striking lack of strategic overview of VA 
services, with no formal managerial involvement and little 
clinical time for strategic (rather than clinical) discussions. 
This issue was conspicuous in its absence from interview 
transcripts. This recommendation seeks to provide VA 
clinicians with the opportunity to consider their service 
performance in a separate forum from clinical discussions. 
23 RDU nurses should be 
formally trained to assess 
and use AVF and AVG, to 
record their findings at 
each haemodialysis 
session, and to identify 
potential access problems. 
Patients with challenging 
Vascular Access should be 
identified and cared for in 
an appropriately staffed 
area of RDU.  
The data suggested a lack of training for RDU staff in the 
assessment and routine use of VA. Interviewees said it was 
common for clinical problems to be unrecognised and 
opportunities for corrective action missed. (Chapter 5.) 
This recommendation seeks to share good practice and 
encourage formal training programmes for staff.  
24 Units should develop 
educational programmes 
that provide secondments 
for RDU nurses to work 
with VAN, to enhance 
The data provided several examples of successful RDU 
engagement in Vascular Access care through the provision 
of a secondment programme. (Chapter 9.) This 
recommendation seeks to share good practice.  
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Vascular Access 
knowledge and skills. 
25 Units should maintain an 
‘access intervention 
history’ as part of the 
haemodialysis patient 
record. This should be 
used to inform decisions 
about problematic access.  
The data suggested clinicians in the wider VA and RDU 
teams lacked awareness of patients’ previous access 
problems. One unit had a highly successful strategy for 
record keeping, which was seen to reduce futile 
interventions and reduce unanticipated failure of existing 
access. (Chapter 5.) This recommendation seeks to share 
good practice. 
26 Vascular access at risk of 
failure should be afforded 
‘clinical emergency’ status 
and managed as such. 
 
The data suggested poor recognition of impending 
Vascular Access failure as a clinical emergency. This was 
said to reduce the likelihood of expediently dealing with 
problems while there was a realistic prospect of salvaging 
the AVF. (Chapter 5, 6, 8.) This recommendation seeks to 
address this problem. 
27 There should be a clearly 
articulated, written policy 
describing the 
management of clotted 
Vascular Access. For 
clotted AVF or AVG this 
should include urgent 
access to combined 
surgical and interventional 
radiology declotting 
procedures. 
The data suggested inconsistency within and between 
centres around the management of patients who presented 
with a clotted AVF or AVG, although this was said to be 
common. Centres with streamlined approaches tended to 
report more successful salvage procedures. They also 
anecdotally encountered the problem much less frequently, 
perhaps reflecting enhanced awareness and greater 
preventative action. (Chapter 5.) This recommendation 
seeks to reduce this variation.  
28 A clearly articulated, 
written description of the 
roles and responsibilities 
of each Vascular Access 
team member should 
available to patients and 
members of the wider 
clinical team. 
The data suggested considerable ambiguity as to who was 
responsible for different elements of the VA service. 
(Chapters 8, 9.) This recommendation seeks to address 
this.  
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29 The Vascular Access 
coordinator role requires 
clinical credibility and 
expertise. The coordinator 
complement within a 
centre should be 
proportional to the patient 
cohort size. Their primary 
responsibility should be 
the efficient processing of 
patients through Vascular 
Access pathways. The post 
demands an individual 
with a clinical background, 
but administrative 
elements of the job could 
be performed by a non-
clinically trained 
individual. 
The data suggested a central role for the Vascular Access 
coordinator, but a significant volume of administrative 
work was said to distract from important clinical issues. 
(Chapters 3, 5, 6.) This recommendation suggests an 
equivalent to a ‘cancer tracker’ administrator role may 
relieve administrative burdens to free up clinical time.  
 
30 The broader Vascular 
Access community should 
develop service 
performance metrics that 
facilitate comparisons 
between centres and 
provide a national 
overview of productivity. 
The literature and individual units had a striking absence of 
data relating to clinical workloads, outcomes and financial 
costs of operating VA services. It was apparent that the 
clinical activity census in this study was the first attempt to 
systematically collect this data. This recommendation 
seeks to embed and standardise this data collection process 
to facilitate further QI. 
31 A named senior manager 
(e.g. the medical director) 
should be nominated by 
NHS boards to provide 
strategic oversight of the 
Vascular Access services. 
This should include 
The data suggested an absence of managerial oversight 
from Vascular Access services. Interviewees reported 
difficulty navigating different areas of the service that had 
different budgets and priorities. (Chapters 4, 9.) This 
recommendation intends to provide a single senior 
manager with strategic oversight of VA services across all 
relevant directorates within the NHS board, to manage 
these challenges.  
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stewardship of the overall 
financial costs. 
 
32 Recruitment exercises 
should anticipate the needs 
of Vascular Access 
services 
The data suggested a lack of succession planning amongst 
Vascular Access services. The absence of job planned time 
also rendered services ‘invisible’ when recruitment 
exercises were planned. (Chapter 8.) This recommendation 
seeks to address these gaps.  
33 The specialty training 
curricula for renal 
medicine, vascular surgery 
and interventional 
radiology should include 
formal training in Vascular 
Access as a core 
competency. This should 
include technical and non-
technical elements of 
service delivery. 
The absence of formal Vascular Access training from 
specialty training curricula appears incongruous, given the 
volume of work associated with Vascular Access, and the 
significant associated potential for morbidity and mortality. 
This also hindered attempts to recruit clinicians with 
Vascular Access skills, in the absence of a recognised 
training qualification in the field. This recommendation 
seeks to address these gaps.  
34 All clinical staff involved 
in the peri-procedural care 
of patients undergoing 
Vascular Access 
procedures should be 
appropriately trained in 
these patients’ specific 
needs. 
The data suggested patients accommodated outside renal 
units for VA procedures were vulnerable to suboptimal 
care, including under-recognition of the need to preserve 
veins, and other aspects of perioperative management 
specific to patients with kidney failure. (Chapter 3.) This 
recommendation seeks to address this problem. 
Table 40 Recommendations for practice 
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Vascular Access Scorecards 
 
The background to the ‘scorecard’ tool is discussed in chapter 2. The scorecards intend to 
fulfil the final aim of this study: to present the recommendations for practice in a manner that 
facilitates ongoing QI efforts. 
The scorecards (appendix 3) present the recommendations as a series of questions about the 
respondent’s local service. Each question can be answered ‘yes’, ‘no’ or ‘don’t know’. The 
intention is to facilitate engagement with the recommendations; to encourage clinicians and 
managers to consider the position of their local service both at the point of completing the 
questionnaires and with the subsequent benchmarking provided by the complete dataset; and 
to stimulate QI activity using the questions as prompts to develop elements of the local 
service.  The questions were written in a manner sympathetic to the structure of the preceding 
results chapters, but using language more commonly used in clinical management circles. 
Table 41 outlines the scorecard domains and their contents.  
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Domain Inclusions 
Governance Questions related to governance of the service. These include integration 
with corporate structures; definition of individual roles and 
responsibilities; written policies for managing VA creation, maintenance 
and unscheduled care. 
Job planning Questions relating to the provision of clinical time for the VA service 
Service 
performance 
Questions relating to local strategies for measuring, auditing and 
discussing service productivity, clinical outcomes, morbidity and 
mortality.  
Education Questions relating to education and training of staff and patients 
Patient 
experience 
Questions relating to processes focused upon patients’ experience of the 
VA service 
Clinical 
Processes 
Questions related to elements of VA creation and maintenance considered 
important to the overall success of the service. 
Table 41 Vascular Access Scorecard domains 
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Results 
 
A total of 42 scorecards were submitted using the online data collection tool. No paper 
responses were received.  
Responses were received over a broad timescale, from December 2015 – November 2016. 
While individual responses were anonymised at the individual level, the submitted 
demographic data made clear whether a representative of a given VA stakeholder group had 
completed the scorecard from a particular centre. Reminder invitation emails were sent twice 
during the data collection period if a centre had not responded; where reliance was made 
upon snowballing254 to identify a particular stakeholder (e.g. a service manager) the reminder 
was sent to the lead nephrologist in the centre, with a request that this invitation be passed to 
the most relevant colleague.  
The respondents represented all specialties across all nine adult renal units in Scotland, with a 
broad range of responses from each unit (tables 42 and 43).  
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Main Vascular Access role Respondents 
Nephrologist 12 
Interventional radiologist 6 
Sonographer 4 
Vascular surgeon 6 
Vascular access coordinator 8 
Clinical manager 2 
Non-clinical manager 3 
Anaesthetist 1 
Table 42 Scorecard respondents by main Vascular Access role 
Scorecards responses were received from a broad range of clinicians and managers. 
Respondents’ demographics broadly reflected those of the VA teams working in each Scottish 
renal unit. Those holding dual roles, for example nephrologist clinical managers, were 
categorised according to what they stated was their ‘main Vascular Access role’. The term 
‘Vascular Access coordinator’ was used instead of ‘Vascular Access nurse’ in recognition 
that in some units this role was performed by someone who was not from a nursing 
background.  
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Unit Respondents 
1 4 
2 6 
3 2 
4 5 
5 4 
6 4 
7 5 
8 8 
9 4 
Table 43 Scorecard respondents by unit 
Responses were received from every adult renal unit. The number of responses from each 
centre was broadly representative of unit size. The paediatric centre was not invited to 
participate in the scorecard exercise, since the clinical processes and workload were seen to 
be significantly different from the adult units earlier in the study. 
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All recommendations had been implemented in at least one unit, no units had implemented 
every recommendation, and no single recommendation was universally in place. Respondents 
within each centre disagreed with one another about whether some recommendations were in 
place.  
The following tables 44-46 respectively describe the scorecard responses according to 
respondents’ main VA role, respondents’ unit and the scorecard domain in question.  
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Role Yes No Don’t know 
Nephrologist 31.9 24.8 5.4 
Surgeon 23 31.5 7.8 
Radiologist 24.3 17.6 20.3 
Sonographer 9.5 4.75 48.5 
VAN 28.8 30.25 3.6 
Anaesthetist 10 41 12 
Clinical manager 15.5 15 31.5 
Non-clinical manager 28.3 9.6 24 
Table 44 Scorecard responses by Vascular Access role 
Values are expressed as the mean number of ‘yes’, ‘no’ and ‘don’t know’ responses 
respectively. There was surprising variation between respondents, perhaps reflecting 
variable awareness and engagement with their local VA service. VANs, nephrologists and 
surgeons responded with the fewest ‘don’t know’ responses; while sonographers, clinical 
managers and radiologists responded with the most ‘don’t know’ responses.   
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Unit Yes No Don’t know 
1 31 28 3.75 
2 37.8 15.8 8.1 
3 25 32.5 5.5 
4 24.6 15.6 22.2 
5 34 18 10.7 
6 16.5 21 25.2 
7 23.6 18.6 20.6 
8 20.3 26.3 15.2 
9 13.7 36 12.2 
Table 45 Scorecard responses by unit 
Values are expressed as the mean number of ‘yes’, ‘no’ and ‘don’t know’ responses 
respectively, across every respondent from that unit. There was significant variation between 
units in the number of recommendations that had and had not been implemented. There were 
also significant differences in the number of ‘don’t know’ responses between units.  
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Domain Yes No Don’t know 
Governance (7 questions) 9.4 22.1 10.4 
Job planned time (2 questions) 14.5 15 12.5 
Service performance (13 questions) 14.3 20.6 6.6 
Education (7 questions) 17.1 9.7 15.1 
Patient Experience (2 questions) 21 11 10 
Clinical Processes (32 questions) 19.3 12.8 9.1 
Total 40.3 91.2 63.7 
Table 46 Scorecard responses by domain 
Values are expressed as the mean number of ‘yes’, ‘no’ and ‘don’t know’ responses 
respectively across each domain. Most recommendations had not been implemented; those in 
the domains ‘clinical processes’ and ‘education’ were most commonly implemented, whereas 
those in the domains ‘governance’ and ‘service performance’ were least commonly 
implemented.  
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The number of ‘yes’, ‘no’ and ‘don’t know’ responses for each recommendation were 
considered and used to determine whether a recommendation was in place. Across all 
responses a median of 22.5 recommendations were implemented, 23 were not implemented, 
and 9.5 had a ‘don’t know’ response.  
There was variation between centres as to which recommendations had been implemented, as 
calculated by amalgamation of ‘yes’, ‘no’ and ‘don’t know’ responses within each centre. 
 
Discussion 
 
The data shows wide variation in the implementation of the recommendations arising from 
the study. Those relating to ‘clinical processes’ and ‘education’ were most likely to be in use, 
whereas ‘service performance measures’ and ‘clinical governance’ measures were least likely 
to have been implemented.  
The recommendations were a product of the thematic analysis; it is therefore unsurprising 
that all were in use in at least one centre. The distribution of ‘yes’ and ‘no’ answers resonates 
with the findings of the study and reflects the conspicuously inadequate clinical governance 
and performance measure arrangements surrounding VA practice.  
Variation in responses within a given unit was interesting, perhaps reflecting uncertainty as to 
whether normal practice was according to a formal policy, or alternatively being uncertain 
about how other elements of the service ran on a routine basis. The large number of ‘don’t 
know’ responses was also intriguing. These could reflect apathy towards the service, although 
it would seem unlikely that someone would be apathetic towards their local VA service but 
prepared to spend time completing the scorecard tool. It is perhaps more likely that these 
responses are a surrogate for the respondent’s sense of detachment from the wider VA team. 
The demographic groups most likely to provide ‘don’t know’ responses were sonographers, 
radiologists and managers; this resonates strongly with the thematic analysis, which 
suggested detachment of these groups from others in the local VA team in many centres.  
The main aim of the scorecard exercise was to present the findings of this study in a manner 
that facilitated ongoing QI within VA services. The manner in which the scorecards were 
written and presented intended to provide a degree of self-awareness to those with 
responsibility for VA services; to provide suggested next-steps for local quality improvement 
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initiatives (based upon scorecard questions to which the answer was ‘no’); and to provide a 
pictures of strength and vulnerability across VA services. These aims are in keeping with the 
principles of Safety II and healthcare resilience engineering, and have a practical focus 
aligned with the quality improvement and change management literatures. 
It was not asserted that implementation of the recommendations would necessarily improve 
service performance metrics, particularly the traditional audit standard measures of incident 
and prevalent haemodialysis VA modality. However it was intriguing to note that the unit 
whose published registry data indicates they have the highest AVF use in Scotland13 was also 
the unit with the most implemented recommendations; conversely, the unit with the lowest 
published AVF use according to registry figures13 was also the unit with fewest 
recommendations in place.  
 
Resilient Vascular Access 
 
In adopting a ‘resilient healthcare engineering’ approach to this study, one remaining 
unanswered question related to the degree of ‘resilience’ seen in Scottish VA services. In this 
context, the term resilience is taken to mean the capacity of a system to continue functioning 
normally in expected and unexpected circumstances195. Resilience is a characteristic of 
system functioning, not a discrete structural element of the system. Those seeking to measure 
resilience have therefore considered the types of structural elements that could serve as 
enablers of this system characteristic280. Perhaps the best known is the ‘resilience analysis 
grid’ (RAG); it questions systems’ ability to respond to challenges, to monitor the need to 
respond, to learn from the past, and to anticipate the future280. The specific questions used 
must be contextually appropriate for the system in question, and responses are given on a 
Likert scale. It is acknowledged that the output does not provide an absolute measure of 
system resilience; instead it gives a window into the system from the perspective of 
resilience, providing a basis for future comparison.  
The VA scorecards are a measure of whether the various findings from the current study have 
been implemented within a given centre. These findings are recommendations for good 
practice and service development in VA, based upon comprehensive appraisal of VA practice 
across Scotland. While the RAG asks questions according to the domains specified in the 
paragraph above, the scorecards use the domains expressed in table 41. Instead of a Likert 
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scale, the scorecards used ‘yes’, ‘no’ and ‘don’t know’ responses. For the purposes of 
statistical analysis, these were allocated a score as follows: 
• Yes = 3 points 
• No = 2 points 
• Don’t know = 1 point 
This scoring system was somewhat arbitrary but intended to capture the following issues:  
• A ‘yes’ scorecard answer represented the presence of a positive VA system element;  
• A ‘no’ scorecard answer represented the absence of a (positive) VA system element; 
• A ‘don’t know’ scorecard answer represented the potential absence of a (positive) VA 
system, and/or a respondent who was disengaged with that element of the service in 
spite of their position as a key stakeholder within the VA system. 
Mean ‘resilience scores’ were thus calculated for each centre, using the mean ‘yes’, ‘no’ and 
‘don’t know’ responses submitted. These were compared with the registry published incident 
and prevalent AVF utilisation data. These figures were similar to those presented in figures 1 
and 2 (chapter 1A), but the updated registry data for 2016 was used for the scorecard 
calculations8. These data are not reproduced here to avoid risking unit anonymity.  
There appeared to be a subtle statistical correlation between the number of implemented 
recommendations and the respective incident and prevalent proportions of AVF utilisation 
within each centre. Correlation coefficients were r=0.74 for incident AVF use, and r=0.67 for 
prevalent AVF use (figure 12).  
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Figure 12 Mean resilience score versus incident and prevalent AVF use by centre 
Scores were calculated as follows: values of 1, 2 and 3 were allocated respectively to ‘don’t 
know’, ‘no’ and ‘yes’ responses, and an average score was calculated for each renal unit. 
Correlation coefficients were calculated, with comparison to published incident and 
prevalent AVF use in each centre (2015 audit data)13. Correlation coefficients were r=0.74 
for incident AVF use, and r=0.67 for prevalent AVF use. 
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This apparent correlation may reflect bias in data analysis, or emphasis being placed in the 
recommendations on quirks of services that appeared to be performing ‘better’. It seemed 
unlikely that the recommendations simply favoured larger or smaller hospital infrastructures, 
since the units with the highest and lowest AVF use (from the registry data) have similar 
RRT and haemodialysis cohort sizes. These results must also be interpreted with some 
caution in view of the lengthy scorecard data submission period: it’s possible that responses 
were given from the same unit across a longitudinal time period, therefore not truly 
representing a ‘snapshot’ of unit status at a given moment. Similarly, there was not a uniform 
number of responses from each centre, and it is possible that the presence or absence of a 
particular staff group in one centre unduly biased the results. Nonetheless this observation 
provides a basis for future study and should stimulate services to recognise potential 
vulnerabilities highlighted by the data. Further work should revisit the scorecard exercise 
after an appropriate time interval and consider the specific questions and domains, changes in 
the pattern of responses, and how this may reflect service characteristics including resilience.  
 
Strengths and weaknesses 
 
There were several strengths offered by the ‘scorecard’ approach to the dissemination of 
findings and implementation of recommendations. The online scorecard data collection tool 
was inexpensive, straightforward to use and did not require a significant time commitment 
from those providing local data. The format lends itself well to repeated data entry to enable 
comparisons over time, and to provide benchmarking data at regional and national level.  
It was intended that the process of completing the scorecard would afford respondents a 
degree of self-awareness in relation to their local VA setup, and serve as a prompt for 
ongoing quality improvement efforts. Indeed, many recommendations were written with this 
specific point in mind. Further study after an appropriate time interval will demonstrate 
whether this ambition has been realised. 
It is acknowledged that scorecard data entry was ultimately incomplete, with 
underrepresentation of some clinical specialties from some units. Submissions were received 
over a long period, and therefore cannot strictly be directly compared. This was not, however, 
an exercise in comparison between centres; instead the intention was to facilitate local quality 
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improvement activities while gaining a baseline understanding of how many measures were 
already in place in each centre.  
The study did not seek to evaluate the acceptability or practicality of implementing each 
recommendation arising from the data analysis. No measurement was made of the financial, 
clinical or opportunity costs associated with implementing any recommendations; this should 
be the subject of further study. Nonetheless, the large number of responses could be seen to 
indicate a general acceptance of the recommendations amongst the Scottish VA community. 
It remains unclear whether the active implementation of these recommendations would lead 
to improvements in service metrics; further study after an appropriate time interval will 
determine whether this is the case.  
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Chapter 11: Discussion  
 
This was a comprehensive appraisal of VA services across NHS Scotland. The study was 
conceived to investigate longstanding, marked variation between centres in the proportions of 
patients receiving haemodialysis treatment using AVF. The study sought to delineate the 
structure of VA clinical pathways, explore their routine functioning, and quantify the 
associated clinical workload. The study intended to highlight misalignments between ‘work-
as-imagined’ and ‘work-as-done’, drawing upon the socio-technical systems and healthcare 
resilience engineering literatures. The aim was to present the findings in a manner that 
facilitated ongoing QI, using a novel ‘scorecard’ approach that enabled units to benchmark 
their clinical pathways against other centres.  
A novel, mixed-methods approach was designed, based upon both the systems literature and 
a working clinical knowledge of the area of investigation. It involved semi-structured 
interviews supplemented by a six-week census of all VA-associated clinical activity. All ten 
adult and paediatric renal units in Scotland were visited, and interviews conducted with 42 
clinicians representing all aspects of Scottish VA practice. Almost 28 hours of interviews 
were recorded, amounting to over 257,000 words of audio-transcript; these were quality 
assured before being subjected to detailed thematic analysis. The first reported census of VA 
clinical activity was undertaken, with data gathered from across the spectrum of VA clinical 
practice including nephrology, vascular surgery and interventional radiology. 
The study illuminated a vast array of issues spanning VA services and highlighted genuine 
potential to improve clinical care while enhancing the efficiency of resource utilisation. 
Findings included the existence of two discrete clinical pathways concerned with VA creation 
and maintenance respectively, with significant associated workload. Multiple barriers to 
idealised VA care were identified; these included a lack of designated clinical resources and 
uncertainty around timelines for VA creation and maintenance activities. Dysfunctional 
multi-disciplinary team working was compounded by significant differences in clinicians’ 
opinions around ‘optimal’ VA for a given patient and the utility of VA surveillance. There 
was an absence of data relating to clinical workloads, while procedural outcomes and VA-
associated morbidity and mortality was never routinely discussed. There was a lack of 
managerial involvement in VA services, and several educational gaps were identified.  
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The data was presented alongside a novel ‘scorecard’ tool, which each renal unit was invited 
to complete. This was designed to operationalise the recommendations arising from the study, 
facilitating their implementation and providing a baseline for further study.  
Qualitative work has been used before to assist clinical service development281, but this was 
the first study to characterise VA as a complex socio-technical system, and to use systems 
thinking to explore this highly complex area of clinical practice. It provided a thorough 
understanding of VA services from the perspectives of clinicians across the multidisciplinary 
team, patients who depend upon the service for their survival, and strategic managers with 
responsibility for funding and otherwise resourcing the service. 
The study analysed VA services’ function from a Safety II, healthcare resilience engineering 
perspective. This differs from the traditional Safety I approach to PS and QI, using an 
epistemological approach that seeks to maximise positive outcomes rather than simply 
minimising negative outcomes. The findings expose considerable variation in processes and 
practice. The potential of this approach to stimulate positive change in complex healthcare 
systems has been described by others156,193,195,196; this is the first work to highlight the 
advantages of understanding the routine workings of VA services from PS, QI, financial 
planning and resource allocation perspectives. 
Linkage with published registry data provide clues as to the impact of such variation in 
practice, particularly with regard to the proportions of patients who receive haemodialysis 
with an AVF or TCVC. Areas of strength and vulnerability are revealed at local, regional and 
national levels, and an impetus has been created for change among domains including 
‘education’, ‘governance’, ‘resource allocation’ and ‘clinical pathways’. An implementation 
‘scorecard’ tool has been developed and made available to the renal community; it is 
anticipated that this will provide a basis for QI activity, and further work will explore its 
potential to measure resilience in VA services.  
The following sections contextualise the study findings in the sociotechnical systems 
literature. The full set of recommendations arising from this work are in table 40. 
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Theoretical constructs 
Several theoretical constructs informed the methodological approach and data analysis in this 
study.  
 
Sociotechnical system design 
 
Cherns’ model and its various adaptations provided a helpful conceptual approach to 
considering the function of a complex sociotechnical system178,207,208,210. This aided interview 
design by highlighting issues that might influence system function, rather than interviews 
simply seeking to explore VA service structure. In the data analysis stage, it acted as a lens 
through which VA system function could be considered. Strengths and weaknesses of each 
service could be identified by considering interview transcripts in light of the Cherns 
principles. Table 47 considers how these principles could be applied to VA.   
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Compatibility The capacity of the VA team to create, utilise and maintain VA must 
adapt to accommodate newer means of VA as they become available. 
Minimum 
critical 
specification 
VA clinical pathways should have freedom to create the most 
appropriate VA for a given patient. MDT function should be 
appropriate for the organisation’s needs; it should facilitate optimised 
patient care and provide a forum for open discussion of VA problems. 
Variance 
control 
A degree of standardisation and discipline is necessary to optimise 
the timing of patients’ referral into VA pathways. Designated time 
should be available within IR and surgery to create and maintain VA 
within a clinically appropriate timeframe.  
Boundary 
location 
Managerial and financial oversight of VA services should be unified, 
rather than sitting between three separate (nephrology, surgery, 
radiology) departments that do not otherwise routinely interact. 
Corporate service configuration should not impede clinical scenarios 
where resources are required from one department to manage a 
problem in another (eg investment in radiology equipment to manage 
nephrology clinical problems). 
Information 
flow 
Electronic health records should be utilised to keep track of patients 
with active VA problems, including all those currently active within 
any of the VA clinical pathways. An access / intervention history 
should be maintained for all patients, and used to plan further VA 
clinical procedures. When a new AVF is created, a fallback plan 
should also be documented to guide clinical thinking in the event that 
it fails to mature.  
Power and 
authority 
VANs (and others) should have the necessary authorities – technical 
and otherwise – to request tests and allocate procedure slots to 
patients. Individual team members should be able to directly raise 
urgent clinical problems with the most appropriate team member 
regardless of hierarchical rank within the team.  
Multifunction All possible VA modalities should be practically available within 
each VA service, to accommodate the changing needs of the patient 
cohort. This includes the technical expertise and capacity to create, 
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maintain and use variations of AVF, AVG, TCVC, PD and other 
technologies as they become available. 
Support 
congruence 
Service configuration should allow procedures to be performed with 
the minimum of logistical and governance challenges. Relevant 
scheduling and other administrative functions within IR and surgery 
should be harmonised with the VA team, and vice versa.  
Transitional 
organisation / 
Incompletion 
The development of new clinical pathways and increasing AVF use 
will require staff development. As patterns of RRT requirement and 
delivery change, strategic oversight of service development will be 
required to ensure it remains adequately resourced and fit for 
purpose.  
Table 47 Socio-technical system design principles applied to Vascular Access services 
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Consensus 
 
Reason’s published work provided a helpful means of understanding how opinions and 
assumptions at strategic level filter down to influence operational activity and decision 
making186. In the context of Wennberg’s model of unwarranted variation143 (see chapter 1B) 
and the potential for clinicians’ opinions to modify variations in practice, this seemed 
especially important. Using Reason’s language of ‘source types’, ‘function types’ and 
‘condition tokens’ enabled recognition of data linkages in the transcripts that would not 
otherwise have been apparent.  
The data illustrated marked differences in clinicians’ opinions about the merits of AVF over 
alternative VA or other RRT modalities. When clinicians believed in the clinical and service 
benefits of AVF, their service tended to support AVF creation and maintenance. Conversely, 
when clinicians do not enthusiastically support AVF use, other factors tended to obstruct 
clinical pathways necessary for AVF creation and maintenance, and patients were less likely 
to utilise an AVF for haemodialysis. In this context, attitudes towards the merits of AVF 
could be considered a ‘source type’. Other factors, some of which may be tethered to the 
source type, could be considered ‘function types’, which describe the translation of strategic 
direction into operational (‘functional’) forms that then disrupt the goal in question. Such 
factors could include decision making around referring patients for VA creation or the 
establishment of a regular, adequately resourced MDT meeting. Using the same 
nomenclature, a ‘condition token’ represents the contextual situation that can lead to an 
unwanted outcome: for example, a patient receiving HD via a TCVC. Such tokens could 
include the provision of clinical time within job plans, the designation of procedural slots for 
VA work, and the availability of administrative support to facilitate MDT meetings and 
attend to other administrative and logistical work associated with the VA service. This fits 
well with Reason’s published work185,186. 
Fischbacher-Smith frames Reason’s work as the ‘consensus’ that underpins sociotechnical 
system function178. This emphasised the key importance of these findings, providing a 
rationale for their exploration in detail, as presented in Chapter 4. Many of the findings 
related there suggest that many VA clinicians in Scotland hold views that are at odds with 
published VA guidelines. No other publications have been identified that explore the issue of 
clinicians’ opinions about VA modalities in any detail.  
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Wicked problems 
 
Much of the language encountered in this study was nihilistic in tone. Several interviewees 
expressed a sense of disempowerment and a feeling that little could be done to change the 
status quo. In many ways this language was alluding to a sense that VA was in fact a ‘wicked 
problem’180. Table 4 (earlier) described the components of a wicked problem; table 48 
considers these criteria in the setting of the current study. It is clear that while VA services 
represent a highly complex area of clinical care, they do not meet the recognised definition of 
a wicked problem. 
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1. It has no 
definitive 
formulation 
The parameters of the VA service are clearly defined. The service 
exists to provide optimal VA for patients who require haemodialysis 
treatment. The available options are AVF, AVG, TCVC, and in 
broader terms the options of PD, transplantation or conservative care 
may also be considered. Clinicians have varying perspectives on the 
clinical challenges associated with service delivery, but these do not 
impact on the parameters of the system. 
2. It has no 
stopping rule 
The context and practice of clinical medicine will continue to evolve, 
but theoretically it should be possible to reach a point where all 
patients within a VA service are being treated with optimised VA.  
3. Solutions are 
‘good’ or ‘bad’, not 
true or false 
It is possible to objectively measure the productivity of a VA service, 
and to evaluate its impact with respect to clinical outcomes.  
4. It has no 
immediate or 
definitive test of a 
solution 
Changes to VA system configuration and function could result in 
(relatively) rapid, measurable changes: for example, the proportions 
of patients receiving treatment using each VA modality. In the longer 
term it will become apparent whether this translates into financial, 
mortality and other clinical benefits. 
5. Every attempted 
solution has 
consequences 
It is possible to change practice within the system, in a relatively 
controlled manner: for example, changes in referral practice, or the 
allocation of additional resources or clinical time. These changes 
may be reversed in the short-term without necessarily creating a 
lasting impact on future system function. 
6. They do not 
have a finite set of 
potential solutions 
Potential solutions to VA service problems can be defined in terms 
of necessary clinical processes and requirements for human and other 
resources.  
7. They are unique  VA represents a niche area of clinical practice, and one of the few 
areas where nephrologists, surgeons and radiologists interface. It is 
not unusual however in clinical medicine for such services to be 
jointly managed by clinicians representing different specialties and 
disciplines.  
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8. They can be 
considered a 
symptom of 
another problem 
VA is a relatively well-defined system, albeit one that is influenced 
by competing clinical activity across nephrology, surgery and 
radiology. It is also subject to influence from other peripheral and 
external factors including geographical concerns and bed availability 
within the hospital. Nonetheless it is possible to at least partly 
modify these external factors in favour of the VA service.  
9. Perspectives on 
the problem govern 
the attempted 
solutions 
There are competing perspectives on what constitutes 'best' VA for a 
given patient, but it is generally accepted that services should 
generally aim to deliver most haemodialysis via AVF or AVG. 
10. Those 
proposing solutions 
are compelled to be 
correct 
This study has demonstrated the willingness of the VA community to 
consider new technologies and alternative ways of working. There 
does remain an overriding need to provide optimal, safe patient care. 
Table 48 Characteristics of wicked problems, in the context of Vascular Access services 
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Vascular access services: a normal accident? 
 
Perrow’s work describing the evolution of the ‘normal accident’174 is also highly relevant to 
this argument. Perrow considers the normalisation of suboptimal practice over time, such that 
a poor outcome becomes an expectation rather than a surprise. This study suggests some of 
the reasons why TCVC use has become ‘normal’ for many patients receiving haemodialysis 
treatment in Scotland despite clear evidence of a better alternative in the form of AVF, AVG 
or PD. Suboptimal care has become ‘normalised’ in this area of practice. The data suggests 
that clinicians' attitudes towards TCVC versus alternatives; the existence of designated 
clinical time and resources (or lack thereof); the physical and functional juxtaposition of the 
renal service in relation to vascular surgery and IR, all influence the likelihood that a patient 
will receive a TCVC rather than an alternative. Moreover, it is clear that efforts to maintain 
AVF are thwarted at several levels: RDU staff have limited training and little practical 
support to optimise the lifespan of a patients' VA, and when a problem is identified and 
escalated to VAN or equivalent, there are often limited options available within a clinically 
appropriate timeframe.  
The findings also suggest a disappointing lack of organisational memory within VA services, 
perhaps in part due to the informality of the VA team in each centre. Despite the high volume 
of clinical work, significant financial expense, and clear impact on patients' lives, it was 
surprising to find that no renal unit in Scotland had a named 'VA manager'; indeed, there 
appeared to be no managerial oversight of the VA service. This was possibly a contributory 
factor towards the conspicuous absence of scrutiny towards VA-associated morbidity and 
mortality. This is at odds with efforts to develop a degree of organisational memory 
recommended several years ago by a wide ranging Department of Health review117,118. 
Similarly, there was a startling lack of structured clinical audit relating to VA, which is 
surprising given the degree of interest in other aspects of haemodialysis care with arguably 
less potential contributions to morbidity and mortality. 
 
Healthcare resilience engineering 
 
Hollnagel characterises dissonance between how one perceives a system to operate, as 
opposed to how it ‘should’ or ‘could’ function, in the frame of ‘work-as-imagined versus 
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‘work-as-done’196. He argues that contradictions in these two perspectives of a system are key 
to understanding the system’s potential to cause harm. He asserts that misunderstanding of 
reality by those with strategic responsibility facilitates the design of ineffective policies and 
encourages a culture where operational staff routinely make use of workarounds in order to 
get the job done. One may also argue that operational staff misunderstanding of strategic 
planning and service orientation is partly responsible for the divergence between both groups 
and perspectives. This was quite apparent throughout Scottish VA services, where there is a 
striking absence of managerial involvement, oversight and regulation.  
Hollnagel’s work also challenges normal practice in relation to improving safety and quality 
in healthcare and other industries. He characterises the traditional focus upon adverse events 
and retrospective, reductionist approaches to their investigation, as ‘Safety I’193. He asserts 
that in the context of highly complex sociotechnical systems there is limited value in 
understanding the specific circumstances that led to the generation of a particular incident108. 
Given the nature of emergence from sociotechnical systems, which arises as a function of 
often unpredictable system component interaction, attempts to ‘fix’ factors that contributed to 
one accident are not likely to render the system any safer. Reductionist approaches to socio-
technical systems analysis are widely discredited in the literature.  
In a broader sense the need to analyse the whole system, rather than just one isolated set of 
circumstances, has been recognised for many years. Leveson speaks of the need to recognise 
complexity and its requirement for more sophisticated analytical tools; simple approaches to 
(historical) simple problems do not provide the required complex approach to complex 
problems104,175. The ‘Safety II’ approach of Hollnagel and others aims to focus upon normal 
system function rather than narrowing understanding to the events surrounding specific 
adverse events. He argues that attempts to maximise good outcomes are potentially more 
helpful than efforts to understand historical problems and implement solutions that may 
ultimately prove ineffective or actively harmful. 
This work used a Safety II perspective in attempting to understand normal VA system 
function. This represented an alternative approach to most studies seeking to reduce variation 
in areas of care – in this case, variable AVF use for haemodialysis despite their morbidity and 
mortality advantages (see chapter 1A). Most published VA literature concerns clinical trials 
comparing the use of different modalities60,282; recognised complications of VA34,275,283; and 
less commonly, comment about patients’ experience of VA284–288. There are no prior studies 
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taking a comprehensive, systems-based approach to understanding the function of VA 
services, but other works have demonstrated the clear utility of such Safety II 
approaches206,289,290. More traditional Safety I approaches are considered unlikely to have 
yielded such a rich tapestry of information about VA systems function.  
Every study participant described multiple interacting factors that influenced their ability to 
provide an effective VA service. Seeking to understand ‘how things normally work’ yielded a 
vast array of findings that enabled the creation of recommendations for practice. The Safety 
II approach also guided the development of the ‘scorecard’ tool, which aimed to 
operationalise the study recommendations in a way that facilitated local VA QI work. In 
essence, the scorecards invited clinicians and managers to consider ‘how things usually work’ 
in their service, using the questions as a prompt to design improvements.  
 
Methodology 
 
The study methodology added several strengths to the project. The sampling strategy 
achieved the involvement of key stakeholders across all Scottish VA services. The use of 
snowballing, and interviewing until saturation was reached, ensured the full range of 
perspectives were gathered about each service, within the confines of practicality. 
Unexpected challenges arose: some units shared surgical and IR resources to an extent that 
had not been fully appreciated when the study was being designed. The geography of 
Scotland and multi-site working meant that visits to 12 separate campuses were required, in 
some cases returning on a further date to conduct a further interview. Visiting sites engaged 
many clinicians in the process; it seems very unlikely that this breadth of data could 
reasonably have been achieved were interviews all conducted on one site or by telephone (see 
also chapter 2). 
The flexibility of the semi-structured interview format, aided by the use of interview guides, 
an interview panel, and the constant comparison technique, facilitated optimal data capture. 
The face validity study appears to confirm that study participants, who themselves form the 
backbone of VA services, considered the study ‘valid’; this will be borne out by subsequent 
efforts to implement the study recommendations.  
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A further strength involved the six-week census of clinical activity. This quantified the 
substantial workload associated with VA services. It is acknowledged that an arbitrary six-
week data collection period, where some centres under-reported activity, is not necessarily 
fully representative of annual workload. Nonetheless the available data suggest that this small 
patient cohort is subjected to a huge volume of IR tests and surgical procedures. This lends 
credibility to the recommendations that data concerning procedure volume, outcomes and 
associated morbidity should be systematically collected, analysed and published. This finding 
also provides a clear mandate to improve clinical pathways and optimise resource use in 
providing a VA service. 
The development of a scorecard tool provided a unique means of engaging the VA 
community with a large number of recommendations, and providing a basis for further study 
in terms of QI and the measurement of resilience. This should proceed after an appropriate 
time interval has elapsed. (Scorecards are discussed in more detail below.) 
 
Comparison with other services 
 
This study sought to explore VA services in the context of unwarranted variation in AVF use 
across Scotland. In other areas of healthcare similar variation has already been identified and 
steps taken to investigate and attenuate its impact. It is unclear why this has not happened 
until now in the setting of VA. One possible explanation lies in this study’s findings of absent 
managerial oversight from VA services, and VA services distribution across multiple clinical 
specialties, directorates and budgets. Despite the significant workload associated with VA 
care, the relatively small number of patients may go unnoticed in the broader context of large 
NHS organisations in which thousands of clinical interactions occur each day.  
It is hoped this work will illuminate VA care to senior health service managers, emphasising 
its costs in financial, resource and clinical terms. Questions must also be asked regarding the 
existence of other services with similar characteristics: niche clinical needs, met by a varied 
multidisciplinary team coming together across specialty, organisational and financial 
boundaries, without clear managerial involvement or oversight. It is possible further service 
appraisals following the methodology of this study would benefit these areas too.  
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Impact on clinical guidelines 
 
Many clinical practice guidelines have described the optimal VA that should be provided for 
patients receiving haemodialysis treatment3,86–89. The recommended strategies for VA 
utilisation, surveillance and maintenance are specified in some detail. In many ways these 
could be considered in the frame of ‘work-as-imagined’, while this study provides a 
contrasting ‘work-as-done’ perspective197. Study findings include the configuration of VA 
services and how they routinely function, providing significant insight as to how the 
guidelines are seen and implemented in practice.  
Guidelines universally recommend prioritising AVF above other VA modalities, but 
clinicians’ opinions (see chapter 4) are less clear cut. It is seen that access to AVG is not 
universal throughout Scotland. Guidelines mandate “early referral” for VA, some specifying 
a time or eGFR threshold for doing so, but in practice many issues complicate this: 
uncertainty about the rate of eGFR decline, unknown internal timelines for VA creation, and 
inadequate tracking of patients throughout the process. These issues, and others described in 
this thesis, all represent barriers to meeting the audit standards regarding the proportion of 
incident and prevalent patients who should dialyse with an AVF.  
The data also illustrate why VA maintenance also fails to live up to guideline standards. 
There was disagreement among clinicians as to the utility of VA surveillance. No centre had 
formally allocated clinical time or resources to performing maintenance activity within a 
clinically appropriate timeframe. TTGs were cited as a frequent cause for other clinical 
activity to displace VA cases for non-clinical reasons. A large volume of clinical time was 
seen to be distracted by unnecessarily complex logistical arrangements, particularly where IR 
was not co-located with the renal unit or where large numbers of TCVC were in use.  
Many of the identified system performance problems (chapter 8) and VA service 
development needs (chapter 9) resonate with the latest European Society for Vascular 
Surgery guidelines89. This study also raises questions over concordance with published 
quality standards, including the need to routinely discuss morbidity and mortality issues and 
to record procedure numbers and outcomes86. 
Overall, this work complements existing literature and guidelines by providing a practical 
view of VA, which as not hitherto been described in this level of detail. This will assist 
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individual centres seeking to implement guidelines, and provides insight to guideline writers 
about the practical limitations on their use. Future guidelines should benefit from this 
‘unfiltered’ view of frontline working197. 
 
Vascular Access Scorecards 
 
In an effort to extend the current work beyond simply understanding VA, a novel ‘scorecard’ 
tool was created to facilitate dissemination of the results to clinicians and managers in VA 
services across Scotland. This was designed using the principles of healthcare resilience 
engineering, providing the means by which managers and clinicians could understand the 
function of their local service. There was significant interest in this exercise and responses 
were received from managers and clinicians representing all specialties in every Scottish 
adult renal unit. 
At an operational level the scorecards enabled units to reconcile ‘work-as-imagined’ with 
‘work-as-done’. This should illuminate opportunities for local service development. Given 
the nihilistic tone emerging from the thematic analysis, and the lack of significant time, 
resource or managerial involvement in VA services, it was hoped that the provision of 
practical ‘things to do’ via the scorecard exercise would stimulate this work.  
At a strategic level the data suggests opportunities for regional and national collaboration. It 
can also be considered an attempt at measuring vulnerability and resilience across a national 
service. As discussed in chapter 10, ‘resilience’ in a systems sense reflects the capacity of a 
system to continue functioning in the face of expected and unexpected circumstances. In the 
context of VA unexpected circumstances could be considered at patient and service level; 
some examples are given below: 
• Patient level issues could include infection or thrombosis of existing VA, the need to 
commence haemodialysis earlier than anticipated, or veins being technically unsuitable 
for AVF creation at the point of surgery; 
• Service level issues could include staff absence, unusable operating theatre space, 
postponed or cancelled MDT meeting. 
Curiously, a number of such ‘unexpected events’ were noted during the conduct of the study. 
During the six-week clinical activity census a number of ad hoc theatre session cancellations, 
unanticipated clinical presentations, and staff absences were noted. More surprising were the 
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anecdotal reports about staff absence and changes within local services, that were 
encountered during the process of data checking, and liaising with colleagues around the time 
of the national feedback event in November 2015. It was also very common for clinicians, 
particularly nephrologists, to regard a large proportion of their patients who required 
emergent haemodialysis to have had an unanticipated, or “unpredictable” catastrophic fall in 
their eGFR. Quantifying these episodes was beyond the scope of this study but it is 
conceivable they could serve as a test on local service resilience, or indeed hamper the ability 
of the service to cope with other events. Further work is required to explore this issue.  
As a characteristic of system function, resilience is a difficult property to measure. The 
scorecards seek to measure elements of the VA system that may promote resilience, for 
example the presence of clearly defined clinical pathways, the provision of adequate clinical 
time for VA work, the use of EHRs to track patient flow. It remains to be seen whether these 
or alternatives represent the most optimal measures of resilience for VA services. 
 
Relation of thematic analysis to scorecard findings 
 
The ‘resilience scores’ indicated a possible moderate correlation with published registry data 
relating to incident (r=0.74) and prevalent (r=0.67) AVF use. Further work, including interval 
reanalysis of scorecards in conjunction with contemporary registry AVF data, may show 
whether this apparent correlation has changed as units progressively implement the 
recommendations.  
Perhaps the key finding from the scorecards was the pattern of ‘don’t know’ responses. While 
most respondents gave this answer to at least one question, there were some respondents for 
whom almost all responses were ‘don’t know’. They were either managers, sonographers or 
radiologists. The thematic analysis suggested these professional groups tended to be detached 
from the rest of the service, which may explain this answer. This exercise seems to present an 
opportunity to engage with colleagues who have taken the time to respond to the scorecard, 
yet ‘don’t know’ about many elements of their local service.  
The ‘governance’ questions asked about the presence of defined pathways and processes for 
managing elective and unscheduled VA care. Most of these questions were answered ‘no’. 
The thematic analysis suggested smaller units may be less vulnerable in the absence of clear 
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pathways, but this relied upon close MDT working. This is difficult to measure objectively, 
but the degree of teamworking could perhaps be inferred by the consideration of scorecard 
‘governance’ results juxtaposed with incident and prevalent AVF rates for a given centre: the 
hypothesis being that units with few governance arrangements, yet high AVF use, manage to 
compensate for this through close teamworking. Further work is needed to address this 
question. 
A predominantly negative response to ‘service performance’ questions confirms the finding 
from the thematic analysis that timelines for VA creation and maintenance procedures were 
uncertain in most units. It is likely that larger units would benefit most from the provision of 
this internal data, with the presumption of higher patient numbers and hence longer waits for 
procedures. Conversely, it may be that larger units have more capacity to manage variable 
clinical demand for procedures. Again, further work is needed to establish the impact of 
providing such data internally within a unit, and whether this positively (or otherwise) 
influences incident and prevalent AVF use.  
The finding that ‘education’ and ‘patient experience’ questions were predominantly answered 
‘yes’ is reassuring. This is in keeping with the thematic analysis findings, which suggested a 
universal wish from individual interviewees to improve their patients’ experience and overall 
wellbeing. In many units the convoluted clinical pathways, dysfunctional MDT working and 
lack of clinical resource frustrated these efforts, and this was clearly expressed in many of the 
interview transcripts. It’s unsurprising however that steps are being taken across all units to 
establish patient education programmes and begin to measure patient experience, and this 
finding sets a tone of optimism for ongoing VA QI activity.  
 
Educational outcomes 
 
A wide range of educational outcomes arise from the data.  
The specialty training curricula for renal medicine291, vascular surgery292 and IR293 
respectively define the requirements to practice as an NHS consultant in these specialties. 
Review of these documents demonstrates a conspicuous lack of VA-related competences:  
• IR trainees are obliged to become technically competent in fistuloplasty, but there is 
little other requirement relating to renal VA; 
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• Vascular surgery trainees must be familiar, but not necessarily competent, with AVF-
related procedures; 
• Nephrology trainees have no formal training requirements whatsoever for VA, and the 
subject does not appear in the blueprint for the Renal Medicine Specialty Certificate 
Examination294. 
Moreover, there are no specific training requirements for individuals wishing to work as a 
VAN (or equivalent) or an RDU nurse. The current work highlighted one Scottish unit with 
an informal training programme for newly recruited RDU nurses; it had no associated formal 
qualification, and it was not subject to external audit or quality assurance, and it had not been 
shared with other centres in Scotland or further afield. Anecdotally it is believed there are 
renal units elsewhere in the United Kingdom using similar training programmes for RDU 
nurses (personal communication); these are also informal practice development initiatives, 
rather than forming part of any compulsory training requirement to practice in this area.  
There is a clear need for formal VA training and credentialing for clinicians wishing to work 
in VA services. The need seems most acute among nephrology training programmes, given 
the substantial contribution of VA to morbidity, morality, hospitalisation and financial cost 
among the patients for whom nephrologists typically have primary responsibility. Training 
programmes should include issues relating to MDT working, familiarity with other 
disciplines’ potential contributions to VA problems, and strategies for optimising VA 
services as well as attending to the more technical aspects of VA. This would benefit training 
grade clinicians and could also serve as a guide for continuing professional development and 
revalidation needs for established clinicians working in this area of practice.  
Projects seeking to meet these training needs are beginning to emerge, for example a 
surgically-led training programme based in Glasgow, and an NHS England sponsored 
initiative intending to upskill RDU nursing staff who deal with AVF and AVG.  
 
Resource implications 
 
The large number of recommendations arising from this study may raise concern about the 
resource implications and practicalities of their implementation.  
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Key recommendations relate to the designation of adequate clinical time for VA creation and 
maintenance. At first glance this means additional resource for both surgical and IR services, 
but in reality the patients are already consuming substantial clinical resources to maintain 
some form of VA, often TCVC rather than VA. It is hoped that reallocation of existing 
resources, rather than investment of additional resource, is all that is required. Similarly, 
several recommendations relate to the collation, publication and discussion of VA clinical 
activity and procedure outcomes. This is in keeping with existing guidelines86 and it is 
possible such data is already collected within organisations, but not presented in a way that 
lends itself to VA service needs.  
It is acknowledged that considerable work would be associated with actioning every 
recommendation, but is should also be recognised that not every recommendation would be 
appropriate in every centre. The provision of a menu-based approach – where 
recommendations are made in granular detail, and benchmarked in comparison with other 
centres (via the scorecard tool) – intends to facilitate iterative QI by interested individuals 
without requiring inordinate investments of time or other resources in order to be realised.  
 
Strengths and weaknesses of this study 
 
This study was the first to attempt to explore a complex clinical system such as VA across 
such a large scale. Its methodology inexpensively attained a comprehensive view of Scottish 
VA services, while the Safety II perspective provided valuable insights into ‘work-as-
imagined’ and ‘work-as-done’ from the perspectives of all key VA stakeholders. The study 
enjoyed strong clinical engagement, and the data highlighted strengths, vulnerabilities and 
potential opportunities to improve for all centres. A number of positive outcomes arose from 
the project, including a publicly available report that has provided services with the ability to 
recognise their areas of strength and vulnerability. A momentum for change has been 
generated, not least through the creation of a de facto network of interested clinicians who 
agreed to be interviewed for the study. The dissemination of the findings and 
recommendations for change, along with a toolkit to assist in their implementation, is an 
attempt to ensure the longevity of the study outputs and maximise the positive impact for the 
wider community. Time will ultimately tell how successful this endeavour has been. 
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There are limitations in the study, both in terms of its design and in its ability to influence 
change within VA systems. The volume of data collected throughout the project was limited 
by financial and logistical considerations, and on a pragmatic basis there was a limit to how 
much data one researcher could reasonably analyse within a sensible timeframe. While 
acknowledging the ‘system of systems’ concept discussed in chapter 1B173, pragmatism 
dictates than arbitrary boundary of VA systems had to be set for the purposes of this study. 
For this purpose, VA services were taken to concern all haemodialysis-associated VA 
modalities; this is in keeping with the author’s professional experience. However, it would be 
remiss to ignore the significant influence of PD, transplantation and conservative care 
programmes within any given centre; these surely have some impact on the VA service too. 
Further work should explore these interfaces and their influences on clinical outcomes.   
A key limitation lies in the absence of a patient perspective from the data. It would have been 
preferable to interview patients representing each centre, but sampling concerns suggested 
this would have involved a large number of additional interviews that were not feasible 
within the scope of this study. Further work should address this gap. A further challenge 
arose from the finding that no Scottish renal unit had a clearly identified ‘Vascular Access 
service manager’ or equivalent; as a result the data focused on front line staff rather than 
those senior members of staff who held strategic responsibility for the service. Further work 
should address this gap, and indeed the nomination of an adequately resourced ‘VA manager’ 
is a recommendation arising from this study. 
The interview process was designed to enable free and unbiased discussion of all relevant 
issues, however the nature of the topic under discussion and the makeup of the interview 
panels almost certainly coloured the discussion. To some extent this was controlled by 
ensuring that the same researcher led all interviews, while the anonymous face-validity 
questionnaire confirmed interviewees had felt able to speak freely, and that a neutral tone had 
been maintained throughout the interviews. This was borne out in the candid nature of the 
interview transcripts. Data analysis was necessarily undertaken by a single researcher; to 
minimise the potential for bias the transcripts were coded in random sequence, and the coded 
dataset and subsequent thematic analysis was sense-checked by others who had been present 
during the interviews, and who also had access to the audio files and audio transcripts. 
Chapter 2 explains in some detail the steps taken to avoid bias in the methodological 
approach. 
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The six-week clinical activity census provided rich insights into the volume of clinical 
activity performed by VA services, the nature of the activity and the marked variation 
between centres. Data collection for this element of the study was limited to six weeks, again 
for financial and logistical reasons. It is possible that the data was incorrectly recorded or that 
cases were missed, and it is known that data submitted from one centre was incomplete at the 
time of the final analysis. It is unclear how representative those six weeks were in relation to 
the rest of the year, and further work should address this topic. Nonetheless the available 
dataset illuminated the realities of VA system function, highlighting the significant clinical 
time occupied by VA procedures and the enormous disruption this must cause to patients’ 
lives. The volume of work emphasises the importance of formalising VA pathways and 
encouraging managerial involvement in the running of the system. The potential for 
collaboration between the nine adult renal units must also be considered: a regional or 
national approach could provide more effective care for patients, particularly during out-of-
hours periods. This census exercise should be repeated on a larger scale and over a broader 
time period, and ideally these data should be systematically collected, analysed and published 
as a matter of routine.  
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Chapter 12: Conclusions 
 
This study was conceived in the context of significant unwarranted variation in AVF use for 
haemodialysis in Scotland. The study aimed to delineate the structure, function and workload 
associated with Scottish VA services; to identify potential for improvement using a systems 
approach that contrasted ‘work-as-imagined’ and ‘work-as-done’ from the perspective of key 
VA stakeholders; and to present recommendations for practice to the clinical community in a 
manner that facilitated ongoing QI.  
The preceding chapters have reported the detailed context, methods, results, 
recommendations and their presentation. Processes for creating and maintaining VA have 
been explored alongside service performance issues, development needs, and a six-week 
clinical activity census. The recommendations for practice have been presented (table 40), as 
has the scorecard tool used to disseminate them to the community.  
The mixed-methods model developed through this study was simple, effective and 
inexpensive to use. The methodology proved acceptable to clinicians, who were extremely 
candid in discussions about their services. These generated significant insights into a highly 
complex area of clinical practice and illuminated many areas for improvement. The 
‘scorecard’ approach to results dissemination generated significant engagement from 
clinicians and managers across Scotland and created an impetus to implement the findings. 
 
This study has shown the worth of systems approaches to healthcare, and the particular merit 
of Safety II approaches seeking to understand normal system function. The mixed-methods 
model was sympathetic to the resilient healthcare engineering literature and was designed to 
be practical and accessible to everyday practising clinicians. 
 
There was a striking absence of published data accounting for VA staffing levels and the 
volume of clinical activity associated with providing a service. This study provides some 
insight as to VA service workload in Scotland; while it is not asserted that these data 
represent ‘optimised’ numbers, they are taken to represent current practice and provide a 
starting point for further clinical and health economic study. 
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The recommendations arising from this study concern aspects of VA creation, maintenance, 
service performance review, and opportunities for service development. These were written 
in light of the thematic analysis and clinical activity census. It was recognised that 
‘standardising’ VA across Scotland was not necessarily the best solution, given the very 
different contexts in which the services exist. Optimal resource utilisation looks different 
between larger, city hospitals and smaller, more rural clinical settings; it is expected therefore 
that some recommendations will be a better fit for larger centres, while others will be more 
suited to smaller settings. Instead of seeking to achieve a standard service configuration in 
every centre, the recommendations centre around patients’ needs and seek to provide a 
balance of high quality care at a local level, while recognising the need for regional and 
national collaboration in areas requiring highly specialised care. Many recommendations 
were made, enabling a spectrum of QI activities across various clinical settings including 
larger, smaller, rural and urban units. They were written in language judged accessible to 
practising clinicians and healthcare managers. It is hoped they will provide a practical means 
of improvement within the context of busy clinical roles where there may be limited time for 
service development.  
 
The 'scorecard' tool proved a useful way to rapidly and inexpensively disseminate the 
recommendations to the clinical community. The scorecards effectively engaged clinicians 
and managers, enabling appraisal of which recommendations were being implemented and 
benchmarking between centres. The scorecard responses can be seen to provide a map of 
service engagement, a guide to future quality improvement needs, and a benchmark as to the 
arrangements in each Scottish VA service across an array of relevant domains. It is 
anticipated that the scorecards will continue to prompt local service improvement alongside 
regional and national collaboration. Updates over time will inexpensively provide a view of 
how these services are evolving. The scorecard approach could easily be applied to VA, and 
other clinical services, in other health services further afield. 
 
At the heart of the recommendations lies a need to more formally recognise VA as a clinical 
subspecialty. NHS boards should formally integrate VA into their corporate structures and 
provide managerial oversight, allocated clinical time and designated technical resources. The 
vulnerabilities of person-dependent services, and strengths of MDT working have been 
highlighted. The need for organisational learning, with routine audit, discussion and 
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publication of clinical outcomes has been emphasised. A range of educational opportunities 
are identified, with the potential to improve clinical standards and provide those who work in 
this area with better recognition and credentialing of their skills. 
 
A detailed report was published containing summarised VA clinical pathways along with 
extensive discussion of the strategic and operational findings from this study295. This was 
written in language that was judged accessible to practising clinicians and was presented in a 
format that encouraged further service development. A national meeting was additionally 
convened at the Teaching and Learning Centre, Queen Elizabeth University Hospital, 
Glasgow, to convey the study results to the VA community.  
The recommendations provide practical suggestions for enhancing VA service design and 
function across multiple domains. It is intended that this will serve as a baseline for service 
development in Scotland and further afield. They were provided in various formats: 
contextualised within the main text of the report, as a full list in an appendix to the report, and 
in the accompanying ‘Vascular Access Scorecard’ document.  
The study has achieved its aims of delineating VA service structure, function and workload; 
identify and presenting recommendations for improvement. It provides the first 
comprehensive description of VA service configuration and forms an evidence-base as to 
how services could operate, the workload associated with different configurations, with 
insights as to how they may improve. The methodology used to achieve this has proven 
highly effective, and this thesis serves as a starting point for others wishing to replicate this 
work in other areas of clinical practice. 
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An appraisal of vascular access provision for patients requiring renal replacement therapy in 
Scotland 
1. Information for interviewee 
a. Purpose of study 
b. Format of interview 
c. Confidentiality 
d. Dissemination of results 
e. Agreement to participate 
2. Study demographics 
a. Title, investigators, sponsor 
b. Date/time/location of interview 
c. Interviewee name/title/contact 
d. Interviewers present 
3. Questions and probes 
4. Closure 
Information for interviewee 
Purpose of study 
The purpose of this study is to describe and appraise the current state of vascular access provision 
for patients requiring renal replacement therapy (RRT) in Scotland.  A mixed-methods quantitative-
qualitative approach is employed to gather: 
1. Quantitative data that may explain / define / describe: 
a. The adequacy of vascular access provision 
b. The incidence / prevalence of complications 
c. The patient-centeredness of current service provision 
2. Qualitative narrative that may explain / define / describe: 
a. Positive and negative vascular access practices across Scotland 
b. Rationale for adopting a particular approach over an alternative 
c. Variation between units and opportunities for improvement 
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Data collection 
Quantitative data is being gathered using a questionnaire that has been supplied separately.  This 
interview focuses upon collecting qualitative data that provides context, insight and meaning to the 
quantitative data.   
Data analysis 
A constructivist grounded theory epistemological approach is being utilised to conduct and analyse 
this study.  This means we do not believe that any one vascular access setup represents a gold 
standard to which others should be compared; rather we acknowledge that real-world clinical 
systems exist within a complex, changing context and each system has its own strengths and 
weaknesses.  We aim to gather quantitative and qualitative data from each renal unit in Scotland, 
and analyse the data in order to determine current practice and identify opportunities for 
improvement across the country.  
Ethical approval 
This project is being conducted under the auspices of the Scottish Renal Registry.  No intervention is 
proposed during this study, which is categorised as a “service evaluation”.  Formal ethical approval 
has therefore not been sought.  
Format of this interview 
A semi-structured interview schedule will be followed.  Notes will be taken during the interview, and 
the discussion will be audio-recorded for later transcription.  The interview is intended to last 
between 20-30 minutes. 
Confidentiality 
All patient and participant data will be held confidentially, and will be destroyed securely once data 
analysis is complete.  Audio is being directly recorded onto a password-protected NHS computer, 
and will be backed-up using a password-protected, encrypted, USB memory stick.   
Dissemination of results 
The results of this study will be disseminated nationally via the Scottish Renal Registry.  The lead 
author (SO) intends to include this project in his forthcoming PhD thesis.  It is also intended that the 
data will be presented at relevant scientific meetings and subsequently published in a peer-reviewed 
journal.   
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Agreement to participate 
Please sign the attached consent form. 
 
Consent to participate in Scottish Vascular Access Appraisal interview 
I understand: 
• The purpose of the interview is to gather qualitative information about the current status of 
vascular access for patients who require renal replacement therapy in Scotland; 
• Interviews will last up to 20-30 minutes, and questions will focus upon the processes involved in 
obtaining and maintaining appropriate vascular access; 
• To facilitate data analysis, notes will be taken and interviews will be audio-recorded for later 
transcription and the audio data destroyed once transcribed; 
• I can refuse to answer any question at any time, or end the interview, without giving reasons; 
• All patient data will be treated in strict confidence, and will be anonymised for analysis and/or 
publication; 
• All unit-specific data will be anonymised for publication according to Scottish Renal Registry 
policy; 
• Information disclosed during this interview will be used only for the purposes described above. 
 
I have read and understand the above information, and have had the opportunity to ask any 
questions.  I consent to participating in this interview.  
Signature: 
Print: 
Date: 
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Interview record 
Date 
Time 
Hospital 
Location 
Interviewee name 
Interviewee job title 
Interviewee consent form? 
Interviewers 
Audio recorded? 
 
Question 1 
Who is involved in vascular access here, and what are their roles? 
Nephrologist / Surgeon / Interventional radiologist / Sonographer / Vascular access coordinator 
How much allocated time do they have? 
Who is responsible for the process / for the individual patient? 
 
Question 2 
What’s the process for obtaining vascular access pre-emptively? 
How are patients identified? 
How do you time referral? 
What is the mechanism of referral? 
What is the timescale for each part of the pathway? 
Is there a means of documenting and keeping track of the process? 
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Question 3 
What’s the process for obtaining vascular access in patients who present late with end-stage renal 
failure? 
What are the timescales? 
Who are the operators performing the procedures?  How available are they? 
How are these patients upgraded to more permanent access? 
 
Question 4 
How do you identify problems with vascular access? 
Is there routine surveillance of access? 
Is there any communication with primary care or phlebotomy or ward staff about preservation of 
access? 
Is there any established patient or staff education programme? 
 
Question 5 
What could other units learn from the way things work here? 
What changes have you made to the way things work? 
What have your biggest challenges been? 
Is there a memorable patient who stands out as a particular success story? 
 
Question 6 
What would you change about the current setup? 
If money was no object, how would you make things better? 
What would you change about current governance arrangements? 
What do your patients think of the current setup? 
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Question 7 
Is there anything else you would like to tell us? 
 
Closure 
Thank you for taking part in the interview. 
Could we contact you again for further information? 
 
Contact phone 
Contact email address 
 
Patient scenarios 
1. CKD in low clearance clinic – no live donor 
48 year old man with progressive IgA Nephropathy and no other comorbidity, diagnosed on biopsy 3 
years ago.  No potential live donors.  eGFR 20ml/min/1.73m2 and declining at 
10ml/min/1.73m2/year. 
2. CKD in low clearance clinic with potential live donor 
48 year old man with progressive IgA Nephropathy and no other comorbidity, diagnosed on biopsy 3 
years ago.  Live donor being actively worked-up.  eGFR 12ml/min/1.73m2 and declining at 
10ml/min/1.73m2/year. 
3. Late presentation with end-stage renal failure 
62 year old man, new patient, presenting with likely diabetic nephropathy, eGFR 10ml/min/1.73m2 
and likely to need to start RRT within 4 weeks. 
 
4.  Failing transplant 
39 year old female, ESRF end-stage renal failure secondary to autosomal dominant polycystic kidney 
disease, who received a cadaveric transplant 9 years ago.  Several episodes of acute rejection 
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treated with steroid / ATG / rituximab since transplantation, and eGFR declining by 8-
10ml/min/1.73m2/year.  Current eGFR 17ml/min/1.73m2.  No potential live donors.  
5.  Difficult vascular access 
64 year old man with end-stage renal failure secondary to diabetic nephropathy, who attends thrice 
weekly for hospital haemodialysis via right brachio-cephalic fistula.  Transplantation contraindicated 
in view of comorbidity.  Admitted as an emergency with clotted fistula.  
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Surgery 
Chi 
Date 
Referred 
Date 
Listed 
Date of 
procedure Procedure 
HD 
Stage 
Complication of 
procedure 
    
 (RCF/BCF/BBF/AVG/other - 
specify) HD / PreD  
 
Interventional radiology 
 
 
Chi Date Listed 
Date of 
Procedure Procedure Complication of procedure 
 
 
Admissions and complications 
 
Chi 
Date 
Admission 
Date 
Discharge Reason/s For Admission 
Out of hours 
admission? 
 
 
Unexpected events 
 
Date Description 
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What health board do you work in? [multiple choice] 
What is your job title? [free text] 
What is your main role in relation to vascular access? [free text] 
Is the vascular access service formally integrated into the corporate structure of the NHS 
board through the presence of a nominated board-level stakeholder? [yes / no / don’t know] 
Is there a named service manager who collates the financial cost data on all vascular access 
related activity from across nephrology, surgery and radiology? [yes / no / don’t know] 
Are the roles and responsibilities of each member of the VA team clearly defined in a written 
description of the VA service, which is accessible to patients and members of the wider 
clinical team? [yes / no / don’t know] 
Is there a clearly articulated, written pathway that describes and governs the referral 
mechanisms and patient flow through the access creation and maintenance pathways? [yes / 
no / don’t know] 
Is there a written policy describing and governing the escalation of potential access 
problems? [yes / no / don’t know] 
Is there a written policy that describes and governs the management of clotted arteriovenous 
fistulae or grafts? [yes / no / don’t know] 
Does the NHS Board have a policy designed specifically to prevent inappropriate 
venepuncture and other such practices that create a hazard for patients who require or already 
have native arteriovenous fistula or graft vascular access? [yes / no / don’t know] 
Do the lead VA clinicians from nephrology, vascular surgery and interventional radiology 
have at least job planned time to attend to strategic aspects of the VA service? [yes / no / 
don’t know] 
Do all clinicians responsible for the care of patients receiving HD have job-planned time 
allocated to attending at the vascular access MDT proportionate to their haemodialysis case 
load? [yes / no / don’t know] 
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Do you know how many vascular access surgical procedures are conducted per year? [yes / 
no / don’t know] 
Do you know how many interventional radiology procedures are conducted per year? [yes / 
no / don’t know] 
Do you know how many vascular access ultrasound examinations are conducted per year? 
[yes / no / don’t know] 
Do you know how many patients require an overnight inpatient hospital stay for an elective 
vascular access procedure? [yes / no / don’t know] 
Are current waiting times for vascular access creation procedures available and accessible to 
the clinical team? [yes / no / don’t know] 
Are all cases where patients require emergency access routinely audited or discussed in the 
setting of a vascular access morbidity and mortality meeting? [yes / no / don’t know] 
Are vascular access procedures that are cancelled for non-clinical reasons routinely audited or 
discussed at a vascular access morbidity and mortality meeting? [yes / no / don’t know] 
Are administrative delays routinely audited or discussed at a vascular access morbidity and 
mortality meeting? [yes / no / don’t know] 
Are informal referrals for vascular access routinely audited or discussed at a vascular access 
morbidity and mortality meeting? [yes / no / don’t know] 
Is primary and secondary arteriovenous access patency routinely audited or discussed at a 
vascular access morbidity and mortality meeting? [yes / no / don’t know] 
Are all cases of clotted arteriovenous fistulae or grafts routinely audited or discussed at a 
vascular access morbidity and mortality meeting? [yes / no / don’t know] 
Are all cases of central venous stenosis routinely audited and discussed at a vascular access 
morbidity and mortality meeting? [yes / no / don’t know] 
Is there a regular meeting, separate to the discussion of individual patient cases, where 
strategic elements of the vascular access service are discussed? [yes / no / don’t know] 
Are RDU staff formally trained in the basic assessment of fistulae, to identify potential fistula 
problems, and to cannulate arteriovenous fistulae and grafts? [yes / no / don’t know] 
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Are all members of the vascular access team trained in the optimal use of the electronic 
patient record and associated electronic health records? [yes / no / don’t know] 
Has appropriate training been given to nurses and other clinical staff who provide 
periprocedural care for patients undergoing access creation or maintenance procedures? [yes / 
no / don’t know] 
Is there formal clinical time set aside for staff to educate patients about vascular access? 
(New patients) [yes / no / don’t know] 
Is there formal clinical time set aside for staff to educate patients about vascular access? 
(Prevalent patients) [yes / no / don’t know] 
Has education been provided to all clinicians who refer patients for vascular access creation 
to enable the clinical identification of vessels that are suitable for AVF creation? [yes / no / 
don’t know] 
Is there an educational secondment programmes that enables RDU nurses to have protected 
time to working with the vascular access coordinator? [yes / no / don’t know] 
Are steps being taken to measure patient experience around the creation and maintenance of 
vascular access? [yes / no / don’t know] 
Do patients have access to arteriovenous graft procedures as a potential access modality? [yes 
/ no / don’t know] 
Do all prospective haemodialysis patients with eGFR <=15ml/min within the centre have a 
documented “personal access strategy”? [yes / no / don’t know] 
Is the patient’s “personal access strategy” documented in the patient’s case record? [yes / no / 
don’t know] 
Are electronic health records used to refer patients into the access creation and maintenance 
pathways? [yes / no / don’t know] 
Are electronic health record used to tracking the patient journey through access pathways? 
[yes / no / don’t know] 
Is there access to a suitably trained sonographer to perform ultrasound vein mapping? [yes / 
no / don’t know] 
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Is USS duplex vein mapping available for all patients within two weeks of referral? [yes / no 
/ don’t know] 
Is there a one-stop clinic (or equivalent) where ultrasound scanning, clinical review and a 
decision for theatre may all be undertaken at a single attendance? [yes / no / don’t know] 
Do operation notes for all arteriovenous access procedures include a statement directing 
subsequent action in the event that the access does not mature? [yes / no / don’t know] 
Are all patients who have arteriovenous access creation or revision surgery seen between two 
to four weeks postoperatively? [yes / no / don’t know] 
Are there protected slots for interventional radiology and surgical vascular access 
procedures? [yes / no / don’t know] 
Are slots for elective vascular access creation and maintenance procedures available to book 
with at least four weeks’ notice? [yes / no / don’t know] 
Are slots for emergency interventional radiology maintenance procedures available with 48 
hours’ notice? [yes / no / don’t know] 
Are all vascular access procedures are given ‘urgent’ or ‘emergency’ priority on waiting 
lists? [yes / no / don’t know] 
Does the Vascular Access Coordinator have the clinical authority and technical / 
administrative ability to directly allocate specific surgery or interventional radiology slots to 
named patients for the creation or maintenance of vascular access? [yes / no / don’t know] 
Can the Vascular Access Coordinator re-order existing vascular access surgery and radiology 
procedure lists? [yes / no / don’t know] 
Are named administrative staff available during normal working hours to liaise with vascular 
access coordinators? [yes / no / don’t know] 
Is there a regular vascular access MDT meeting at least every three weeks? [yes / no / don’t 
know] 
Does the minimum time allocated to the vascular access MDT meeting per week equate to 
the same number, in minutes, as the number of patients in 10-15% of the prevalent HD 
population? [yes / no / don’t know] 
Is an attendance register taken at the MDT meeting? [yes / no / don’t know] 
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Is it possible to directly book interventional radiology procedures at the MDT meeting? [yes / 
no / don’t know] 
Are MDT outcomes recorded on the electronic health record? [yes / no / don’t know] 
Do sonographers have direct access to an interventional radiologist to discuss cases outwith 
the MDT meeting? [yes / no / don’t know] 
Is a ‘priority list’ maintained, that identifies which patient is next in line to have a procedure 
performed? [yes / no / don’t know] 
Do renal services have access to ‘Day surgery’ beds for elective/semi-elective arteriovenous 
access work? [yes / no / don’t know] 
Are co-located nephrology, vascular and interventional radiology services available for 
patients undergoing complex access work or who require an overnight stay? [yes / no / don’t 
know] 
Is there a proactive approach to identifying the failing arteriovenous access? [yes / no / don’t 
know] 
Are ‘threatened’ arteriovenous fistulae or grafts considered medical emergencies and 
managed accordingly? [yes / no / don’t know] 
Do patients have access to a combined surgical / interventional radiology declotting 
procedure within 48 hours of presentation with a clotted AVF or AVG? [yes / no / don’t 
know] 
Is an ‘intervention history’ recorded in the patient’s record for every arteriovenous access? 
[yes / no / don’t know] 
Is there a tracking system that allows team members to determine where an individual patient 
is in their vascular access journey? [yes / no / don’t know] 
Is there a named lead vascular access nephrologist, vascular surgeon, interventional 
radiologist and service manager? [yes / no / don’t know] 
Is there a vascular access coordinator role, staffed equivalent to a minimum of 0.75 WTE 
coordinators per 100 prevalent HD patients? [yes / no / don’t know] 
Do you have any comments to add? [freetext] 
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